Loading...
RECEPTOR
|
STRUCTURE
|
SIGNAL PROTEIN
|
AUXILIARY PROTEIN
|
STRUCTURE LIGAND
|
ENDOGENOUS LIGAND
|
SODIUM ION SITE
|
REFERENCE
|
ANNOTATED
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UniProt
|
IUPHAR | Receptor family | Cl. | Species | Method |
PDB
|
Refined structure |
Resolution | Preferred chain |
State |
Degree active (%) |
% of Seq | Family | Subtype | Note | % of Seq | Fusion | Antibodies | Name | Type | Function | Name | Type | D2x50 S3x39 |
Sodium in structure |
Authors | Reference | PDB Date | ||
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 1F88 | 1F88_refined | 2.8 | A | Inactive | 21 | 97 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M | 10.1126/SCIENCE.289.5480.739 | 2000-08-04 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 1HZX | - | 2.8 | A | Inactive | 21 | 98 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Teller DC, Okada T, Behnke CA, Palczewski K, Stenkamp RE | 10.1021/BI0155091 | 2001-07-04 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 1L9H | - | 2.6 | A | Inactive | 21 | 98 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Okada T, Fujiyoshi Y, Silow M, Navarro J, Landau EM, Shichida Y | 10.1073/PNAS.082666399 | 2002-05-15 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 1GZM | 1GZM_refined | 2.7 | A | Inactive | 21 | 94 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Li J, Edwards PC, Burghammer M, Villa C, Schertler GF | 10.1016/J.JMB.2004.08.090 | 2003-11-20 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 1U19 | 1U19_refined | 2.2 | A | Inactive | 21 | 100 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Okada T, Sugihara M, Bondar AN, Elstner M, Entel P, Buss V | 10.1016/J.JMB.2004.07.044 | 2004-10-12 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 2HPY | - | 2.8 | B | Inactive | 21 | 100 | - | - | - | - | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Nakamichi H, Okada T | 10.1073/PNAS.0601765103 | 2006-08-22 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 2G87 | 2G87_refined | 2.6 | A | Inactive | 21 | 100 | - | - | - | - | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Nakamichi H, Okada T | 10.1002/ANIE.200600595 | 2006-09-02 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 2I35 | - | 3.8 | A | Inactive | 21 | 94 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, Jastrzebska B, Harris T, Ballesteros JA, Palczewski K | 10.1073/PNAS.0608022103 | 2006-10-17 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 2I36 | - | 4.1 | A | Inactive | 21 | 94 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, Jastrzebska B, Harris T, Ballesteros JA, Palczewski K | 10.1073/PNAS.0608022103 | 2006-10-17 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 2I37 | 2I37_refined | 4.2 | A | Inactive | 21 | 91 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, Jastrzebska B, Harris T, Ballesteros JA, Palczewski K | 10.1073/PNAS.0608022103 | 2006-10-17 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 2J4Y | - | 3.4 | B | Inactive | 21 | 94 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Standfuss J, Xie G, Edwards PC, Burghammer M, Oprian DD, Schertler GF | 10.1016/J.JMB.2007.03.007 | 2007-09-25 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 2PED | - | 3.0 | B | Inactive | 21 | 100 | - | - | - | - | - | - |
Retinal (9-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Nakamichi H, Buss V, Okada T | 10.1529/BIOPHYSJ.107.108225 | 2007-10-30 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 2RH1 | - | 2.4 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
Carazolol
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC | 10.1126/SCIENCE.1150577 | 2007-10-30 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 2R4R | 2R4R_refined | 3.4 | A | Inactive | 1 | 52 | - | - | - | - | - | Antibody | - | - | - | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK | 10.1038/NATURE06325 | 2007-11-06 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 2R4S | 2R4S_refined | 3.4 | A | Inactive | 1 | 52 | - | - | - | - | - | Antibody | - | - | - | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK | 10.1038/NATURE06325 | 2007-11-06 | Yes | |
OPSD | Rhodopsin | Opsins | A | Japanese flying squid | X-ray | 2ZIY | - | 3.7 | A | Inactive | 16 | 83 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | Yes | No | Shimamura T, Hiraki K, Takahashi N, Hori T, Ago H, Masuda K, Takio K, Ishiguro M, Miyano M | 10.1074/JBC.C800040200 | 2008-05-06 | Yes | |
OPSD | Rhodopsin | Opsins | A | Japanese flying squid | X-ray | 2Z73 | 2Z73_refined | 2.5 | A | Inactive | 16 | 78 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | Yes | No | Murakami M, Kouyama T | 10.1038/NATURE06925 | 2008-05-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 3D4S | 3D4S_refined | 2.8 | A | Inactive | 0 | 67 | - | - | - | - | T4-Lysozyme | - |
timolol
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, Velasquez J, Kuhn P, Stevens RC | 10.1016/J.STR.2008.05.001 | 2008-06-17 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2VT4 | - | 2.7 | B | Inactive | 0 | 57 | - | - | - | - | - | - |
(S)-Cyanopindolol
|
small-molecule | Antagonist | - | - | Yes | No | Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF | 10.1038/NATURE07101 | 2008-06-24 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 3CAP | - | 2.9 | A | Active | 98 | 94 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Park JH, Scheerer P, Hofmann KP, Choe HW, Ernst OP | 10.1038/NATURE07063 | 2008-06-24 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 3C9L | 3C9L_refined | 2.7 | A | Inactive | 21 | 94 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Stenkamp RE | 10.1107/S0907444908017162 | 2008-08-05 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 3C9M | - | 3.4 | A | Inactive | 21 | 94 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Stenkamp RE | 10.1107/S0907444908017162 | 2008-08-05 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 3DQB | 3DQB_refined | 3.2 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe HW, Hofmann KP, Ernst OP | 10.1038/NATURE07330 | 2008-09-23 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3EML | - | 2.6 | A | Inactive | 1 | 70 | - | - | - | - | T4-Lysozyme | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC | 10.1126/SCIENCE.1164772 | 2008-10-14 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 3KJ6 | - | 3.4 | A | Inactive | 1 | 54 | - | - | - | - | - | Antibody | - | - | - | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Bokoch MP, Zou Y, Rasmussen SG, Liu CW, Nygaard R, Rosenbaum DM, Fung JJ, Choi HJ, Thian FS, Kobilka TS, Puglisi JD, Weis WI, Pardo L, Prosser RS, Mueller L, Kobilka BK | 10.1038/NATURE08650 | 2010-02-16 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 3NY8 | 3NY8_refined | 2.8 | A | Inactive | 0 | 67 | - | - | - | - | T4-Lysozyme | - |
ICI 118551
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Wacker D, Fenalti G, Brown MA, Katritch V, Abagyan R, Cherezov V, Stevens RC | 10.1021/JA105108Q | 2010-08-11 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 3NY9 | 3NY9_refined | 2.8 | A | Inactive | 0 | 67 | - | - | - | - | T4-Lysozyme | - |
CHEMBL1233771
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Wacker D, Fenalti G, Brown MA, Katritch V, Abagyan R, Cherezov V, Stevens RC | 10.1021/JA105108Q | 2010-08-11 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 3NYA | 3NYA_refined | 3.2 | A | Inactive | 0 | 67 | - | - | - | - | T4-Lysozyme | - |
CHEMBL1160734
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Wacker D, Fenalti G, Brown MA, Katritch V, Abagyan R, Cherezov V, Stevens RC | 10.1021/JA105108Q | 2010-08-11 | Yes | |
CXCR4 | CXCR4 | Chemokine | A | Human | X-ray | 3ODU | 3ODU_refined | 2.5 | A | Inactive | 4 | 83 | - | - | - | - | T4-Lysozyme | - |
isothiourea-1t
|
small-molecule | Antagonist | CXCL12ε, CXCL12φ, CXCL12α, CXCL12γ, CXCL12, CXCL12β, CXCL12δ | peptide | Yes | No | Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC | 10.1126/SCIENCE.1194396 | 2010-10-27 | Yes | |
CXCR4 | CXCR4 | Chemokine | A | Human | X-ray | 3OE0 | - | 2.9 | A | Inactive | 4 | 78 | - | - | - | - | T4-Lysozyme | - |
CVX15
|
peptide | Antagonist | CXCL12ε, CXCL12φ, CXCL12α, CXCL12γ, CXCL12, CXCL12β, CXCL12δ | peptide | Yes | No | Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC | 10.1126/SCIENCE.1194396 | 2010-10-27 | Yes | |
CXCR4 | CXCR4 | Chemokine | A | Human | X-ray | 3OE6 | 3OE6_refined | 3.2 | A | Inactive | 4 | 77 | - | - | - | - | T4-Lysozyme | - |
isothiourea-1t
|
small-molecule | Antagonist | CXCL12ε, CXCL12φ, CXCL12α, CXCL12γ, CXCL12, CXCL12β, CXCL12δ | peptide | Yes | No | Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC | 10.1126/SCIENCE.1194396 | 2010-10-27 | Yes | |
CXCR4 | CXCR4 | Chemokine | A | Human | X-ray | 3OE8 | 3OE8_refined | 3.1 | A | Inactive | 4 | 76 | - | - | - | - | T4-Lysozyme | - |
isothiourea-1t
|
small-molecule | Antagonist | CXCL12ε, CXCL12φ, CXCL12α, CXCL12γ, CXCL12, CXCL12β, CXCL12δ | peptide | Yes | No | Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC | 10.1126/SCIENCE.1194396 | 2010-10-27 | Yes | |
CXCR4 | CXCR4 | Chemokine | A | Human | X-ray | 3OE9 | 3OE9_refined | 3.1 | A | Inactive | 4 | 74 | - | - | - | - | T4-Lysozyme | - |
isothiourea-1t
|
small-molecule | Antagonist | CXCL12ε, CXCL12φ, CXCL12α, CXCL12γ, CXCL12, CXCL12β, CXCL12δ | peptide | Yes | No | Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC | 10.1126/SCIENCE.1194396 | 2010-10-27 | Yes | |
DRD3 | D3 | Dopamine | A | Human | X-ray | 3PBL | 3PBL_refined | 2.9 | A | Inactive | 1 | 68 | - | - | - | - | T4-Lysozyme | - |
eticlopride
|
small-molecule | Antagonist | dopamine | small-molecule | Yes | No | Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, Shi L, Newman AH, Javitch JA, Cherezov V, Stevens RC | 10.1126/SCIENCE.1197410 | 2010-11-03 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2Y00 | 2Y00_refined | 2.5 | B | Inactive | 0 | 62 | - | - | - | - | - | - |
Dobutamine
|
small-molecule | Agonist (partial) | - | - | Yes | No | Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, Leslie AG, Schertler GF, Tate CG | 10.1038/NATURE09746 | 2011-01-12 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2Y02 | 2Y02_refined | 2.6 | B | Inactive | 0 | 62 | - | - | - | - | - | - |
CARMOTEROL
|
small-molecule | Agonist | - | - | Yes | No | Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, Leslie AG, Schertler GF, Tate CG | 10.1038/NATURE09746 | 2011-01-12 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2Y03 | 2Y03_refined | 2.9 | B | Inactive | 0 | 62 | - | - | - | - | - | - |
LEVISOPRENALINE
|
small-molecule | Agonist | - | - | Yes | No | Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, Leslie AG, Schertler GF, Tate CG | 10.1038/NATURE09746 | 2011-01-12 | Yes | |
MC4R | MC4 | Melanocortin | A | Human | Cryo-EM | 7PIV | 7PIV_refined | 2.9 | R | Active | 100 | 78 | Gs | αs | - | 46 | - | Nanobody-35 |
afamelanotide
|
peptide | Agonist | ACTH, β-MSH, γ-MSH, α-MSH, agouti-related protein | peptide | Yes | No | Heyder NA, Kleinau G, Speck D, Schmidt A, Paisdzior S, Szczepek M, Bauer B, Koch A, Gallandi M, Kwiatkowski D, Burger J, Mielke T, Beck-Sickinger AG, Hildebrand PW, Spahn CMT, Hilger D, Schacherl M, Biebermann H, Hilal T, Kuhnen P, Kobilka BK, Scheerer P | 10.1038/S41422-021-00569-8 | 2021-11-17 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2Y04 | 2Y04_refined | 3.1 | B | Inactive | 0 | 62 | - | - | - | - | - | - |
levosalbutamol
|
small-molecule | Agonist (partial) | - | - | Yes | No | Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, Leslie AG, Schertler GF, Tate CG | 10.1038/NATURE09746 | 2011-01-12 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 3PDS | 3PDS_refined | 3.5 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
FAUC50
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Rosenbaum DM, Zhang C, Lyons JA, Holl R, Aragao D, Arlow DH, Rasmussen SG, Choi HJ, Devree BT, Sunahara RK, Chae PS, Gellman SH, Dror RO, Shaw DE, Weis WI, Caffrey M, Gmeiner P, Kobilka BK | 10.1038/NATURE09665 | 2011-01-12 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 3OAX | - | 2.6 | A | Inactive | 21 | 100 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Makino CL, Riley CK, Looney J, Crouch RK, Okada T | 10.1016/J.BPJ.2010.08.003 | 2011-01-19 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 3P0G | 3P0G_refined | 3.5 | A | Active | 99 | 69 | - | - | - | - | T4-Lysozyme | Nanobody |
CHEMBL1615159
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, Devree BT, Rosenbaum DM, Thian FS, Kobilka TS, Schnapp A, Konetzki I, Sunahara RK, Gellman SH, Pautsch A, Steyaert J, Weis WI, Kobilka BK | 10.1038/NATURE09648 | 2011-01-19 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 3PQR | - | 2.9 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Choe HW, Kim YJ, Park JH, Morizumi T, Pai EF, Krauss N, Hofmann KP, Scheerer P, Ernst OP | 10.1038/NATURE09789 | 2011-03-09 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 3PXO | - | 3.0 | A | Active | 98 | 94 | - | - | - | - | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Choe HW, Kim YJ, Park JH, Morizumi T, Pai EF, Krauss N, Hofmann KP, Scheerer P, Ernst OP | 10.1038/NATURE09789 | 2011-03-09 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3QAK | 3QAK_refined | 2.7 | A | Active | 67 | 69 | - | - | - | - | T4-Lysozyme | - |
UK-432,097
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao ZG, Cherezov V, Stevens RC | 10.1126/SCIENCE.1202793 | 2011-03-09 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 2X72 | 2X72_refined | 3.0 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Standfuss J, Edwards PC, D'Antona A, Fransen M, Xie G, Oprian DD, Schertler GF | 10.1038/NATURE09795 | 2011-03-16 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2Y01 | - | 2.6 | A | Inactive | 0 | 59 | - | - | - | - | - | - |
Dobutamine
|
small-molecule | Agonist (partial) | - | - | Yes | No | Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, Leslie AG, Schertler GF, Tate CG | 10.1038/NATURE09746 | 2011-03-30 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 2YDO | 2YDO_refined | 3.0 | A | Active | 67 | 73 | - | - | - | - | - | - |
adenosine
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Lebon G, Warne T, Edwards PC, Bennett K, Langmead CJ, Leslie AG, Tate CG | 10.1038/NATURE10136 | 2011-05-18 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 2YDV | 2YDV_refined | 2.6 | A | Active | 67 | 75 | - | - | - | - | - | - |
NECA
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Lebon G, Warne T, Edwards PC, Bennett K, Langmead CJ, Leslie AG, Tate CG | 10.1038/NATURE10136 | 2011-05-18 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2YCW | 2YCW_refined | 3.0 | A | Inactive | 0 | 61 | - | - | - | - | - | - |
Carazolol
|
small-molecule | Antagonist | - | - | Yes | No | Moukhametzianov R, Warne T, Edwards PC, Serrano-Vega MJ, Leslie AG, Tate CG, Schertler GF | 10.1073/PNAS.1100185108 | 2011-06-01 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2YCX | - | 3.3 | A | Inactive | 0 | 59 | - | - | - | - | - | - |
(S)-Cyanopindolol
|
small-molecule | Antagonist | - | - | Yes | No | Moukhametzianov R, Warne T, Edwards PC, Serrano-Vega MJ, Leslie AG, Tate CG, Schertler GF | 10.1073/PNAS.1100185108 | 2011-06-01 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2YCZ | 2YCZ_refined | 3.7 | B | Inactive | 0 | 60 | - | - | - | - | - | - |
Iodocyanopindolol
|
small-molecule | Antagonist | - | - | Yes | No | Moukhametzianov R, Warne T, Edwards PC, Serrano-Vega MJ, Leslie AG, Tate CG, Schertler GF | 10.1073/PNAS.1100185108 | 2011-06-01 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 2YCY | - | 3.2 | A | Inactive | 0 | 60 | - | - | - | - | - | - |
(S)-Cyanopindolol
|
small-molecule | Antagonist | - | - | Yes | No | Moukhametzianov R, Warne T, Edwards PC, Serrano-Vega MJ, Leslie AG, Tate CG, Schertler GF | 10.1073/PNAS.1100185108 | 2011-06-08 | Yes | |
HRH1 | H1 | Histamine | A | Human | X-ray | 3RZE | 3RZE_refined | 3.1 | A | Inactive | 2 | 55 | - | - | - | - | T4-Lysozyme | - |
doxepin
|
small-molecule | Antagonist | histamine | small-molecule | Yes | No | Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, Abagyan R, Cherezov V, Liu W, Han GW, Kobayashi T, Stevens RC, Iwata S | 10.1038/NATURE10236 | 2011-06-15 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 3SN6 | - | 3.2 | R | Active | 100 | 69 | Gs | αs | - | 89 | T4-Lysozyme | Antibody |
CHEMBL1615159
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D, Mathiesen JM, Shah ST, Lyons JA, Caffrey M, Gellman SH, Steyaert J, Skiniotis G, Weis WI, Sunahara RK, Kobilka BK | 10.1038/NATURE10361 | 2011-07-20 | Yes | |
OPSD | Rhodopsin | Opsins | A | Japanese flying squid | X-ray | 3AYM | - | 2.8 | B | Inactive | 16 | 77 | - | - | - | - | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | Yes | No | Murakami M, Kouyama T | 10.1016/J.JMB.2011.08.044 | 2011-08-17 | Yes | |
OPSD | Rhodopsin | Opsins | A | Japanese flying squid | X-ray | 3AYN | - | 2.7 | B | Inactive | 16 | 77 | - | - | - | - | - | - |
Retinal (9-cis)
|
small-molecule | Inverse agonist | - | - | Yes | No | Murakami M, Kouyama T | 10.1016/J.JMB.2011.08.044 | 2011-08-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3PWH | 3PWH_refined | 3.3 | A | Inactive | 1 | 71 | - | - | - | - | - | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Dore AS, Robertson N, Errey JC, Ng I, Hollenstein K, Tehan B, Hurrell E, Bennett K, Congreve M, Magnani F, Tate CG, Weir M, Marshall FH | 10.1016/J.STR.2011.06.014 | 2011-09-07 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3REY | 3REY_refined | 3.3 | A | Inactive | 1 | 71 | - | - | - | - | - | - |
xanthine amine congener
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Dore AS, Robertson N, Errey JC, Ng I, Hollenstein K, Tehan B, Hurrell E, Bennett K, Congreve M, Magnani F, Tate CG, Weir M, Marshall FH | 10.1016/J.STR.2011.06.014 | 2011-09-07 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3RFM | 3RFM_refined | 3.6 | A | Inactive | 1 | 71 | - | - | - | - | - | - |
caffeine
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Dore AS, Robertson N, Errey JC, Ng I, Hollenstein K, Tehan B, Hurrell E, Bennett K, Congreve M, Magnani F, Tate CG, Weir M, Marshall FH | 10.1016/J.STR.2011.06.014 | 2011-09-07 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 4A4M | 4A4M_refined | 3.3 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Deupi X, Edwards P, Singhal A, Nickle B, Oprian D, Schertler G, Standfuss J | 10.1073/PNAS.1114089108 | 2012-01-25 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | X-ray | 3UON | 3UON_refined | 3.0 | A | Inactive | 2 | 60 | - | - | - | - | T4-Lysozyme | - |
CHEMBL558910
|
small-molecule | Antagonist | acetylcholine | small-molecule | Yes | No | Haga K, Kruse AC, Asada H, Yurugi-Kobayashi T, Shiroishi M, Zhang C, Weis WI, Okada T, Kobilka BK, Haga T, Kobayashi T | 10.1038/NATURE10753 | 2012-02-01 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3VG9 | 3VG9_refined | 2.7 | A | Inactive | 1 | 72 | - | - | - | - | - | Antibody fab fragment light chain Antibody fab fragment heavy chain |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Hino T, Arakawa T, Iwanari H, Yurugi-Kobayashi T, Ikeda-Suno C, Nakada-Nakura Y, Kusano-Arai O, Weyand S, Shimamura T, Nomura N, Cameron AD, Kobayashi T, Hamakubo T, Iwata S, Murata T | 10.1038/NATURE10750 | 2012-02-01 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3VGA | - | 3.1 | A | Inactive | 1 | 72 | - | - | - | - | - | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Hino T, Arakawa T, Iwanari H, Yurugi-Kobayashi T, Ikeda-Suno C, Nakada-Nakura Y, Kusano-Arai O, Weyand S, Shimamura T, Nomura N, Cameron AD, Kobayashi T, Hamakubo T, Iwata S, Murata T | 10.1038/NATURE10750 | 2012-02-01 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | X-ray | 3V2W | 3V2W_refined | 3.4 | A | Inactive | 1 | 68 | - | - | - | - | T4-Lysozyme | - |
W146
|
small-molecule | Antagonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, Sanna MG, Han GW, Kuhn P, Rosen H, Stevens RC | 10.1126/SCIENCE.1215904 | 2012-02-15 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | X-ray | 3V2Y | 3V2Y_refined | 2.8 | A | Inactive | 1 | 76 | - | - | - | - | T4-Lysozyme | - |
W146
|
small-molecule | Antagonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, Sanna MG, Han GW, Kuhn P, Rosen H, Stevens RC | 10.1126/SCIENCE.1215904 | 2012-02-15 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Rat | X-ray | 4DAJ | - | 3.4 | A | Inactive | 2 | 46 | - | - | - | - | T4-Lysozyme | - |
tiotropium
|
small-molecule | Antagonist | acetylcholine | small-molecule | Yes | No | Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, Rosemond E, Green HF, Liu T, Chae PS, Dror RO, Shaw DE, Weis WI, Wess J, Kobilka BK | 10.1038/NATURE10867 | 2012-02-22 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3UZA | 3UZA_refined | 3.3 | A | Inactive | 1 | 71 | - | - | - | - | - | - |
compound 4g [PMID: 22220592]
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Congreve M, Andrews SP, Doré AS, Hollenstein K, Hurrell E, Langmead CJ, Mason JS, Ng IW, Tehan B, Zhukov A, Weir M, Marshall FH. | 10.1021/jm201376w | 2012-03-21 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 3UZC | 3UZC_refined | 3.3 | A | Inactive | 1 | 71 | - | - | - | - | - | - |
CHEMBL2024114
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Congreve M, Andrews SP, Doré AS, Hollenstein K, Hurrell E, Langmead CJ, Mason JS, Ng IW, Tehan B, Zhukov A, Weir M, Marshall FH. | 10.1021/jm201376w | 2012-03-21 | Yes | |
OPRK | κ | Opioid | A | Human | X-ray | 4DJH | 4DJH_refined | 2.9 | A | Inactive | 4 | 76 | - | - | - | - | T4-Lysozyme | - |
JDTic
|
small-molecule | Antagonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC | 10.1038/NATURE10939 | 2012-03-21 | Yes | |
OPRM | μ | Opioid | A | Mouse | X-ray | 4DKL | 4DKL_refined | 2.8 | A | Inactive | 4 | 71 | - | - | - | - | T4-Lysozyme | - |
Methyl 4-[[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-4-oxobutanoate
|
small-molecule | Antagonist | - | - | Yes | No | Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S | 10.1038/NATURE10954 | 2012-03-21 | Yes | |
OPRX | NOP | Opioid | A | Human | X-ray | 4EA3 | 4EA3_refined | 3.0 | A | Inactive | 4 | 75 | - | - | - | - | BRIL | - |
compound 24 [PMID: 16451050]
|
small-molecule | Antagonist | nociceptin/orphanin FQ | peptide | Yes | No | Thompson AA, Liu W, Chun E, Katritch V, Wu H, Vardy E, Huang XP, Trapella C, Guerrini R, Calo G, Roth BL, Cherezov V, Stevens RC | 10.1038/NATURE11085 | 2012-04-25 | Yes | |
OPRD | δ | Opioid | A | Mouse | X-ray | 4EJ4 | 4EJ4_refined | 3.4 | A | Inactive | 4 | 76 | - | - | - | - | T4-Lysozyme | - |
naltrindole
|
small-molecule | Antagonist | α-neoendorphin, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, Kobilka BK | 10.1038/NATURE11111 | 2012-05-16 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 4AMI | 4AMI_refined | 3.2 | A | Inactive | 0 | 58 | - | - | - | - | - | - |
Bucindolol
|
small-molecule | Agonist | - | - | Yes | No | Warne T, Edwards PC, Leslie AG, Tate CG | 10.1016/J.STR.2012.03.014 | 2012-05-23 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 4AMJ | 4AMJ_refined | 2.3 | B | Inactive | 0 | 62 | - | - | - | - | - | - |
CHEMBL3799125
|
small-molecule | Inverse agonist | - | - | Yes | No | Warne T, Edwards PC, Leslie AG, Tate CG | 10.1016/J.STR.2012.03.014 | 2012-05-23 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 4EIY | 4EIY_refined | 1.8 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Katritch V, Han GW, Roth CB, Heitman LH, IJzerman AP, Cherezov V, Stevens RC | 10.1126/SCIENCE.1219218 | 2012-07-25 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 4GRV | 4GRV_refined | 2.8 | A | Active | 87 | 69 | - | - | - | - | T4-Lysozyme | - |
JMV431
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | White JF, Noinaj N, Shibata Y, Love J, Kloss B, Xu F, Gvozdenovic-Jeremic J, Shah P, Shiloach J, Tate CG, Grisshammer R | 10.1038/NATURE11558 | 2012-10-17 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 4GBR | 4GBR_refined | 4.0 | A | Inactive | 0 | 69 | - | - | - | - | T4-Lysozyme | - |
Carazolol
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Zou Y, Weis WI, Kobilka BK | 10.1371/JOURNAL.PONE.0046039 | 2012-10-24 | Yes | |
PAR1 | PAR1 | Proteinase-activated | A | Human | X-ray | 3VW7 | 3VW7_refined | 2.2 | A | Intermediate | 41 | 66 | - | - | - | - | T4-Lysozyme | - |
vorapaxar
|
small-molecule | Antagonist | thrombin | peptide | Yes | No | Zhang C, Srinivasan Y, Arlow DH, Fung JJ, Palmer D, Zheng Y, Green HF, Pandey A, Dror RO, Shaw DE, Weis WI, Coughlin SR, Kobilka BK | 10.1038/NATURE11701 | 2012-12-12 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 4GPO | 4GPO_refined | 3.5 | B | Inactive | 0 | 58 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Huang J, Chen S, Zhang JJ, Huang XY | 10.1038/NSMB.2504 | 2013-02-27 | Yes | |
5HT1B | 5-HT1B | 5-Hydroxytryptamine | A | Human | X-ray | 4IAQ | 4IAQ_refined | 2.8 | A | Inactive | 14 | 70 | - | - | - | - | BRIL | - |
dihydroergotamine
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine, 5-HT-moduline | small-molecule | Yes | No | Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Han GW, Liu W, Huang XP, Vardy E, McCorvy JD, Gao X, Zhou XE, Melcher K, Zhang C, Bai F, Yang H, Yang L, Jiang H, Roth BL, Cherezov V, Stevens RC, Xu HE | 10.1126/SCIENCE.1232807 | 2013-03-13 | Yes | |
5HT1B | 5-HT1B | 5-Hydroxytryptamine | A | Human | X-ray | 4IAR | 4IAR_refined | 2.7 | A | Inactive | 14 | 70 | - | - | - | - | BRIL | - |
ergotamine
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine, 5-HT-moduline | small-molecule | Yes | No | Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Han GW, Liu W, Huang XP, Vardy E, McCorvy JD, Gao X, Zhou XE, Melcher K, Zhang C, Bai F, Yang H, Yang L, Jiang H, Roth BL, Cherezov V, Stevens RC, Xu HE | 10.1126/SCIENCE.1232807 | 2013-03-13 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | X-ray | 4IB4 | 4IB4_refined | 2.7 | A | Intermediate | 41 | 59 | - | - | - | - | BRIL | - |
ergotamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Wacker D, Wang C, Katritch V, Han GW, Huang XP, Vardy E, McCorvy JD, Jiang Y, Chu M, Siu FY, Liu W, Xu HE, Cherezov V, Roth BL, Stevens RC | 10.1126/science.1232808 | 2013-03-13 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 3ZPQ | 3ZPQ_refined | 2.8 | B | Inactive | 0 | 62 | - | - | - | - | - | - |
CHEMBL200234
|
small-molecule | Antagonist | - | - | Yes | Yes | Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M. | 10.1021/jm400140q | 2013-04-03 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 3ZPR | 3ZPR_refined | 2.7 | B | Inactive | 0 | 61 | - | - | - | - | - | - |
CHEMBL1559535
|
small-molecule | Antagonist | - | - | Yes | Yes | Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M. | 10.1021/jm400140q | 2013-04-03 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 4BEZ | 4BEZ_refined | 3.3 | A | Active | 98 | 94 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Singhal A, Ostermaier MK, Vishnivetskiy SA, Panneels V, Homan KT, Tesmer JJ, Veprintsev D, Deupi X, Gurevich VV, Schertler GF, Standfuss J | 10.1038/EMBOR.2013.44 | 2013-04-24 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 4JKV | 4JKV_refined | 2.5 | A | Inactive | 0 | 44 | - | - | - | - | BRIL | - |
taladegib
|
small-molecule | Antagonist | - | - | No | No | Wang C, Wu H, Katritch V, Han GW, Huang XP, Liu W, Siu FY, Roth BL, Cherezov V, Stevens RC | 10.1038/NATURE12167 | 2013-04-24 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 4BEY | 4BEY_refined | 2.9 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Singhal A, Ostermaier MK, Vishnivetskiy SA, Panneels V, Homan KT, Tesmer JJ, Veprintsev D, Deupi X, Gurevich VV, Schertler GF, Standfuss J | 10.1038/EMBOR.2013.44 | 2013-05-08 | Yes | |
CRFR1 | CRF1 | Corticotropin-releasing factor | B1 | Human | X-ray | 4K5Y | - | 3.0 | C | Inactive | 17 | 60 | - | - | - | - | T4-Lysozyme | - |
CP 376,395
|
small-molecule | Antagonist | urocortin 1, corticotrophin-releasing hormone, urocortin 2 | peptide | No | No | Hollenstein K, Kean J, Bortolato A, Cheng RK, Dore AS, Jazayeri A, Cooke RM, Weir M, Marshall FH | 10.1038/NATURE12357 | 2013-07-17 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | X-ray | 4L6R | 4L6R_refined | 3.3 | A | Inactive | 5 | 61 | - | - | - | - | BRIL | - | - | - | - | glucagon | peptide | No | No | Siu FY, He M, de Graaf C, Han GW, Yang D, Zhang Z, Zhou C, Xu Q, Wacker D, Joseph JS, Liu W, Lau J, Cherezov V, Katritch V, Wang MW, Stevens RC | 10.1038/nature12393 | 2013-07-24 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | X-ray | 4MQS | 4MQS_refined | 3.5 | A | Active | 99 | 59 | - | - | - | - | - | Nanobody |
iperoxo
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | Kruse AC, Ring AM, Manglik A, Hu J, Hu K, Eitel K, Hubner H, Pardon E, Valant C, Sexton PM, Christopoulos A, Felder CC, Gmeiner P, Steyaert J, Weis WI, Garcia KC, Wess J, Kobilka BK | 10.1038/NATURE12735 | 2013-11-27 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | X-ray | 4MQT | 4MQT_refined | 3.7 | A | Active | 99 | 59 | - | - | - | - | - | Nanobody |
iperoxo
LY2119620 |
small-molecule small-molecule |
Agonist PAM |
acetylcholine | small-molecule | Yes | No | Kruse AC, Ring AM, Manglik A, Hu J, Hu K, Eitel K, Hubner H, Pardon E, Valant C, Sexton PM, Christopoulos A, Felder CC, Gmeiner P, Steyaert J, Weis WI, Garcia KC, Wess J, Kobilka BK | 10.1038/NATURE12735 | 2013-11-27 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | X-ray | 4NC3 | 4NC3_refined | 2.8 | A | Intermediate | 41 | 60 | - | - | - | - | BRIL | - |
ergotamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Liu W, Wacker D, Gati C, Han GW, James D, Wang D, Nelson G, Weierstall U, Katritch V, Barty A, Zatsepin NA, Li D, Messerschmidt M, Boutet S, Williams GJ, Koglin JE, Seibert MM, Wang C, Shah ST, Basu S, Fromme R, Kupitz C, Rendek KN, Grotjohann I, Fromme P, Kirian RA, Beyerlein KR, White TA, Chapman HN, Caffrey M, Spence JC, Stevens RC, Cherezov V | 10.1126/SCIENCE.1244142 | 2013-12-18 | Yes | |
OPRD | δ | Opioid | A | Human | X-ray | 4N6H | 4N6H_refined | 1.8 | A | Inactive | 4 | 81 | - | - | - | - | BRIL | - |
naltrindole
|
small-molecule | Antagonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | Yes | Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, Cherezov V, Roth BL, Stevens RC | 10.1038/NATURE12944 | 2013-12-25 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 4N4W | 4N4W_refined | 2.8 | A | Inactive | 0 | 44 | - | - | - | - | BRIL | - |
SANT-1
|
small-molecule | Antagonist | - | - | No | No | Wang C, Wu H, Evron T, Vardy E, Han GW, Huang XP, Hufeisen SJ, Mangano TJ, Urban DJ, Katritch V, Cherezov V, Caron MG, Roth BL, Stevens RC | 10.1038/NCOMMS5355 | 2014-01-22 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 3ZEV | 3ZEV_refined | 3.0 | A | Inactive | 3 | 72 | - | - | - | - | - | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Egloff P, Hillenbrand M, Klenk C, Batyuk A, Heine P, Balada S, Schlinkmann KM, Scott DJ, Schutz M, Pluckthun A | 10.1073/PNAS.1317903111 | 2014-01-29 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 4BUO | 4BUO_refined | 2.8 | A | Inactive | 3 | 72 | - | - | - | - | - | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Egloff P, Hillenbrand M, Klenk C, Batyuk A, Heine P, Balada S, Schlinkmann KM, Scott DJ, Schutz M, Pluckthun A | 10.1073/PNAS.1317903111 | 2014-01-29 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 4BV0 | 4BV0_refined | 3.1 | A | Inactive | 3 | 70 | - | - | - | - | - | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Egloff P, Hillenbrand M, Klenk C, Batyuk A, Heine P, Balada S, Schlinkmann KM, Scott DJ, Schutz M, Pluckthun A | 10.1073/PNAS.1317903111 | 2014-01-29 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 4BWB | - | 3.6 | A | Inactive | 3 | 72 | - | - | - | - | - | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Egloff P, Hillenbrand M, Klenk C, Batyuk A, Heine P, Balada S, Schlinkmann KM, Scott DJ, Schutz M, Pluckthun A | 10.1073/PNAS.1317903111 | 2014-01-29 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 4O9R | 4O9R_refined | 3.2 | A | Inactive | 11 | 42 | - | - | - | - | BRIL | - |
cyclopamine
|
small-molecule | Antagonist | - | - | No | No | Weierstall U, James D, Wang C, White TA, Wang D, Liu W, Spence JC, Bruce Doak R, Nelson G, Fromme P, Fromme R, Grotjohann I, Kupitz C, Zatsepin NA, Liu H, Basu S, Wacker D, Han GW, Katritch V, Boutet S, Messerschmidt M, Williams GJ, Koglin JE, Marvin Seibert M, Klinker M, Gati C, Shoeman RL, Barty A, Chapman HN, Kirian RA, Beyerlein KR, Stevens RC, Li D, Shah ST, Howe N, Caffrey M, Cherezov V | 10.1038/NCOMMS4309 | 2014-03-05 | Yes | |
GRM1 | mGlu1 | Metabotropic glutamate | C | Human | X-ray | 4OR2 | 4OR2_refined | 2.8 | B | Inactive | - | 22 | - | - | - | - | BRIL | - |
FITM
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Wu H, Wang C, Gregory KJ, Han GW, Cho HP, Xia Y, Niswender CM, Katritch V, Meiler J, Cherezov V, Conn PJ, Stevens RC | 10.1126/science.1249489 | 2014-03-19 | Yes | |
P2Y12 | P2Y12 | P2Y | A | Human | X-ray | 4NTJ | 4NTJ_refined | 2.6 | A | Intermediate | 41 | 78 | - | - | - | - | BRIL | - |
AZD1283
|
small-molecule | Antagonist | ATP, ADP | small-molecule | Yes | No | Zhang K, Zhang J, Gao ZG, Zhang D, Zhu L, Han GW, Moss SM, Paoletta S, Kiselev E, Lu W, Fenalti G, Zhang W, Muller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q | 10.1038/NATURE13083 | 2014-03-26 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 4BVN | 4BVN_refined | 2.1 | A | Inactive | 0 | 60 | - | - | - | - | - | - |
(S)-Cyanopindolol
|
small-molecule | Antagonist | - | - | Yes | Yes | Miller-Gallacher JL, Nehme R, Warne T, Edwards PC, Schertler GF, Leslie AG, Tate CG | 10.1371/JOURNAL.PONE.0092727 | 2014-04-02 | Yes | |
P2Y12 | P2Y12 | P2Y | A | Human | X-ray | 4PXZ | 4PXZ_refined | 2.5 | A | Intermediate | 41 | 84 | - | - | - | - | BRIL | - |
2MeSADP
|
small-molecule | Agonist | ATP, ADP | small-molecule | Yes | No | Zhang J, Zhang K, Gao ZG, Paoletta S, Zhang D, Han GW, Li T, Ma L, Zhang W, Muller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q | 10.1038/NATURE13288 | 2014-04-30 | Yes | |
P2Y12 | P2Y12 | P2Y | A | Human | X-ray | 4PY0 | 4PY0_refined | 3.1 | A | Intermediate | 41 | 83 | - | - | - | - | BRIL | - |
2MeSATP
|
small-molecule | Agonist (partial) | ATP, ADP | small-molecule | Yes | No | Zhang J, Zhang K, Gao ZG, Paoletta S, Zhang D, Han GW, Li T, Ma L, Zhang W, Muller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q | 10.1038/NATURE13288 | 2014-04-30 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | X-ray | 4OO9 | 4OO9_refined | 2.6 | A | Inactive | - | 20 | - | - | - | - | T4-Lysozyme | - |
MAVOGLURANT
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Dore AS, Okrasa K, Patel JC, Serrano-Vega M, Bennett K, Cooke RM, Errey JC, Jazayeri A, Khan S, Tehan B, Weir M, Wiggin GR, Marshall FH | 10.1038/NATURE13396 | 2014-07-02 | Yes | |
FFAR1 | FFA1 | Free fatty acid | A | Human | X-ray | 4PHU | 4PHU_refined | 2.3 | A | Intermediate | 41 | 90 | - | - | - | - | T4-Lysozyme | - |
fasiglifam
|
small-molecule | Allosteric agonist | α-linolenic acid, oleic acid, myristic acid, docosahexaenoic acid | small-molecule | No | No | Srivastava A, Yano J, Hirozane Y, Kefala G, Gruswitz F, Snell G, Lane W, Ivetac A, Aertgeerts K, Nguyen J, Jennings A, Okada K | 10.1038/NATURE13494 | 2014-07-16 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 4QIM | 4QIM_refined | 2.6 | A | Inactive | 7 | 45 | - | - | - | - | BRIL | - |
ANTA XV
|
small-molecule | Antagonist | - | - | No | No | Wang C, Wu H, Evron T, Vardy E, Han GW, Huang XP, Hufeisen SJ, Mangano TJ, Urban DJ, Katritch V, Cherezov V, Caron MG, Roth BL, Stevens RC | 10.1038/NCOMMS5355 | 2014-07-23 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 4QIN | 4QIN_refined | 2.6 | A | Inactive | 11 | 43 | - | - | - | - | BRIL | - |
SAG1.5
|
small-molecule | Agonist | - | - | No | No | Wang C, Wu H, Evron T, Vardy E, Han GW, Huang XP, Hufeisen SJ, Mangano TJ, Urban DJ, Katritch V, Cherezov V, Caron MG, Roth BL, Stevens RC | 10.1038/NCOMMS5355 | 2014-07-23 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 4QKX | 4QKX_refined | 3.3 | A | Active | 99 | 69 | - | - | - | - | T4-Lysozyme | Nanobody |
Q27453560
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Weichert D, Kruse AC, Manglik A, Hiller C, Zhang C, Hubner H, Kobilka BK, Gmeiner P | 10.1073/PNAS.1410415111 | 2014-07-23 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 4PXF | 4PXF_refined | 2.8 | A | Active | 100 | 93 | Visual | S-arrestin | Fragment | 2 | - | - |
B-Octylglucoside
|
small-molecule | unknown | - | - | No | No | Szczepek M, Beyriere F, Hofmann KP, Elgeti M, Kazmin R, Rose A, Bartl FJ, von Stetten D, Heck M, Sommer ME, Hildebrand PW, Scheerer P | 10.1038/NCOMMS5801 | 2014-09-17 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Rat | X-ray | 4U14 | 4U14_refined | 3.6 | A | Inactive | 2 | 47 | - | - | - | - | T4-Lysozyme | - |
tiotropium
|
small-molecule | Antagonist | acetylcholine | small-molecule | Yes | No | Thorsen TS, Matt R, Weis WI, Kobilka BK | 10.1016/J.STR.2014.08.022 | 2014-11-26 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Rat | X-ray | 4U15 | 4U15_refined | 2.8 | B | Inactive | 2 | 47 | - | - | - | - | T4-Lysozyme | - |
tiotropium
|
small-molecule | Antagonist | acetylcholine | small-molecule | Yes | No | Thorsen TS, Matt R, Weis WI, Kobilka BK | 10.1016/J.STR.2014.08.022 | 2014-11-26 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Rat | X-ray | 4U16 | 4U16_refined | 3.7 | B | Inactive | 2 | 47 | - | - | - | - | T4-Lysozyme | - |
N-methyl scopolamine
|
small-molecule | Antagonist | acetylcholine | small-molecule | Yes | No | Thorsen TS, Matt R, Weis WI, Kobilka BK | 10.1016/J.STR.2014.08.022 | 2014-11-26 | Yes | |
OPRD | δ | Opioid | A | Human | X-ray | 4RWA | 4RWA_refined | 3.3 | A | Inactive | 4 | 77 | - | - | - | - | BRIL | - |
DIPP-NH2
|
peptide | Antagonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Fenalti G, Zatsepin NA, Betti C, Giguere P, Han GW, Ishchenko A, Liu W, Guillemyn K, Zhang H, James D, Wang D, Weierstall U, Spence JC, Boutet S, Messerschmidt M, Williams GJ, Gati C, Yefanov OM, White TA, Oberthuer D, Metz M, Yoon CH, Barty A, Chapman HN, Basu S, Coe J, Conrad CE, Fromme R, Fromme P, Tourwe D, Schiller PW, Roth BL, Ballet S, Katritch V, Stevens RC, Cherezov V | 10.1038/NSMB.2965 | 2015-01-14 | Yes | |
OPRD | δ | Opioid | A | Human | X-ray | 4RWD | 4RWD_refined | 2.7 | A | Inactive | 4 | 79 | - | - | - | - | BRIL | - |
DIPP-NH2
|
peptide | Antagonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | Yes | Fenalti G, Zatsepin NA, Betti C, Giguere P, Han GW, Ishchenko A, Liu W, Guillemyn K, Zhang H, James D, Wang D, Weierstall U, Spence JC, Boutet S, Messerschmidt M, Williams GJ, Gati C, Yefanov OM, White TA, Oberthuer D, Metz M, Yoon CH, Barty A, Chapman HN, Basu S, Coe J, Conrad CE, Fromme R, Fromme P, Tourwe D, Schiller PW, Roth BL, Ballet S, Katritch V, Stevens RC, Cherezov V | 10.1038/NSMB.2965 | 2015-01-14 | Yes | |
OX2R | OX2 | Orexin | A | Human | X-ray | 4S0V | 4S0V_refined | 2.5 | A | Inactive | 1 | 64 | - | - | - | - | Glycogen synthase | - |
suvorexant
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | Yes | No | Yin J, Mobarec JC, Kolb P, Rosenbaum DM | 10.1038/NATURE14035 | 2015-01-14 | Yes | |
CXCR4 | CXCR4 | Chemokine | A | Human | X-ray | 4RWS | 4RWS_refined | 3.1 | A | Inactive | 4 | 78 | - | - | - | - | T4-Lysozyme | - |
vMIP-II
|
peptide | Antagonist | CXCL12ε, CXCL12φ, CXCL12α, CXCL12γ, CXCL12, CXCL12β, CXCL12δ | peptide | Yes | No | Qin L, Kufareva I, Holden LG, Wang C, Zheng Y, Zhao C, Fenalti G, Wu H, Han GW, Cherezov V, Abagyan R, Stevens RC, Handel TM | 10.1126/SCIENCE.1261064 | 2015-02-11 | Yes | |
US28 | US28 | Unclassified | A | strain AD169 | X-ray | 4XT1 | - | 2.9 | A | Active | 100 | 82 | - | - | - | - | - | Nanobody |
CX3CL1
|
peptide | Agonist (partial) | - | - | Yes | No | Burg JS, Ingram JR, Venkatakrishnan AJ, Jude KM, Dukkipati A, Feinberg EN, Angelini A, Waghray D, Dror RO, Ploegh HL, Garcia KC | 10.1126/SCIENCE.AAA5026 | 2015-03-04 | Yes | |
US28 | US28 | Unclassified | A | strain AD169 | X-ray | 4XT3 | 4XT3_refined | 3.8 | A | Active | 100 | 81 | - | - | - | - | - | - |
CX3CL1
|
peptide | Agonist (partial) | - | - | Yes | No | Burg JS, Ingram JR, Venkatakrishnan AJ, Jude KM, Dukkipati A, Feinberg EN, Angelini A, Waghray D, Dror RO, Ploegh HL, Garcia KC | 10.1126/SCIENCE.AAA5026 | 2015-03-04 | Yes | |
P2RY1 | P2Y1 | P2Y | A | Human | X-ray | 4XNV | - | 2.2 | A | Intermediate | 41 | 78 | - | - | - | - | Rubredoxin | - |
BMS compound 16 [PMID:23368907]
|
small-molecule | NAM | ATP, ADP | small-molecule | Yes | No | Zhang D, Gao ZG, Zhang K, Kiselev E, Crane S, Wang J, Paoletta S, Yi C, Ma L, Zhang W, Han GW, Liu H, Cherezov V, Katritch V, Jiang H, Stevens RC, Jacobson KA, Zhao Q, Wu B | 10.1038/NATURE14287 | 2015-04-01 | Yes | |
P2RY1 | P2Y1 | P2Y | A | Human | X-ray | 4XNW | 4XNW_refined | 2.7 | A | Intermediate | 41 | 78 | - | - | - | - | Rubredoxin | - |
MRS2500
|
small-molecule | Antagonist | ATP, ADP | small-molecule | Yes | No | Zhang D, Gao ZG, Zhang K, Kiselev E, Crane S, Wang J, Paoletta S, Yi C, Ma L, Zhang W, Han GW, Liu H, Cherezov V, Katritch V, Jiang H, Stevens RC, Jacobson KA, Zhao Q, Wu B | 10.1038/NATURE14287 | 2015-04-01 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 4UG2 | 4UG2_refined | 2.6 | A | Active | 67 | 71 | - | - | - | - | - | - |
CGS 21680
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Lebon G, Edwards PC, Leslie AG, Tate CG | 10.1124/mol.114.097360 | 2015-04-08 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 4UHR | 4UHR_refined | 2.6 | A | Active | 67 | 75 | - | - | - | - | - | - |
CGS 21680
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Lebon G, Edwards PC, Leslie AG, Tate CG | 10.1124/mol.114.097360 | 2015-04-08 | Yes | |
AGTR1 | AT1 | Angiotensin | A | Human | X-ray | 4YAY | 4YAY_refined | 2.9 | A | Inactive | 4 | 79 | - | - | - | - | BRIL | - |
ZD-7155
|
small-molecule | Antagonist | angiotensin II, angiotensin III, angiotensin IV, angiotensin A | peptide | Yes | No | Zhang H, Unal H, Gati C, Han GW, Liu W, Zatsepin NA, James D, Wang D, Nelson G, Weierstall U, Sawaya MR, Xu Q, Messerschmidt M, Williams GJ, Boutet S, Yefanov OM, White TA, Wang C, Ishchenko A, Tirupula KC, Desnoyer R, Coe J, Conrad CE, Fromme P, Stevens RC, Katritch V, Karnik SS, Cherezov V | 10.1016/J.CELL.2015.04.011 | 2015-04-22 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | X-ray | 4Z34 | 4Z34_refined | 3.0 | A | Inactive | 1 | 80 | - | - | - | - | BRIL | - |
ONO-9780307
|
small-molecule | Antagonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Chrencik JE, Roth CB, Terakado M, Kurata H, Omi R, Kihara Y, Warshaviak D, Nakade S, Asmar-Rovira G, Mileni M, Mizuno H, Griffith MT, Rodgers C, Han GW, Velasquez J, Chun J, Stevens RC, Hanson MA | 10.1016/J.CELL.2015.06.002 | 2015-06-03 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | X-ray | 4Z35 | 4Z35_refined | 2.9 | A | Inactive | 1 | 80 | - | - | - | - | BRIL | - |
ONO-9910539
|
small-molecule | Antagonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Chrencik JE, Roth CB, Terakado M, Kurata H, Omi R, Kihara Y, Warshaviak D, Nakade S, Asmar-Rovira G, Mileni M, Mizuno H, Griffith MT, Rodgers C, Han GW, Velasquez J, Chun J, Stevens RC, Hanson MA | 10.1016/J.CELL.2015.06.002 | 2015-06-03 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | X-ray | 4Z36 | 4Z36_refined | 2.9 | A | Inactive | 1 | 79 | - | - | - | - | BRIL | - |
ONO-3080573
|
small-molecule | Antagonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Chrencik JE, Roth CB, Terakado M, Kurata H, Omi R, Kihara Y, Warshaviak D, Nakade S, Asmar-Rovira G, Mileni M, Mizuno H, Griffith MT, Rodgers C, Han GW, Velasquez J, Chun J, Stevens RC, Hanson MA | 10.1016/J.CELL.2015.06.002 | 2015-06-03 | Yes | |
OPSD | Rhodopsin | Opsins | A | Japanese flying squid | X-ray | 4WW3 | 4WW3_refined | 2.8 | A | Inactive | 16 | 78 | - | - | - | - | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | Yes | No | Murakami M, Kouyama T | 10.1371/JOURNAL.PONE.0126970 | 2015-06-17 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 4XEE | 4XEE_refined | 2.9 | A | Active | 87 | 71 | - | - | - | - | T4-Lysozyme | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Krumm BE, White JF, Shah P, Grisshammer R | 10.1038/NCOMMS8895 | 2015-07-29 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 4XES | 4XES_refined | 2.6 | A | Active | 87 | 72 | - | - | - | - | T4-Lysozyme | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Krumm BE, White JF, Shah P, Grisshammer R | 10.1038/NCOMMS8895 | 2015-07-29 | Yes | |
OPSD | Rhodopsin | Opsins | A | Human | X-ray | 4ZWJ | 4ZWJ_refined | 3.3 | A | Active | 100 | 94 | Visual | S-arrestin | - | 86 | T4-Lysozyme | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Kang Y, Zhou XE, Gao X, He Y, Liu W, Ishchenko A, Barty A, White TA, Yefanov O, Han GW, Xu Q, de Waal PW, Ke J, Tan MH, Zhang C, Moeller A, West GM, Pascal BD, Van Eps N, Caro LN, Vishnivetskiy SA, Lee RJ, Suino-Powell KM, Gu X, Pal K, Ma J, Zhi X, Boutet S, Williams GJ, Messerschmidt M, Gati C, Zatsepin NA, Wang D, James D, Basu S, Roy-Chowdhury S, Conrad CE, Coe J, Liu H, Lisova S, Kupitz C, Grotjohann I, Fromme R, Jiang Y, Tan M, Yang H, Li J, Wang M, Zheng Z, Li D, Howe N, Zhao Y, Standfuss J, Diederichs K, Dong Y, Potter CS, Carragher B, Caffrey M, Jiang H, Chapman HN, Spence JC, Fromme P, Weierstall U, Ernst OP, Katritch V, Gurevich VV, Griffin PR, Hubbell WL, Stevens RC, Cherezov V, Melcher K, Xu HE | 10.1038/NATURE14656 | 2015-07-29 | Yes | |
OPRM | μ | Opioid | A | Mouse | X-ray | 5C1M | 5C1M_refined | 2.1 | A | Active | 100 | 74 | - | - | - | - | - | Antibody |
BU72
|
small-molecule | Agonist | - | - | Yes | No | Huang W, Manglik A, Venkatakrishnan AJ, Laeremans T, Feinberg EN, Sanborn AL, Kato HE, Livingston KE, Thorsen TS, Kling RC, Granier S, Gmeiner P, Husbands SM, Traynor JR, Weis WI, Steyaert J, Dror RO, Kobilka BK | 10.1038/NATURE14886 | 2015-08-05 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | X-ray | 5CGC | 5CGC_refined | 3.1 | A | Inactive | - | 20 | - | - | - | - | T4-Lysozyme | - |
CHEMBL3603915
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Christopher JA, Aves SJ, Bennett KA, Doré AS, Errey JC, Jazayeri A, Marshall FH, Okrasa K, Serrano-Vega MJ, Tehan BG, Wiggin GR, Congreve M. | 10.1021/acs.jmedchem.5b00892 | 2015-08-12 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 4ZJ8 | 4ZJ8_refined | 2.8 | A | Inactive | 1 | 72 | - | - | - | - | GlgA glycogen synthase | - |
suvorexant
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Yin J, Babaoglu K, Brautigam CA, Clark L, Shao Z, Scheuermann TH, Harrell CM, Gotter AL, Roecker AJ, Winrow CJ, Renger JJ, Coleman PJ, Rosenbaum DM | 10.1038/NSMB.3183 | 2016-03-09 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 4ZJC | 4ZJC_refined | 2.8 | A | Inactive | 1 | 72 | - | - | - | - | GlgA glycogen synthase | - |
SB-674042
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Yin J, Babaoglu K, Brautigam CA, Clark L, Shao Z, Scheuermann TH, Harrell CM, Gotter AL, Roecker AJ, Winrow CJ, Renger JJ, Coleman PJ, Rosenbaum DM | 10.1038/NSMB.3183 | 2016-03-09 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | X-ray | 5CGD | 5CGD_refined | 2.6 | A | Inactive | - | 20 | - | - | - | - | T4-Lysozyme | - |
CHEMBL3603923
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Christopher JA, Aves SJ, Bennett KA, Doré AS, Errey JC, Jazayeri A, Marshall FH, Okrasa K, Serrano-Vega MJ, Tehan BG, Wiggin GR, Congreve M. | 10.1021/acs.jmedchem.5b00892 | 2015-08-12 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 5A8E | 5A8E_refined | 2.4 | A | Inactive | 0 | 59 | - | - | - | - | - | - |
7-methylcyanopindolol
|
small-molecule | Inverse agonist | - | - | Yes | Yes | Sato T, Baker J, Warne T, Brown GA, Leslie AG, Congreve M, Tate CG | 10.1124/MOL.115.101030 | 2015-09-30 | Yes | |
AGTR1 | AT1 | Angiotensin | A | Human | X-ray | 4ZUD | 4ZUD_refined | 2.8 | A | Inactive | 4 | 75 | - | - | - | - | BRIL | - |
OLMESARTAN
|
small-molecule | Inverse agonist | angiotensin II, angiotensin III, angiotensin IV, angiotensin A | peptide | Yes | No | Zhang H, Unal H, Desnoyer R, Han GW, Patel N, Katritch V, Karnik SS, Cherezov V, Stevens RC | 10.1074/JBC.M115.689000 | 2015-10-07 | Yes | |
OPRX | NOP | Opioid | A | Human | X-ray | 5DHG | 5DHG_refined | 3.0 | A | Inactive | 4 | 76 | - | - | - | - | BRIL | - |
CHEMBL1783826
|
small-molecule | Antagonist | nociceptin/orphanin FQ | peptide | Yes | No | Miller RL, Thompson AA, Trapella C, Guerrini R, Malfacini D, Patel N, Han GW, Cherezov V, Calo G, Katritch V, Stevens RC | 10.1016/J.STR.2015.07.024 | 2015-10-21 | Yes | |
OPRX | NOP | Opioid | A | Human | X-ray | 5DHH | 5DHH_refined | 3.0 | A | Inactive | 4 | 76 | - | - | - | - | BRIL | - |
SB 612111
|
small-molecule | Antagonist | nociceptin/orphanin FQ | peptide | Yes | No | Miller RL, Thompson AA, Trapella C, Guerrini R, Malfacini D, Patel N, Han GW, Cherezov V, Calo G, Katritch V, Stevens RC | 10.1016/J.STR.2015.07.024 | 2015-10-21 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 4X1H | 4X1H_refined | 2.3 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
B-Nonylglucoside
|
small-molecule | unknown | - | - | No | No | Blankenship E, Vahedi-Faridi A, Lodowski DT | 10.1016/J.STR.2015.09.015 | 2015-11-04 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 5F8U | 5F8U_refined | 3.4 | A | Inactive | 0 | 57 | - | - | - | - | - | - |
(S)-Cyanopindolol
|
small-molecule | Antagonist | - | - | Yes | No | Leslie AG, Warne T, Tate CG | 10.1038/NSMB.3130 | 2015-12-23 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 5D5A | 5D5A_refined | 2.5 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
Carazolol
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Huang CY, Olieric V, Ma P, Howe N, Vogeley L, Liu X, Warshamanage R, Weinert T, Panepucci E, Kobilka B, Diederichs K, Wang M, Caffrey M | 10.1107/S2059798315021683 | 2016-01-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 5D5B | 5D5B_refined | 3.8 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
Carazolol
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Huang CY, Olieric V, Ma P, Howe N, Vogeley L, Liu X, Warshamanage R, Weinert T, Panepucci E, Kobilka B, Diederichs K, Wang M, Caffrey M | 10.1107/S2059798315021683 | 2016-01-13 | Yes | |
ACM1 | M1 | Acetylcholine (muscarinic) | A | Human | X-ray | 5CXV | 5CXV_refined | 2.7 | A | Inactive | 2 | 62 | - | - | - | - | T4-Lysozyme | - |
0HK
|
small-molecule | Antagonist | acetylcholine | small-molecule | Yes | No | Thal DM, Sun B, Feng D, Nawaratne V, Leach K, Felder CC, Bures MG, Evans DA, Weis WI, Bachhawat P, Kobilka TS, Sexton PM, Kobilka BK, Christopoulos A | 10.1038/NATURE17188 | 2016-03-09 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | X-ray | 5DSG | 5DSG_refined | 2.6 | B | Inactive | 2 | 60 | - | - | - | - | T4-Lysozyme | - |
tiotropium
|
small-molecule | Antagonist | acetylcholine | small-molecule | Yes | No | Thal DM, Sun B, Feng D, Nawaratne V, Leach K, Felder CC, Bures MG, Evans DA, Weis WI, Bachhawat P, Kobilka TS, Sexton PM, Kobilka BK, Christopoulos A | 10.1038/NATURE17188 | 2016-03-16 | Yes | |
OPSD | Rhodopsin | Opsins | A | Human | X-ray | 5DGY | 5DGY_refined | 7.7 | A | Active | 100 | 94 | Visual | S-arrestin | - | 86 | T4-Lysozyme | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Zhou XE, Gao X, Barty A, Kang Y, He Y, Liu W, Ishchenko A, White TA, Yefanov O, Han GW, Xu Q, de Waal PW, Suino-Powell KM, Boutet S, Williams GJ, Wang M, Li D, Caffrey M, Chapman HN, Spence JC, Fromme P, Weierstall U, Stevens RC, Cherezov V, Melcher K, Xu HE | 10.1038/SDATA.2016.21 | 2016-03-23 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | X-ray | 5EE7 | 5EE7_refined | 2.5 | A | Inactive | 0 | 54 | - | - | - | - | T4-Lysozyme | - |
Octaethylene glycol monoethyl ether
MK-0893 |
small-molecule small-molecule |
Antagonist NAM |
glucagon | peptide | No | No | Jazayeri A, Dore AS, Lamb D, Krishnamurthy H, Southall SM, Baig AH, Bortolato A, Koglin M, Robertson NJ, Errey JC, Andrews SP, Teobald I, Brown AJ, Cooke RM, Weir M, Marshall FH | 10.1038/NATURE17414 | 2016-04-20 | Yes | |
CRFR1 | CRF1 | Corticotropin-releasing factor | B1 | Human | X-ray | 4Z9G | - | 3.2 | A | Inactive | 17 | 63 | - | - | - | - | T4-Lysozyme | - |
CP 376,395
|
small-molecule | Antagonist | urocortin 1, corticotrophin-releasing hormone, urocortin 2 | peptide | No | No | Dore AS, Bortolato A, Hollenstein K, Cheng RKY, Read RJ, Marshall FH | 10.2174/1874467210666170110114727 | 2016-06-29 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5IU4 | 5IU4_refined | 1.7 | A | Inactive | 1 | 71 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Segala E, Guo D, Cheng RK, Bortolato A, Deflorian F, Doré AS, Errey JC, Heitman LH, IJzerman AP, Marshall FH, Cooke RM. | 10.1021/acs.jmedchem.6b00653 | 2016-06-29 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5IU7 | 5IU7_refined | 1.9 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
2-(Furan-2-yl)-5-N-[2-(4-phenylpiperidin-1-yl)ethyl]-1H-[1,2,4]triazolo[1,5-a][1,3,5]triazin-8-ium-5,7-diamine
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Segala E, Guo D, Cheng RK, Bortolato A, Deflorian F, Doré AS, Errey JC, Heitman LH, IJzerman AP, Marshall FH, Cooke RM. | 10.1021/acs.jmedchem.6b00653 | 2016-06-29 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5IU8 | 5IU8_refined | 2.0 | A | Inactive | 1 | 71 | - | - | - | - | BRIL | - |
CHEMBL3934661
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Segala E, Guo D, Cheng RK, Bortolato A, Deflorian F, Doré AS, Errey JC, Heitman LH, IJzerman AP, Marshall FH, Cooke RM. | 10.1021/acs.jmedchem.6b00653 | 2016-06-29 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5IUA | 5IUA_refined | 2.2 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
2-(Furan-2-yl)-5-N-[3-(4-phenylpiperazin-1-yl)propyl]-1H-[1,2,4]triazolo[1,5-a][1,3,5]triazin-8-ium-5,7-diamine
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Segala E, Guo D, Cheng RK, Bortolato A, Deflorian F, Doré AS, Errey JC, Heitman LH, IJzerman AP, Marshall FH, Cooke RM. | 10.1021/acs.jmedchem.6b00653 | 2016-06-29 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5IUB | 5IUB_refined | 2.1 | A | Inactive | 1 | 71 | - | - | - | - | BRIL | - |
CHEMBL184061
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Segala E, Guo D, Cheng RK, Bortolato A, Deflorian F, Doré AS, Errey JC, Heitman LH, IJzerman AP, Marshall FH, Cooke RM. | 10.1021/acs.jmedchem.6b00653 | 2016-06-29 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7S8L | - | 2.5 | R | Active | 100 | 76 | Gq/11 | αq | Gq-Gs chimera | 57 | - | scFv16 |
Cortistatin 14
|
peptide | Agonist | PAMP-20 | peptide | No | No | Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, Hayes BW, Liu J, Gumpper RH, Bender BJ, Slocum ST, Krumm BE, Lansu K, McCorvy JD, Kroeze WK, English JG, DiBerto JF, Olsen RHJ, Huang XP, Zhang S, Liu Y, Kim K, Karpiak J, Jan LY, Abraham SN, Jin J, Shoichet BK, Fay JF, Roth BL | 10.1038/S41586-021-04126-6 | 2021-11-17 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 5JQH | 5JQH_refined | 3.2 | A | Inactive | 0 | 70 | - | - | - | - | T4-Lysozyme | Nanobody |
Carazolol
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Staus DP, Strachan RT, Manglik A, Pani B, Kahsai AW, Kim TH, Wingler LM, Ahn S, Chatterjee A, Masoudi A, Kruse AC, Pardon E, Steyaert J, Weis WI, Prosser RS, Kobilka BK, Costa T, Lefkowitz RJ | 10.1038/NATURE18636 | 2016-07-13 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 5L7D | 5L7D_refined | 3.2 | B | Inactive | 4 | 59 | - | - | - | - | BRIL | - | - | - | - | - | - | No | No | Byrne EFX, Sircar R, Miller PS, Hedger G, Luchetti G, Nachtergaele S, Tully MD, Mydock-McGrane L, Covey DF, Rambo RP, Sansom MSP, Newstead S, Rohatgi R, Siebold C | 10.1038/NATURE18934 | 2016-07-20 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 5L7I | 5L7I_refined | 3.3 | B | Inactive | 4 | 59 | - | - | - | - | BRIL | - |
vismodegib
|
small-molecule | Antagonist | - | - | No | No | Byrne EFX, Sircar R, Miller PS, Hedger G, Luchetti G, Nachtergaele S, Tully MD, Mydock-McGrane L, Covey DF, Rambo RP, Sansom MSP, Newstead S, Rohatgi R, Siebold C | 10.1038/NATURE18934 | 2016-07-20 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5G53 | 5G53_refined | 3.4 | A | Active | 100 | 68 | Gs | αs | Engineered G protein | 50 | - | - |
NECA
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Carpenter B, Nehme R, Warne T, Leslie AG, Tate CG | 10.1038/NATURE18966 | 2016-08-03 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 5DYS | 5DYS_refined | 2.3 | A | Active | 98 | 94 | - | - | - | - | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Singhal A, Guo Y, Matkovic M, Schertler G, Deupi X, Yan EC, Standfuss J | 10.15252/EMBR.201642671 | 2016-08-10 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 5EN0 | 5EN0_refined | 2.8 | A | Active | 100 | 94 | Gi/o | αt3 | Only H5 | 3 | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Singhal A, Guo Y, Matkovic M, Schertler G, Deupi X, Yan EC, Standfuss J | 10.15252/EMBR.201642671 | 2016-08-10 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 5D6L | 5D6L_refined | 3.2 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
Carazolol
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ma P, Weichert D, Aleksandrov LA, Jensen TJ, Riordan JR, Liu X, Kobilka BK, Caffrey M | 10.1038/NPROT.2017.057 | 2016-08-17 | Yes | |
EDNRB | ETB | Endothelin | A | Human | X-ray | 5GLH | 5GLH_refined | 2.8 | A | Inactive | 14 | 66 | - | - | - | - | T4-Lysozyme | - |
ENDOTHELIN
|
protein | Agonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | Shihoya W, Nishizawa T, Okuta A, Tani K, Dohmae N, Fujiyoshi Y, Nureki O, Doi T | 10.1038/nature19319 | 2016-09-07 | Yes | |
EDNRB | ETB | Endothelin | A | Human | X-ray | 5GLI | 5GLI_refined | 2.5 | A | Inactive | 4 | 71 | - | - | - | - | T4-Lysozyme | - |
Apo (no ligand)
|
none | Apo (no ligand) | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | Shihoya W, Nishizawa T, Okuta A, Tani K, Dohmae N, Fujiyoshi Y, Nureki O, Doi T | 10.1038/nature19319 | 2016-09-07 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5K2A | 5K2A_refined | 2.5 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Batyuk A, Galli L, Ishchenko A, Han GW, Gati C, Popov PA, Lee MY, Stauch B, White TA, Barty A, Aquila A, Hunter MS, Liang M, Boutet S, Pu M, Liu ZJ, Nelson G, James D, Li C, Zhao Y, Spence JC, Liu W, Fromme P, Katritch V, Weierstall U, Stevens RC, Cherezov V | 10.1126/SCIADV.1600292 | 2016-09-21 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5K2B | 5K2B_refined | 2.5 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | - | - | 2016-09-21 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5K2C | 5K2C_refined | 1.9 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Batyuk A, Galli L, Ishchenko A, Han GW, Gati C, Popov PA, Lee MY, Stauch B, White TA, Barty A, Aquila A, Hunter MS, Liang M, Boutet S, Pu M, Liu ZJ, Nelson G, James D, Li C, Zhao Y, Spence JC, Liu W, Fromme P, Katritch V, Weierstall U, Stevens RC, Cherezov V | 10.1126/SCIADV.1600292 | 2016-09-21 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5K2D | 5K2D_refined | 1.9 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Batyuk A, Galli L, Ishchenko A, Han GW, Gati C, Popov PA, Lee MY, Stauch B, White TA, Barty A, Aquila A, Hunter MS, Liang M, Boutet S, Pu M, Liu ZJ, Nelson G, James D, Li C, Zhao Y, Spence JC, Liu W, Fromme P, Katritch V, Weierstall U, Stevens RC, Cherezov V | 10.1126/SCIADV.1600292 | 2016-09-21 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | X-ray | 5TGZ | 5TGZ_refined | 2.8 | A | Inactive | 10 | 61 | - | - | - | - | Flavodoxin | - |
AM6538
|
small-molecule | Antagonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Hua T, Vemuri K, Pu M, Qu L, Han GW, Wu Y, Zhao S, Shui W, Li S, Korde A, Laprairie RB, Stahl EL, Ho JH, Zvonok N, Zhou H, Kufareva I, Wu B, Zhao Q, Hanson MA, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ | 10.1016/J.CELL.2016.10.004 | 2016-11-02 | Yes | |
CCR9 | CCR9 | Chemokine | A | Human | X-ray | 5LWE | - | 2.8 | B | Inactive | 52 | 67 | - | - | - | - | - | - |
vercirnon
|
small-molecule | Allosteric antagonist | CCL25 | peptide | No | No | Oswald C, Rappas M, Kean J, Dore AS, Errey JC, Bennett K, Deflorian F, Christopher JA, Jazayeri A, Mason JS, Congreve M, Cooke RM, Marshall FH | 10.1038/NATURE20606 | 2016-12-07 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | X-ray | 5U09 | 5U09_refined | 2.6 | A | Inactive | 10 | 60 | - | - | - | - | Glycogen synthase | - |
taranabant
|
small-molecule | Inverse agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Shao Z, Yin J, Chapman K, Grzemska M, Clark L, Wang J, Rosenbaum DM | 10.1038/NATURE20613 | 2016-12-07 | Yes | |
CCR2 | CCR2 | Chemokine | A | Human | X-ray | 5T1A | 5T1A_refined | 2.8 | A | Inactive | 15 | 76 | - | - | - | - | T4-Lysozyme | - |
CCR2-RA-[R]
BMS-681 |
small-molecule small-molecule |
Allosteric antagonist Antagonist |
CCL16, CCL24, CCL7, CCL2, CCL13, CCL26, CCL11, CCL8 | peptide | No | No | Zheng Y, Qin L, Zacarias NV, de Vries H, Han GW, Gustavsson M, Dabros M, Zhao C, Cherney RJ, Carter P, Stamos D, Abagyan R, Cherezov V, Stevens RC, IJzerman AP, Heitman LH, Tebben A, Kufareva I, Handel TM | 10.1038/NATURE20605 | 2016-12-14 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 5T04 | 5T04_refined | 3.3 | A | Active | 87 | 69 | - | - | - | - | T4-Lysozyme | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Krumm BE, Lee S, Bhattacharya S, Botos I, White CF, Du H, Vaidehi N, Grisshammer R | 10.1038/SREP38564 | 2016-12-21 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | X-ray | 5TVN | 5TVN_refined | 2.9 | A | Intermediate | 41 | 61 | - | - | - | - | BRIL | - |
Lysergide
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Wacker D, Wang S, McCorvy JD, Betz RM, Venkatakrishnan AJ, Levit A, Lansu K, Schools ZL, Che T, Nichols DE, Shoichet BK, Dror RO, Roth BL | 10.1016/J.CELL.2016.12.033 | 2017-02-01 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5UIG | 5UIG_refined | 3.5 | A | Inactive | 18 | 70 | - | - | - | - | BRIL | - |
5-Amino-N-[(2-Methoxyphenyl)methyl]-2-(3-Methylphenyl)-2h-1,2,3-Triazole-4-Carboximidamide
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Sun B, Bachhawat P, Chu ML, Wood M, Ceska T, Sands ZA, Mercier J, Lebon F, Kobilka TS, Kobilka BK | 10.1073/PNAS.1621423114 | 2017-02-08 | Yes | |
AA1R | A1 | Adenosine | A | Human | X-ray | 5UEN | 5UEN_refined | 3.2 | B | Inactive | 1 | 91 | - | - | - | - | BRIL | - |
DU172
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Glukhova A, Thal DM, Nguyen AT, Vecchio EA, Jorg M, Scammells PJ, May LT, Sexton PM, Christopoulos A | 10.1016/j.cell.2017.01.042 | 2017-03-01 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 5TE3 | 5TE3_refined | 2.7 | A | Active | 98 | 94 | - | - | - | - | - | - |
B-Octylglucoside
|
small-molecule | unknown | - | - | No | No | Gulati S, Jastrzebska B, Banerjee S, Placeres AL, Miszta P, Gao S, Gunderson K, Tochtrop GP, Filipek S, Katayama K, Kiser PD, Mogi M, Stewart PL, Palczewski K | 10.1073/PNAS.1617446114 | 2017-03-15 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 5TE5 | 5TE5_refined | 4.0 | A | Inactive | 21 | 100 | - | - | - | - | - | - |
10,20-Methanoretinal
|
small-molecule | Agonist | - | - | No | No | Gulati S, Jastrzebska B, Banerjee S, Placeres AL, Miszta P, Gao S, Gunderson K, Tochtrop GP, Filipek S, Katayama K, Kiser PD, Mogi M, Stewart PL, Palczewski K | 10.1073/PNAS.1617446114 | 2017-03-15 | Yes | |
AGTR2 | AT2 | Angiotensin | A | Human | X-ray | 5UNF | 5UNF_refined | 2.8 | A | Active | 99 | 79 | - | - | - | - | BRIL | - |
compound 1 [PMID: 28379944]
|
small-molecule | Antagonist | angiotensin-(1-7), angiotensin III, angiotensin II | peptide | Yes | No | Zhang H, Han GW, Batyuk A, Ishchenko A, White KL, Patel N, Sadybekov A, Zamlynny B, Rudd MT, Hollenstein K, Tolstikova A, White TA, Hunter MS, Weierstall U, Liu W, Babaoglu K, Moore EL, Katz RD, Shipman JM, Garcia-Calvo M, Sharma S, Sheth P, Soisson SM, Stevens RC, Katritch V, Cherezov V | 10.1038/NATURE22035 | 2017-04-05 | Yes | |
AGTR2 | AT2 | Angiotensin | A | Human | X-ray | 5UNG | 5UNG_refined | 2.8 | B | Active | 99 | 83 | - | - | - | - | BRIL | - |
compound 1 [PMID: 28379944]
|
small-molecule | Antagonist | angiotensin-(1-7), angiotensin III, angiotensin II | peptide | Yes | No | Zhang H, Han GW, Batyuk A, Ishchenko A, White KL, Patel N, Sadybekov A, Zamlynny B, Rudd MT, Hollenstein K, Tolstikova A, White TA, Hunter MS, Weierstall U, Liu W, Babaoglu K, Moore EL, Katz RD, Shipman JM, Garcia-Calvo M, Sharma S, Sheth P, Soisson SM, Stevens RC, Katritch V, Cherezov V | 10.1038/NATURE22035 | 2017-04-05 | Yes | |
AGTR2 | AT2 | Angiotensin | A | Human | X-ray | 5UNH | 5UNH_refined | 2.9 | B | Active | 99 | 75 | - | - | - | - | BRIL | - |
compound 2 [PMID: 28379944]
|
small-molecule | Antagonist | angiotensin-(1-7), angiotensin III, angiotensin II | peptide | Yes | No | Zhang H, Han GW, Batyuk A, Ishchenko A, White KL, Patel N, Sadybekov A, Zamlynny B, Rudd MT, Hollenstein K, Tolstikova A, White TA, Hunter MS, Weierstall U, Liu W, Babaoglu K, Moore EL, Katz RD, Shipman JM, Garcia-Calvo M, Sharma S, Sheth P, Soisson SM, Stevens RC, Katritch V, Cherezov V | 10.1038/NATURE22035 | 2017-04-05 | Yes | |
PAR2 | PAR2 | Proteinase-activated | A | Human | X-ray | 5NDD | 5NDD_refined | 2.8 | A | Intermediate | 41 | 74 | - | - | - | - | BRIL | - |
AZ8838
|
small-molecule | Antagonist | - | - | Yes | Yes | Cheng RKY, Fiez-Vandal C, Schlenker O, Edman K, Aggeler B, Brown DG, Brown GA, Cooke RM, Dumelin CE, Dore AS, Geschwindner S, Grebner C, Hermansson NO, Jazayeri A, Johansson P, Leong L, Prihandoko R, Rappas M, Soutter H, Snijder A, Sundstrom L, Tehan B, Thornton P, Troast D, Wiggin G, Zhukov A, Marshall FH, Dekker N | 10.1038/NATURE22309 | 2017-05-03 | Yes | |
PAR2 | PAR2 | Proteinase-activated | A | Human | X-ray | 5NDZ | 5NDZ_refined | 3.6 | A | Intermediate | 41 | 74 | - | - | - | - | BRIL | - |
AZ3451
|
small-molecule | Allosteric antagonist | - | - | Yes | Yes | Cheng RKY, Fiez-Vandal C, Schlenker O, Edman K, Aggeler B, Brown DG, Brown GA, Cooke RM, Dumelin CE, Dore AS, Geschwindner S, Grebner C, Hermansson NO, Jazayeri A, Johansson P, Leong L, Prihandoko R, Rappas M, Soutter H, Snijder A, Sundstrom L, Tehan B, Thornton P, Troast D, Wiggin G, Zhukov A, Marshall FH, Dekker N | 10.1038/NATURE22309 | 2017-05-03 | Yes | |
PAR2 | PAR2 | Proteinase-activated | A | Human | X-ray | 5NJ6 | 5NJ6_refined | 4.0 | A | Intermediate | 41 | 74 | - | - | - | - | BRIL | Fab3949 | - | - | - | - | - | Yes | No | Cheng RKY, Fiez-Vandal C, Schlenker O, Edman K, Aggeler B, Brown DG, Brown GA, Cooke RM, Dumelin CE, Dore AS, Geschwindner S, Grebner C, Hermansson NO, Jazayeri A, Johansson P, Leong L, Prihandoko R, Rappas M, Soutter H, Snijder A, Sundstrom L, Tehan B, Thornton P, Troast D, Wiggin G, Zhukov A, Marshall FH, Dekker N | 10.1038/NATURE22309 | 2017-05-03 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 5UZ7 | 5UZ7_refined | 4.1 | R | Active | 100 | 56 | Gs | αs | - | 47 | - | - | - | - | - | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Liang YL, Khoshouei M, Radjainia M, Zhang Y, Glukhova A, Tarrasch J, Thal DM, Furness SGB, Christopoulos G, Coudrat T, Danev R, Baumeister W, Miller LJ, Christopoulos A, Kobilka BK, Wootten D, Skiniotis G, Sexton PM | 10.1038/NATURE22327 | 2017-05-03 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | X-ray | 5VEX | 5VEX_refined | 3.0 | B | Inactive | 0 | 57 | - | - | - | - | T4-Lysozyme | - |
NNC0640
|
small-molecule | NAM | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Song G, Yang D, Wang Y, de Graaf C, Zhou Q, Jiang S, Liu K, Cai X, Dai A, Lin G, Liu D, Wu F, Wu Y, Zhao S, Ye L, Han GW, Lau J, Wu B, Hanson MA, Liu ZJ, Wang MW, Stevens RC | 10.1038/NATURE22378 | 2017-05-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5UVI | 5UVI_refined | 3.2 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Martin-Garcia JM, Conrad CE, Nelson G, Stander N, Zatsepin NA, Zook J, Zhu L, Geiger J, Chun E, Kissick D, Hilgart MC, Ogata C, Ishchenko A, Nagaratnam N, Roy-Chowdhury S, Coe J, Subramanian G, Schaffer A, James D, Ketwala G, Venugopalan N, Xu S, Corcoran S, Ferguson D, Weierstall U, Spence JCH, Cherezov V, Fromme P, Fischetti RF, Liu W | 10.1107/S205225251700570X | 2017-05-24 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 5V56 | 5V56_refined | 2.9 | B | Inactive | 1 | 61 | - | - | - | - | Flavodoxin | - |
N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-4-nitro-2-(trifluoromethyl)benzamide
|
small-molecule | Antagonist | - | - | No | No | Zhang X, Zhao F, Wu Y, Yang J, Han GW, Zhao S, Ishchenko A, Ye L, Lin X, Ding K, Dharmarajan V, Griffin PR, Gati C, Nelson G, Hunter MS, Hanson MA, Cherezov V, Stevens RC, Tan W, Tao H, Xu F | 10.1038/NCOMMS15383 | 2017-05-24 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 5V57 | 5V57_refined | 3.0 | A | Inactive | 1 | 62 | - | - | - | - | Flavodoxin | - |
N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-4-nitro-2-(trifluoromethyl)benzamide
|
small-molecule | Antagonist | - | - | No | No | Zhang X, Zhao F, Wu Y, Yang J, Han GW, Zhao S, Ishchenko A, Ye L, Lin X, Ding K, Dharmarajan V, Griffin PR, Gati C, Nelson G, Hunter MS, Hanson MA, Cherezov V, Stevens RC, Tan W, Tao H, Xu F | 10.1038/NCOMMS15383 | 2017-05-24 | Yes | |
G1SGD4 | GLP-1 | Glucagon | B1 | Rabbit | Cryo-EM | 5VAI | - | 4.1 | R | Active | 100 | 84 | Gs | αs | - | 59 | - | - |
CHEMBL410972
|
protein | Agonist | - | - | No | No | Zhang Y, Sun B, Feng D, Hu H, Chu M, Qu Q, Tarrasch JT, Li S, Sun Kobilka T, Kobilka BK, Skiniotis G | 10.1038/NATURE22394 | 2017-05-24 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | X-ray | 5VEW | 5VEW_refined | 2.7 | A | Inactive | 0 | 57 | - | - | - | - | T4-Lysozyme | - |
PF-06372222
|
small-molecule | NAM | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Song G, Yang D, Wang Y, de Graaf C, Zhou Q, Jiang S, Liu K, Cai X, Dai A, Lin G, Liu D, Wu F, Wu Y, Zhao S, Ye L, Han GW, Lau J, Wu B, Hanson MA, Liu ZJ, Wang MW, Stevens RC | 10.1038/NATURE22378 | 2017-05-24 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | X-ray | 5XEZ | 5XEZ_refined | 3.0 | B | Inactive | 0 | 82 | - | - | - | - | T4-Lysozyme | Antibody |
NNC0640
|
small-molecule | NAM | glucagon | peptide | No | No | Zhang H, Qiao A, Yang D, Yang L, Dai A, de Graaf C, Reedtz-Runge S, Dharmarajan V, Zhang H, Han GW, Grant TD, Sierra RG, Weierstall U, Nelson G, Liu W, Wu Y, Ma L, Cai X, Lin G, Wu X, Geng Z, Dong Y, Song G, Griffin PR, Lau J, Cherezov V, Yang H, Hanson MA, Stevens RC, Zhao Q, Jiang H, Wang MW, Wu B | 10.1038/NATURE22363 | 2017-05-24 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | X-ray | 5XF1 | 5XF1_refined | 3.2 | B | Inactive | 0 | 81 | - | - | - | - | T4-Lysozyme | Antibody |
NNC0640
|
small-molecule | NAM | glucagon | peptide | No | No | Zhang H, Qiao A, Yang D, Yang L, Dai A, de Graaf C, Reedtz-Runge S, Dharmarajan V, Zhang H, Han GW, Grant TD, Sierra RG, Weierstall U, Nelson G, Liu W, Wu Y, Ma L, Cai X, Lin G, Wu X, Geng Z, Dong Y, Song G, Griffin PR, Lau J, Cherezov V, Yang H, Hanson MA, Stevens RC, Zhao Q, Jiang H, Wang MW, Wu B | 10.1038/NATURE22363 | 2017-05-24 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5JTB | 5JTB_refined | 2.8 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Melnikov I, Polovinkin V, Kovalev K, Gushchin I, Shevtsov M, Shevchenko V, Mishin A, Alekseev A, Rodriguez-Valera F, Borshchevskiy V, Cherezov V, Leonard GA, Gordeliy V, Popov A | 10.1126/SCIADV.1602952 | 2017-05-31 | Yes | |
APJ | apelin | Apelin | A | Human | X-ray | 5VBL | - | 2.6 | B | Inactive | 4 | 79 | - | - | - | - | Rubredoxin | - |
AMG3054
|
peptide | Agonist | apelin-36, apelin-13, apelin receptor early endogenous ligand, Elabela/Toddler-32, Elabela/Toddler-11, [Pyr1]apelin-13, apelin-17, Elabela/Toddler-21 | peptide | Yes | No | Ma Y, Yue Y, Ma Y, Zhang Q, Zhou Q, Song Y, Shen Y, Li X, Ma X, Li C, Hanson MA, Han GW, Sickmier EA, Swaminath G, Zhao S, Stevens RC, Hu LA, Zhong W, Zhang M, Xu F | 10.1016/J.STR.2017.04.008 | 2017-05-31 | Yes | |
FFAR1 | FFA1 | Free fatty acid | A | Human | X-ray | 5TZR | 5TZR_refined | 2.2 | A | Intermediate | 41 | 91 | - | - | - | - | T4-Lysozyme | - |
MK-8666
|
small-molecule | Allosteric agonist | α-linolenic acid, oleic acid, myristic acid, docosahexaenoic acid | small-molecule | No | No | Lu J, Byrne N, Wang J, Bricogne G, Brown FK, Chobanian HR, Colletti SL, Di Salvo J, Thomas-Fowlkes B, Guo Y, Hall DL, Hadix J, Hastings NB, Hermes JD, Ho T, Howard AD, Josien H, Kornienko M, Lumb KJ, Miller MW, Patel SB, Pio B, Plummer CW, Sherborne BS, Sheth P, Souza S, Tummala S, Vonrhein C, Webb M, Allen SJ, Johnston JM, Weinglass AB, Sharma S, Soisson SM | 10.1038/NSMB.3417 | 2017-06-07 | Yes | |
FFAR1 | FFA1 | Free fatty acid | A | Human | X-ray | 5TZY | 5TZY_refined | 3.2 | A | Intermediate | 41 | 91 | - | - | - | - | T4-Lysozyme | - |
MK-8666
(2S,3R)-3-Cyclopropyl-3-[(2R)-2-[1-[(1S)-1-[5-fluoro-2-(trifluoromethoxy)phenyl]ethyl]piperidin-4-yl]-3,4-dihydro-2H-chromen-7-yl]-2-methylpropanoic acid |
small-molecule small-molecule |
Agonist PAM |
α-linolenic acid, oleic acid, myristic acid, docosahexaenoic acid | small-molecule | No | No | Lu J, Byrne N, Wang J, Bricogne G, Brown FK, Chobanian HR, Colletti SL, Di Salvo J, Thomas-Fowlkes B, Guo Y, Hall DL, Hadix J, Hastings NB, Hermes JD, Ho T, Howard AD, Josien H, Kornienko M, Lumb KJ, Miller MW, Patel SB, Pio B, Plummer CW, Sherborne BS, Sheth P, Souza S, Tummala S, Vonrhein C, Webb M, Allen SJ, Johnston JM, Weinglass AB, Sharma S, Soisson SM | 10.1038/NSMB.3417 | 2017-06-07 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | X-ray | 5NX2 | - | 3.7 | A | Intermediate | 30 | 84 | - | - | - | - | - | - |
Truncated protein agonist
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, Fiez-Vandal C, Andrews SP, Congreve M, Bortolato A, Mason JS, Baig AH, Teobald I, Dore AS, Weir M, Cooke RM, Marshall FH | 10.1038/NATURE22800 | 2017-06-14 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | X-ray | 5UIW | - | 2.2 | A | Inactive | 15 | 85 | - | - | - | - | Rubredoxin | - |
5P7-CCL5
|
protein | Antagonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | Zheng Y, Han GW, Abagyan R, Wu B, Stevens RC, Cherezov V, Kufareva I, Handel TM | 10.1016/J.IMMUNI.2017.05.002 | 2017-06-28 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | X-ray | 5XR8 | 5XR8_refined | 3.0 | A | Active | 94 | 60 | - | - | - | - | Flavodoxin | - |
AM841
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Hua T, Vemuri K, Nikas SP, Laprairie RB, Wu Y, Qu L, Pu M, Korde A, Jiang S, Ho JH, Han GW, Ding K, Li X, Liu H, Hanson MA, Zhao S, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ | 10.1038/NATURE23272 | 2017-07-12 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | X-ray | 5XRA | 5XRA_refined | 2.8 | A | Active | 94 | 60 | - | - | - | - | Flavodoxin | - |
AM11542
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Hua T, Vemuri K, Nikas SP, Laprairie RB, Wu Y, Qu L, Pu M, Korde A, Jiang S, Ho JH, Han GW, Ding K, Li X, Liu H, Hanson MA, Zhao S, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ | 10.1038/NATURE23272 | 2017-07-12 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5MZJ | 5MZJ_refined | 2.0 | A | Inactive | 1 | 71 | - | - | - | - | BRIL | - |
theophylline
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Cheng RKY, Segala E, Robertson N, Deflorian F, Dore AS, Errey JC, Fiez-Vandal C, Marshall FH, Cooke RM | 10.1016/j.str.2017.06.012 | 2017-07-26 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5MZP | 5MZP_refined | 2.1 | A | Inactive | 1 | 71 | - | - | - | - | BRIL | - |
caffeine
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Cheng RKY, Segala E, Robertson N, Deflorian F, Dore AS, Errey JC, Fiez-Vandal C, Marshall FH, Cooke RM | 10.1016/j.str.2017.06.012 | 2017-07-26 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5N2R | 5N2R_refined | 2.8 | A | Inactive | 1 | 71 | - | - | - | - | BRIL | - |
PSB36
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Cheng RKY, Segala E, Robertson N, Deflorian F, Dore AS, Errey JC, Fiez-Vandal C, Marshall FH, Cooke RM | 10.1016/j.str.2017.06.012 | 2017-07-26 | Yes | |
AA1R | A1 | Adenosine | A | Human | X-ray | 5N2S | 5N2S_refined | 3.3 | A | Inactive | 1 | 86 | - | - | - | - | BRIL | - |
PSB36
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Cheng RKY, Segala E, Robertson N, Deflorian F, Dore AS, Errey JC, Fiez-Vandal C, Marshall FH, Cooke RM | 10.1016/j.str.2017.06.012 | 2017-07-26 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | X-ray | 5TUD | 5TUD_refined | 3.0 | D | Active | 88 | 58 | - | - | - | - | BRIL | Antibody |
ergotamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Ishchenko A, Wacker D, Kapoor M, Zhang A, Han GW, Basu S, Patel N, Messerschmidt M, Weierstall U, Liu W, Katritch V, Roth BL, Stevens RC, Cherezov V | 10.1073/PNAS.1700891114 | 2017-07-26 | Yes | |
OPSD | Rhodopsin | Opsins | A | Human | X-ray | 5W0P | 5W0P_refined | 3.0 | D | Active | 100 | 93 | Visual | S-arrestin | - | 90 | T4-Lysozyme | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Zhou XE, He Y, de Waal PW, Gao X, Kang Y, Van Eps N, Yin Y, Pal K, Goswami D, White TA, Barty A, Latorraca NR, Chapman HN, Hubbell WL, Dror RO, Stevens RC, Cherezov V, Gurevich VV, Griffin PR, Ernst OP, Melcher K, Xu HE | 10.1016/J.CELL.2017.07.002 | 2017-08-09 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 5X7D | 5X7D_refined | 2.7 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
4-carbamoyl-N-[(2R)-2-cyclohexyl-2-phenylacetyl]-L-phenylalanyl-3-bromo-N-methyl-L-phenylalaninamide
Carazolol |
small-molecule small-molecule |
Allosteric antagonist Antagonist |
L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Liu X, Ahn S, Kahsai AW, Meng KC, Latorraca NR, Pani B, Venkatakrishnan AJ, Masoudi A, Weis WI, Dror RO, Chen X, Lefkowitz RJ, Kobilka BK | 10.1038/NATURE23652 | 2017-08-16 | Yes | |
EDNRB | ETB | Endothelin | A | Human | X-ray | 5X93 | 5X93_refined | 2.2 | A | Inactive | 4 | 71 | - | - | - | - | T4-Lysozyme | - |
K-8794
|
small-molecule | Antagonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | Shihoya W, Nishizawa T, Yamashita K, Inoue A, Hirata K, Kadji FMN, Okuta A, Tani K, Aoki J, Fujiyoshi Y, Doi T, Nureki O | 10.1038/NSMB.3450 | 2017-08-16 | Yes | |
EDNRB | ETB | Endothelin | A | Human | X-ray | 5XPR | 5XPR_refined | 3.6 | A | Inactive | 4 | 69 | - | - | - | - | T4-Lysozyme | - |
bosentan
|
small-molecule | Antagonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | Shihoya W, Nishizawa T, Yamashita K, Inoue A, Hirata K, Kadji FMN, Okuta A, Tani K, Aoki J, Fujiyoshi Y, Doi T, Nureki O | 10.1038/NSMB.3450 | 2017-08-16 | Yes | |
Q08BG4 | LPA6 | Lysophospholipid (LPA) | A | Zebrafish | X-ray | 5XSZ | 5XSZ_refined | 3.2 | A | Active | 67 | 78 | - | - | - | - | T4-Lysozyme | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Taniguchi R, Inoue A, Sayama M, Uwamizu A, Yamashita K, Hirata K, Yoshida M, Tanaka Y, Kato HE, Nakada-Nakura Y, Otani Y, Nishizawa T, Doi T, Ohwada T, Ishitani R, Aoki J, Nureki O | 10.1038/NATURE23448 | 2017-08-16 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5NLX | - | 2.1 | A | Inactive | 1 | 73 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Weinert T, Olieric N, Cheng R, Brunle S, James D, Ozerov D, Gashi D, Vera L, Marsh M, Jaeger K, Dworkowski F, Panepucci E, Basu S, Skopintsev P, Dore AS, Geng T, Cooke RM, Liang M, Prota AE, Panneels V, Nogly P, Ermler U, Schertler G, Hennig M, Steinmetz MO, Wang M, Standfuss J | 10.1038/S41467-017-00630-4 | 2017-09-27 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5NM2 | 5NM2_refined | 2.0 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Weinert T, Olieric N, Cheng R, Brunle S, James D, Ozerov D, Gashi D, Vera L, Marsh M, Jaeger K, Dworkowski F, Panepucci E, Basu S, Skopintsev P, Dore AS, Geng T, Cooke RM, Liang M, Prota AE, Panneels V, Nogly P, Ermler U, Schertler G, Hennig M, Steinmetz MO, Wang M, Standfuss J | 10.1038/S41467-017-00630-4 | 2017-09-27 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5NM4 | - | 1.7 | A | Inactive | 1 | 73 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Weinert T, Olieric N, Cheng R, Brunle S, James D, Ozerov D, Gashi D, Vera L, Marsh M, Jaeger K, Dworkowski F, Panepucci E, Basu S, Skopintsev P, Dore AS, Geng T, Cooke RM, Liang M, Prota AE, Panneels V, Nogly P, Ermler U, Schertler G, Hennig M, Steinmetz MO, Wang M, Standfuss J | 10.1038/S41467-017-00630-4 | 2017-09-27 | Yes | |
DRD4 | D4 | Dopamine | A | Human | X-ray | 5WIU | - | 2.0 | A | Inactive | 1 | 64 | - | - | - | - | BRIL | - |
[3H]NEMONAPRIDE
|
small-molecule | Antagonist | dopamine | small-molecule | Yes | No | Wang S, Wacker D, Levit A, Che T, Betz RM, McCorvy JD, Venkatakrishnan AJ, Huang XP, Dror RO, Shoichet BK, Roth BL | 10.1126/SCIENCE.AAN5468 | 2017-10-18 | Yes | |
DRD4 | D4 | Dopamine | A | Human | X-ray | 5WIV | - | 2.1 | A | Inactive | 1 | 65 | - | - | - | - | BRIL | - |
[3H]NEMONAPRIDE
|
small-molecule | Antagonist | dopamine | small-molecule | Yes | Yes | Wang S, Wacker D, Levit A, Che T, Betz RM, McCorvy JD, Venkatakrishnan AJ, Huang XP, Dror RO, Shoichet BK, Roth BL | 10.1126/SCIENCE.AAN5468 | 2017-10-18 | Yes | |
Q9WTK1 | BLT1 | Leukotriene | A | Guinea pig | X-ray | 5X33 | 5X33_refined | 3.7 | A | Inactive | 4 | 78 | - | - | - | - | T4-Lysozyme | - |
BIIL 260
|
small-molecule | Antagonist | - | - | Yes | No | Hori T, Okuno T, Hirata K, Yamashita K, Kawano Y, Yamamoto M, Hato M, Nakamura M, Shimizu T, Yokomizo T, Miyano M, Yokoyama S | 10.1038/NCHEMBIO.2547 | 2018-01-03 | Yes | |
C5AR1 | C5a1 | Complement peptide | A | Human | X-ray | 5O9H | 5O9H_refined | 2.7 | A | Inactive | 6 | 84 | - | - | - | - | - | - |
NDT9513727
|
small-molecule | Antagonist | C5a des-Arg, C5a, ribosomal protein S19, C3a | peptide | Yes | No | Robertson N, Rappas M, Dore AS, Brown J, Bottegoni G, Koglin M, Cansfield J, Jazayeri A, Cooke RM, Marshall FH | 10.1038/NATURE25025 | 2018-01-10 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6AQF | 6AQF_refined | 2.5 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Eddy MT, Lee MY, Gao ZG, White KL, Didenko T, Horst R, Audet M, Stanczak P, McClary KM, Han GW, Jacobson KA, Stevens RC, Wuthrich K | 10.1016/J.CELL.2017.12.004 | 2018-01-10 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5OLG | 5OLG_refined | 1.9 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Rucktooa P, Cheng RKY, Segala E, Geng T, Errey JC, Brown GA, Cooke RM, Marshall FH, Dore AS | 10.1038/S41598-017-18570-W | 2018-01-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5OLH | 5OLH_refined | 2.6 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
vipadenant
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Rucktooa P, Cheng RKY, Segala E, Geng T, Errey JC, Brown GA, Cooke RM, Marshall FH, Dore AS | 10.1038/S41598-017-18570-W | 2018-01-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5OLO | 5OLO_refined | 3.1 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
tozadenant
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Rucktooa P, Cheng RKY, Segala E, Geng T, Errey JC, Brown GA, Cooke RM, Marshall FH, Dore AS | 10.1038/S41598-017-18570-W | 2018-01-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5OLV | 5OLV_refined | 2.0 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
CHEMBL1671936
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Rucktooa P, Cheng RKY, Segala E, Geng T, Errey JC, Brown GA, Cooke RM, Marshall FH, Dore AS | 10.1038/S41598-017-18570-W | 2018-01-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5OLZ | 5OLZ_refined | 1.9 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
CHEMBL2024114
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Rucktooa P, Cheng RKY, Segala E, Geng T, Errey JC, Brown GA, Cooke RM, Marshall FH, Dore AS | 10.1038/S41598-017-18570-W | 2018-01-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5OM1 | 5OM1_refined | 2.1 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
CHEMBL2024114
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Rucktooa P, Cheng RKY, Segala E, Geng T, Errey JC, Brown GA, Cooke RM, Marshall FH, Dore AS | 10.1038/S41598-017-18570-W | 2018-01-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5OM4 | 5OM4_refined | 2.0 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
CHEMBL2024114
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Rucktooa P, Cheng RKY, Segala E, Geng T, Errey JC, Brown GA, Cooke RM, Marshall FH, Dore AS | 10.1038/S41598-017-18570-W | 2018-01-17 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | X-ray | 5YQZ | 5YQZ_refined | 3.0 | R | Inactive | 3 | 83 | - | - | - | - | T4-Lysozyme | - |
NNC1702
|
peptide | Agonist (partial) | glucagon | peptide | No | No | Zhang H, Qiao A, Yang L, Van Eps N, Frederiksen KS, Yang D, Dai A, Cai X, Zhang H, Yi C, Cao C, He L, Yang H, Lau J, Ernst OP, Hanson MA, Stevens RC, Wang MW, Reedtz-Runge S, Jiang H, Zhao Q, Wu B | 10.1038/NATURE25153 | 2018-01-17 | Yes | |
OPRK | κ | Opioid | A | Human | X-ray | 6B73 | 6B73_refined | 3.1 | A | Active | 100 | 73 | - | - | - | - | BRIL | Nanobody |
MP1104
|
small-molecule | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Che T, Majumdar S, Zaidi SA, Ondachi P, McCorvy JD, Wang S, Mosier PD, Uprety R, Vardy E, Krumm BE, Han GW, Lee MY, Pardon E, Steyaert J, Huang XP, Strachan RT, Tribo AR, Pasternak GW, Carroll FI, Stevens RC, Cherezov V, Katritch V, Wacker D, Roth BL | 10.1016/J.CELL.2017.12.011 | 2018-01-17 | Yes | |
5HT1B | 5-HT1B | 5-Hydroxytryptamine | A | Human | X-ray | 5V54 | 5V54_refined | 3.9 | A | Inactive | 14 | 71 | - | - | - | - | BRIL | - |
CHEMBL428892
|
small-molecule | Antagonist | tryptamine, 5-hydroxytryptamine, 5-HT-moduline | small-molecule | Yes | No | - | - | 2018-02-07 | Yes | |
OX2R | OX2 | Orexin | A | Human | X-ray | 5WQC | 5WQC_refined | 2.0 | A | Inactive | 1 | 68 | - | - | - | - | Glycogen synthase | - |
EMPA
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | Yes | No | Suno R, Kimura KT, Nakane T, Yamashita K, Wang J, Fujiwara T, Yamanaka Y, Im D, Horita S, Tsujimoto H, Tawaramoto MS, Hirokawa T, Nango E, Tono K, Kameshima T, Hatsui T, Joti Y, Yabashi M, Shimamoto K, Yamamoto M, Rosenbaum DM, Iwata S, Shimamura T, Kobayashi T | 10.1016/J.STR.2017.11.005 | 2017-11-29 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5VRA | 5VRA_refined | 2.4 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Broecker J, Morizumi T, Ou WL, Klingel V, Kuo A, Kissick DJ, Ishchenko A, Lee MY, Xu S, Makarov O, Cherezov V, Ogata CM, Ernst OP | 10.1038/NPROT.2017.135 | 2017-12-13 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 5WKT | 5WKT_refined | 3.2 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
B-Octylglucoside
|
small-molecule | unknown | - | - | No | No | Broecker J, Morizumi T, Ou WL, Klingel V, Kuo A, Kissick DJ, Ishchenko A, Lee MY, Xu S, Makarov O, Cherezov V, Ogata CM, Ernst OP | 10.1038/NPROT.2017.135 | 2017-12-13 | Yes | |
OX2R | OX2 | Orexin | A | Human | X-ray | 5WS3 | 5WS3_refined | 2.3 | A | Inactive | 1 | 70 | - | - | - | - | Glycogen synthase | - |
EMPA
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | Yes | No | Suno R, Kimura KT, Nakane T, Yamashita K, Wang J, Fujiwara T, Yamanaka Y, Im D, Horita S, Tsujimoto H, Tawaramoto MS, Hirokawa T, Nango E, Tono K, Kameshima T, Hatsui T, Joti Y, Yabashi M, Shimamoto K, Yamamoto M, Rosenbaum DM, Iwata S, Shimamura T, Kobayashi T | 10.1016/J.STR.2017.11.005 | 2017-12-13 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | X-ray | 4MBS | 4MBS_refined | 2.7 | A | Inactive | 15 | 83 | - | - | - | - | Rubredoxin | - |
maraviroc
|
small-molecule | Antagonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, Li T, Ma L, Fenalti G, Li J, Zhang W, Xie X, Yang H, Jiang H, Cherezov V, Liu H, Stevens RC, Zhao Q, Wu B | 10.1126/SCIENCE.1241475 | 2013-09-11 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 4LDE | 4LDE_refined | 2.8 | A | Active | 99 | 69 | - | - | - | - | T4-Lysozyme | Nanobody |
CHEMBL1615159
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ring AM, Manglik A, Kruse AC, Enos MD, Weis WI, Garcia KC, Kobilka BK | 10.1038/NATURE12572 | 2013-09-25 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 4LDL | 4LDL_refined | 3.1 | A | Active | 99 | 69 | - | - | - | - | T4-Lysozyme | Nanobody |
hydroxybenzylisoproterenol
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ring AM, Manglik A, Kruse AC, Enos MD, Weis WI, Garcia KC, Kobilka BK | 10.1038/NATURE12572 | 2013-09-25 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 4LDO | 4LDO_refined | 3.2 | A | Active | 99 | 69 | - | - | - | - | T4-Lysozyme | Nanobody |
(-)-adrenaline
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ring AM, Manglik A, Kruse AC, Enos MD, Weis WI, Garcia KC, Kobilka BK | 10.1038/NATURE12572 | 2013-09-25 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 4J4Q | 4J4Q_refined | 2.7 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
B-Octylglucoside
|
small-molecule | unknown | - | - | No | No | Park JH, Morizumi T, Li Y, Hong JE, Pai EF, Hofmann KP, Choe HW, Ernst OP | 10.1002/ANIE.201302374 | 2013-10-30 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FKB | 6FKB_refined | 3.0 | A | Active | 98 | 94 | - | - | - | - | - | - |
2-(4-Chlorophenyl)-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-ethanone
|
small-molecule | Agonist | - | - | No | No | Mattle D, Kuhn B, Aebi J, Bedoucha M, Kekilli D, Grozinger N, Alker A, Rudolph MG, Schmid G, Schertler GFX, Hennig M, Standfuss J, Dawson RJP | 10.1073/PNAS.1718084115 | 2018-04-04 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FKC | 6FKC_refined | 2.5 | A | Active | 98 | 94 | - | - | - | - | - | - |
3-[1'-[(2~{S})-2-(4-chlorophenyl)-3-methyl-butanoyl]spiro[1,3-benzodioxole-2,4'-piperidine]-5-yl]propanoic acid
|
small-molecule | Agonist | - | - | No | No | Mattle D, Kuhn B, Aebi J, Bedoucha M, Kekilli D, Grozinger N, Alker A, Rudolph MG, Schmid G, Schertler GFX, Hennig M, Standfuss J, Dawson RJP | 10.1073/PNAS.1718084115 | 2018-04-04 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FKD | 6FKD_refined | 2.5 | A | Active | 98 | 94 | - | - | - | - | - | - |
5-chloro-2-(2-oxo-2-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-ylethyl)-3H-pyridin-6-one
|
small-molecule | Agonist | - | - | No | No | Mattle D, Kuhn B, Aebi J, Bedoucha M, Kekilli D, Grozinger N, Alker A, Rudolph MG, Schmid G, Schertler GFX, Hennig M, Standfuss J, Dawson RJP | 10.1073/PNAS.1718084115 | 2018-04-04 | Yes | |
NPY1R | Y1 | Neuropeptide Y | A | Human | X-ray | 5ZBH | 5ZBH_refined | 3.0 | A | Inactive | 1 | 78 | - | - | - | - | T4-Lysozyme | - |
BMS-193885
|
small-molecule | Antagonist | neuropeptide Y, peptide YY, pancreatic polypeptide | peptide | Yes | No | Yang Z, Han S, Keller M, Kaiser A, Bender BJ, Bosse M, Burkert K, Kogler LM, Wifling D, Bernhardt G, Plank N, Littmann T, Schmidt P, Yi C, Li B, Ye S, Zhang R, Xu B, Larhammar D, Stevens RC, Huster D, Meiler J, Zhao Q, Beck-Sickinger AG, Buschauer A, Wu B | 10.1038/S41586-018-0046-X | 2018-04-25 | Yes | |
NPY1R | Y1 | Neuropeptide Y | A | Human | X-ray | 5ZBQ | 5ZBQ_refined | 2.7 | A | Inactive | 1 | 80 | - | - | - | - | T4-Lysozyme | - |
CHEMBL3747822
|
small-molecule | Antagonist | neuropeptide Y, peptide YY, pancreatic polypeptide | peptide | Yes | No | Yang Z, Han S, Keller M, Kaiser A, Bender BJ, Bosse M, Burkert K, Kogler LM, Wifling D, Bernhardt G, Plank N, Littmann T, Schmidt P, Yi C, Li B, Ye S, Zhang R, Xu B, Larhammar D, Stevens RC, Huster D, Meiler J, Zhao Q, Beck-Sickinger AG, Buschauer A, Wu B | 10.1038/S41586-018-0046-X | 2018-04-25 | Yes | |
FFAR1 | FFA1 | Free fatty acid | A | Human | X-ray | 5KW2 | 5KW2_refined | 2.8 | A | Intermediate | 41 | 82 | - | - | - | - | T4-Lysozyme | - |
(3~{S})-3-cyclopropyl-3-[2-[1-[2-[2,2-dimethylpropyl-(6-methylpyridin-2-yl)carbamoyl]-5-methoxy-phenyl]piperidin-4-yl]-1-benzofuran-6-yl]propanoic acid
|
small-molecule | Allosteric agonist | α-linolenic acid, oleic acid, myristic acid, docosahexaenoic acid | small-molecule | No | No | Ho JD, Chau B, Rodgers L, Lu F, Wilbur KL, Otto KA, Chen Y, Song M, Riley JP, Yang HC, Reynolds NA, Kahl SD, Lewis AP, Groshong C, Madsen RE, Conners K, Lineswala JP, Gheyi T, Saflor MD, Lee MR, Benach J, Baker KA, Montrose-Rafizadeh C, Genin MJ, Miller AR, Hamdouchi C | 10.1038/S41467-017-01240-W | 2018-05-02 | Yes | |
AA2AR | A2A | Adenosine | A | Human | Cryo-EM | 6GDG | 6GDG_refined | 4.1 | A | Active | 100 | 64 | Gs | αs | - | 57 | TrxA | Nanobody-35 |
NECA
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Garcia-Nafria J, Lee Y, Bai X, Carpenter B, Tate CG | 10.7554/ELIFE.35946 | 2018-05-16 | Yes | |
Q98SW5 | SMO | Frizzled | F | African clawed frog | X-ray | 6D32 | 6D32_refined | 3.8 | A | Active | 78 | 58 | - | - | - | - | BRIL | - |
cyclopamine
|
small-molecule | Agonist (partial) | - | - | No | No | Huang P, Zheng S, Wierbowski BM, Kim Y, Nedelcu D, Aravena L, Liu J, Kruse AC, Salic A | 10.1016/J.CELL.2018.04.029 | 2018-05-23 | Yes | |
Q98SW5 | SMO | Frizzled | F | African clawed frog | X-ray | 6D35 | 6D35_refined | 3.9 | A | Active | 78 | 58 | - | - | - | - | BRIL | - |
Cholesterol
|
small-molecule | Agonist | - | - | No | No | Huang P, Zheng S, Wierbowski BM, Kim Y, Nedelcu D, Aravena L, Liu J, Kruse AC, Salic A | 10.1016/J.CELL.2018.04.029 | 2018-05-23 | Yes | |
C5AR1 | C5a1 | Complement peptide | A | Human | X-ray | 6C1Q | 6C1Q_refined | 2.9 | B | Inactive | 6 | 82 | - | - | - | - | BRIL | - |
PMX53
NDT9513727 |
peptide small-molecule |
Antagonist NAM |
C5a des-Arg, C5a, ribosomal protein S19, C3a | peptide | Yes | No | Liu H, Kim HR, Deepak RNVK, Wang L, Chung KY, Fan H, Wei Z, Zhang C | 10.1038/S41594-018-0067-Z | 2018-05-30 | Yes | |
C5AR1 | C5a1 | Complement peptide | A | Human | X-ray | 6C1R | 6C1R_refined | 2.2 | B | Inactive | 6 | 83 | - | - | - | - | BRIL | - |
PMX53
avacopan |
peptide small-molecule |
Antagonist NAM |
C5a des-Arg, C5a, ribosomal protein S19, C3a | peptide | Yes | No | Liu H, Kim HR, Deepak RNVK, Wang L, Chung KY, Fan H, Wei Z, Zhang C | 10.1038/S41594-018-0067-Z | 2018-05-30 | Yes | |
Q80KM9 | US28 | Unclassified | A | strain AD169 | X-ray | 5WB1 | 5WB1_refined | 3.5 | A | Active | 100 | 82 | - | - | - | - | - | Nanobody | - | - | - | - | - | Yes | No | Miles TF, Spiess K, Jude KM, Tsutsumi N, Burg JS, Ingram JR, Waghray D, Hjorto GM, Larsen O, Ploegh HL, Rosenkilde MM, Garcia KC | 10.7554/ELIFE.35850 | 2018-06-13 | Yes | |
Q80KM9 | US28 | Unclassified | A | strain AD169 | X-ray | 5WB2 | 5WB2_refined | 3.5 | A | Active | 100 | 82 | - | - | - | - | - | Nanobody |
CX3CL1
|
peptide | Agonist | - | - | Yes | No | Miles TF, Spiess K, Jude KM, Tsutsumi N, Burg JS, Ingram JR, Waghray D, Hjorto GM, Larsen O, Ploegh HL, Rosenkilde MM, Garcia KC | 10.7554/ELIFE.35850 | 2018-06-13 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 6DDE | - | 3.5 | R | Active | 100 | 71 | Gi/o | αi1 | - | 61 | - | Antibody |
DAMGO
|
peptide | Agonist | - | - | Yes | No | Koehl A, Hu H, Maeda S, Zhang Y, Qu Q, Paggi JM, Latorraca NR, Hilger D, Dawson R, Matile H, Schertler GFX, Granier S, Weis WI, Dror RO, Manglik A, Skiniotis G, Kobilka BK | 10.1038/S41586-018-0219-7 | 2018-06-13 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 6DDF | - | 3.5 | R | Active | 100 | 71 | Gi/o | αi1 | - | 61 | - | - |
DAMGO
|
peptide | Agonist | - | - | Yes | No | Koehl A, Hu H, Maeda S, Zhang Y, Qu Q, Paggi JM, Latorraca NR, Hilger D, Dawson R, Matile H, Schertler GFX, Granier S, Weis WI, Dror RO, Manglik A, Skiniotis G, Kobilka BK | 10.1038/S41586-018-0219-7 | 2018-06-13 | Yes | |
PTAFR | PAF | Platelet-activating factor | A | Human | X-ray | 5ZKP | 5ZKP_refined | 2.8 | A | Other | - | 85 | - | - | - | - | Flavodoxin | - |
foropafant
|
small-molecule | Antagonist | PAF | small-molecule | Yes | No | Cao C, Tan Q, Xu C, He L, Yang L, Zhou Y, Zhou Y, Qiao A, Lu M, Yi C, Han GW, Wang X, Li X, Yang H, Rao Z, Jiang H, Zhao Y, Liu J, Stevens RC, Zhao Q, Zhang XC, Wu B | 10.1038/S41594-018-0068-Y | 2018-06-20 | Yes | |
PTAFR | PAF | Platelet-activating factor | A | Human | X-ray | 5ZKQ | 5ZKQ_refined | 2.9 | B | Intermediate | 41 | 83 | - | - | - | - | T4-Lysozyme | - |
ABT-491
|
small-molecule | Inverse agonist | PAF | small-molecule | Yes | No | Cao C, Tan Q, Xu C, He L, Yang L, Zhou Y, Zhou Y, Qiao A, Lu M, Yi C, Han GW, Wang X, Li X, Yang H, Rao Z, Jiang H, Zhao Y, Liu J, Stevens RC, Zhao Q, Zhang XC, Wu B | 10.1038/S41594-018-0068-Y | 2018-06-20 | Yes | |
OPSD | Rhodopsin | Opsins | A | Human | Cryo-EM | 6CMO | 6CMO_refined | 4.5 | R | Active | 80 | 92 | Gi/o | αi1 | - | 100 | BRIL | Fab |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Kang Y, Kuybeda O, de Waal PW, Mukherjee S, Van Eps N, Dutka P, Zhou XE, Bartesaghi A, Erramilli S, Morizumi T, Gu X, Yin Y, Liu P, Jiang Y, Meng X, Zhao G, Melcher K, Ernst OP, Kossiakoff AA, Subramaniam S, Xu HE | 10.1038/S41586-018-0215-Y | 2018-06-20 | Yes | |
AA1R | A1 | Adenosine | A | Human | Cryo-EM | 6D9H | 6D9H_refined | 3.6 | R | Active | 100 | 88 | Gi/o | αi2 | - | 59 | - | - |
adenosine
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Draper-Joyce CJ, Khoshouei M, Thal DM, Liang YL, Nguyen ATN, Furness SGB, Venugopal H, Baltos JA, Plitzko JM, Danev R, Baumeister W, May LT, Wootten D, Sexton PM, Glukhova A, Christopoulos A | 10.1038/S41586-018-0236-6 | 2018-06-20 | Yes | |
5HT1B | 5-HT1B | 5-Hydroxytryptamine | A | Human | Cryo-EM | 6G79 | 6G79_refined | 3.8 | S | Active | 100 | 67 | Gi/o | αo | - | 59 | - | - |
donitriptan
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine, 5-HT-moduline | small-molecule | Yes | No | Garcia-Nafria J, Nehme R, Edwards PC, Tate CG | 10.1038/S41586-018-0241-9 | 2018-06-20 | Yes | |
AGTR2 | AT2 | Angiotensin | A | Human | X-ray | 5XJM | 5XJM_refined | 3.2 | A | Active | 100 | 78 | - | - | - | - | BRIL | Fab |
CHEMBL404594
|
protein | Agonist | angiotensin-(1-7), angiotensin III, angiotensin II | peptide | Yes | No | Asada H, Horita S, Hirata K, Shiroishi M, Shiimura Y, Iwanari H, Hamakubo T, Shimamura T, Nomura N, Kusano-Arai O, Uemura T, Suno C, Kobayashi T, Iwata S | 10.1038/S41594-018-0079-8 | 2018-07-11 | Yes | |
FZD4 | FZD4 | Frizzled | F | Human | X-ray | 6BD4 | 6BD4_refined | 2.4 | A | Inactive | 22 | 61 | - | - | - | - | Rubredoxin | - | - | - | - | - | - | No | No | Yang S, Wu Y, Xu TH, de Waal PW, He Y, Pu M, Chen Y, DeBruine ZJ, Zhang B, Zaidi SA, Popov P, Guo Y, Han GW, Lu Y, Suino-Powell K, Dong S, Harikumar KG, Miller LJ, Katritch V, Xu HE, Shui W, Stevens RC, Melcher K, Zhao S, Xu F | 10.1038/S41586-018-0447-X | 2018-08-22 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | X-ray | 6DRX | 6DRX_refined | 3.1 | A | Intermediate | 41 | 59 | - | - | - | - | BRIL | - |
lisuride
|
small-molecule | Antagonist | 5-hydroxytryptamine | small-molecule | Yes | No | McCorvy JD, Wacker D, Wang S, Agegnehu B, Liu J, Lansu K, Tribo AR, Olsen RHJ, Che T, Jin J, Roth BL | 10.1038/s41594-018-0116-7 | 2018-08-29 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | X-ray | 6DRY | 6DRY_refined | 2.9 | A | Intermediate | 41 | 60 | - | - | - | - | BRIL | - |
methylergonovine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | McCorvy JD, Wacker D, Wang S, Agegnehu B, Liu J, Lansu K, Tribo AR, Olsen RHJ, Che T, Jin J, Roth BL | 10.1038/s41594-018-0116-7 | 2018-08-29 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | X-ray | 6DRZ | 6DRZ_refined | 3.1 | A | Intermediate | 41 | 61 | - | - | - | - | BRIL | - |
methysergide
|
small-molecule | Antagonist | 5-hydroxytryptamine | small-molecule | Yes | No | McCorvy JD, Wacker D, Wang S, Agegnehu B, Liu J, Lansu K, Tribo AR, Olsen RHJ, Che T, Jin J, Roth BL | 10.1038/s41594-018-0116-7 | 2018-08-29 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | X-ray | 6DS0 | 6DS0_refined | 3.2 | A | Intermediate | 41 | 59 | - | - | - | - | BRIL | - |
LY266097
|
small-molecule | Antagonist | 5-hydroxytryptamine | small-molecule | Yes | No | McCorvy JD, Wacker D, Wang S, Agegnehu B, Liu J, Lansu K, Tribo AR, Olsen RHJ, Che T, Jin J, Roth BL | 10.1038/s41594-018-0116-7 | 2018-08-29 | Yes | |
CALRL | calcitonin-like | Calcitonin | B1 | Human | Cryo-EM | 6E3Y | 6E3Y_refined | 3.3 | R | Active | 100 | 75 | Gs | αs | - | 48 | - | Nanobody-35 RAMP1 |
Calcitonin gene-related peptide 1
|
peptide | Agonist | - | - | No | No | Liang YL, Khoshouei M, Deganutti G, Glukhova A, Koole C, Peat TS, Radjainia M, Plitzko JM, Baumeister W, Miller LJ, Hay DL, Christopoulos A, Reynolds CA, Wootten D, Sexton PM | 10.1038/S41586-018-0535-Y | 2018-09-19 | Yes | |
PD2R2 | DP2 | Prostanoid | A | Human | X-ray | 6D26 | 6D26_refined | 2.8 | A | Inactive | 24 | 82 | - | - | - | - | T4-Lysozyme | - |
fevipiprant
|
small-molecule | Antagonist | PGD2, PGJ2, thromboxane A2, PGF2α, PGE2, PGI2, PGD3 | small-molecule | Yes | No | Wang L, Yao D, Deepak RNVK, Liu H, Xiao Q, Fan H, Gong W, Wei Z, Zhang C | 10.1016/J.MOLCEL.2018.08.009 | 2018-10-03 | Yes | |
PD2R2 | DP2 | Prostanoid | A | Human | X-ray | 6D27 | 6D27_refined | 2.7 | A | Inactive | 24 | 81 | - | - | - | - | T4-Lysozyme | - |
CHEMBL179036
|
small-molecule | Antagonist | PGD2, PGJ2, thromboxane A2, PGF2α, PGE2, PGI2, PGD3 | small-molecule | Yes | No | Wang L, Yao D, Deepak RNVK, Liu H, Xiao Q, Fan H, Gong W, Wei Z, Zhang C | 10.1016/J.MOLCEL.2018.08.009 | 2018-10-03 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FUF | 6FUF_refined | 3.1 | A | Active | 100 | 91 | Gi/o | αo | Mini-Go | 51 | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Tsai CJ, Pamula F, Nehme R, Muhle J, Weinert T, Flock T, Nogly P, Edwards PC, Carpenter B, Gruhl T, Ma P, Deupi X, Standfuss J, Tate CG, Schertler GFX | 10.1126/SCIADV.AAT7052 | 2018-10-03 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 6H7J | 6H7J_refined | 2.8 | A | Active | 99 | 60 | - | - | - | - | Thioredoxin 1 | Camelid antibody fragment Nb80 |
LEVISOPRENALINE
|
small-molecule | Agonist | - | - | Yes | No | Warne T, Edwards PC, Dore AS, Leslie AGW, Tate CG | 10.1126/SCIENCE.AAU5595 | 2018-10-17 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 6H7L | 6H7L_refined | 2.7 | A | Active | 99 | 60 | - | - | - | - | Thioredoxin 1 | Camelid antibody fragment Nb6B9 |
Dobutamine
|
small-molecule | Agonist | - | - | Yes | No | Warne T, Edwards PC, Dore AS, Leslie AGW, Tate CG | 10.1126/SCIENCE.AAU5595 | 2018-10-17 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 6H7M | 6H7M_refined | 2.8 | A | Active | 99 | 60 | - | - | - | - | Thioredoxin 1 | Camelid antibody fragment Nb6B9 |
levosalbutamol
|
small-molecule | Agonist | - | - | Yes | No | Warne T, Edwards PC, Dore AS, Leslie AGW, Tate CG | 10.1126/SCIENCE.AAU5595 | 2018-10-17 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 6H7N | 6H7N_refined | 2.5 | A | Active | 99 | 60 | - | - | - | - | Thioredoxin 1 | Camelid antibody fragment Nb6B9 |
(S)-Xamoterol
|
small-molecule | Agonist | - | - | Yes | No | Chaung K, Baharav TZ, Henderson G, Zheludev IN, Wang PL, Salzman J | 10.1101/436212 | 2018-10-17 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 6H7O | 6H7O_refined | 2.8 | A | Active | 99 | 60 | - | - | - | - | Thioredoxin 1 | Camelid antibody fragment Nb6B9 |
(S)-Cyanopindolol
|
small-molecule | Agonist | - | - | Yes | No | Warne T, Edwards PC, Dore AS, Leslie AGW, Tate CG | 10.1126/SCIENCE.AAU5595 | 2018-10-17 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | X-ray | 6AKX | 6AKX_refined | 2.8 | B | Inactive | 15 | 82 | - | - | - | - | Rubredoxin | - |
CHEMBL4238063
|
small-molecule | Antagonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | Peng P, Chen H, Zhu Y, Wang Z, Li J, Luo RH, Wang J, Chen L, Yang LM, Jiang H, Xie X, Wu B, Zheng YT, Liu H. | 10.1021/acs.jmedchem.8b01077 | 2018-10-24 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | X-ray | 6AKY | 6AKY_refined | 2.8 | A | Inactive | 15 | 81 | - | - | - | - | Rubredoxin | - |
CCR5 antagonist 34
|
small-molecule | Antagonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | Peng P, Chen H, Zhu Y, Wang Z, Li J, Luo RH, Wang J, Chen L, Yang LM, Jiang H, Xie X, Wu B, Zheng YT, Liu H. | 10.1021/acs.jmedchem.8b01077 | 2018-10-24 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6MXT | 6MXT_refined | 3.0 | A | Active | 98 | 69 | - | - | - | - | T4-Lysozyme | Nanobody-71 |
salmeterol
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Masureel M, Zou Y, Picard LP, van der Westhuizen E, Mahoney JP, Rodrigues JPGLM, Mildorf TJ, Dror RO, Shaw DE, Bouvier M, Pardon E, Steyaert J, Sunahara RK, Weis WI, Zhang C, Kobilka BK | 10.1038/s41589-018-0145-x | 2018-11-14 | Yes | |
MRGX4 | MRGPRX4 | A orphans | A | Human | Cryo-EM | 7S8P | 7S8P_refined | 2.6 | R | Active | 100 | 77 | Gq/11 | αq | Gq-Gs chimera | 57 | BRIL | scFv16 |
N-[(1r,3R,5S,7R)-3,5-dimethyltricyclo[3.3.1.1~3,7~]decane-1-carbonyl]-D-phenylalanine
|
small-molecule | Agonist | - | - | No | No | Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, Hayes BW, Liu J, Gumpper RH, Bender BJ, Slocum ST, Krumm BE, Lansu K, McCorvy JD, Kroeze WK, English JG, DiBerto JF, Olsen RHJ, Huang XP, Zhang S, Liu Y, Kim K, Karpiak J, Jan LY, Abraham SN, Jin J, Shoichet BK, Fay JF, Roth BL | 10.1038/S41586-021-04126-6 | 2021-11-17 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | X-ray | 5YC8 | 5YC8_refined | 2.5 | A | Inactive | 2 | 60 | - | - | - | - | BRIL | - |
N-methyl scopolamine
|
small-molecule | Antagonist | acetylcholine | small-molecule | No | No | Suno R, Lee S, Maeda S, Yasuda S, Yamashita K, Hirata K, Horita S, Tawaramoto MS, Tsujimoto H, Murata T, Kinoshita M, Yamamoto M, Kobilka BK, Vaidehi N, Iwata S, Kobayashi T | 10.1038/S41589-018-0152-Y | 2018-11-21 | Yes | |
5HT2C | 5-HT2C | 5-Hydroxytryptamine | A | Human | X-ray | 6BQH | 6BQH_refined | 2.7 | A | Inactive | 1 | 63 | - | - | - | - | BRIL | - |
ritanserin
|
small-molecule | Inverse agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Peng Y, McCorvy JD, Harpsoe K, Lansu K, Yuan S, Popov P, Qu L, Pu M, Che T, Nikolajsen LF, Huang XP, Wu Y, Shen L, Bjorn-Yoshimoto WE, Ding K, Wacker D, Han GW, Cheng J, Katritch V, Jensen AA, Hanson MA, Zhao S, Gloriam DE, Roth BL, Stevens RC, Liu ZJ | 10.1016/j.cell.2018.01.001 | 2018-02-14 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5WF5 | 5WF5_refined | 2.6 | A | Active | 67 | 69 | - | - | - | - | T4-Lysozyme | - |
UK-432,097
|
small-molecule | Agonist | adenosine | small-molecule | No | No | White KL, Eddy MT, Gao ZG, Han GW, Lian T, Deary A, Patel N, Jacobson KA, Katritch V, Stevens RC | 10.1016/J.STR.2017.12.013 | 2018-02-21 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 5WF6 | 5WF6_refined | 2.9 | A | Active | 67 | 68 | - | - | - | - | T4-Lysozyme | - |
UK-432,097
|
small-molecule | Agonist | adenosine | small-molecule | No | No | White KL, Eddy MT, Gao ZG, Han GW, Lian T, Deary A, Patel N, Jacobson KA, Katritch V, Stevens RC | 10.1016/J.STR.2017.12.013 | 2018-02-21 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 6B3J | 6B3J_refined | 3.3 | R | Active | 100 | 82 | Gs | αs | - | 49 | - | - |
Exendin-P5
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Liang YL, Khoshouei M, Glukhova A, Furness SGB, Zhao P, Clydesdale L, Koole C, Truong TT, Thal DM, Lei S, Radjainia M, Danev R, Baumeister W, Wang MW, Miller LJ, Christopoulos A, Sexton PM, Wootten D | 10.1038/NATURE25773 | 2018-02-21 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | X-ray | 6FFH | 6FFH_refined | 2.7 | A | Inactive | - | 21 | - | - | - | - | T4-Lysozyme | - |
fenobam
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Christopher JA, Orgovan Z, Congreve M, Dore AS, Errey JC, Marshall FH, Mason JS, Okrasa K, Rucktooa P, Serrano-Vega MJ, Ferenczy GG, Keseru GM | 10.1021/ACS.JMEDCHEM.7B01722 | 2018-03-07 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | X-ray | 6FFI | 6FFI_refined | 2.2 | A | Inactive | - | 20 | - | - | - | - | T4-Lysozyme | - |
methoxy-MPEP
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Christopher JA, Orgovan Z, Congreve M, Dore AS, Errey JC, Marshall FH, Mason JS, Okrasa K, Rucktooa P, Serrano-Vega MJ, Ferenczy GG, Keseru GM | 10.1021/ACS.JMEDCHEM.7B01722 | 2018-03-07 | Yes | |
DRD2 | D2 | Dopamine | A | Human | X-ray | 6CM4 | 6CM4_refined | 2.9 | A | Inactive | 1 | 59 | - | - | - | - | T4-Lysozyme | - |
risperidone
|
small-molecule | Inverse agonist | dopamine | small-molecule | Yes | No | Wang S, Che T, Levit A, Shoichet BK, Wacker D, Roth BL | 10.1038/NATURE25758 | 2018-03-14 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FK6 | 6FK6_refined | 2.4 | A | Active | 98 | 94 | - | - | - | - | - | - |
COMPOUND SUMMARY
|
small-molecule | Agonist | - | - | No | No | Mattle D, Kuhn B, Aebi J, Bedoucha M, Kekilli D, Grozinger N, Alker A, Rudolph MG, Schmid G, Schertler GFX, Hennig M, Standfuss J, Dawson RJP | 10.1073/PNAS.1718084115 | 2018-04-04 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FK7 | 6FK7_refined | 2.6 | A | Active | 98 | 94 | - | - | - | - | - | - |
(2~{S})-2-(4-chlorophenyl)-3-methyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one
|
small-molecule | Agonist | - | - | No | No | Mattle D, Kuhn B, Aebi J, Bedoucha M, Kekilli D, Grozinger N, Alker A, Rudolph MG, Schmid G, Schertler GFX, Hennig M, Standfuss J, Dawson RJP | 10.1073/PNAS.1718084115 | 2018-04-04 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FK8 | 6FK8_refined | 2.9 | A | Active | 98 | 94 | - | - | - | - | - | - |
(2~{R},3~{S})-3-azanyl-2-(4-chlorophenyl)-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one
|
small-molecule | Agonist | - | - | No | No | Mattle D, Kuhn B, Aebi J, Bedoucha M, Kekilli D, Grozinger N, Alker A, Rudolph MG, Schmid G, Schertler GFX, Hennig M, Standfuss J, Dawson RJP | 10.1073/PNAS.1718084115 | 2018-04-04 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FK9 | 6FK9_refined | 2.6 | A | Active | 98 | 94 | - | - | - | - | - | - |
(2~{S})-3-methyl-2-phenyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one
|
small-molecule | Agonist | - | - | No | No | Mattle D, Kuhn B, Aebi J, Bedoucha M, Kekilli D, Grozinger N, Alker A, Rudolph MG, Schmid G, Schertler GFX, Hennig M, Standfuss J, Dawson RJP | 10.1073/PNAS.1718084115 | 2018-04-04 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6FKA | 6FKA_refined | 2.7 | A | Active | 98 | 94 | - | - | - | - | - | - |
(2~{S})-2-(3,4-dichlorophenyl)-3-methyl-1-spiro[1,3-benzodioxole-2,4'-piperidine]-1'-yl-butan-1-one
|
small-molecule | Agonist | - | - | No | No | Mattle D, Kuhn B, Aebi J, Bedoucha M, Kekilli D, Grozinger N, Alker A, Rudolph MG, Schmid G, Schertler GFX, Hennig M, Standfuss J, Dawson RJP | 10.1073/PNAS.1718084115 | 2018-04-04 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | X-ray | 5ZK3 | 5ZK3_refined | 2.6 | A | Inactive | 2 | 59 | - | - | - | - | BRIL | - |
CHEMBL558910
|
small-molecule | Antagonist | acetylcholine | small-molecule | No | No | Suno R, Lee S, Maeda S, Yasuda S, Yamashita K, Hirata K, Horita S, Tawaramoto MS, Tsujimoto H, Murata T, Kinoshita M, Yamamoto M, Kobilka BK, Vaidehi N, Iwata S, Kobayashi T | 10.1038/S41589-018-0152-Y | 2018-11-21 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | X-ray | 5ZK8 | 5ZK8_refined | 3.0 | A | Inactive | 2 | 59 | - | - | - | - | BRIL | - |
N-methyl scopolamine
|
small-molecule | Antagonist | acetylcholine | small-molecule | Yes | No | Suno R, Lee S, Maeda S, Yasuda S, Yamashita K, Hirata K, Horita S, Tawaramoto MS, Tsujimoto H, Murata T, Kinoshita M, Yamamoto M, Kobilka BK, Vaidehi N, Iwata S, Kobayashi T | 10.1038/S41589-018-0152-Y | 2018-11-21 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | X-ray | 5ZKB | 5ZKB_refined | 3.0 | A | Inactive | 2 | 60 | - | - | - | - | BRIL | - |
AF-DX 384
|
small-molecule | Antagonist | acetylcholine | small-molecule | No | No | Suno R, Lee S, Maeda S, Yasuda S, Yamashita K, Hirata K, Horita S, Tawaramoto MS, Tsujimoto H, Murata T, Kinoshita M, Yamamoto M, Kobilka BK, Vaidehi N, Iwata S, Kobayashi T | 10.1038/S41589-018-0152-Y | 2018-11-21 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | X-ray | 5ZKC | 5ZKC_refined | 2.3 | A | Inactive | 2 | 60 | - | - | - | - | BRIL | - |
N-methyl scopolamine
|
small-molecule | Antagonist | acetylcholine | small-molecule | No | No | Suno R, Lee S, Maeda S, Yasuda S, Yamashita K, Hirata K, Horita S, Tawaramoto MS, Tsujimoto H, Murata T, Kinoshita M, Yamamoto M, Kobilka BK, Vaidehi N, Iwata S, Kobayashi T | 10.1038/S41589-018-0152-Y | 2018-11-21 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | X-ray | 6FJ3 | - | 2.5 | A | Inactive | 0 | 62 | - | - | - | - | GlgA glycogen synthase | - |
ePTH
|
peptide | Agonist (partial) | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Ehrenmann J, Schoppe J, Klenk C, Rappas M, Kummer L, Dore AS, Pluckthun A | 10.1038/S41594-018-0151-4 | 2018-11-21 | Yes | |
EDNRB | ETB | Endothelin | A | Human | X-ray | 6IGK | 6IGK_refined | 2.0 | A | Inactive | 4 | 70 | - | - | - | - | T4-Lysozyme | - |
endothelin-3
|
peptide | Agonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | Shihoya W, Izume T, Inoue A, Yamashita K, Kadji FMN, Hirata K, Aoki J, Nishizawa T, Nureki O | 10.1038/S41467-018-07094-0 | 2018-11-21 | Yes | |
EDNRB | ETB | Endothelin | A | Human | X-ray | 6IGL | - | 2.7 | A | Inactive | 4 | 70 | - | - | - | - | T4-Lysozyme | - |
sovateltide
|
peptide | Agonist (partial) | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | Shihoya W, Izume T, Inoue A, Yamashita K, Kadji FMN, Hirata K, Aoki J, Nishizawa T, Nureki O | 10.1038/S41467-018-07094-0 | 2018-11-21 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Rat | X-ray | 5ZHP | 5ZHP_refined | 3.1 | B | Inactive | 2 | 47 | - | - | - | - | T4-Lysozyme | - |
(1R,2R,4S,5S,7s)-7-({[4-fluoro-2-(thiophen-2-yl)phenyl]carbamoyl}oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-9-ium
|
small-molecule | Antagonist | acetylcholine | small-molecule | No | No | Liu H, Hofmann J, Fish I, Schaake B, Eitel K, Bartuschat A, Kaindl J, Rampp H, Banerjee A, Hubner H, Clark MJ, Vincent SG, Fisher JT, Heinrich MR, Hirata K, Liu X, Sunahara RK, Shoichet BK, Kobilka BK, Gmeiner P | 10.1073/PNAS.1813988115 | 2018-11-28 | Yes | |
PE2R4 | EP4 | Prostanoid | A | Human | X-ray | 5YHL | 5YHL_refined | 4.2 | A | Inactive | 9 | 57 | - | - | - | - | - | Fab |
ONO-AE3-208-Br
|
small-molecule | Antagonist | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | No | No | Toyoda Y, Morimoto K, Suno R, Horita S, Yamashita K, Hirata K, Sekiguchi Y, Yasuda S, Shiroishi M, Shimizu T, Urushibata Y, Kajiwara Y, Inazumi T, Hotta Y, Asada H, Nakane T, Shiimura Y, Nakagita T, Tsuge K, Yoshida S, Kuribara T, Hosoya T, Sugimoto Y, Nomura N, Sato M, Hirokawa T, Kinoshita M, Murata T, Takayama K, Yamamoto M, Narumiya S, Iwata S, Kobayashi T | 10.1038/S41589-018-0131-3 | 2018-12-05 | Yes | |
PE2R4 | EP4 | Prostanoid | A | Human | X-ray | 5YWY | 5YWY_refined | 3.2 | A | Inactive | 9 | 57 | - | - | - | - | - | Fab |
ONO-AE3-208
|
small-molecule | Antagonist | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | No | No | Toyoda Y, Morimoto K, Suno R, Horita S, Yamashita K, Hirata K, Sekiguchi Y, Yasuda S, Shiroishi M, Shimizu T, Urushibata Y, Kajiwara Y, Inazumi T, Hotta Y, Asada H, Nakane T, Shiimura Y, Nakagita T, Tsuge K, Yoshida S, Kuribara T, Hosoya T, Sugimoto Y, Nomura N, Sato M, Hirokawa T, Kinoshita M, Murata T, Takayama K, Yamamoto M, Narumiya S, Iwata S, Kobayashi T | 10.1038/S41589-018-0131-3 | 2018-12-05 | Yes | |
PE2R3 | EP3 | Prostanoid | A | Human | X-ray | 6AK3 | 6AK3_refined | 2.9 | B | Active | 86 | 69 | - | - | - | - | BRIL | - |
PGE2
|
small-molecule | Agonist | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | Yes | No | Morimoto K, Suno R, Hotta Y, Yamashita K, Hirata K, Yamamoto M, Narumiya S, Iwata S, Kobayashi T | 10.1038/S41589-018-0171-8 | 2018-12-05 | Yes | |
PE2R3 | EP3 | Prostanoid | A | Human | X-ray | 6M9T | 6M9T_refined | 2.5 | A | Active | 86 | 70 | - | - | - | - | T4-Lysozyme | - |
Misoprostol-FA
|
small-molecule | Agonist | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | Yes | No | Audet M, White KL, Breton B, Zarzycka B, Han GW, Lu Y, Gati C, Batyuk A, Popov P, Velasquez J, Manahan D, Hu H, Weierstall U, Liu W, Shui W, Katritch V, Cherezov V, Hanson MA, Stevens RC | 10.1038/S41589-018-0160-Y | 2018-12-05 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | X-ray | 6E59 | 6E59_refined | 3.4 | A | Inactive | 1 | 70 | - | - | - | - | GlgA glycogen synthase | - |
L760735
|
small-molecule | Antagonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Yin J, Chapman K, Clark LD, Shao Z, Borek D, Xu Q, Wang J, Rosenbaum DM | 10.1073/PNAS.1812717115 | 2018-12-12 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | Cryo-EM | 6MEO | 6MEO_refined | 3.9 | B | Inactive | 15 | 89 | - | - | - | - | - | T-cell surface glycoprotein CD4 |
Envelope glycoprotein gp160
|
protein | Antagonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | Shaik MM, Peng H, Lu J, Rits-Volloch S, Xu C, Liao M, Chen B | 10.1038/S41586-018-0804-9 | 2018-12-12 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | Cryo-EM | 6MET | 6MET_refined | 4.5 | B | Inactive | 15 | 89 | - | - | - | - | - | T-cell surface glycoprotein CD4 |
Envelope glycoprotein gp160
|
protein | Antagonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | Shaik MM, Peng H, Lu J, Rits-Volloch S, Xu C, Liao M, Chen B | 10.1038/S41586-018-0804-9 | 2018-12-12 | Yes | |
TA2R | TP | Prostanoid | A | Human | X-ray | 6IIU | 6IIU_refined | 2.5 | A | Intermediate | 41 | 87 | - | - | - | - | Rubredoxin | - |
ramatroban
|
small-molecule | Antagonist | PGD2, thromboxane A2, PGF2α, PGH2, PGE2, PGI2 | small-molecule | No | No | Fan H, Chen S, Yuan X, Han S, Zhang H, Xia W, Xu Y, Zhao Q, Wu B | 10.1038/S41589-018-0170-9 | 2018-12-19 | Yes | |
TA2R | TP | Prostanoid | A | Human | X-ray | 6IIV | 6IIV_refined | 3.0 | A | Intermediate | 41 | 87 | - | - | - | - | Rubredoxin | - |
daltroban
|
small-molecule | Antagonist | PGD2, thromboxane A2, PGF2α, PGH2, PGE2, PGI2 | small-molecule | No | No | Fan H, Chen S, Yuan X, Han S, Zhang H, Xia W, Xu Y, Zhao Q, Wu B | 10.1038/S41589-018-0170-9 | 2018-12-19 | Yes | |
CCR2 | CCR2 | Chemokine | A | Human | X-ray | 6GPS | 6GPS_refined | 3.3 | A | Inactive | 15 | 74 | - | - | - | - | Rubredoxin | - |
MK-0812
|
small-molecule | Antagonist | CCL16, CCL24, CCL7, CCL2, CCL13, CCL26, CCL11, CCL8 | peptide | No | No | Apel AK, Cheng RKY, Tautermann CS, Brauchle M, Huang CY, Pautsch A, Hennig M, Nar H, Schnapp G | 10.1016/J.STR.2018.10.027 | 2019-01-02 | Yes | |
CCR2 | CCR2 | Chemokine | A | Human | X-ray | 6GPX | 6GPX_refined | 2.7 | B | Inactive | 15 | 70 | - | - | - | - | Rubredoxin | - |
MK-0812
|
small-molecule | Antagonist | CCL16, CCL24, CCL7, CCL2, CCL13, CCL26, CCL11, CCL8 | peptide | No | No | Apel AK, Cheng RKY, Tautermann CS, Brauchle M, Huang CY, Pautsch A, Hennig M, Nar H, Schnapp G | 10.1016/J.STR.2018.10.027 | 2019-01-02 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | X-ray | 6IBL | 6IBL_refined | 2.7 | A | Active | 99 | 60 | - | - | - | - | Thioredoxin 1 | Camelid antibody fragment Nb80 |
arformoterol
|
small-molecule | Agonist | - | - | Yes | No | Lee Y, Warne T, Nehme R, Pandey S, Dwivedi-Agnihotri H, Chaturvedi M, Edwards PC, Garcia-Nafria J, Leslie AGW, Shukla AK, Tate CG | 10.1038/S41586-020-2419-1 | 2019-01-09 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | X-ray | 6HLL | 6HLL_refined | 3.3 | A | Inactive | 1 | 67 | - | - | - | - | GlgA glycogen synthase | - |
CP 99994
|
small-molecule | Antagonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Schoppe J, Ehrenmann J, Klenk C, Rucktooa P, Schutz M, Dore AS, Pluckthun A | 10.1038/S41467-018-07939-8 | 2019-01-16 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | X-ray | 6HLO | 6HLO_refined | 2.4 | A | Inactive | 1 | 70 | - | - | - | - | GlgA glycogen synthase | - |
aprepitant
|
small-molecule | Antagonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Schoppe J, Ehrenmann J, Klenk C, Rucktooa P, Schutz M, Dore AS, Pluckthun A | 10.1038/S41467-018-07939-8 | 2019-01-16 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | X-ray | 6HLP | 6HLP_refined | 2.2 | A | Inactive | 1 | 71 | - | - | - | - | GlgA glycogen synthase | - |
netupitant
|
small-molecule | Antagonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Schoppe J, Ehrenmann J, Klenk C, Rucktooa P, Schutz M, Dore AS, Pluckthun A | 10.1038/S41467-018-07939-8 | 2019-01-16 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6PRZ | 6PRZ_refined | 2.8 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
CHEMBL1160734
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6PS0 | 6PS0_refined | 3.4 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
carazolol
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6PS1 | 6PS1_refined | 3.2 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
timolol
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6PS2 | 6PS2_refined | 2.4 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
CHEMBL1160734
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6PS3 | 6PS3_refined | 2.5 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
CHEMBL3799125
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6PS4 | 6PS4_refined | 2.6 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
ICI 118551
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6PS5 | 6PS5_refined | 2.9 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
propranolol
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6PS6 | 6PS6_refined | 2.7 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
timolol
|
small-molecule | Antagonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6PS7 | 6PS7_refined | 1.9 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
MTR1A | MT1 | Melatonin | A | Human | X-ray | 6PS8 | 6PS8_refined | 3.3 | A | Inactive | 1 | 83 | - | - | - | - | GlgA glycogen synthase | - |
CHEMBL15060
|
small-molecule | Agonist | melatonin | small-molecule | No | No | Ishchenko A, Stauch B, Han GW, Batyuk A, Shiriaeva A, Li C, Zatsepin N, Weierstall U, Liu W, Nango E, Nakane T, Tanaka R, Tono K, Joti Y, Iwata S, Moraes I, Gati C, Cherezov V | 10.1107/S2052252519013137 | 2019-11-13 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | Cryo-EM | 6NI3 | 6NI3_refined | 3.8 | R | Active | 100 | 69 | Gs | αs | - | 59 | - | Nanobody-35 |
CHEMBL1615159
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Nguyen AH, Thomsen ARB, Cahill TJ 3rd, Huang R, Huang LY, Marcink T, Clarke OB, Heissel S, Masoudi A, Ben-Hail D, Samaan F, Dandey VP, Tan YZ, Hong C, Mahoney JP, Triest S, Little J 4th, Chen X, Sunahara R, Steyaert J, Molina H, Yu Z, des Georges A, Lefkowitz RJ | 10.1038/S41594-019-0330-Y | 2019-11-20 | Yes | |
DRD4 | D4 | Dopamine | A | Mouse | X-ray | 6IQL | 6IQL_refined | 3.5 | A | Inactive | 14 | 65 | - | - | - | - | BRIL | - |
L745870
|
small-molecule | Antagonist | - | - | Yes | No | Zhou Y, Cao C, He L, Wang X, Zhang XC | 10.7554/ELIFE.48822 | 2019-12-04 | Yes | |
ADA2C | α2C | Adrenoceptors | A | Human | X-ray | 6KUW | 6KUW_refined | 2.8 | A | Inactive | 1 | 60 | - | - | - | - | GlgA glycogen synthase | - |
(8Ar,12aS,13aR)-12-ethylsulfonyl-3-methoxy-5,6,8,8a,9,10,11,12a,13,13a-decahydroisoquinolino[2,1-g][1,6]naphthyridine
|
small-molecule | Antagonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | - | - | 2019-12-04 | Yes | |
ADA2A | α2A | Adrenoceptors | A | Human | X-ray | 6KUX | 6KUX_refined | 2.7 | A | Inactive | 1 | 57 | - | - | - | - | BRIL | - |
RSC
|
small-molecule | Antagonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | - | - | 2019-12-04 | Yes | |
ADA2A | α2A | Adrenoceptors | A | Human | X-ray | 6KUY | 6KUY_refined | 3.2 | A | Inactive | 1 | 56 | - | - | - | - | BRIL | - |
(2~{S})-4-fluoranyl-2-(1~{H}-imidazol-5-yl)-1-propan-2-yl-2,3-dihydroindole
|
small-molecule | Agonist (partial) | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | - | - | 2019-12-04 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Human | Cryo-EM | 6PWC | 6PWC_refined | 4.9 | R | Active | 100 | 77 | Beta | Beta-arrestin-1 | - | 84 | - | Fab30 heavy chain Fab30 light chain |
CHEMBL48981
|
protein | Agonist | neuromedin N, large neurotensin, neurotensin, large neuromedin N | peptide | Yes | No | Yin W, Li Z, Jin M, Yin YL, de Waal PW, Pal K, Yin Y, Gao X, He Y, Gao J, Wang X, Zhang Y, Zhou H, Melcher K, Jiang Y, Cong Y, Edward Zhou X, Yu X, Eric Xu H | 10.1038/S41422-019-0256-2 | 2019-12-04 | Yes | |
ACM5 | M5 | Acetylcholine (muscarinic) | A | Human | X-ray | 6OL9 | 6OL9_refined | 2.5 | A | Inactive | 2 | 53 | - | - | - | - | T4-Lysozyme | - |
tiotropium
|
small-molecule | Inverse agonist | acetylcholine | small-molecule | No | No | Vuckovic Z, Gentry PR, Berizzi AE, Hirata K, Varghese S, Thompson G, van der Westhuizen ET, Burger WAC, Rahmani R, Valant C, Langmead CJ, Lindsley CW, Baell JB, Tobin AB, Sexton PM, Christopoulos A, Thal DM | 10.1073/PNAS.1914446116 | 2019-12-11 | Yes | |
OPRD | δ | Opioid | A | Human | X-ray | 6PT2 | 6PT2_refined | 2.8 | A | Active | 67 | 78 | - | - | - | - | BRIL | - |
KGCHM07
|
peptide | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin | peptide | No | No | Claff T, Yu J, Blais V, Patel N, Martin C, Wu L, Han GW, Holleran BJ, Van der Poorten O, White KL, Hanson MA, Sarret P, Gendron L, Cherezov V, Katritch V, Ballet S, Liu ZJ, Muller CE, Stevens RC | 10.1126/SCIADV.AAX9115 | 2019-12-11 | Yes | |
OPRD | δ | Opioid | A | Human | X-ray | 6PT3 | 6PT3_refined | 3.3 | A | Active | 67 | 78 | - | - | - | - | BRIL | - |
DPI-287
|
small-molecule | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin | peptide | No | No | Claff T, Yu J, Blais V, Patel N, Martin C, Wu L, Han GW, Holleran BJ, Van der Poorten O, White KL, Hanson MA, Sarret P, Gendron L, Cherezov V, Katritch V, Ballet S, Liu ZJ, Muller CE, Stevens RC | 10.1126/SCIADV.AAX9115 | 2019-12-11 | Yes | |
CLTR2 | CysLT2 | Leukotriene | A | Human | X-ray | 6RZ6 | 6RZ6_refined | 2.4 | A | Intermediate | 41 | 82 | - | - | - | - | BRIL | - |
ONO-2570366
|
small-molecule | Antagonist | LTD4, LTC4, LTE4 | small-molecule | No | No | Gusach A, Luginina A, Marin E, Brouillette RL, Besserer-Offroy E, Longpre JM, Ishchenko A, Popov P, Patel N, Fujimoto T, Maruyama T, Stauch B, Ergasheva M, Romanovskaia D, Stepko A, Kovalev K, Shevtsov M, Gordeliy V, Han GW, Katritch V, Borshchevskiy V, Sarret P, Mishin A, Cherezov V | 10.1038/S41467-019-13348-2 | 2019-12-11 | Yes | |
CLTR2 | CysLT2 | Leukotriene | A | Human | X-ray | 6RZ7 | 6RZ7_refined | 2.4 | A | Intermediate | 41 | 79 | - | - | - | - | BRIL | - |
ONO-2570366
|
small-molecule | Antagonist | LTD4, LTC4, LTE4 | small-molecule | No | No | - | - | 2019-12-11 | Yes | |
CLTR2 | CysLT2 | Leukotriene | A | Human | X-ray | 6RZ8 | 6RZ8_refined | 2.7 | A | Intermediate | 41 | 78 | - | - | - | - | BRIL | - |
ONO-2080365
|
small-molecule | Antagonist | LTD4, LTC4, LTE4 | small-molecule | No | No | Gusach A, Luginina A, Marin E, Brouillette RL, Besserer-Offroy E, Longpre JM, Ishchenko A, Popov P, Patel N, Fujimoto T, Maruyama T, Stauch B, Ergasheva M, Romanovskaia D, Stepko A, Kovalev K, Shevtsov M, Gordeliy V, Han GW, Katritch V, Borshchevskiy V, Sarret P, Mishin A, Cherezov V | 10.1038/S41467-019-13348-2 | 2019-12-11 | Yes | |
CLTR2 | CysLT2 | Leukotriene | A | Human | X-ray | 6RZ9 | 6RZ9_refined | 2.7 | A | Intermediate | 41 | 81 | - | - | - | - | BRIL | - |
ONO-2770372
|
small-molecule | Antagonist | LTD4, LTC4, LTE4 | small-molecule | No | No | Gusach A, Luginina A, Marin E, Brouillette RL, Besserer-Offroy E, Longpre JM, Ishchenko A, Popov P, Patel N, Fujimoto T, Maruyama T, Stauch B, Ergasheva M, Romanovskaia D, Stepko A, Kovalev K, Shevtsov M, Gordeliy V, Han GW, Katritch V, Borshchevskiy V, Sarret P, Mishin A, Cherezov V | 10.1038/S41467-019-13348-2 | 2019-12-11 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TO7 | - | 2.3 | A | Inactive | 1 | 71 | - | - | - | - | - | - |
suvorexant
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TOD | - | 2.1 | A | Inactive | 1 | 71 | - | - | - | - | - | - |
EMPA
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TP3 | 6TP3_refined | 3.0 | A | Inactive | 1 | 74 | - | - | - | - | - | - |
daridorexant
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TP4 | - | 3.0 | A | Inactive | 1 | 70 | - | - | - | - | - | - |
ACT-462206
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TP6 | 6TP6_refined | 2.3 | B | Inactive | 1 | 71 | - | - | - | - | - | - |
filorexant
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX2R | OX2 | Orexin | A | Human | X-ray | 6TPG | 6TPG_refined | 2.7 | A | Inactive | 1 | 69 | - | - | - | - | GlgA glycogen synthase | - |
EMPA
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX2R | OX2 | Orexin | A | Human | X-ray | 6TPJ | 6TPJ_refined | 2.7 | A | Inactive | 1 | 68 | - | - | - | - | GlgA glycogen synthase | - |
suvorexant
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX2R | OX2 | Orexin | A | Human | X-ray | 6TPN | 6TPN_refined | 2.6 | A | Inactive | 1 | 71 | - | - | - | - | GlgA glycogen synthase | - |
HTL6641
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TQ4 | 6TQ4_refined | 2.3 | B | Inactive | 1 | 70 | - | - | - | - | - | - |
CHEMBL4590386
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TQ6 | 6TQ6_refined | 2.6 | B | Inactive | 1 | 71 | - | - | - | - | - | - |
CHEMBL4592653
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TQ7 | 6TQ7_refined | 2.7 | A | Inactive | 1 | 71 | - | - | - | - | - | - |
SB-334867
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TQ9 | 6TQ9_refined | 2.7 | B | Inactive | 1 | 71 | - | - | - | - | - | - |
SB-408124
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-01 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 6ORV | - | 3.0 | E | Active | 100 | 61 | Gs | αs | - | 49 | - | Nanobody-35 |
CHEMBL3950796
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhao P, Liang YL, Belousoff MJ, Deganutti G, Fletcher MM, Willard FS, Bell MG, Christe ME, Sloop KW, Inoue A, Truong TT, Clydesdale L, Furness SGB, Christopoulos A, Wang MW, Miller LJ, Reynolds CA, Danev R, Sexton PM, Wootten D | 10.1038/s41586-019-1902-z | 2020-01-08 | Yes | |
AGTR2 | AT2 | Angiotensin | A | Human | X-ray | 6JOD | 6JOD_refined | 3.2 | A | Active | 100 | 84 | - | - | - | - | BRIL | Heavy chain of 4A03Fab Light chain of 4A03Fab |
angiotensin II
|
peptide | Agonist | angiotensin-(1-7), angiotensin III, angiotensin II | peptide | Yes | No | Asada H, Inoue A, Ngako Kadji FM, Hirata K, Shiimura Y, Im D, Shimamura T, Nomura N, Iwanari H, Hamakubo T, Kusano-Arai O, Hisano H, Uemura T, Suno C, Aoki J, Iwata S | 10.1016/J.STR.2019.12.003 | 2020-01-15 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TOS | 6TOS_refined | 2.1 | B | Inactive | 1 | 72 | - | - | - | - | - | - |
CHEMBL2413522
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-15 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6TOT | 6TOT_refined | 2.2 | B | Inactive | 1 | 71 | - | - | - | - | - | - |
lemborexant
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. | 10.1021/acs.jmedchem.9b01787 | 2020-01-15 | Yes | |
APJ | apelin | Apelin | A | Human | X-ray | 6KNM | 6KNM_refined | 3.2 | B | Inactive | 4 | 78 | - | - | - | - | Rubredoxin | - |
Single domain antibody JN241
|
protein | Agonist | apelin-36, apelin-13, apelin receptor early endogenous ligand, Elabela/Toddler-32, Elabela/Toddler-11, [Pyr1]apelin-13, apelin-17, Elabela/Toddler-21 | peptide | Yes | No | Ma Y, Ding Y, Song X, Ma X, Li X, Zhang N, Song Y, Sun Y, Shen Y, Zhong W, Hu LA, Ma Y, Zhang MY | 10.1126/SCIADV.AAX7379 | 2020-01-29 | Yes | |
CRFR1 | CRF1 | Corticotropin-releasing factor | B1 | Human | Cryo-EM | 6P9X | - | 2.9 | R | Active | 100 | 65 | Gs | αs | - | 49 | - | Nanobody-35 |
Corticoliberin
|
peptide | Agonist | urocortin 1, corticotrophin-releasing hormone, urocortin 2 | peptide | No | No | Liang YL, Belousoff MJ, Zhao P, Koole C, Fletcher MM, Truong TT, Julita V, Christopoulos G, Xu HE, Zhang Y, Khoshouei M, Christopoulos A, Danev R, Sexton PM, Wootten D | 10.1016/J.MOLCEL.2020.01.012 | 2020-02-05 | Yes | |
PACR | PAC1 | VIP and PACAP | B1 | Human | Cryo-EM | 6P9Y | 6P9Y_refined | 3.0 | R | Active | 100 | 55 | Gs | αs | - | 49 | - | Nanobody-35 |
[Ac-His1]PACAP-27
|
peptide | Agonist | PHV, PACAP-38, PACAP-27, PHM, VIP, PHI | peptide | No | No | Liang YL, Belousoff MJ, Zhao P, Koole C, Fletcher MM, Truong TT, Julita V, Christopoulos G, Xu HE, Zhang Y, Khoshouei M, Christopoulos A, Danev R, Sexton PM, Wootten D | 10.1016/J.MOLCEL.2020.01.012 | 2020-02-05 | Yes | |
CNR2 | CB2 | Cannabinoid | A | Human | X-ray | 6KPC | 6KPC_refined | 3.2 | A | Inactive | 10 | 79 | - | - | - | - | T4-Lysozyme | - |
7-[(6aR,9R,10aR)-1-Hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-3-yl]-7-methyloctanenitrile
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Hua T, Li X, Wu L, Iliopoulos-Tsoutsouvas C, Wang Y, Wu M, Shen L, Brust CA, Nikas SP, Song F, Song X, Yuan S, Sun Q, Wu Y, Jiang S, Grim TW, Benchama O, Stahl EL, Zvonok N, Zhao S, Bohn LM, Makriyannis A, Liu ZJ | 10.1016/J.CELL.2020.01.008 | 2020-02-12 | Yes | |
CNR2 | CB2 | Cannabinoid | A | Human | Cryo-EM | 6KPF | 6KPF_refined | 2.9 | R | Active | 100 | 81 | Gi/o | αi1 | - | 62 | - | scFv16 |
7-[(6aR,9R,10aR)-1-Hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-3-yl]-7-methyloctanenitrile
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Hua T, Li X, Wu L, Iliopoulos-Tsoutsouvas C, Wang Y, Wu M, Shen L, Brust CA, Nikas SP, Song F, Song X, Yuan S, Sun Q, Wu Y, Jiang S, Grim TW, Benchama O, Stahl EL, Zvonok N, Zhao S, Bohn LM, Makriyannis A, Liu ZJ | 10.1016/J.CELL.2020.01.008 | 2020-02-12 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | Cryo-EM | 6KPG | 6KPG_refined | 3.0 | R | Active | 100 | 60 | Gi/o | αi1 | - | 64 | - | scFv16 |
AM841
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Hua T, Li X, Wu L, Iliopoulos-Tsoutsouvas C, Wang Y, Wu M, Shen L, Brust CA, Nikas SP, Song F, Song X, Yuan S, Sun Q, Wu Y, Jiang S, Grim TW, Benchama O, Stahl EL, Zvonok N, Zhao S, Bohn LM, Makriyannis A, Liu ZJ | 10.1016/J.CELL.2020.01.008 | 2020-02-12 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6NWE | 6NWE_refined | 2.7 | A | Active | 100 | 94 | Gi/o | αt1 | Only H5 | 3 | - | - |
B-Octylglucoside
|
small-molecule | unknown | - | - | No | No | - | - | 2020-02-12 | Yes | |
EDNRB | ETB | Endothelin | A | Human | X-ray | 6LRY | 6LRY_refined | 3.0 | A | Inactive | 14 | 70 | - | - | - | - | T4-Lysozyme | - |
sarafotoxin S6b
|
peptide | Agonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | Izume T, Miyauchi H, Shihoya W, Nureki O | 10.1016/J.BBRC.2019.12.091 | 2020-02-12 | Yes | |
CRFR1 | CRF1 | Corticotropin-releasing factor | B1 | Human | Cryo-EM | 6PB0 | - | 3.0 | R | Active | 100 | 68 | Gs | αs | Gs-Gi1 chimera | 58 | - | Nanobody-35 |
Urocortin
|
peptide | Agonist | urocortin 1, corticotrophin-releasing hormone, urocortin 2 | peptide | No | No | Ma S, Shen Q, Zhao LH, Mao C, Zhou XE, Shen DD, de Waal PW, Bi P, Li C, Jiang Y, Wang MW, Sexton PM, Wootten D, Melcher K, Zhang Y, Xu HE | 10.1016/J.MOLCEL.2020.01.013 | 2020-02-12 | Yes | |
CRFR2 | CRF2 | Corticotropin-releasing factor | B1 | Human | Cryo-EM | 6PB1 | 6PB1_refined | 2.8 | P | Active | 100 | 68 | Gs | αs | - | 58 | - | Nanobody-35 |
Urocortin
|
peptide | Agonist | urocortin 1, urocortin 3, corticotrophin-releasing hormone, urocortin 2 | peptide | No | No | Ma S, Shen Q, Zhao LH, Mao C, Zhou XE, Shen DD, de Waal PW, Bi P, Li C, Jiang Y, Wang MW, Sexton PM, Wootten D, Melcher K, Zhang Y, Xu HE | 10.1016/J.MOLCEL.2020.01.013 | 2020-02-12 | Yes | |
CNR2 | CB2 | Cannabinoid | A | Human | Cryo-EM | 6PT0 | 6PT0_refined | 3.2 | R | Active | 100 | 83 | Gi/o | αi1 | - | 100 | - | scFv16 |
WIN55212-2
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Xing C, Zhuang Y, Xu TH, Feng Z, Zhou XE, Chen M, Wang L, Meng X, Xue Y, Wang J, Liu H, McGuire TF, Zhao G, Melcher K, Zhang C, Xu HE, Xie XQ | 10.1016/J.CELL.2020.01.007 | 2020-02-12 | Yes | |
AGTR1 | AT1 | Angiotensin | A | Human | X-ray | 6OS0 | 6OS0_refined | 2.9 | A | Active | 96 | 85 | - | - | - | - | BRIL | Nanobody-Nb.AT110i1 |
angiotensin II
|
peptide | Agonist | angiotensin II, angiotensin III, angiotensin IV, angiotensin A | peptide | Yes | No | Wingler LM, Skiba MA, McMahon C, Staus DP, Kleinhenz ALW, Suomivuori CM, Latorraca NR, Dror RO, Lefkowitz RJ, Kruse AC | 10.1126/SCIENCE.AAY9813 | 2020-02-19 | Yes | |
AGTR1 | AT1 | Angiotensin | A | Human | X-ray | 6OS1 | - | 2.8 | A | Active | 96 | 85 | - | - | - | - | BRIL | Nanobody-Nb.AT110i1_le |
TRV023
|
peptide | Agonist | angiotensin II, angiotensin III, angiotensin IV, angiotensin A | peptide | Yes | No | Wingler LM, Skiba MA, McMahon C, Staus DP, Kleinhenz ALW, Suomivuori CM, Latorraca NR, Dror RO, Lefkowitz RJ, Kruse AC | 10.1126/SCIENCE.AAY9813 | 2020-02-19 | Yes | |
AGTR1 | AT1 | Angiotensin | A | Human | X-ray | 6OS2 | - | 2.7 | A | Active | 96 | 85 | - | - | - | - | BRIL | Nanobody-Nb.AT110i1_le |
TRV026
|
peptide | Agonist | angiotensin II, angiotensin III, angiotensin IV, angiotensin A | peptide | Yes | No | Wingler LM, Skiba MA, McMahon C, Staus DP, Kleinhenz ALW, Suomivuori CM, Latorraca NR, Dror RO, Lefkowitz RJ, Kruse AC | 10.1126/SCIENCE.AAY9813 | 2020-02-19 | Yes | |
GPR52 | GPR52 | A orphans | A | Human | X-ray | 6LI0 | 6LI0_refined | 2.2 | A | Inactive | 37 | 81 | - | - | - | - | Flavodoxin | - |
derivative 17 [Nakahata et al., 2018]
|
small-molecule | Agonist | - | - | Yes | No | Lin X, Li M, Wang N, Wu Y, Luo Z, Guo S, Han GW, Li S, Yue Y, Wei X, Xie X, Chen Y, Zhao S, Wu J, Lei M, Xu F | 10.1038/S41586-020-2019-0 | 2020-02-26 | Yes | |
GPR52 | GPR52 | A orphans | A | Human | X-ray | 6LI1 | 6LI1_refined | 2.9 | A | Inactive | 37 | 81 | - | - | - | - | Flavodoxin | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Li M, Wang N, Wu Y, Luo Z, Guo S, Han GW, Li S, Yue Y, Wei X, Xie X, Chen Y, Zhao S, Wu J, Lei M, Xu F | 10.1038/S41586-020-2019-0 | 2020-02-26 | Yes | |
GPR52 | GPR52 | A orphans | A | Human | X-ray | 6LI2 | 6LI2_refined | 2.8 | A | Inactive | 37 | 80 | - | - | - | - | Rubredoxin | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Li M, Wang N, Wu Y, Luo Z, Guo S, Han GW, Li S, Yue Y, Wei X, Xie X, Chen Y, Zhao S, Wu J, Lei M, Xu F | 10.1038/S41586-020-2019-0 | 2020-02-26 | Yes | |
GPR52 | GPR52 | A orphans | A | Human | Cryo-EM | 6LI3 | - | 3.3 | R | Active | 100 | 79 | Gs | αs | Mini-Gs | 61 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Li M, Wang N, Wu Y, Luo Z, Guo S, Han GW, Li S, Yue Y, Wei X, Xie X, Chen Y, Zhao S, Wu J, Lei M, Xu F | 10.1038/S41586-020-2019-0 | 2020-02-26 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | Cryo-EM | 6OMM | 6OMM_refined | 3.2 | R | Active | 100 | 85 | Gi/o | αi1 | - | 61 | - | - |
CHEMBL552527
|
protein | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Zhuang Y, Liu H, Edward Zhou X, Kumar Verma R, de Waal PW, Jang W, Xu TH, Wang L, Meng X, Zhao G, Kang Y, Melcher K, Fan H, Lambert NA, Eric Xu H, Zhang C | 10.1038/S41467-020-14728-9 | 2020-02-26 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 6U1N | 6U1N_refined | 4.0 | R | Active | 100 | 57 | Beta | Beta-arrestin-1 | - | 86 | - | Fab30 light chain Fab30 heavy chain |
LY2119620
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | Staus DP, Hu H, Robertson MJ, Kleinhenz ALW, Wingler LM, Capel WD, Latorraca NR, Lefkowitz RJ, Skiniotis G | 10.1038/S41586-020-1954-0 | 2020-02-26 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Human | Cryo-EM | 6UP7 | 6UP7_refined | 4.2 | R | Active | 100 | 77 | Beta | Beta-arrestin-1 | - | 83 | - | - |
JMV431
|
peptide | Agonist | neuromedin N, large neurotensin, neurotensin, large neuromedin N | peptide | Yes | No | Huang W, Masureel M, Qu Q, Janetzko J, Inoue A, Kato HE, Robertson MJ, Nguyen KC, Glenn JS, Skiniotis G, Kobilka BK | 10.1038/S41586-020-1953-1 | 2020-02-26 | Yes | |
DRD2 | D2 | Dopamine | A | Human | X-ray | 6LUQ | 6LUQ_refined | 3.1 | A | Inactive | 1 | 59 | - | - | - | - | T4-Lysozyme | - |
haloperidol
|
small-molecule | Antagonist | dopamine | small-molecule | Yes | No | Fan L, Tan L, Chen Z, Qi J, Nie F, Luo Z, Cheng J, Wang S | 10.1038/S41467-020-14884-Y | 2020-03-04 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | X-ray | 6KP6 | 6KP6_refined | 3.0 | A | Inactive | 2 | 59 | - | - | - | - | GlgA glycogen synthase | - |
Apo (no ligand)
|
none | Apo (no ligand) | acetylcholine | small-molecule | Yes | No | Wang J, Wu M, Wu L, Xu Y, Li F, Wu Y, Popov P, Wang L, Bai F, Zhao S, Liu ZJ, Hua T | 10.1107/S2052252520000597 | 2020-03-11 | Yes | |
PACR | PAC1 | VIP and PACAP | B1 | Human | Cryo-EM | 6LPB | - | 3.9 | R | Active | 100 | 71 | Gs | αs | - | 57 | - | Nanobody-35 |
[Ac-His1]PACAP-27
|
peptide | Agonist | PHV, PACAP-38, PACAP-27, PHM, VIP, PHI | peptide | No | No | Kobayashi K, Shihoya W, Nishizawa T, Kadji FMN, Aoki J, Inoue A, Nureki O | 10.1038/S41594-020-0386-8 | 2020-03-11 | Yes | |
PACR | PAC1 | VIP and PACAP | B1 | Human | Cryo-EM | 6M1H | - | 3.6 | A | Active | 100 | 73 | Gs | αs | - | 55 | - | Nanobody-35 |
maxadilan
|
peptide | Agonist | PHV, PACAP-38, PACAP-27, PHM, VIP, PHI | peptide | No | No | Wang J, Song X, Zhang D, Chen X, Li X, Sun Y, Li C, Song Y, Ding Y, Ren R, Harrington EH, Hu LA, Zhong W, Xu C, Huang X, Wang HW, Ma Y | 10.1038/S41422-020-0280-2 | 2020-03-11 | Yes | |
PACR | PAC1 | VIP and PACAP | B1 | Human | Cryo-EM | 6M1I | - | 3.5 | A | Active | 100 | 75 | Gs | αs | - | 57 | - | Nanobody-35 |
[Ac-His1]PACAP-27
|
peptide | Agonist | PHV, PACAP-38, PACAP-27, PHM, VIP, PHI | peptide | No | No | Wang J, Song X, Zhang D, Chen X, Li X, Sun Y, Li C, Song Y, Ding Y, Ren R, Harrington EH, Hu LA, Zhong W, Xu C, Huang X, Wang HW, Ma Y | 10.1038/S41422-020-0280-2 | 2020-03-11 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | X-ray | 6LN2 | 6LN2_refined | 3.2 | A | Inactive | 0 | 83 | - | - | - | - | - | Fab7F38 light chain Fab7F38 heavy chain |
PF-06372222
|
small-molecule | NAM | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Wu F, Yang L, Hang K, Laursen M, Wu L, Han GW, Ren Q, Roed NK, Lin G, Hanson MA, Jiang H, Wang MW, Reedtz-Runge S, Song G, Stevens RC | 10.1038/S41467-020-14934-5 | 2020-03-18 | Yes | |
OPRK | κ | Opioid | A | Human | X-ray | 6VI4 | 6VI4_refined | 3.3 | B | Inactive | 4 | 73 | - | - | - | - | - | Nanobody-6 |
JDTic
|
small-molecule | Antagonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Che T, English J, Krumm BE, Kim K, Pardon E, Olsen RHJ, Wang S, Zhang S, Diberto JF, Sciaky N, Carroll FI, Steyaert J, Wacker D, Roth BL | 10.1038/S41467-020-14889-7 | 2020-03-18 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | X-ray | 6LW5 | 6LW5_refined | 2.8 | A | Active | 100 | 91 | - | - | - | - | BRIL | - |
CHEMBL552527
|
protein | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Chen T, Xiong M, Zong X, Ge Y, Zhang H, Wang M, Won Han G, Yi C, Ma L, Ye RD, Xu Y, Zhao Q, Wu B | 10.1038/S41467-020-15009-1 | 2020-03-25 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6OBA | 6OBA_refined | 3.1 | A | Inactive | 0 | 68 | - | - | - | - | T4-Lysozyme | - |
CHEMBL1160734
AS408 |
small-molecule small-molecule |
Antagonist NAM |
L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Liu X, Kaindl J, Korczynska M, Stossel A, Dengler D, Stanek M, Hubner H, Clark MJ, Mahoney J, Matt RA, Xu X, Hirata K, Shoichet BK, Sunahara RK, Kobilka BK, Gmeiner P | 10.1038/S41589-020-0549-2 | 2020-03-25 | Yes | |
5HT2C | 5-HT2C | 5-Hydroxytryptamine | A | Human | X-ray | 6BQG | 6BQG_refined | 3.0 | A | Active | 88 | 62 | - | - | - | - | BRIL | - |
ergotamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Peng Y, McCorvy JD, Harpsoe K, Lansu K, Yuan S, Popov P, Qu L, Pu M, Che T, Nikolajsen LF, Huang XP, Wu Y, Shen L, Bjorn-Yoshimoto WE, Ding K, Wacker D, Han GW, Cheng J, Katritch V, Jensen AA, Hanson MA, Zhao S, Gloriam DE, Roth BL, Stevens RC, Liu ZJ | 10.1016/j.cell.2018.01.001 | 2018-02-14 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VUZ | 7VUZ_refined | 2.9 | R | Active | 100 | 76 | Gi/o | αi1 | - | 62 | - | scFv16 |
PAMP-12
|
peptide | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | Cryo-EM | 6N51 | 6N51_refined | 4.0 | B | Intermediate | - | 65 | - | - | - | - | - | Nanobody-43 |
quisqualate
|
small-molecule | Agonist | L-glutamic acid | small-molecule | No | No | Koehl A, Hu H, Feng D, Sun B, Zhang Y, Robertson MJ, Chu M, Kobilka TS, Laeremans T, Steyaert J, Tarrasch J, Dutta S, Fonseca R, Weis WI, Mathiesen JM, Skiniotis G, Kobilka BK | 10.1038/S41586-019-0881-4 | 2019-01-23 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | Cryo-EM | 6N52 | 6N52_refined | 4.0 | A | Inactive | - | 64 | - | - | - | - | - | Nanobody-43 | - | - | - | L-glutamic acid | small-molecule | No | No | Koehl A, Hu H, Feng D, Sun B, Zhang Y, Robertson MJ, Chu M, Kobilka TS, Laeremans T, Steyaert J, Tarrasch J, Dutta S, Fonseca R, Weis WI, Mathiesen JM, Skiniotis G, Kobilka BK | 10.1038/S41586-019-0881-4 | 2019-01-23 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 6NIY | 6NIY_refined | 3.3 | R | Active | 100 | 55 | Gs | αs | - | 43 | - | - |
Calcitonin salmon
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Dal Maso E, Glukhova A, Zhu Y, Garcia-Nafria J, Tate CG, Atanasio S, Reynolds CA, Ramirez-Aportela E, Carazo JM, Hick CA, Furness SGB, Hay DL, Liang YL, Miller LJ, Christopoulos A, Wang MW, Wootten D, Sexton PM | 10.1021/ACSPTSCI.8B00056 | 2019-01-23 | Yes | |
CNR2 | CB2 | Cannabinoid | A | Human | X-ray | 5ZTY | 5ZTY_refined | 2.8 | A | Inactive | 10 | 80 | - | - | - | - | T4-Lysozyme | - |
AM10257
|
small-molecule | Antagonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Li X, Hua T, Vemuri K, Ho JH, Wu Y, Wu L, Popov P, Benchama O, Zvonok N, Locke K, Qu L, Han GW, Iyer MR, Cinar R, Coffey NJ, Wang J, Wu M, Katritch V, Zhao S, Kunos G, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ | 10.1016/J.CELL.2018.12.011 | 2019-01-30 | Yes | |
AGTR1 | AT1 | Angiotensin | A | Human | X-ray | 6DO1 | 6DO1_refined | 2.9 | A | Active | 96 | 85 | - | - | - | - | BRIL | Nanobody-Nb.AT110i1 |
CHEMBL404594
|
protein | Agonist | angiotensin II, angiotensin III, angiotensin IV, angiotensin A | peptide | Yes | No | Wingler LM, McMahon C, Staus DP, Lefkowitz RJ, Kruse AC | 10.1016/J.CELL.2018.12.006 | 2019-01-30 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | Cryo-EM | 6N4B | 6N4B_refined | 3.0 | R | Active | 100 | 58 | Gi/o | αi1 | - | 62 | - | scFv16 |
MDMB-Fubinaca
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Krishna Kumar K, Shalev-Benami M, Robertson MJ, Hu H, Banister SD, Hollingsworth SA, Latorraca NR, Kato HE, Hilger D, Maeda S, Weis WI, Farrens DL, Dror RO, Malhotra SV, Kobilka BK, Skiniotis G | 10.1016/J.CELL.2018.11.040 | 2019-01-30 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 6A93 | 6A93_refined | 3.0 | A | Inactive | 1 | 60 | - | - | - | - | BRIL | - |
risperidone
|
small-molecule | Antagonist | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Kimura KT, Asada H, Inoue A, Kadji FMN, Im D, Mori C, Arakawa T, Hirata K, Nomura Y, Nomura N, Aoki J, Iwata S, Shimamura T | 10.1038/S41594-018-0180-Z | 2019-02-13 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 6A94 | 6A94_refined | 2.9 | A | Inactive | 1 | 60 | - | - | - | - | BRIL | - |
zotepine
|
small-molecule | Antagonist | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Kimura KT, Asada H, Inoue A, Kadji FMN, Im D, Mori C, Arakawa T, Hirata K, Nomura Y, Nomura N, Aoki J, Iwata S, Shimamura T | 10.1038/S41594-018-0180-Z | 2019-02-13 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | X-ray | 6J20 | 6J20_refined | 2.7 | A | Inactive | 1 | 71 | - | - | - | - | T4-Lysozyme | - |
aprepitant
|
small-molecule | Antagonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | No | No | Chen S, Lu M, Liu D, Yang L, Yi C, Ma L, Zhang H, Liu Q, Frimurer TM, Wang MW, Schwartz TW, Stevens RC, Wu B, Wuthrich K, Zhao Q | 10.1038/S41467-019-08568-5 | 2019-03-06 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | X-ray | 6J21 | 6J21_refined | 3.2 | A | Inactive | 1 | 71 | - | - | - | - | T4-Lysozyme | - |
aprepitant
|
small-molecule | Antagonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Chen S, Lu M, Liu D, Yang L, Yi C, Ma L, Zhang H, Liu Q, Frimurer TM, Wang MW, Schwartz TW, Stevens RC, Wu B, Wuthrich K, Zhao Q | 10.1038/S41467-019-08568-5 | 2019-03-06 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 6NBF | - | 3.0 | R | Active | 100 | 62 | Gs | αs | - | 58 | - | Nanobody-35 |
Long-acting parathyroid hormone analog
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Zhao LH, Ma S, Sutkeviciute I, Shen DD, Zhou XE, de Waal PW, Li CY, Kang Y, Clark LJ, Jean-Alphonse FG, White AD, Yang D, Dai A, Cai X, Chen J, Li C, Jiang Y, Watanabe T, Gardella TJ, Melcher K, Wang MW, Vilardaga JP, Xu HE, Zhang Y | 10.1126/SCIENCE.AAV7942 | 2019-04-17 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 6NBH | - | 3.5 | R | Active | 100 | 64 | Gs | αs | - | 57 | - | Nanobody-35 |
Long-acting parathyroid hormone analog
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Zhao LH, Ma S, Sutkeviciute I, Shen DD, Zhou XE, de Waal PW, Li CY, Kang Y, Clark LJ, Jean-Alphonse FG, White AD, Yang D, Dai A, Cai X, Chen J, Li C, Jiang Y, Watanabe T, Gardella TJ, Melcher K, Wang MW, Vilardaga JP, Xu HE, Zhang Y | 10.1126/SCIENCE.AAV7942 | 2019-04-17 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 6NBI | - | 4.0 | R | Active | 100 | 62 | Gs | αs | - | 56 | - | Nanobody-35 |
Long-acting parathyroid hormone analog
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Zhao LH, Ma S, Sutkeviciute I, Shen DD, Zhou XE, de Waal PW, Li CY, Kang Y, Clark LJ, Jean-Alphonse FG, White AD, Yang D, Dai A, Cai X, Chen J, Li C, Jiang Y, Watanabe T, Gardella TJ, Melcher K, Wang MW, Vilardaga JP, Xu HE, Zhang Y | 10.1126/SCIENCE.AAV7942 | 2019-04-17 | Yes | |
MTR1A | MT1 | Melatonin | A | Human | X-ray | 6ME2 | 6ME2_refined | 2.8 | A | Inactive | 1 | 83 | - | - | - | - | GlgA glycogen synthase | - |
ramelteon
|
small-molecule | Agonist | melatonin | small-molecule | No | No | Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, Gati C, Batyuk A, Slocum ST, Ishchenko A, Brehm W, White TA, Michaelian N, Madsen C, Zhu L, Grant TD, Grandner JM, Shiriaeva A, Olsen RHJ, Tribo AR, Yous S, Stevens RC, Weierstall U, Katritch V, Roth BL, Liu W, Cherezov V | 10.1038/S41586-019-1141-3 | 2019-04-24 | Yes | |
MTR1A | MT1 | Melatonin | A | Human | X-ray | 6ME3 | 6ME3_refined | 2.9 | A | Inactive | 1 | 82 | - | - | - | - | GlgA glycogen synthase | - |
CHEMBL15060
|
small-molecule | Agonist | melatonin | small-molecule | No | No | Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, Gati C, Batyuk A, Slocum ST, Ishchenko A, Brehm W, White TA, Michaelian N, Madsen C, Zhu L, Grant TD, Grandner JM, Shiriaeva A, Olsen RHJ, Tribo AR, Yous S, Stevens RC, Weierstall U, Katritch V, Roth BL, Liu W, Cherezov V | 10.1038/S41586-019-1141-3 | 2019-04-24 | Yes | |
ACM1 | M1 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 6OIJ | 6OIJ_refined | 3.3 | R | Active | 100 | 64 | Gq/11 | α11 | - | 63 | - | Antibody fragment |
iperoxo
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | Maeda S, Qu Q, Robertson MJ, Skiniotis G, Kobilka BK | 10.1126/SCIENCE.AAW5188 | 2019-05-08 | Yes | |
MTR1A | MT1 | Melatonin | A | Human | X-ray | 6ME4 | 6ME4_refined | 3.2 | A | Inactive | 1 | 83 | - | - | - | - | GlgA glycogen synthase | - |
2-iodo-melatonin
|
small-molecule | Agonist | melatonin | small-molecule | No | No | Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, Gati C, Batyuk A, Slocum ST, Ishchenko A, Brehm W, White TA, Michaelian N, Madsen C, Zhu L, Grant TD, Grandner JM, Shiriaeva A, Olsen RHJ, Tribo AR, Yous S, Stevens RC, Weierstall U, Katritch V, Roth BL, Liu W, Cherezov V | 10.1038/S41586-019-1141-3 | 2019-04-24 | Yes | |
MTR1A | MT1 | Melatonin | A | Human | X-ray | 6ME5 | 6ME5_refined | 3.2 | A | Inactive | 1 | 83 | - | - | - | - | GlgA glycogen synthase | - |
agomelatine
|
small-molecule | Agonist | melatonin | small-molecule | No | No | Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, Gati C, Batyuk A, Slocum ST, Ishchenko A, Brehm W, White TA, Michaelian N, Madsen C, Zhu L, Grant TD, Grandner JM, Shiriaeva A, Olsen RHJ, Tribo AR, Yous S, Stevens RC, Weierstall U, Katritch V, Roth BL, Liu W, Cherezov V | 10.1038/S41586-019-1141-3 | 2019-04-24 | Yes | |
GP119 | GPR119 | GPR18, GPR55 and GPR119 | A | Human | Cryo-EM | 7XZ5 | - | 3.1 | R | Active | 100 | 87 | Gs | αs | - | 60 | BRIL | Nanobody-35 |
(4R,7R,18E)-4,7-dihydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphaheptacos-18-en-1-aminium 4-oxide
|
small-molecule | Agonist | N-palmitoylethanolamine, SEA, N-oleoylethanolamide, anandamide | small-molecule | Yes | No | Xu P, Huang S, Guo S, Yun Y, Cheng X, He X, Cai P, Lan Y, Zhou H, Jiang H, Jiang Y, Xie X, Xu HE | 10.1038/S41594-022-00816-5 | 2022-08-24 | Yes | |
MTR1B | MT2 | Melatonin | A | Human | X-ray | 6ME6 | 6ME6_refined | 2.8 | B | Inactive | 1 | 78 | - | - | - | - | Rubredoxin | - |
CHEMBL15060
|
small-molecule | Agonist | melatonin | small-molecule | No | No | Johansson LC, Stauch B, McCorvy JD, Han GW, Patel N, Huang XP, Batyuk A, Gati C, Slocum ST, Li C, Grandner JM, Hao S, Olsen RHJ, Tribo AR, Zaare S, Zhu L, Zatsepin NA, Weierstall U, Yous S, Stevens RC, Liu W, Roth BL, Katritch V, Cherezov V | 10.1038/S41586-019-1144-0 | 2019-04-24 | Yes | |
MTR1B | MT2 | Melatonin | A | Human | X-ray | 6ME7 | 6ME7_refined | 3.2 | A | Inactive | 1 | 79 | - | - | - | - | Rubredoxin | - |
CHEMBL15060
|
small-molecule | Agonist | melatonin | small-molecule | No | No | Johansson LC, Stauch B, McCorvy JD, Han GW, Patel N, Huang XP, Batyuk A, Gati C, Slocum ST, Li C, Grandner JM, Hao S, Olsen RHJ, Tribo AR, Zaare S, Zhu L, Zatsepin NA, Weierstall U, Yous S, Stevens RC, Liu W, Roth BL, Katritch V, Cherezov V | 10.1038/S41586-019-1144-0 | 2019-04-24 | Yes | |
MTR1B | MT2 | Melatonin | A | Human | X-ray | 6ME8 | 6ME8_refined | 3.1 | B | Inactive | 1 | 78 | - | - | - | - | Rubredoxin | - |
CHEMBL15060
|
small-molecule | Agonist | melatonin | small-molecule | Yes | No | Johansson LC, Stauch B, McCorvy JD, Han GW, Patel N, Huang XP, Batyuk A, Gati C, Slocum ST, Li C, Grandner JM, Hao S, Olsen RHJ, Tribo AR, Zaare S, Zhu L, Zatsepin NA, Weierstall U, Yous S, Stevens RC, Liu W, Roth BL, Katritch V, Cherezov V | 10.1038/S41586-019-1144-0 | 2019-04-24 | Yes | |
MTR1B | MT2 | Melatonin | A | Human | X-ray | 6ME9 | 6ME9_refined | 3.3 | B | Inactive | 1 | 79 | - | - | - | - | Rubredoxin | - |
ramelteon
|
small-molecule | Agonist | melatonin | small-molecule | No | No | Johansson LC, Stauch B, McCorvy JD, Han GW, Patel N, Huang XP, Batyuk A, Gati C, Slocum ST, Li C, Grandner JM, Hao S, Olsen RHJ, Tribo AR, Zaare S, Zhu L, Zatsepin NA, Weierstall U, Yous S, Stevens RC, Liu W, Roth BL, Katritch V, Cherezov V | 10.1038/S41586-019-1144-0 | 2019-04-24 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6MH8 | 6MH8_refined | 4.2 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Martin-Garcia JM, Zhu L, Mendez D, Lee MY, Chun E, Li C, Hu H, Subramanian G, Kissick D, Ogata C, Henning R, Ishchenko A, Dobson Z, Zhang S, Weierstall U, Spence JCH, Fromme P, Zatsepin NA, Fischetti RF, Cherezov V, Liu W | 10.1107/S205225251900263X | 2019-04-24 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 6OIK | 6OIK_refined | 3.6 | R | Active | 100 | 60 | Gi/o | αo | - | 61 | - | - |
LY2119620
iperoxo |
small-molecule small-molecule |
Ago-PAM Agonist |
acetylcholine | small-molecule | Yes | No | Maeda S, Qu Q, Robertson MJ, Skiniotis G, Kobilka BK | 10.1126/SCIENCE.AAW5188 | 2019-05-08 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6E67 | 6E67_refined | 3.7 | B | Active | 100 | 72 | Gs | αs | Fused partial Gs | 44 | T4-Lysozyme | - |
CHEMBL1615159
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Liu X, Xu X, Hilger D, Aschauer P, Tiemann JKS, Du Y, Liu H, Hirata K, Sun X, Guixa-Gonzalez R, Mathiesen JM, Hildebrand PW, Kobilka BK | 10.1016/J.CELL.2019.04.021 | 2019-06-05 | Yes | |
SMO | SMO | Frizzled | F | Human | Cryo-EM | 6OT0 | - | 3.9 | R | Active | 100 | 46 | Gi/o | αi1 | - | 100 | - | Fab light chain Fab heavy chain |
24,25-Epoxy-cholesterol
|
small-molecule | Agonist | - | - | No | No | Qi X, Liu H, Thompson B, McDonald J, Zhang C, Li X | 10.1038/S41586-019-1286-0 | 2019-06-12 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6GT3 | 6GT3_refined | 2.0 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
imaradenant
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | - | - | 2019-06-26 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 6N48 | 6N48_refined | 3.2 | A | Active | 99 | 70 | - | - | - | - | T4-Lysozyme | Camelid Antibody Fragment |
CHEMBL1615159
2-[[(3R)-4-(4-Tert-butylphenyl)-3-[[2-(4-methoxyphenyl)sulfanyl-5-[methyl(propan-2-yl)sulfamoyl]benzoyl]amino]butanoyl]amino]acetic acid |
small-molecule small-molecule |
Agonist PAM |
L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Liu X, Masoudi A, Kahsai AW, Huang LY, Pani B, Staus DP, Shim PJ, Hirata K, Simhal RK, Schwalb AM, Rambarat PK, Ahn S, Lefkowitz RJ, Kobilka B | 10.1126/SCIENCE.AAW8981 | 2019-06-26 | Yes | |
B1B1U5 | Rhodopsin | Opsins | A | Hasarius adansoni | X-ray | 6I9K | - | 2.2 | A | Inactive | 16 | 83 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | Yes | No | Varma N, Mutt E, Muhle J, Panneels V, Terakita A, Deupi X, Nogly P, Schertler GFX, Lesca E | 10.1073/PNAS.1902192116 | 2019-07-03 | Yes | |
SMO | SMO | Frizzled | F | Mouse | X-ray | 6O3C | 6O3C_refined | 2.8 | A | Active | 95 | 61 | - | - | - | - | - | Nanobody-Smo8 |
SAG21k
|
small-molecule | Agonist | - | - | No | No | Deshpande I, Liang J, Hedeen D, Roberts KJ, Zhang Y, Ha B, Latorraca NR, Faust B, Dror RO, Beachy PA, Myers BR, Manglik A | 10.1038/S41586-019-1355-4 | 2019-07-03 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Human | Cryo-EM | 6OS9 | 6OS9_refined | 3.0 | R | Active | 100 | 73 | Gi/o | αi1 | - | 62 | - | scFv16 |
JMV449
|
peptide | Agonist | neuromedin N, large neurotensin, neurotensin, large neuromedin N | peptide | Yes | No | Kato HE, Zhang Y, Hu H, Suomivuori CM, Kadji FMN, Aoki J, Krishna Kumar K, Fonseca R, Hilger D, Huang W, Latorraca NR, Inoue A, Dror RO, Kobilka BK, Skiniotis G | 10.1038/S41586-019-1337-6 | 2019-07-10 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Human | Cryo-EM | 6OSA | - | 3.0 | R | Active | 100 | 77 | Gi/o | αi1 | Non-canonical conformation | 62 | - | - |
JMV449
|
peptide | Agonist | neuromedin N, large neurotensin, neurotensin, large neuromedin N | peptide | Yes | No | Kato HE, Zhang Y, Hu H, Suomivuori CM, Kadji FMN, Aoki J, Krishna Kumar K, Fonseca R, Hilger D, Huang W, Latorraca NR, Inoue A, Dror RO, Kobilka BK, Skiniotis G | 10.1038/S41586-019-1337-6 | 2019-07-10 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | Cryo-EM | 6QNO | - | 4.4 | R | Active | 100 | 96 | Gi/o | αi1 | - | 60 | - | Fab antibody fragment light chain Fab antibody fragment heavy chain |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Tsai CJ, Marino J, Adaixo R, Pamula F, Muehle J, Maeda S, Flock T, Taylor NM, Mohammed I, Matile H, Dawson RJ, Deupi X, Stahlberg H, Schertler G | 10.7554/ELIFE.46041 | 2019-07-10 | Yes | |
EDNRB | ETB | Endothelin | A | Human | X-ray | 6K1Q | 6K1Q_refined | 2.7 | A | Inactive | 4 | 68 | - | - | - | - | T4-Lysozyme | - |
IRL 2500
|
peptide | Inverse agonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | Nagiri C, Shihoya W, Inoue A, Kadji FMN, Aoki J, Nureki O | 10.1038/S42003-019-0482-7 | 2019-07-17 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | Cryo-EM | 6OY9 | - | 3.9 | R | Active | 100 | 94 | Gi/o | αt1 | - | 64 | - | - |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Gao Y, Hu H, Ramachandran S, Erickson JW, Cerione RA, Skiniotis G | 10.1016/J.MOLCEL.2019.06.007 | 2019-07-24 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | Cryo-EM | 6OYA | - | 3.3 | R | Active | 100 | 94 | Gi/o | αt1 | - | 59 | - | Camelid antibody VHH fragment |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Gao Y, Hu H, Ramachandran S, Erickson JW, Cerione RA, Skiniotis G | 10.1016/J.MOLCEL.2019.06.007 | 2019-07-24 | Yes | |
SUCR1 | succinate | Succinate | A | Rat | X-ray | 6IBB | 6IBB_refined | 2.1 | A | Active | 67 | 93 | - | - | - | - | - | Nanobody-6 | - | - | - | - | - | Yes | No | Haffke M, Fehlmann D, Rummel G, Boivineau J, Duckely M, Gommermann N, Cotesta S, Sirockin F, Freuler F, Littlewood-Evans A, Kaupmann K, Jaakola VP | 10.1038/S41586-019-1663-8 | 2019-08-14 | Yes | |
SUCR1 | succinate | Succinate | A | Rat | X-ray | 6RNK | 6RNK_refined | 1.9 | A | Active | 67 | 90 | - | - | - | - | - | Nanobody-6 |
NF-56-EJ40
|
small-molecule | Antagonist | - | - | Yes | No | Haffke M, Fehlmann D, Rummel G, Boivineau J, Duckely M, Gommermann N, Cotesta S, Sirockin F, Freuler F, Littlewood-Evans A, Kaupmann K, Jaakola VP | 10.1038/S41586-019-1663-8 | 2019-08-14 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | Cryo-EM | 6OFJ | 6OFJ_refined | 4.5 | A | Inactive | 21 | 93 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Zhao DY, Poge M, Morizumi T, Gulati S, Van Eps N, Zhang J, Miszta P, Filipek S, Mahamid J, Plitzko JM, Baumeister W, Ernst OP, Palczewski K | 10.1074/JBC.RA119.010089 | 2019-08-21 | Yes | |
CCR7 | CCR7 | Chemokine | A | Human | X-ray | 6QZH | 6QZH_refined | 2.1 | A | Inactive | 5 | 71 | - | - | - | - | Sialidase NanA | - |
SCHEMBL13407377
|
small-molecule | Allosteric antagonist | CCL21, CCL19 | peptide | No | No | Jaeger K, Bruenle S, Weinert T, Guba W, Muehle J, Miyazaki T, Weber M, Furrer A, Haenggi N, Tetaz T, Huang CY, Mattle D, Vonach JM, Gast A, Kuglstatter A, Rudolph MG, Nogly P, Benz J, Dawson RJP, Standfuss J | 10.1016/J.CELL.2019.07.028 | 2019-09-04 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | X-ray | 6KQI | 6KQI_refined | 3.3 | A | Inactive | 10 | 60 | - | - | - | - | GlgA glycogen synthase | - |
CP55940
Org27569 |
small-molecule small-molecule |
Agonist NAM |
anandamide, 2-arachidonoylglycerol | small-molecule | No | No | Shao Z, Yan W, Chapman K, Ramesh K, Ferrell AJ, Yin J, Wang X, Xu Q, Rosenbaum DM | 10.1038/S41589-019-0387-2 | 2019-10-23 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6JZH | 6JZH_refined | 2.3 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Shimazu Y, Tono K, Tanaka T, Yamanaka Y, Nakane T, Mori C, Terakado Kimura K, Fujiwara T, Sugahara M, Tanaka R, Doak RB, Shimamura T, Iwata S, Nango E, Yabashi M | 10.1107/S1600576719012846 | 2019-10-30 | Yes | |
CLTR1 | CysLT1 | Leukotriene | A | Human | X-ray | 6RZ4 | 6RZ4_refined | 2.7 | A | Intermediate | 41 | 85 | - | - | - | - | BRIL | - |
pranlukast
|
small-molecule | Antagonist | LTD4, LTC4, LTE4 | small-molecule | Yes | Yes | Luginina A, Gusach A, Marin E, Mishin A, Brouillette R, Popov P, Shiriaeva A, Besserer-Offroy E, Longpre JM, Lyapina E, Ishchenko A, Patel N, Polovinkin V, Safronova N, Bogorodskiy A, Edelweiss E, Hu H, Weierstall U, Liu W, Batyuk A, Gordeliy V, Han GW, Sarret P, Katritch V, Borshchevskiy V, Cherezov V | 10.1126/SCIADV.AAX2518 | 2019-10-30 | Yes | |
CLTR1 | CysLT1 | Leukotriene | A | Human | X-ray | 6RZ5 | 6RZ5_refined | 2.5 | B | Intermediate | 41 | 84 | - | - | - | - | BRIL | - |
zafirlukast
|
small-molecule | Antagonist | LTD4, LTC4, LTE4 | small-molecule | Yes | Yes | Luginina A, Gusach A, Marin E, Mishin A, Brouillette R, Popov P, Shiriaeva A, Besserer-Offroy E, Longpre JM, Lyapina E, Ishchenko A, Patel N, Polovinkin V, Safronova N, Bogorodskiy A, Edelweiss E, Hu H, Weierstall U, Liu W, Batyuk A, Gordeliy V, Han GW, Sarret P, Katritch V, Borshchevskiy V, Cherezov V | 10.1126/SCIADV.AAX2518 | 2019-10-30 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | X-ray | 6KJV | 6KJV_refined | 2.8 | B | Inactive | 0 | 57 | - | - | - | - | T4-Lysozyme | - |
PF-06372222
|
small-molecule | NAM | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Xu Y, Wang Y, Wang Y, Liu K, Peng Y, Yao D, Tao H, Liu H, Song G | 10.1107/S2052252519013496 | 2019-11-13 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | X-ray | 6KK1 | 6KK1_refined | 2.8 | B | Inactive | 0 | 57 | - | - | - | - | T4-Lysozyme | - |
PF-06372222
|
small-molecule | NAM | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Xu Y, Wang Y, Wang Y, Liu K, Peng Y, Yao D, Tao H, Liu H, Song G | 10.1107/S2052252519013496 | 2019-11-13 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | X-ray | 6KK7 | 6KK7_refined | 3.1 | B | Inactive | 0 | 56 | - | - | - | - | T4-Lysozyme | - |
PF-06372222
|
small-molecule | NAM | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Xu Y, Wang Y, Wang Y, Liu K, Peng Y, Yao D, Tao H, Liu H, Song G | 10.1107/S2052252519013496 | 2019-11-13 | Yes | |
CALRL | calcitonin-like | Calcitonin | B1 | Human | Cryo-EM | 6UUN | - | 3.0 | R | Active | 100 | 77 | Gs | αs | - | 48 | - | Nanobody-35 RAMP2 |
Adrenomedullin
|
peptide | Agonist | - | - | No | No | Liang YL, Belousoff MJ, Fletcher MM, Zhang X, Khoshouei M, Deganutti G, Koole C, Furness SGB, Miller LJ, Hay DL, Christopoulos A, Reynolds CA, Danev R, Wootten D, Sexton PM | 10.1021/ACSPTSCI.9B00080 | 2020-03-25 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | Cryo-EM | 6LMK | 6LMK_refined | 3.7 | R | Active | 100 | 83 | Gs | αs | - | 59 | - | Nanobody-35 |
glucagon
|
peptide | Agonist | glucagon | peptide | No | No | Qiao A, Han S, Li X, Li Z, Zhao P, Dai A, Chang R, Tai L, Tan Q, Chu X, Ma L, Thorsen TS, Reedtz-Runge S, Yang D, Wang MW, Sexton PM, Wootten D, Sun F, Zhao Q, Wu B | 10.1126/SCIENCE.AAZ5346 | 2020-04-01 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | Cryo-EM | 6LML | 6LML_refined | 3.9 | R | Active | 100 | 83 | Gi/o | αi1 | - | 63 | - | scFv16 |
glucagon
|
peptide | Agonist | glucagon | peptide | No | No | Qiao A, Han S, Li X, Li Z, Zhao P, Dai A, Chang R, Tai L, Tan Q, Chu X, Ma L, Thorsen TS, Reedtz-Runge S, Yang D, Wang MW, Sexton PM, Wootten D, Sun F, Zhao Q, Wu B | 10.1126/SCIENCE.AAZ5346 | 2020-04-01 | Yes | |
CALRL | calcitonin-like | Calcitonin | B1 | Human | Cryo-EM | 6UUS | 6UUS_refined | 2.4 | R | Active | 100 | 74 | Gs | αs | - | 48 | - | Nanobody-35 RAMP3 |
Adrenomedullin
|
peptide | Agonist | - | - | No | No | Liang YL, Belousoff MJ, Fletcher MM, Zhang X, Khoshouei M, Deganutti G, Koole C, Furness SGB, Miller LJ, Hay DL, Christopoulos A, Reynolds CA, Danev R, Wootten D, Sexton PM | 10.1021/ACSPTSCI.9B00080 | 2020-04-01 | Yes | |
CALRL | calcitonin-like | Calcitonin | B1 | Human | Cryo-EM | 6UVA | - | 2.3 | R | Active | 100 | 75 | Gs | αs | - | 48 | - | Nanobody-35 RAMP3 |
adrenomedullin 2/intermedin
|
peptide | Agonist | - | - | No | No | Liang YL, Belousoff MJ, Fletcher MM, Zhang X, Khoshouei M, Deganutti G, Koole C, Furness SGB, Miller LJ, Hay DL, Christopoulos A, Reynolds CA, Danev R, Wootten D, Sexton PM | 10.1021/ACSPTSCI.9B00080 | 2020-04-01 | Yes | |
ADA2B | α2B | Adrenoceptors | A | Human | Cryo-EM | 6K41 | - | 2.9 | R | Active | 100 | 54 | Gi/o | αo | - | 60 | T4-Lysozyme | scFv |
dexmedetomidine
|
small-molecule | Agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Yuan D, Liu Z, Kaindl J, Maeda S, Zhao J, Sun X, Xu J, Gmeiner P, Wang HW, Kobilka BK | 10.1038/S41589-020-0492-2 | 2020-04-15 | Yes | |
ADA2B | α2B | Adrenoceptors | A | Human | Cryo-EM | 6K42 | - | 4.1 | R | Active | 100 | 60 | Gi/o | αi1 | - | 62 | T4-Lysozyme | scFv |
dexmedetomidine
|
small-molecule | Agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Yuan D, Liu Z, Kaindl J, Maeda S, Zhao J, Sun X, Xu J, Gmeiner P, Wang HW, Kobilka BK | 10.1038/S41589-020-0492-2 | 2020-04-15 | Yes | |
MC4R | MC4 | Melanocortin | A | Human | X-ray | 6W25 | - | 2.8 | A | Intermediate | 46 | 79 | - | - | - | - | GlgA glycogen synthase | - |
SHU9119
Calcium |
peptide small-molecule |
Antagonist Cofactor |
ACTH, β-MSH, γ-MSH, α-MSH, agouti-related protein | peptide | Yes | No | Yu J, Gimenez LE, Hernandez CC, Wu Y, Wein AH, Han GW, McClary K, Mittal SR, Burdsall K, Stauch B, Wu L, Stevens SN, Peisley A, Williams SY, Chen V, Millhauser GL, Zhao S, Cone RD, Stevens RC | 10.1126/SCIENCE.AAZ8995 | 2020-04-29 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | Cryo-EM | 6WHC | 6WHC_refined | 3.4 | R | Active | 100 | 78 | Gs | αs | - | 56 | - | Nanobody-35 |
Dual-agonist peptide P15
|
peptide | Agonist | glucagon | peptide | No | No | Chang R, Zhang X, Qiao A, Dai A, Belousoff MJ, Tan Q, Shao L, Zhong L, Lin G, Liang YL, Ma L, Han S, Yang D, Danev R, Wang MW, Wootten D, Wu B, Sexton PM | 10.1074/JBC.RA120.013793 | 2020-05-27 | Yes | |
GABR1 | GABAB1 | GABAB | C | Human | Cryo-EM | 6W2Y | - | 3.2 | B | Inactive | - | 69 | - | - | - | - | - | - |
CGP55845
1-Stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine |
small-molecule small-molecule |
Inverse agonist NAM |
GABA | small-molecule | No | No | Papasergi-Scott MM, Robertson MJ, Seven AB, Panova O, Mathiesen JM, Skiniotis G | 10.1038/S41586-020-2469-4 | 2020-07-01 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 6WIV | - | 3.3 | B | Inactive | - | 71 | - | - | - | - | - | - |
(2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-{[(9Z)-octadec-9-enoyl]oxy}propyl(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
[(2R)-3-[(Z)-icos-11-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethylphosphate |
small-molecule small-molecule |
NAM | - | - | No | No | Park J, Fu Z, Frangaj A, Liu J, Mosyak L, Shen T, Slavkovich VN, Ray KM, Taura J, Cao B, Geng Y, Zuo H, Kou Y, Grassucci R, Chen S, Liu Z, Lin X, Williams JP, Rice WJ, Eng ET, Huang RK, Soni RK, Kloss B, Yu Z, Javitch JA, Hendrickson WA, Slesinger PA, Quick M, Graziano J, Yu H, Fiehn O, Clarke OB, Frank J, Fan QR | 10.1038/S41586-020-2452-0 | 2020-07-01 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 7C7Q | - | 3.0 | B | Active | - | 71 | - | - | - | - | - | - |
(-)-baclofen
BHFF |
small-molecule small-molecule |
Agonist PAM |
- | - | No | No | Mao C, Shen C, Li C, Shen DD, Xu C, Zhang S, Zhou R, Shen Q, Chen LN, Jiang Z, Liu J, Zhang Y | 10.1038/S41422-020-0350-5 | 2020-07-01 | Yes | |
SCTR | secretin | Glucagon | B1 | Human | Cryo-EM | 7D3S | 7D3S_refined | 2.9 | R | Active | 100 | 60 | Gs | αs | - | 58 | - | Nanobody-35 |
SECRETIN
|
protein | Agonist | VIP, secretin | peptide | No | No | Fukuhara S, Kobayashi K, Kusakizako T, Iida W, Kato M, Shihoya W, Nureki O | 10.1016/J.BBRC.2020.08.042 | 2020-11-04 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 7CA3 | - | 4.5 | B | Active | - | 72 | - | - | - | - | - | - |
BHFF
|
small-molecule | PAM | - | - | No | No | Kim Y, Jeong E, Jeong JH, Kim Y, Cho Y | 10.1016/J.JMB.2020.09.023 | 2020-11-11 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 7CA5 | - | 7.6 | B | Inactive | - | 70 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Kim Y, Jeong E, Jeong JH, Kim Y, Cho Y | 10.1016/J.JMB.2020.09.023 | 2020-11-11 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 7CUM | - | 3.5 | B | Inactive | - | 72 | - | - | - | - | - | - |
CGP 54626A
Unknown ligand |
small-molecule none |
NAM | - | - | No | No | Kim Y, Jeong E, Jeong JH, Kim Y, Cho Y | 10.1016/J.JMB.2020.09.023 | 2020-11-11 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6WQA | 6WQA_refined | 2.0 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Lee MY, Geiger J, Ishchenko A, Han GW, Barty A, White TA, Gati C, Batyuk A, Hunter MS, Aquila A, Boutet S, Weierstall U, Cherezov V, Liu W | 10.1107/S2052252520012701 | 2020-11-18 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 6XOX | - | 3.1 | R | Active | 100 | 82 | Gs | αs | - | 56 | - | scFv16 Nanobody-35 |
oforglipron
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Kawai T, Sun B, Yoshino H, Feng D, Suzuki Y, Fukazawa M, Nagao S, Wainscott DB, Showalter AD, Droz BA, Kobilka TS, Coghlan MP, Willard FS, Kawabe Y, Kobilka BK, Sloop KW | 10.1073/PNAS.2014879117 | 2020-11-18 | Yes | |
GHRHR | GHRH | Glucagon | B1 | Human | Cryo-EM | 7CZ5 | 7CZ5_refined | 2.6 | R | Active | 100 | 64 | Gs | αs | - | 58 | - | Nanobody-35 |
Somatoliberin
|
peptide | Agonist | GHRH | peptide | No | No | Zhou F, Zhang H, Cong Z, Zhao LH, Zhou Q, Mao C, Cheng X, Shen DD, Cai X, Ma C, Wang Y, Dai A, Zhou Y, Sun W, Zhao F, Zhao S, Jiang H, Jiang Y, Yang D, Eric Xu H, Zhang Y, Wang MW | 10.1038/S41467-020-18945-0 | 2020-11-18 | Yes | |
PE2R4 | EP4 | Prostanoid | A | Human | Cryo-EM | 7D7M | 7D7M_refined | 3.3 | A | Active | 100 | 58 | Gs | αs | - | 58 | - | Nanobody-35 |
PGE2
|
small-molecule | Agonist | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | No | No | Nojima S, Fujita Y, Kimura KT, Nomura N, Suno R, Morimoto K, Yamamoto M, Noda T, Iwata S, Shigematsu H, Kobayashi T | 10.1016/J.STR.2020.11.007 | 2020-11-18 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6LPJ | 6LPJ_refined | 1.8 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Ihara K, Hato M, Nakane T, Yamashita K, Kimura-Someya T, Hosaka T, Ishizuka-Katsura Y, Tanaka R, Tanaka T, Sugahara M, Hirata K, Yamamoto M, Nureki O, Tono K, Nango E, Iwata S, Shirouzu M | 10.1038/S41598-020-76277-X | 2020-11-25 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6LPK | 6LPK_refined | 1.8 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Ihara K, Hato M, Nakane T, Yamashita K, Kimura-Someya T, Hosaka T, Ishizuka-Katsura Y, Tanaka R, Tanaka T, Sugahara M, Hirata K, Yamamoto M, Nureki O, Tono K, Nango E, Iwata S, Shirouzu M | 10.1038/S41598-020-76277-X | 2020-11-25 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6LPL | 6LPL_refined | 2.0 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Ihara K, Hato M, Nakane T, Yamashita K, Kimura-Someya T, Hosaka T, Ishizuka-Katsura Y, Tanaka R, Tanaka T, Sugahara M, Hirata K, Yamamoto M, Nureki O, Tono K, Nango E, Iwata S, Shirouzu M | 10.1038/S41598-020-76277-X | 2020-11-25 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Human | X-ray | 7BTS | 7BTS_refined | 3.1 | A | Active | 99 | 58 | - | - | - | - | T4-Lysozyme | Camelid antibody fragment Nb6B9 |
(-)-adrenaline
|
small-molecule | Agonist | L-NOREPINEPHRINE, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Xu X, Kaindl J, Clark MJ, Hubner H, Hirata K, Sunahara RK, Gmeiner P, Kobilka BK, Liu X | 10.1038/S41422-020-00424-2 | 2020-12-02 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Human | X-ray | 7BU6 | 7BU6_refined | 2.7 | A | Active | 99 | 58 | - | - | - | - | T4-Lysozyme | Camelid antibody fragment Nb6B9 |
Noradrenaline
|
small-molecule | Agonist | L-NOREPINEPHRINE, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Xu X, Kaindl J, Clark MJ, Hubner H, Hirata K, Sunahara RK, Gmeiner P, Kobilka BK, Liu X | 10.1038/S41422-020-00424-2 | 2020-12-02 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Human | X-ray | 7BU7 | 7BU7_refined | 2.6 | A | Active | 99 | 58 | - | - | - | - | T4-Lysozyme | Camelid antibody fragment Nb6B9 |
CHEMBL1615159
|
small-molecule | Agonist | L-NOREPINEPHRINE, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Xu X, Kaindl J, Clark MJ, Hubner H, Hirata K, Sunahara RK, Gmeiner P, Kobilka BK, Liu X | 10.1038/S41422-020-00424-2 | 2020-12-02 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Human | X-ray | 7BVQ | 7BVQ_refined | 2.5 | A | Inactive | 0 | 60 | - | - | - | - | T4-Lysozyme | - |
Carazolol
|
small-molecule | Inverse agonist | L-NOREPINEPHRINE, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Xu X, Kaindl J, Clark MJ, Hubner H, Hirata K, Sunahara RK, Gmeiner P, Kobilka BK, Liu X | 10.1038/S41422-020-00424-2 | 2020-12-02 | Yes | |
STE2 | STE2 | STE2 | D1 | strain ATCC 204508 / S288c | Cryo-EM | 7AD3 | - | 3.5 | A | Active | - | 69 | GPa1 family | αPa1 | Two alpha subunits bound to STE2 dimer | 46 | - | - |
Alpha-factor mating pheromone
|
peptide | Agonist | - | - | No | No | Velazhahan V, Ma N, Pandy-Szekeres G, Kooistra AJ, Lee Y, Gloriam DE, Vaidehi N, Tate CG | 10.1038/S41586-020-2994-1 | 2020-12-09 | Yes | |
GLP2R | GLP-2 | Glucagon | B1 | Human | Cryo-EM | 7D68 | - | 3.0 | R | Active | 100 | 53 | Gs | αs | - | 57 | - | Nanobody-35 |
glucagon
|
peptide | Agonist | glucagon-like peptide 2, glucagon-like peptide 2-(3-33) | peptide | No | No | Sun W, Chen LN, Zhou Q, Zhao LH, Yang D, Zhang H, Cong Z, Shen DD, Zhao F, Zhou F, Cai X, Chen Y, Zhou Y, Gadgaard S, van der Velden WJC, Zhao S, Jiang Y, Rosenkilde MM, Xu HE, Zhang Y, Wang MW | 10.1038/S41422-020-00442-0 | 2020-12-16 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | Cryo-EM | 7DHI | - | 3.3 | R | Active | 100 | 70 | Gs | αs | - | 55 | - | Nanobody-35 |
levosalbutamol
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Liu QS, An HW, Wang XF, Kong FP, Sun YC, Gong YX, Lou SF, Shi YF, Sun N, Deng B, Wang J, Wang JJ | 10.1093/NSR/NWAA284 | 2020-12-16 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | Cryo-EM | 7DHR | 7DHR_refined | 3.8 | R | Active | 100 | 69 | Gs | αs | - | 49 | - | Nanobody-35 |
LEVISOPRENALINE
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Liu QS, An HW, Wang XF, Kong FP, Sun YC, Gong YX, Lou SF, Shi YF, Sun N, Deng B, Wang J, Wang JJ | 10.1093/NSR/NWAA284 | 2020-12-16 | Yes | |
DRD2 | D2 | Dopamine | A | Human | X-ray | 7DFP | 7DFP_refined | 3.1 | A | Inactive | 1 | 57 | - | - | - | - | BRIL | Fab heavy chain Fab light chain |
spiperone
|
small-molecule | Antagonist | dopamine | small-molecule | No | No | Im D, Inoue A, Fujiwara T, Nakane T, Yamanaka Y, Uemura T, Mori C, Shiimura Y, Kimura KT, Asada H, Nomura N, Tanaka T, Yamashita A, Nango E, Tono K, Kadji FMN, Aoki J, Iwata S, Shimamura T | 10.1038/S41467-020-20221-0 | 2020-12-30 | Yes | |
NPY2R | Y2 | Neuropeptide Y | A | Human | X-ray | 7DDZ | 7DDZ_refined | 2.8 | A | Inactive | 1 | 76 | - | - | - | - | Flavodoxin | - |
CHEMBL1823578
|
small-molecule | Antagonist | neuropeptide Y-(3-36), peptide YY, pancreatic polypeptide, PYY-(3-36), neuropeptide Y | peptide | Yes | No | Tang T, Hartig C, Chen Q, Zhao W, Kaiser A, Zhang X, Zhang H, Qu H, Yi C, Ma L, Han S, Zhao Q, Beck-Sickinger AG, Wu B | 10.1038/S41467-021-21030-9 | 2021-01-27 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | Cryo-EM | 7L0P | - | 4.1 | C | Active | 100 | 73 | Gi/o | αi1 | - | 63 | - | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Zhang M, Gui M, Wang ZF, Gorgulla C, Yu JJ, Wu H, Sun ZJ, Klenk C, Merklinger L, Morstein L, Hagn F, Pluckthun A, Brown A, Nasr ML, Wagner G | 10.1038/S41594-020-00554-6 | 2021-01-06 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | Cryo-EM | 7L0Q | - | 4.3 | C | Active | 100 | 73 | Gi/o | αi1 | - | 95 | - | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Zhang M, Gui M, Wang ZF, Gorgulla C, Yu JJ, Wu H, Sun ZJ, Klenk C, Merklinger L, Morstein L, Hagn F, Pluckthun A, Brown A, Nasr ML, Wagner G | 10.1038/S41594-020-00554-6 | 2021-01-06 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | Cryo-EM | 7L0R | - | 4.2 | C | Active | 100 | 73 | Gi/o | αi1 | Non-canonical conformation | 63 | - | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Zhang M, Gui M, Wang ZF, Gorgulla C, Yu JJ, Wu H, Sun ZJ, Klenk C, Merklinger L, Morstein L, Hagn F, Pluckthun A, Brown A, Nasr ML, Wagner G | 10.1038/S41594-020-00554-6 | 2021-01-06 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | Cryo-EM | 7L0S | - | 4.5 | C | Active | 100 | 73 | Gi/o | αi1 | Non-canonical conformation | 95 | - | - |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Zhang M, Gui M, Wang ZF, Gorgulla C, Yu JJ, Wu H, Sun ZJ, Klenk C, Merklinger L, Morstein L, Hagn F, Pluckthun A, Brown A, Nasr ML, Wagner G | 10.1038/S41594-020-00554-6 | 2021-01-06 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7LCI | 7LCI_refined | 2.9 | R | Active | 100 | 85 | Gs | αs | - | 62 | - | - |
danuglipron
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhang X, Johnson RM, Drulyte I, Yu L, Kotecha A, Danev R, Wootten D, Sexton PM, Belousoff MJ | 10.1016/J.STR.2021.04.008 | 2021-01-20 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7LCJ | 7LCJ_refined | 2.8 | R | Active | 98 | 84 | - | - | - | - | - | - |
danuglipron
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhang X, Johnson RM, Drulyte I, Yu L, Kotecha A, Danev R, Wootten D, Sexton PM, Belousoff MJ | 10.1016/J.STR.2021.04.008 | 2021-01-20 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7LCK | 7LCK_refined | 3.2 | R | Active | 98 | 84 | - | - | - | - | - | - |
danuglipron
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhang X, Johnson RM, Drulyte I, Yu L, Kotecha A, Danev R, Wootten D, Sexton PM, Belousoff MJ | 10.1016/J.STR.2021.04.008 | 2021-01-20 | Yes | |
AGRG3 | ADGRG3 | ADGRG | B2 | Human | Cryo-EM | 7D76 | - | 3.1 | R | Active | - | 48 | Gi/o | αo | - | 61 | - | - |
Beclomethasone
|
small-molecule | Agonist | - | - | No | No | Ping YQ, Mao C, Xiao P, Zhao RJ, Jiang Y, Yang Z, An WT, Shen DD, Yang F, Zhang H, Qu C, Shen Q, Tian C, Li ZJ, Li S, Wang GY, Tao X, Wen X, Zhong YN, Yang J, Yi F, Yu X, Xu HE, Zhang Y, Sun JP | 10.1038/S41586-020-03083-W | 2021-02-03 | Yes | |
AGRG3 | ADGRG3 | ADGRG | B2 | Human | Cryo-EM | 7D77 | - | 2.9 | R | Active | - | 48 | Gi/o | αo | - | 61 | - | scFv16 |
HYDROCORTISONE
|
small-molecule | Agonist | - | - | No | No | Ping YQ, Mao C, Xiao P, Zhao RJ, Jiang Y, Yang Z, An WT, Shen DD, Yang F, Zhang H, Qu C, Shen Q, Tian C, Li ZJ, Li S, Wang GY, Tao X, Wen X, Zhong YN, Yang J, Yi F, Yu X, Xu HE, Zhang Y, Sun JP | 10.1038/S41586-020-03083-W | 2021-02-03 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 6YVR | - | 2.5 | B | Inactive | 3 | 83 | - | - | - | - | DARPin D12 | - |
JMV431
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Deluigi M, Klipp A, Klenk C, Merklinger L, Eberle SA, Morstein L, Heine P, Mittl PRE, Ernst P, Kamenecka TM, He Y, Vacca S, Egloff P, Honegger A, Pluckthun A | 10.1126/sciadv.abe5504 | 2021-02-10 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 6Z4Q | - | 2.9 | A | Inactive | 30 | 75 | - | - | - | - | DARPin D12 | - |
SR142948A
|
small-molecule | Inverse agonist | neuromedin N, neurotensin | peptide | Yes | No | Deluigi M, Klipp A, Klenk C, Merklinger L, Eberle SA, Morstein L, Heine P, Mittl PRE, Ernst P, Kamenecka TM, He Y, Vacca S, Egloff P, Honegger A, Pluckthun A | 10.1126/sciadv.abe5504 | 2021-02-10 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 6Z4S | - | 2.7 | A | Inactive | 3 | 77 | - | - | - | - | DARPin D12 | - |
meclinertant
|
small-molecule | Inverse agonist | neuromedin N, neurotensin | peptide | Yes | No | Deluigi M, Klipp A, Klenk C, Merklinger L, Eberle SA, Morstein L, Heine P, Mittl PRE, Ernst P, Kamenecka TM, He Y, Vacca S, Egloff P, Honegger A, Pluckthun A | 10.1126/sciadv.abe5504 | 2021-02-10 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 6Z4V | - | 2.6 | A | Intermediate | 14 | 79 | - | - | - | - | DARPin D12 | - |
JMV431
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Deluigi M, Klipp A, Klenk C, Merklinger L, Eberle SA, Morstein L, Heine P, Mittl PRE, Ernst P, Kamenecka TM, He Y, Vacca S, Egloff P, Honegger A, Pluckthun A | 10.1126/sciadv.abe5504 | 2021-02-10 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 6Z66 | 6Z66_refined | 3.2 | A | Intermediate | 14 | 80 | - | - | - | - | DARPin D12 | - |
Apo (no ligand)
|
none | Apo (no ligand) | neuromedin N, neurotensin | peptide | Yes | No | Deluigi M, Klipp A, Klenk C, Merklinger L, Eberle SA, Morstein L, Heine P, Mittl PRE, Ernst P, Kamenecka TM, He Y, Vacca S, Egloff P, Honegger A, Pluckthun A | 10.1126/sciadv.abe5504 | 2021-02-10 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 6Z8N | 6Z8N_refined | 2.8 | A | Intermediate | 14 | 80 | - | - | - | - | DARPin D12 | - |
(2~{S})-4-methyl-2-[(1-quinolin-8-ylsulfonylindol-3-yl)carbonylamino]pentanoic acid
|
small-molecule | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Deluigi M, Klipp A, Klenk C, Merklinger L, Eberle SA, Morstein L, Heine P, Mittl PRE, Ernst P, Kamenecka TM, He Y, Vacca S, Egloff P, Honegger A, Pluckthun A | 10.1126/sciadv.abe5504 | 2021-02-10 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 6ZA8 | 6ZA8_refined | 2.7 | A | Intermediate | 14 | 78 | - | - | - | - | DARPin D12 | - |
CHEMBL508044
|
small-molecule | Agonist (partial) | neuromedin N, neurotensin | peptide | Yes | No | Deluigi M, Klipp A, Klenk C, Merklinger L, Eberle SA, Morstein L, Heine P, Mittl PRE, Ernst P, Kamenecka TM, He Y, Vacca S, Egloff P, Honegger A, Pluckthun A | 10.1126/sciadv.abe5504 | 2021-02-10 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 6UO8 | - | 3.6 | B | Active | - | 74 | - | - | - | - | - | - |
CHEMBL112710
GS39783 |
small-molecule small-molecule |
Agonist PAM |
- | - | No | No | Shaye H, Ishchenko A, Lam JH, Han GW, Xue L, Rondard P, Pin JP, Katritch V, Gati C, Cherezov V | 10.1038/S41586-020-2408-4 | 2020-06-10 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 6UO9 | - | 4.8 | B | Intermediate | - | 73 | - | - | - | - | - | - |
CHEMBL112710
|
small-molecule | Agonist | - | - | No | No | Shaye H, Ishchenko A, Lam JH, Han GW, Xue L, Rondard P, Pin JP, Katritch V, Gati C, Cherezov V | 10.1038/S41586-020-2408-4 | 2020-06-10 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 6UOA | - | 6.3 | B | Intermediate | - | 71 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Shaye H, Ishchenko A, Lam JH, Han GW, Xue L, Rondard P, Pin JP, Katritch V, Gati C, Cherezov V | 10.1038/S41586-020-2408-4 | 2020-06-10 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 6VJM | - | 4.0 | B | Inactive | - | 73 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Shaye H, Ishchenko A, Lam JH, Han GW, Xue L, Rondard P, Pin JP, Katritch V, Gati C, Cherezov V | 10.1038/S41586-020-2408-4 | 2020-06-10 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | Cryo-EM | 6TKO | 6TKO_refined | 3.3 | A | Active | 100 | 58 | Beta | Beta-arrestin-1 | - | 82 | - | Fab30 heavy chain Fab30 light chain |
arformoterol
|
small-molecule | Agonist | - | - | Yes | No | Lee Y, Warne T, Nehme R, Pandey S, Dwivedi-Agnihotri H, Chaturvedi M, Edwards PC, Garcia-Nafria J, Leslie AGW, Shukla AK, Tate CG | 10.1038/S41586-020-2419-1 | 2020-06-17 | Yes | |
DRD2 | D2 | Dopamine | A | Human | Cryo-EM | 6VMS | 6VMS_refined | 3.8 | R | Active | 100 | 63 | Gi/o | αi1 | - | 64 | T4-Lysozyme | scFv16 |
bromocriptine
|
small-molecule | Agonist | dopamine | small-molecule | Yes | No | Yin J, Chen KM, Clark MJ, Hijazi M, Kumari P, Bai XC, Sunahara RK, Barth P, Rosenbaum DM | 10.1038/S41586-020-2379-5 | 2020-06-17 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6PEL | 6PEL_refined | 3.2 | A | Active | 100 | 93 | Gi/o | αt1 | Only H5 | 3 | - | - |
Citronellol
|
small-molecule | unknown | - | - | No | No | - | - | 2020-06-24 | Yes | |
CCR6 | CCR6 | Chemokine | A | Human | Cryo-EM | 6WWZ | 6WWZ_refined | 3.3 | R | Active | 100 | 83 | Gi/o | αo | - | 59 | - | scFv16 |
CCL20
|
peptide | Agonist | CCL20, beta-defensin 4A | peptide | No | No | Wasilko DJ, Johnson ZL, Ammirati M, Che Y, Griffor MC, Han S, Wu H | 10.1038/S41467-020-16820-6 | 2020-06-24 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6PGS | 6PGS_refined | 2.9 | A | Active | 100 | 94 | Gi/o | αt2 | Only H5 | 3 | - | - |
Geraniol
|
small-molecule | unknown | - | - | No | No | - | - | 2020-07-01 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 6PH7 | 6PH7_refined | 2.9 | A | Active | 100 | 94 | Gi/o | αt2 | Only H5 | 3 | - | - |
Nerol
|
small-molecule | unknown | - | - | No | No | - | - | 2020-07-01 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 6W2X | - | 3.6 | B | Inactive | - | 71 | - | - | - | - | - | - |
CGP55845
1-Stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine |
small-molecule small-molecule |
Inverse agonist NAM |
- | - | No | No | Papasergi-Scott MM, Robertson MJ, Seven AB, Panova O, Mathiesen JM, Skiniotis G | 10.1038/S41586-020-2469-4 | 2020-07-01 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 7C7S | - | 2.9 | B | Inactive | - | 71 | - | - | - | - | - | - |
CGP 54626A
|
small-molecule | Antagonist | - | - | No | No | Mao C, Shen C, Li C, Shen DD, Xu C, Zhang S, Zhou R, Shen Q, Chen LN, Jiang Z, Liu J, Zhang Y | 10.1038/S41422-020-0350-5 | 2020-07-01 | Yes | |
ACM1 | M1 | Acetylcholine (muscarinic) | A | Human | X-ray | 6WJC | - | 2.6 | A | Inactive | 2 | 62 | - | - | - | - | T4-Lysozyme | - |
ENDO-ATROPINE
muscarinic toxin 7 |
small-molecule peptide |
Antagonist NAM |
acetylcholine | small-molecule | No | No | Maeda S, Xu J, N Kadji FM, Clark MJ, Zhao J, Tsutsumi N, Aoki J, Sunahara RK, Inoue A, Garcia KC, Kobilka BK | 10.1126/SCIENCE.AAX2517 | 2020-07-08 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6S0L | 6S0L_refined | 2.7 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Nass K, Cheng R, Vera L, Mozzanica A, Redford S, Ozerov D, Basu S, James D, Knopp G, Cirelli C, Martiel I, Casadei C, Weinert T, Nogly P, Skopintsev P, Usov I, Leonarski F, Geng T, Rappas M, Dore AS, Cooke R, Nasrollahi Shirazi S, Dworkowski F, Sharpe M, Olieric N, Bacellar C, Bohinc R, Steinmetz MO, Schertler G, Abela R, Patthey L, Schmitt B, Hennig M, Standfuss J, Wang M, Milne CJ | 10.1107/S2052252520011379 | 2020-07-15 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6S0Q | 6S0Q_refined | 2.7 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Nass K, Cheng R, Vera L, Mozzanica A, Redford S, Ozerov D, Basu S, James D, Knopp G, Cirelli C, Martiel I, Casadei C, Weinert T, Nogly P, Skopintsev P, Usov I, Leonarski F, Geng T, Rappas M, Dore AS, Cooke R, Nasrollahi Shirazi S, Dworkowski F, Sharpe M, Olieric N, Bacellar C, Bohinc R, Steinmetz MO, Schertler G, Abela R, Patthey L, Schmitt B, Hennig M, Standfuss J, Wang M, Milne CJ | 10.1107/S2052252520011379 | 2020-07-15 | Yes | |
OX1R | OX1 | Orexin | A | Human | X-ray | 6V9S | 6V9S_refined | 3.5 | A | Inactive | 1 | 72 | - | - | - | - | GlgA glycogen synthase | - |
JH112
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Hellmann J, Drabek M, Yin J, Gunera J, Proll T, Kraus F, Langmead CJ, Hubner H, Weikert D, Kolb P, Rosenbaum DM, Gmeiner P | 10.1073/PNAS.2002704117 | 2020-07-15 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 6VCB | 6VCB_refined | 3.3 | R | Active | 100 | 82 | Gs | αs | - | 57 | - | Nanobody-35 |
glucagon-like peptide 1-(7-37)
CHEMBL5197819 |
peptide small-molecule |
Agonist PAM |
glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Bueno AB, Sun B, Willard FS, Feng D, Ho JD, Wainscott DB, Showalter AD, Vieth M, Chen Q, Stutsman C, Chau B, Ficorilli J, Agejas FJ, Cumming GR, Jimenez A, Rojo I, Kobilka TS, Kobilka BK, Sloop KW | 10.1038/S41589-020-0589-7 | 2020-07-22 | Yes | |
5HT1B | 5-HT1B | 5-Hydroxytryptamine | A | Human | X-ray | 7C61 | 7C61_refined | 3.0 | A | Inactive | 14 | 68 | - | - | - | - | BRIL | IgG heavy chain IgG light chain |
ergotamine
|
small-molecule | Antagonist | tryptamine, 5-hydroxytryptamine, 5-HT-moduline | small-molecule | Yes | No | Miyagi H, Asada H, Suzuki M, Takahashi Y, Yasunaga M, Suno C, Iwata S, Saito JI | 10.1038/S41598-020-68355-X | 2020-07-29 | Yes | |
AGTR2 | AT2 | Angiotensin | A | Human | X-ray | 7C6A | 7C6A_refined | 3.4 | A | Active | 99 | 77 | - | - | - | - | BRIL | IgG heavy chain IgG light chain |
CHEMBL404594
|
protein | Agonist | angiotensin-(1-7), angiotensin III, angiotensin II | peptide | Yes | No | Miyagi H, Asada H, Suzuki M, Takahashi Y, Yasunaga M, Suno C, Iwata S, Saito JI | 10.1038/S41598-020-68355-X | 2020-07-29 | Yes | |
OXYR | OT | Vasopressin and oxytocin | A | Human | X-ray | 6TPK | 6TPK_refined | 3.2 | A | Inactive | 14 | 68 | - | - | - | - | GlgA glycogen synthase | - |
retosiban
|
small-molecule | Antagonist | vasopressin, oxytocin | peptide | Yes | No | Waltenspuhl Y, Schoppe J, Ehrenmann J, Kummer L, Pluckthun A | 10.1126/SCIADV.ABB5419 | 2020-08-05 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | Cryo-EM | 7BZ2 | 7BZ2_refined | 3.8 | R | Active | 100 | 69 | Gs | αs | - | 50 | - | Nanobody-35 |
arformoterol
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Zhang Y, Yang F, Ling S, Lv P, Zhou Y, Fang W, Sun W, Zhang L, Shi P, Tian C | 10.1038/S41421-020-0176-9 | 2020-08-05 | Yes | |
GHSR | ghrelin | Ghrelin | A | Human | X-ray | 6KO5 | 6KO5_refined | 3.3 | A | Inactive | 1 | 80 | - | - | - | - | BRIL | Fab7881 heavy chain Fab7881 light chain |
CHEMBL1956994
|
small-molecule | Antagonist | [des-Gln14]ghrelin, ghrelin | peptide | No | No | Shiimura Y, Horita S, Hamamoto A, Asada H, Hirata K, Tanaka M, Mori K, Uemura T, Kobayashi T, Iwata S, Kojima M | 10.1038/S41467-020-17554-1 | 2020-08-12 | Yes | |
SCTR | secretin | Glucagon | B1 | Human | Cryo-EM | 6WI9 | 6WI9_refined | 4.3 | R | Active | 100 | 84 | Gs | αs | - | 49 | - | Nanobody-35 |
SECRETIN
|
protein | Agonist | VIP, secretin | peptide | No | No | Dong M, Deganutti G, Piper SJ, Liang YL, Khoshouei M, Belousoff MJ, Harikumar KG, Reynolds CA, Glukhova A, Furness SGB, Christopoulos A, Danev R, Wootten D, Sexton PM, Miller LJ | 10.1038/S41467-020-17791-4 | 2020-08-12 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | Cryo-EM | 6WPW | 6WPW_refined | 3.1 | R | Active | 100 | 83 | Gs | αs | - | 56 | - | Nanobody-35 |
Glucagon derivative ZP3780
|
peptide | Agonist | glucagon | peptide | No | No | Hilger D, Kumar KK, Hu H, Pedersen MF, O'Brien ES, Giehm L, Jennings C, Eskici G, Inoue A, Lerch M, Mathiesen JM, Skiniotis G, Kobilka BK | 10.1126/SCIENCE.ABA3373 | 2020-08-12 | Yes | |
SCTR | secretin | Glucagon | B1 | Human | Cryo-EM | 6WZG | 6WZG_refined | 2.3 | R | Active | 100 | 86 | Gs | αs | - | 61 | - | Nanobody-35 |
SECRETIN
|
protein | Agonist | VIP, secretin | peptide | No | No | Dong M, Deganutti G, Piper SJ, Liang YL, Khoshouei M, Belousoff MJ, Harikumar KG, Reynolds CA, Glukhova A, Furness SGB, Christopoulos A, Danev R, Wootten D, Sexton PM, Miller LJ | 10.1038/S41467-020-17791-4 | 2020-08-12 | Yes | |
FZD5 | FZD5 | Frizzled | F | Human | Cryo-EM | 6WW2 | 6WW2_refined | 3.7 | R | Inactive | 22 | 55 | - | - | - | - | BRIL | anti-BRIL Fab heavy chain anti-BRIL Fab light chain anti-Fab Nanobody |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Tsutsumi N, Mukherjee S, Waghray D, Janda CY, Jude KM, Miao Y, Burg JS, Aduri NG, Kossiakoff AA, Gati C, Garcia KC | 10.7554/ELIFE.58464 | 2020-08-19 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7C2E | 7C2E_refined | 4.2 | R | Active | 100 | 82 | Gs | αs | - | 49 | - | Nanobody-35 |
2-[[4-[6-[(4-cyano-2-fluoranyl-phenyl)methoxy]pyridin-2-yl]-3,6-dihydro-2~{H}-pyridin-1-yl]methyl]-3-[[(2~{S})-oxetan-2-yl]methyl]imidazo[4,5-b]pyridine-5-carboxylic acid
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Ma H, Huang W, Wang X, Zhao L, Jiang Y, Liu F, Guo W, Sun X, Zhong W, Yuan D, Xu HE | 10.1038/S41422-020-0384-8 | 2020-08-26 | Yes | |
CXCR2 | CXCR2 | Chemokine | A | Human | X-ray | 6LFL | 6LFL_refined | 3.2 | A | Inactive | 5 | 76 | - | - | - | - | GlgA glycogen synthase | - |
4-[[3,4-Dioxo-2-[[(1R)-1-(4-propan-2-ylfuran-2-yl)propyl]amino]cyclobuten-1-yl]amino]-3-hydroxy-N,N-dimethylpyridine-2-carboxamide
|
small-molecule | Allosteric antagonist | CXCL2, CXCL6, CXCL7, CXCL5, CXCL1, CXCL3, CXCL8 | peptide | No | No | Liu K, Wu L, Yuan S, Wu M, Xu Y, Sun Q, Li S, Zhao S, Hua T, Liu ZJ | 10.1038/S41586-020-2492-5 | 2020-09-02 | Yes | |
CXCR2 | CXCR2 | Chemokine | A | Human | Cryo-EM | 6LFM | - | 3.5 | R | Active | 100 | 85 | Gi/o | αi1 | - | 65 | - | scFv16 |
Interleukin-8
|
protein | Agonist | CXCL2, CXCL6, CXCL7, CXCL5, CXCL1, CXCL3, CXCL8 | peptide | No | No | Liu K, Wu L, Yuan S, Wu M, Xu Y, Sun Q, Li S, Zhao S, Hua T, Liu ZJ | 10.1038/S41586-020-2492-5 | 2020-09-02 | Yes | |
CXCR2 | CXCR2 | Chemokine | A | Human | Cryo-EM | 6LFO | - | 3.4 | R | Active | 100 | 85 | Gi/o | αi1 | - | 65 | - | scFv16 |
Interleukin-8
|
protein | Agonist | CXCL2, CXCL6, CXCL7, CXCL5, CXCL1, CXCL3, CXCL8 | peptide | No | No | Liu K, Wu L, Yuan S, Wu M, Xu Y, Sun Q, Li S, Zhao S, Hua T, Liu ZJ | 10.1038/S41586-020-2492-5 | 2020-09-02 | Yes | |
VIPR1 | VPAC1 | VIP and PACAP | B1 | Human | Cryo-EM | 6VN7 | 6VN7_refined | 3.2 | R | Active | 100 | 58 | Gs | αs | - | 61 | - | Nanobody-35 |
[Ac-His1]PACAP-27
|
peptide | Agonist | PACAP-38, secretin, PACAP-27, PHM, VIP, GHRH, PHI | peptide | No | No | Duan J, Shen DD, Zhou XE, Bi P, Liu QF, Tan YX, Zhuang YW, Zhang HB, Xu PY, Huang SJ, Ma SS, He XH, Melcher K, Zhang Y, Xu HE, Jiang Y | 10.1038/S41467-020-17933-8 | 2020-09-02 | Yes | |
GPBAR | GPBA | Bile acid | A | Human | Cryo-EM | 7BW0 | 7BW0_refined | 3.9 | R | Active | 100 | 85 | Gs | αs | - | 57 | BRIL | Nanobody-35 | - | - | - | lithocholic acid, cholic acid, chenodeoxycholic acid, deoxycholic acid | small-molecule | No | No | Chen G, Wang X, Ge Y, Ma L, Chen Q, Liu H, Du Y, Ye RD, Hu H, Ren R | 10.1038/S41392-020-00262-Z | 2020-09-02 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | Cryo-EM | 7JJO | - | 2.6 | R | Active | 100 | 58 | Gs | αs | - | 51 | - | Nanobody-35 |
LEVISOPRENALINE
|
small-molecule | Agonist | - | - | Yes | No | Su M, Zhu L, Zhang Y, Paknejad N, Dey R, Huang J, Lee MY, Williams D, Jordan KD, Eng ET, Ernst OP, Meyerson JR, Hite RK, Walz T, Liu W, Huang XY | 10.1016/J.MOLCEL.2020.08.001 | 2020-09-02 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 6X18 | - | 2.1 | R | Active | 100 | 83 | Gs | αs | - | 90 | - | Nanobody-35 |
CHEMBL410972
|
protein | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, Senel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D | 10.1016/J.MOLCEL.2020.09.020 | 2020-09-09 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 6X19 | - | 2.1 | R | Active | 100 | 84 | Gs | αs | - | 89 | - | Nanobody-35 |
CHU-128
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, Senel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D | 10.1016/J.MOLCEL.2020.09.020 | 2020-09-09 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 6X1A | - | 2.5 | R | Active | 100 | 84 | Gs | αs | - | 89 | - | Nanobody-35 |
danuglipron
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, Senel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D | 10.1016/J.MOLCEL.2020.09.020 | 2020-09-09 | Yes | |
GPBAR | GPBA | Bile acid | A | Human | Cryo-EM | 7CFM | - | 3.0 | R | Active | 100 | 83 | Gs | αs | - | 58 | - | Nanobody-35 |
CHEMBL2331646
|
small-molecule | Agonist | lithocholic acid, cholic acid, chenodeoxycholic acid, deoxycholic acid | small-molecule | No | No | Yang F, Mao C, Guo L, Lin J, Ming Q, Xiao P, Wu X, Shen Q, Guo S, Shen DD, Lu R, Zhang L, Huang S, Ping Y, Zhang C, Ma C, Zhang K, Liang X, Shen Y, Nan F, Yi F, Luca VC, Zhou J, Jiang C, Sun JP, Xie X, Yu X, Zhang Y | 10.1038/S41586-020-2569-1 | 2020-09-09 | Yes | |
GPBAR | GPBA | Bile acid | A | Human | Cryo-EM | 7CFN | 7CFN_refined | 3.0 | R | Active | 100 | 83 | Gs | αs | - | 59 | - | Nanobody-35 |
INT-777
INT-777 |
small-molecule small-molecule |
Agonist PAM |
lithocholic acid, cholic acid, chenodeoxycholic acid, deoxycholic acid | small-molecule | No | No | Yang F, Mao C, Guo L, Lin J, Ming Q, Xiao P, Wu X, Shen Q, Guo S, Shen DD, Lu R, Zhang L, Huang S, Ping Y, Zhang C, Ma C, Zhang K, Liang X, Shen Y, Nan F, Yi F, Luca VC, Zhou J, Jiang C, Sun JP, Xie X, Yu X, Zhang Y | 10.1038/S41586-020-2569-1 | 2020-09-09 | Yes | |
SUCR1 | succinate | Succinate | A | Rat | X-ray | 6Z10 | 6Z10_refined | 2.3 | A | Active | 67 | 90 | - | - | - | - | - | Nanobody-6 |
CHEMBL4751488
|
small-molecule | Antagonist | - | - | Yes | No | Velcicky J,Wilcken R,Cotesta S,Janser P,Schlapbach A,Wagner T,Piechon P,Villard F,Bouhelal R,Piller F,Harlfinger S,Stringer R,Fehlmann D,Kaupmann K,Littlewood-Evans A,Haffke M,Gommermann N | 10.1021/acs.jmedchem.0c01020 | 2020-09-16 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6ZDR | 6ZDR_refined | 1.9 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
CHEMBL2030687
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Jespers W, Verdon G, Azuaje J, Majellaro M, Keranen H, Garcia-Mera X, Congreve M, Deflorian F, de Graaf C, Zhukov A, Dore AS, Mason JS, Aqvist J, Cooke RM, Sotelo E, Gutierrez-de-Teran H | 10.1002/ANIE.202003788 | 2020-09-16 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 6ZDV | 6ZDV_refined | 2.1 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
2-Methyl-3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl acetate
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Jespers W, Verdon G, Azuaje J, Majellaro M, Keranen H, Garcia-Mera X, Congreve M, Deflorian F, de Graaf C, Zhukov A, Dore AS, Mason JS, Aqvist J, Cooke RM, Sotelo E, Gutierrez-de-Teran H | 10.1002/ANIE.202003788 | 2020-09-16 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 6WGT | 6WGT_refined | 3.4 | B | Inactive | 1 | 59 | - | - | - | - | BRIL | - |
Lysergide
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | Yes | No | Kim K, Che T, Panova O, DiBerto JF, Lyu J, Krumm BE, Wacker D, Robertson MJ, Seven AB, Nichols DE, Shoichet BK, Skiniotis G, Roth BL | 10.1016/J.CELL.2020.08.024 | 2020-09-23 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 6WH4 | 6WH4_refined | 3.4 | C | Inactive | 1 | 59 | - | - | - | - | BRIL | - |
CHEMBL428892
|
small-molecule | Inverse agonist | tryptamine, 5-hydroxytryptamine | small-molecule | Yes | No | Kim K, Che T, Panova O, DiBerto JF, Lyu J, Krumm BE, Wacker D, Robertson MJ, Seven AB, Nichols DE, Shoichet BK, Skiniotis G, Roth BL | 10.1016/J.CELL.2020.08.024 | 2020-09-23 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 6WHA | - | 3.4 | A | Active | 100 | 52 | Gq/11 | αq | Gq-Gi2-Gs chimera | 59 | BRIL | scFv16 |
CHEMBL5184791
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | Yes | No | Kim K, Che T, Panova O, DiBerto JF, Lyu J, Krumm BE, Wacker D, Robertson MJ, Seven AB, Nichols DE, Shoichet BK, Skiniotis G, Roth BL | 10.1016/J.CELL.2020.08.024 | 2020-09-23 | Yes | |
SMO | SMO | Frizzled | F | Human | Cryo-EM | 6XBJ | - | 3.9 | R | Active | 100 | 59 | Gi/o | αi1 | - | 61 | - | scFv16 |
Cholesterol
|
small-molecule | Agonist | - | - | No | No | Qi X, Friedberg L, De Bose-Boyd R, Long T, Li X | 10.1038/S41589-020-0646-2 | 2020-09-30 | Yes | |
SMO | SMO | Frizzled | F | Human | Cryo-EM | 6XBK | - | 3.2 | R | Active | 100 | 59 | Gi/o | αi1 | - | 61 | - | scFv16 |
Cholesterol
|
small-molecule | Agonist | - | - | No | No | Qi X, Friedberg L, De Bose-Boyd R, Long T, Li X | 10.1038/S41589-020-0646-2 | 2020-09-30 | Yes | |
SMO | SMO | Frizzled | F | Human | Cryo-EM | 6XBL | - | 3.9 | R | Active | 100 | 59 | Gi/o | αi1 | - | 61 | - | scFv16 |
Cholesterol
SAG1.3 |
small-molecule small-molecule |
Agonist PAM |
- | - | No | No | Qi X, Friedberg L, De Bose-Boyd R, Long T, Li X | 10.1038/S41589-020-0646-2 | 2020-09-30 | Yes | |
SMO | SMO | Frizzled | F | Human | Cryo-EM | 6XBM | - | 3.2 | R | Active | 100 | 42 | Gi/o | αi1 | - | 61 | - | scFv16 |
24,25-Epoxy-cholesterol
24,25-Epoxy-cholesterol |
small-molecule small-molecule |
Agonist PAM |
- | - | No | No | Qi X, Friedberg L, De Bose-Boyd R, Long T, Li X | 10.1038/S41589-020-0646-2 | 2020-09-30 | Yes | |
GNRHR | GnRH1 | Gonadotrophin-releasing hormone | A | Human | X-ray | 7BR3 | 7BR3_refined | 2.8 | A | Inactive | 34 | 84 | - | - | - | - | GlgA glycogen synthase | - |
elagolix
|
small-molecule | Antagonist | GnRH II, GnRH I | peptide | No | No | Yan W, Cheng L, Wang W, Wu C, Yang X, Du X, Ma L, Qi S, Wei Y, Lu Z, Yang S, Shao Z | 10.1038/S41467-020-19109-W | 2020-10-07 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | X-ray | 6ZIN | - | 2.6 | A | Inactive | 30 | 76 | - | - | - | - | DARPin D12 | - |
meclinertant
|
small-molecule | Inverse agonist | neuromedin N, neurotensin | peptide | Yes | No | Deluigi M, Klipp A, Klenk C, Merklinger L, Eberle SA, Morstein L, Heine P, Mittl PRE, Ernst P, Kamenecka TM, He Y, Vacca S, Egloff P, Honegger A, Pluckthun A | 10.1126/sciadv.abe5504 | 2021-02-10 | Yes | |
OX2R | OX2 | Orexin | A | Human | Cryo-EM | 7L1U | 7L1U_refined | 3.2 | R | Active | 100 | 63 | Gs | αs | Engineered G alpha | 58 | - | scFv16 |
Orexin-A
|
peptide | Agonist | orexin-A, orexin-B | peptide | Yes | No | Hong C, Byrne NJ, Zamlynny B, Tummala S, Xiao L, Shipman JM, Partridge AT, Minnick C, Breslin MJ, Rudd MT, Stachel SJ, Rada VL, Kern JC, Armacost KA, Hollingsworth SA, O'Brien JA, Hall DL, McDonald TP, Strickland C, Brooun A, Soisson SM, Hollenstein K | 10.1038/S41467-021-21087-6 | 2021-02-10 | Yes | |
OX2R | OX2 | Orexin | A | Human | Cryo-EM | 7L1V | - | 3.0 | R | Active | 100 | 64 | Gs | αs | Engineered G alpha | 58 | - | scFv16 Nanobody-51 |
compound 1 [PMID: 33547286]
|
small-molecule | Agonist | orexin-A, orexin-B | peptide | Yes | No | Hong C, Byrne NJ, Zamlynny B, Tummala S, Xiao L, Shipman JM, Partridge AT, Minnick C, Breslin MJ, Rudd MT, Stachel SJ, Rada VL, Kern JC, Armacost KA, Hollingsworth SA, O'Brien JA, Hall DL, McDonald TP, Strickland C, Brooun A, Soisson SM, Hollenstein K | 10.1038/S41467-021-21087-6 | 2021-02-10 | Yes | |
LT4R1 | BLT1 | Leukotriene | A | Human | X-ray | 7K15 | 7K15_refined | 2.9 | A | Inactive | 4 | 85 | - | - | - | - | Flavodoxin | - |
N-(tert-butylsulfonyl)-4-fluoro-2-{(3S,4R)-4-hydroxy-3-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1-benzopyran-7-yl}benzamide
|
small-molecule | Antagonist | LTB4, 20-hydroxy-LTB4, 12R-HETE | small-molecule | Yes | Yes | Michaelian N, Sadybekov A, Besserer-Offroy E, Han GW, Krishnamurthy H, Zamlynny BA, Fradera X, Siliphaivanh P, Presland J, Spencer KB, Soisson SM, Popov P, Sarret P, Katritch V, Cherezov V | 10.1038/S41467-021-23149-1 | 2021-02-17 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7JV5 | - | 3.0 | R | Active | 100 | 63 | Gs | αs | - | 60 | - | Nanobody-35 |
CHEMBL1160787
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Zhuang Y, Xu P, Mao C, Wang L, Krumm B, Zhou XE, Huang S, Liu H, Cheng X, Huang XP, Shen DD, Xu T, Liu YF, Wang Y, Guo J, Jiang Y, Jiang H, Melcher K, Roth BL, Zhang Y, Zhang C, Xu HE | 10.1016/J.CELL.2021.01.027 | 2021-02-24 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7JVP | - | 2.9 | R | Active | 100 | 63 | Gs | αs | - | 60 | - | Nanobody-35 |
39YLC3L0ZU
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Zhuang Y, Xu P, Mao C, Wang L, Krumm B, Zhou XE, Huang S, Liu H, Cheng X, Huang XP, Shen DD, Xu T, Liu YF, Wang Y, Guo J, Jiang Y, Jiang H, Melcher K, Roth BL, Zhang Y, Zhang C, Xu HE | 10.1016/J.CELL.2021.01.027 | 2021-02-24 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7JVQ | - | 3.0 | R | Active | 100 | 64 | Gs | αs | Engineered G alpha | 60 | - | Nanobody-35 |
apomorphine
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Zhuang Y, Xu P, Mao C, Wang L, Krumm B, Zhou XE, Huang S, Liu H, Cheng X, Huang XP, Shen DD, Xu T, Liu YF, Wang Y, Guo J, Jiang Y, Jiang H, Melcher K, Roth BL, Zhang Y, Zhang C, Xu HE | 10.1016/J.CELL.2021.01.027 | 2021-02-24 | Yes | |
DRD2 | D2 | Dopamine | A | Human | Cryo-EM | 7JVR | 7JVR_refined | 2.8 | R | Active | 100 | 61 | Gi/o | αi1 | - | 63 | - | scFv16 |
bromocriptine
|
small-molecule | Agonist | dopamine | small-molecule | Yes | No | Zhuang Y, Xu P, Mao C, Wang L, Krumm B, Zhou XE, Huang S, Liu H, Cheng X, Huang XP, Shen DD, Xu T, Liu YF, Wang Y, Guo J, Jiang Y, Jiang H, Melcher K, Roth BL, Zhang Y, Zhang C, Xu HE | 10.1016/J.CELL.2021.01.027 | 2021-02-24 | Yes | |
CALRL | calcitonin-like | Calcitonin | B1 | Human | Cryo-EM | 7KNT | 7KNT_refined | 3.2 | R | Inactive | 8 | 74 | - | - | - | - | - | RAMP1 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Josephs TM, Belousoff MJ, Liang YL, Piper SJ, Cao J, Garama DJ, Leach K, Gregory KJ, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABF7258 | 2021-02-24 | Yes | |
CALRL | calcitonin-like | Calcitonin | B1 | Human | Cryo-EM | 7KNU | 7KNU_refined | 3.5 | R | Inactive | 8 | 74 | - | - | - | - | - | RAMP1 |
Calcitonin gene-related peptide 1
|
peptide | Agonist | - | - | No | No | Josephs TM, Belousoff MJ, Liang YL, Piper SJ, Cao J, Garama DJ, Leach K, Gregory KJ, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABF7258 | 2021-02-24 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7CKW | 7CKW_refined | 3.2 | R | Active | 100 | 61 | Gs | αs | - | 60 | - | Nanobody-35 |
fenoldopam
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Xiao P, Yan W, Gou L, Zhong YN, Kong L, Wu C, Wen X, Yuan Y, Cao S, Qu C, Yang X, Yang CC, Xia A, Hu Z, Zhang Q, He YH, Zhang DL, Zhang C, Hou GH, Liu H, Zhu L, Fu P, Yang S, Rosenbaum DM, Sun JP, Du Y, Zhang L, Yu X, Shao Z | 10.1016/J.CELL.2021.01.028 | 2021-03-03 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7CKX | 7CKX_refined | 3.5 | R | Active | 100 | 61 | Gs | αs | - | 60 | - | Nanobody-35 |
A77636
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Xiao P, Yan W, Gou L, Zhong YN, Kong L, Wu C, Wen X, Yuan Y, Cao S, Qu C, Yang X, Yang CC, Xia A, Hu Z, Zhang Q, He YH, Zhang DL, Zhang C, Hou GH, Liu H, Zhu L, Fu P, Yang S, Rosenbaum DM, Sun JP, Du Y, Zhang L, Yu X, Shao Z | 10.1016/J.CELL.2021.01.028 | 2021-03-03 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7CKY | - | 3.2 | R | Active | 100 | 62 | Gs | αs | - | 60 | - | Nanobody-35 |
CHEMBL3697578
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Xiao P, Yan W, Gou L, Zhong YN, Kong L, Wu C, Wen X, Yuan Y, Cao S, Qu C, Yang X, Yang CC, Xia A, Hu Z, Zhang Q, He YH, Zhang DL, Zhang C, Hou GH, Liu H, Zhu L, Fu P, Yang S, Rosenbaum DM, Sun JP, Du Y, Zhang L, Yu X, Shao Z | 10.1016/J.CELL.2021.01.028 | 2021-03-03 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7CKZ | - | 3.1 | R | Active | 100 | 62 | Gs | αs | - | 60 | - | Nanobody-35 |
dopamine
mevidalen |
small-molecule small-molecule |
Agonist PAM |
L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Xiao P, Yan W, Gou L, Zhong YN, Kong L, Wu C, Wen X, Yuan Y, Cao S, Qu C, Yang X, Yang CC, Xia A, Hu Z, Zhang Q, He YH, Zhang DL, Zhang C, Hou GH, Liu H, Zhu L, Fu P, Yang S, Rosenbaum DM, Sun JP, Du Y, Zhang L, Yu X, Shao Z | 10.1016/J.CELL.2021.01.028 | 2021-03-03 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7CRH | 7CRH_refined | 3.3 | R | Active | 100 | 61 | Gs | αs | - | 60 | - | Nanobody-35 |
CHEMBL1416789
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Xiao P, Yan W, Gou L, Zhong YN, Kong L, Wu C, Wen X, Yuan Y, Cao S, Qu C, Yang X, Yang CC, Xia A, Hu Z, Zhang Q, He YH, Zhang DL, Zhang C, Hou GH, Liu H, Zhu L, Fu P, Yang S, Rosenbaum DM, Sun JP, Du Y, Zhang L, Yu X, Shao Z | 10.1016/J.CELL.2021.01.028 | 2021-03-03 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | X-ray | 7EPF | 7EPF_refined | 2.7 | A | Inactive | - | 28 | - | - | - | - | Flavodoxin | - |
(8~{R})-4-[2,4-Bis(fluoranyl)phenyl]-8-methyl-7-[(2-methylpyrazol-3-yl)methyl]-6,8-dihydro-5~{H}-1,7-naphthyridine-2-carboxamide
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Du J, Wang D, Fan H, Xu C, Tai L, Lin S, Han S, Tan Q, Wang X, Xu T, Zhang H, Chu X, Yi C, Liu P, Wang X, Zhou Y, Pin JP, Rondard P, Liu H, Liu J, Sun F, Wu B, Zhao Q | 10.1038/S41586-021-03641-W | 2021-06-23 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7LJC | - | 3.0 | R | Active | 100 | 63 | Gs | αs | Engineered G alpha | 60 | - | Nanobody-35 |
CHEMBL1160787
mevidalen |
small-molecule small-molecule |
Agonist PAM |
L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Zhuang Y, Krumm B, Zhang H, Zhou XE, Wang Y, Huang XP, Liu Y, Cheng X, Jiang Y, Jiang H, Zhang C, Yi W, Roth BL, Zhang Y, Xu HE | 10.1038/S41422-021-00482-0 | 2021-03-03 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7LJD | - | 3.2 | R | Active | 100 | 64 | Gs | αs | Engineered G alpha | 60 | - | Nanobody-35 |
dopamine
mevidalen |
small-molecule small-molecule |
Agonist PAM |
L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Zhuang Y, Krumm B, Zhang H, Zhou XE, Wang Y, Huang XP, Liu Y, Cheng X, Jiang Y, Jiang H, Zhang C, Yi W, Roth BL, Zhang Y, Xu HE | 10.1038/S41422-021-00482-0 | 2021-03-03 | Yes | |
DRD3 | D3 | Dopamine | A | Human | Cryo-EM | 7CMU | 7CMU_refined | 3.0 | R | Active | 100 | 68 | Gi/o | αi1 | - | 64 | BRIL | scFv16 |
pramipexole
|
small-molecule | Agonist | dopamine | small-molecule | Yes | No | Xu P, Huang S, Mao C, Krumm BE, Zhou XE, Tan Y, Huang XP, Liu Y, Shen DD, Jiang Y, Yu X, Jiang H, Melcher K, Roth BL, Cheng X, Zhang Y, Xu HE | 10.1016/J.MOLCEL.2021.01.003 | 2021-03-10 | Yes | |
DRD3 | D3 | Dopamine | A | Human | Cryo-EM | 7CMV | 7CMV_refined | 2.7 | R | Active | 100 | 68 | Gi/o | αi1 | - | 64 | BRIL | scFv16 |
CHEMBL70565
|
small-molecule | Agonist | dopamine | small-molecule | Yes | No | - | - | 2021-03-10 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7DTT | 7DTT_refined | 3.8 | A | Active | - | 72 | - | - | - | - | - | - |
Calcium
|
small-molecule | Agonist | Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Ling S, Shi P, Liu S, Meng X, Zhou Y, Sun W, Chang S, Zhang X, Zhang L, Shi C, Sun D, Liu L, Tian C | 10.1038/S41422-021-00474-0 | 2021-03-10 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7DTU | 7DTU_refined | 4.4 | A | Intermediate | - | 72 | - | - | - | - | - | - |
L-tryptophan
|
small-molecule | PAM | Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | - | - | 2021-03-10 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7DTV | 7DTV_refined | 3.5 | A | Active | - | 72 | - | - | - | - | - | - |
Calcium
L-tryptophan |
small-molecule small-molecule |
Agonist PAM |
Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Ling S, Shi P, Liu S, Meng X, Zhou Y, Sun W, Chang S, Zhang X, Zhang L, Shi C, Sun D, Liu L, Tian C | 10.1038/S41422-021-00474-0 | 2021-03-10 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7DTW | 7DTW_refined | 4.5 | A | Inactive | - | 72 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Ling S, Shi P, Liu S, Meng X, Zhou Y, Sun W, Chang S, Zhang X, Zhang L, Shi C, Sun D, Liu L, Tian C | 10.1038/S41422-021-00474-0 | 2021-03-10 | Yes | |
HRH1 | H1 | Histamine | A | Human | Cryo-EM | 7DFL | 7DFL_refined | 3.3 | R | Active | 100 | 56 | Gq/11 | αq | - | 63 | - | scFv16 |
histamine
|
small-molecule | Agonist | histamine | small-molecule | Yes | No | Xia R, Wang N, Xu Z, Lu Y, Song J, Zhang A, Guo C, He Y | 10.1038/S41467-021-22427-2 | 2021-03-31 | Yes | |
5HT1A | 5-HT1A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7E2Y | - | 3.0 | R | Active | 100 | 65 | Gi/o | αi1 | - | 62 | - | - |
5-hydroxytryptamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Xu P, Huang S, Zhang H, Mao C, Zhou XE, Cheng X, Simon IA, Shen DD, Yen HY, Robinson CV, Harpsoe K, Svensson B, Guo J, Jiang H, Gloriam DE, Melcher K, Jiang Y, Zhang Y, Xu HE | 10.1038/S41586-021-03376-8 | 2021-04-14 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 7ARO | 7ARO_refined | 3.1 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
CHEMBL124345
|
small-molecule | Agonist (partial) | adenosine | small-molecule | Yes | Yes | Amelia T, van Veldhoven JPD, Falsini M, Liu R, Heitman LH, van Westen GJP, Segala E, Verdon G, Cheng RKY, Cooke RM, van der Es D, IJzerman AP. | 10.1021/acs.jmedchem.0c01856 | 2021-04-07 | Yes | |
5HT1A | 5-HT1A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7E2X | - | 3.0 | R | Active | 100 | 66 | Gi/o | αi1 | - | 62 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | 5-hydroxytryptamine | small-molecule | Yes | No | Xu P, Huang S, Zhang H, Mao C, Zhou XE, Cheng X, Simon IA, Shen DD, Yen HY, Robinson CV, Harpsoe K, Svensson B, Guo J, Jiang H, Gloriam DE, Melcher K, Jiang Y, Zhang Y, Xu HE | 10.1038/S41586-021-03376-8 | 2021-04-14 | Yes | |
5HT1A | 5-HT1A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7E2Z | 7E2Z_refined | 3.1 | R | Active | 100 | 66 | Gi/o | αi1 | - | 62 | - | - |
aripiprazole
|
small-molecule | Agonist (partial) | 5-hydroxytryptamine | small-molecule | Yes | No | Xu P, Huang S, Zhang H, Mao C, Zhou XE, Cheng X, Simon IA, Shen DD, Yen HY, Robinson CV, Harpsoe K, Svensson B, Guo J, Jiang H, Gloriam DE, Melcher K, Jiang Y, Zhang Y, Xu HE | 10.1038/S41586-021-03376-8 | 2021-04-14 | Yes | |
5HT1E | 5-HT1E | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7E33 | 7E33_refined | 2.9 | R | Active | 100 | 70 | Gi/o | αi1 | - | 61 | - | scFv16 |
BRL-54443
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | Yes | No | Xu P, Huang S, Zhang H, Mao C, Zhou XE, Cheng X, Simon IA, Shen DD, Yen HY, Robinson CV, Harpsoe K, Svensson B, Guo J, Jiang H, Gloriam DE, Melcher K, Jiang Y, Zhang Y, Xu HE | 10.1038/S41586-021-03376-8 | 2021-04-14 | Yes | |
DRD1 | D1 | Dopamine | A | Human | X-ray | 7JOZ | 7JOZ_refined | 3.8 | R | Active | 100 | 64 | Gs | αs | - | 86 | - | Nanobody-35 |
CHEMBL4453318
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Sun B, Feng D, Chu ML, Fish I, Lovera S, Sands ZA, Kelm S, Valade A, Wood M, Ceska T, Kobilka TS, Lebon F, Kobilka BK | 10.1038/S41467-021-23519-9 | 2021-04-14 | Yes | |
5HT1D | 5-HT1D | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7E32 | - | 2.9 | R | Active | 100 | 76 | Gi/o | αi1 | - | 62 | - | scFv16 |
5-hydroxytryptamine
|
small-molecule | Agonist | 5-hydroxytryptamine, 5-HT-moduline | small-molecule | Yes | No | Xu P, Huang S, Zhang H, Mao C, Zhou XE, Cheng X, Simon IA, Shen DD, Yen HY, Robinson CV, Harpsoe K, Svensson B, Guo J, Jiang H, Gloriam DE, Melcher K, Jiang Y, Zhang Y, Xu HE | 10.1038/S41586-021-03376-8 | 2021-04-21 | Yes | |
MC4R | MC4 | Melanocortin | A | Human | Cryo-EM | 7AUE | 7AUE_refined | 3.0 | R | Active | 100 | 79 | Gs | αs | - | 59 | - | scFv16 |
setmelanotide
|
peptide | Agonist | ACTH, β-MSH, γ-MSH, α-MSH, agouti-related protein | peptide | Yes | No | Israeli H, Degtjarik O, Fierro F, Chunilal V, Gill AK, Roth NJ, Botta J, Prabahar V, Peleg Y, Chan LF, Ben-Zvi D, McCormick PJ, Niv MY, Shalev-Benami M | 10.1126/SCIENCE.ABF7958 | 2021-04-28 | Yes | |
PE2R2 | EP2 | Prostanoid | A | Human | Cryo-EM | 7CX2 | - | 2.8 | R | Active | 100 | 74 | Gs | αs | - | 58 | - | Nanobody-35 |
PGE2
|
small-molecule | Agonist | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | Yes | No | Qu C, Mao C, Xiao P, Shen Q, Zhong YN, Yang F, Shen DD, Tao X, Zhang H, Yan X, Zhao RJ, He J, Guan Y, Zhang C, Hou G, Zhang PJ, Hou G, Li Z, Yu X, Chai RJ, Guan YF, Sun JP, Zhang Y | 10.1126/SCIADV.ABF1268 | 2021-05-05 | Yes | |
PE2R2 | EP2 | Prostanoid | A | Human | Cryo-EM | 7CX3 | - | 2.8 | R | Active | 100 | 74 | Gs | αs | - | 58 | - | Nanobody-35 |
taprenepag
|
small-molecule | Agonist | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | Yes | No | Qu C, Mao C, Xiao P, Shen Q, Zhong YN, Yang F, Shen DD, Tao X, Zhang H, Yan X, Zhao RJ, He J, Guan Y, Zhang C, Hou G, Zhang PJ, Hou G, Li Z, Yu X, Chai RJ, Guan YF, Sun JP, Zhang Y | 10.1126/SCIADV.ABF1268 | 2021-05-05 | Yes | |
PE2R2 | EP2 | Prostanoid | A | Human | Cryo-EM | 7CX4 | 7CX4_refined | 2.9 | R | Active | 100 | 74 | Gs | αs | - | 58 | - | Nanobody-35 |
evatanepag
|
small-molecule | Agonist | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | Yes | No | Qu C, Mao C, Xiao P, Shen Q, Zhong YN, Yang F, Shen DD, Tao X, Zhang H, Yan X, Zhao RJ, He J, Guan Y, Zhang C, Hou G, Zhang PJ, Hou G, Li Z, Yu X, Chai RJ, Guan YF, Sun JP, Zhang Y | 10.1126/SCIADV.ABF1268 | 2021-05-05 | Yes | |
GABR2 | GABAB2 | GABAB | C | Human | Cryo-EM | 7EB2 | - | 3.5 | D | Active | - | 72 | Gi/o | αi1 | - | 99 | - | scFv16 |
(-)-baclofen
BHFF |
small-molecule small-molecule |
Agonist PAM |
- | - | No | No | Shen C, Mao C, Xu C, Jin N, Zhang H, Shen DD, Shen Q, Wang X, Hou T, Chen Z, Rondard P, Pin JP, Zhang Y, Liu J | 10.1038/S41586-021-03507-1 | 2021-05-05 | Yes | |
V2R | V2 | Vasopressin and oxytocin | A | Human | Cryo-EM | 7KH0 | 7KH0_refined | 2.8 | R | Active | 100 | 74 | Gs | αs | - | 58 | - | scFv16 Nanobody-35 |
vasopressin
|
peptide | Agonist | vasopressin, oxytocin | peptide | Yes | No | Wang L, Xu J, Cao S, Sun D, Liu H, Lu Q, Liu Z, Du Y, Zhang C | 10.1038/S41422-021-00483-Z | 2021-05-26 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | Cryo-EM | 7MBX | 7MBX_refined | 2.0 | R | Active | 100 | 68 | Gs | αs | - | 61 | - | Nanobody-35 |
CHEMBL216166
|
protein | Agonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | Yes | No | Mobbs JI, Belousoff MJ, Harikumar KG, Piper SJ, Xu X, Furness SGB, Venugopal H, Christopoulos A, Danev R, Wootten D, Thal DM, Miller LJ, Sexton PM | 10.1371/JOURNAL.PBIO.3001295 | 2021-05-26 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | Cryo-EM | 7MBY | - | 2.4 | R | Active | 100 | 66 | Gq/11 | αq | Gq-Gs-Gi1 chimera | 55 | - | - |
CHEMBL216166
|
protein | Agonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | Yes | No | Mobbs JI, Belousoff MJ, Harikumar KG, Piper SJ, Xu X, Furness SGB, Venugopal H, Christopoulos A, Danev R, Wootten D, Thal DM, Miller LJ, Sexton PM | 10.1371/JOURNAL.PBIO.3001295 | 2021-05-26 | Yes | |
V2R | V2 | Vasopressin and oxytocin | A | Human | Cryo-EM | 7BB6 | 7BB6_refined | 4.2 | A | Active | 100 | 73 | Gs | αs | - | 54 | - | Nanobody-35 |
vasopressin
|
peptide | Agonist | vasopressin, oxytocin | peptide | Yes | No | Bous J, Orcel H, Floquet N, Leyrat C, Lai-Kee-Him J, Gaibelet G, Ancelin A, Saint-Paul J, Trapani S, Louet M, Sounier R, Demene H, Granier S, Bron P, Mouillac B | 10.1126/SCIADV.ABG5628 | 2021-06-02 | Yes | |
V2R | V2 | Vasopressin and oxytocin | A | Human | Cryo-EM | 7BB7 | 7BB7_refined | 4.4 | A | Active | 100 | 72 | Gs | αs | - | 55 | - | Nanobody-35 |
vasopressin
|
peptide | Agonist | vasopressin, oxytocin | peptide | Yes | No | Bous J, Orcel H, Floquet N, Leyrat C, Lai-Kee-Him J, Gaibelet G, Ancelin A, Saint-Paul J, Trapani S, Louet M, Sounier R, Demene H, Granier S, Bron P, Mouillac B | 10.1126/SCIADV.ABG5628 | 2021-06-02 | Yes | |
S1PR3 | S1P3 | Lysophospholipid (S1P) | A | Human | X-ray | 7C4S | 7C4S_refined | 3.2 | A | Active | 74 | 75 | - | - | - | - | - | Fab light chain Fab heavy chain |
sphingosine 1-phosphate
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Maeda S, Shiimura Y, Asada H, Hirata K, Luo F, Nango E, Tanaka N, Toyomoto M, Inoue A, Aoki J, Iwata S, Hagiwara M | 10.1126/SCIADV.ABF5325 | 2021-06-09 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7DD5 | - | 3.2 | A | Inactive | - | 74 | - | - | - | - | - | - |
Calcium
NPS 2143 L-tryptophan |
small-molecule small-molecule small-molecule |
Agonist NAM PAM |
Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Wen T, Wang Z, Chen X, Ren Y, Lu X, Xing Y, Lu J, Chang S, Zhang X, Shen Y, Yang X | 10.1126/SCIADV.ABG1483 | 2021-06-16 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7DD6 | - | 3.2 | B | Active | - | 73 | - | - | - | - | - | - |
Calcium
L-tryptophan |
small-molecule small-molecule |
Agonist PAM |
Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Wen T, Wang Z, Chen X, Ren Y, Lu X, Xing Y, Lu J, Chang S, Zhang X, Shen Y, Yang X | 10.1126/SCIADV.ABG1483 | 2021-06-16 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7DD7 | - | 3.2 | B | Active | - | 73 | - | - | - | - | - | - |
Calcium
evocalcet L-tryptophan |
small-molecule small-molecule small-molecule |
Agonist PAM PAM |
Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Wen T, Wang Z, Chen X, Ren Y, Lu X, Xing Y, Lu J, Chang S, Zhang X, Shen Y, Yang X | 10.1126/SCIADV.ABG1483 | 2021-06-16 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | Cryo-EM | 7E9G | - | 3.5 | R | Intermediate | - | 88 | Gi/o | αi1 | - | 63 | - | scFv16 |
eglumegad
JNJ-40411813 |
small-molecule small-molecule |
Agonist PAM |
L-glutamic acid | small-molecule | No | No | Lin S, Han S, Cai X, Tan Q, Zhou K, Wang D, Wang X, Du J, Yi C, Chu X, Dai A, Zhou Y, Chen Y, Zhou Y, Liu H, Liu J, Yang D, Wang MW, Zhao Q, Wu B | 10.1038/S41586-021-03495-2 | 2021-06-23 | Yes | |
GRM4 | mGlu4 | Metabotropic glutamate | C | Human | Cryo-EM | 7E9H | - | 4.0 | R | Intermediate | - | 84 | Gi/o | αi3 | - | 63 | - | scFv16 |
L-serine-O-phosphate
|
small-molecule | Agonist | L-glutamic acid, L-serine-O-phosphate | small-molecule | No | No | Lin S, Han S, Cai X, Tan Q, Zhou K, Wang D, Wang X, Du J, Yi C, Chu X, Dai A, Zhou Y, Chen Y, Zhou Y, Liu H, Liu J, Yang D, Wang MW, Zhao Q, Wu B | 10.1038/S41586-021-03495-2 | 2021-06-23 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | Cryo-EM | 7EPA | 7EPA_refined | 3.6 | A | Intermediate | - | 90 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | L-glutamic acid | small-molecule | No | No | Du J, Wang D, Fan H, Xu C, Tai L, Lin S, Han S, Tan Q, Wang X, Xu T, Zhang H, Chu X, Yi C, Liu P, Wang X, Zhou Y, Pin JP, Rondard P, Liu H, Liu J, Sun F, Wu B, Zhao Q | 10.1038/S41586-021-03641-W | 2021-06-23 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | Cryo-EM | 7EPB | 7EPB_refined | 3.1 | B | Active | - | 89 | - | - | - | - | - | Anti-RON nanobody |
eglumegad
|
small-molecule | Agonist | L-glutamic acid | small-molecule | No | No | Du J, Wang D, Fan H, Xu C, Tai L, Lin S, Han S, Tan Q, Wang X, Xu T, Zhang H, Chu X, Yi C, Liu P, Wang X, Zhou Y, Pin JP, Rondard P, Liu H, Liu J, Sun F, Wu B, Zhao Q | 10.1038/S41586-021-03641-W | 2021-06-23 | Yes | |
GRM7 | mGlu7 | Metabotropic glutamate | C | Human | Cryo-EM | 7EPC | 7EPC_refined | 4.0 | B | Inactive | - | 85 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | L-glutamic acid, L-serine-O-phosphate | small-molecule | No | No | Du J, Wang D, Fan H, Xu C, Tai L, Lin S, Han S, Tan Q, Wang X, Xu T, Zhang H, Chu X, Yi C, Liu P, Wang X, Zhou Y, Pin JP, Rondard P, Liu H, Liu J, Sun F, Wu B, Zhao Q | 10.1038/S41586-021-03641-W | 2021-06-23 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | Cryo-EM | 7EPD | 7EPD_refined | 3.9 | A | Inactive | - | 89 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | L-glutamic acid | small-molecule | No | No | Du J, Wang D, Fan H, Xu C, Tai L, Lin S, Han S, Tan Q, Wang X, Xu T, Zhang H, Chu X, Yi C, Liu P, Wang X, Zhou Y, Pin JP, Rondard P, Liu H, Liu J, Sun F, Wu B, Zhao Q | 10.1038/S41586-021-03641-W | 2021-06-23 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | X-ray | 7EPE | 7EPE_refined | 2.5 | A | Inactive | - | 28 | - | - | - | - | Flavodoxin | - |
CHEMBL3894759
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Du J, Wang D, Fan H, Xu C, Tai L, Lin S, Han S, Tan Q, Wang X, Xu T, Zhang H, Chu X, Yi C, Liu P, Wang X, Zhou Y, Pin JP, Rondard P, Liu H, Liu J, Sun F, Wu B, Zhao Q | 10.1038/S41586-021-03641-W | 2021-06-23 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7M3E | 7M3E_refined | 3.2 | B | Inactive | - | 75 | - | - | - | - | - | - |
Calcium
NPS 2143 L-tryptophan |
small-molecule small-molecule small-molecule |
Agonist NAM PAM |
Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Gao Y, Robertson MJ, Rahman SN, Seven AB, Zhang C, Meyerowitz JG, Panova O, Hannan FM, Thakker RV, Brauner-Osborne H, Mathiesen JM, Skiniotis G | 10.1038/S41586-021-03691-0 | 2021-06-30 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7M3F | 7M3F_refined | 2.8 | B | Active | - | 75 | - | - | - | - | - | - |
Calcium
cinacalcet L-tryptophan |
small-molecule small-molecule small-molecule |
Agonist PAM PAM |
Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Gao Y, Robertson MJ, Rahman SN, Seven AB, Zhang C, Meyerowitz JG, Panova O, Hannan FM, Thakker RV, Brauner-Osborne H, Mathiesen JM, Skiniotis G | 10.1038/S41586-021-03691-0 | 2021-06-30 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7M3G | 7M3G_refined | 2.5 | A | Active | - | 76 | - | - | - | - | - | - |
Calcium
evocalcet L-tryptophan |
small-molecule small-molecule small-molecule |
Agonist PAM PAM |
Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Gao Y, Robertson MJ, Rahman SN, Seven AB, Zhang C, Meyerowitz JG, Panova O, Hannan FM, Thakker RV, Brauner-Osborne H, Mathiesen JM, Skiniotis G | 10.1038/S41586-021-03691-0 | 2021-06-30 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7M3J | 7M3J_refined | 4.1 | A | Inactive | - | 72 | - | - | - | - | - | - |
NPS 2143
|
small-molecule | NAM | Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Gao Y, Robertson MJ, Rahman SN, Seven AB, Zhang C, Meyerowitz JG, Panova O, Hannan FM, Thakker RV, Brauner-Osborne H, Mathiesen JM, Skiniotis G | 10.1038/S41586-021-03691-0 | 2021-06-30 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | Cryo-EM | 7O7F | 7O7F_refined | 3.2 | C | Active | 100 | 85 | Gi/o | αi1 | - | 62 | - | Fab heavy chain Fab light chain |
CCL5
|
peptide | Agonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | Isaikina P, Tsai CJ, Dietz N, Pamula F, Grahl A, Goldie KN, Guixa-Gonzalez R, Branco C, Paolini-Bertrand M, Calo N, Cerini F, Schertler GFX, Hartley O, Stahlberg H, Maier T, Deupi X, Grzesiek S | 10.1126/SCIADV.ABG8685 | 2021-06-30 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7E14 | - | 2.9 | R | Active | 100 | 81 | Gs | αs | - | 49 | - | Nanobody-35 |
N-Tert-butyl-6,7-dichloroquinoxalin-2-amine
oforglipron |
small-molecule small-molecule |
Ago-PAM Agonist |
glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Cong Z, Chen LN, Ma H, Zhou Q, Zou X, Ye C, Dai A, Liu Q, Huang W, Sun X, Wang X, Xu P, Zhao L, Xia T, Zhong W, Yang D, Eric Xu H, Zhang Y, Wang MW | 10.1038/S41467-021-24058-Z | 2021-07-07 | Yes | |
Q3KSP2 | BILF1 | Unclassified | A | strain GD1 | Cryo-EM | 7JHJ | - | 3.2 | R | Active | 100 | 89 | Gi/o | αi1 | - | 62 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Tsutsumi N, Qu Q, Mavri M, Baggesen MS, Maeda S, Waghray D, Berg C, Kobilka BK, Rosenkilde MM, Skiniotis G, Garcia KC | 10.1016/J.IMMUNI.2021.06.001 | 2021-07-07 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | Cryo-EM | 7MT8 | 7MT8_refined | 5.8 | R | Active | 98 | 93 | - | - | - | - | - | GRK1 |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Chen Q, Plasencia M, Li Z, Mukherjee S, Patra D, Chen CL, Klose T, Yao XQ, Kossiakoff AA, Chang L, Andrews PC, Tesmer JJG | 10.1038/S41586-021-03721-X | 2021-07-07 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | Cryo-EM | 7MT9 | 7MT9_refined | 7.0 | R | Active | 98 | 93 | - | - | - | - | - | GRK1 |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Chen Q, Plasencia M, Li Z, Mukherjee S, Patra D, Chen CL, Klose T, Yao XQ, Kossiakoff AA, Chang L, Andrews PC, Tesmer JJG | 10.1038/S41586-021-03721-X | 2021-07-07 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | Cryo-EM | 7MTA | 7MTA_refined | 4.1 | R | Active | 98 | 93 | - | - | - | - | - | Fab heavy chain Fab light chain GRK1 |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Chen Q, Plasencia M, Li Z, Mukherjee S, Patra D, Chen CL, Klose T, Yao XQ, Kossiakoff AA, Chang L, Andrews PC, Tesmer JJG | 10.1038/S41586-021-03721-X | 2021-07-07 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | Cryo-EM | 7MTB | 7MTB_refined | 4.0 | R | Active | 98 | 93 | - | - | - | - | - | Fab light chain Fab heavy chain GRK1 |
Retinal (all-trans)
|
small-molecule | Agonist | - | - | No | No | Chen Q, Plasencia M, Li Z, Mukherjee S, Patra D, Chen CL, Klose T, Yao XQ, Kossiakoff AA, Chang L, Andrews PC, Tesmer JJG | 10.1038/S41586-021-03721-X | 2021-07-07 | Yes | |
PD2R2 | DP2 | Prostanoid | A | Human | X-ray | 7M8W | 7M8W_refined | 2.6 | A | Inactive | 24 | 83 | - | - | - | - | T4-Lysozyme | - |
15(R)-15-methyl-PGD2
|
small-molecule | Antagonist | PGD2, PGJ2, thromboxane A2, PGF2α, PGE2, PGI2, PGD3 | small-molecule | Yes | Yes | Liu H, Deepak RNVK, Shiriaeva A, Gati C, Batyuk A, Hu H, Weierstall U, Liu W, Wang L, Cherezov V, Fan H, Zhang C | 10.1073/PNAS.2102813118 | 2021-08-25 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | Cryo-EM | 7FD8 | 7FD8_refined | 3.8 | A | Active | - | 63 | - | - | - | - | - | - |
quisqualate
|
small-molecule | Agonist | L-glutamic acid | small-molecule | No | No | Nasrallah C, Cannone G, Briot J, Rottier K, Berizzi AE, Huang CY, Quast RB, Hoh F, Baneres JL, Malhaire F, Berto L, Dumazer A, Font-Ingles J, Gomez-Santacana X, Catena J, Kniazeff J, Goudet C, Llebaria A, Pin JP, Vinothkumar KR, Lebon G | 10.1016/J.CELREP.2021.109648 | 2021-09-08 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | Cryo-EM | 7FD9 | 7FD9_refined | 4.0 | A | Inactive | - | 63 | - | - | - | - | - | - |
LY341495
|
small-molecule | Antagonist | L-glutamic acid | small-molecule | No | No | Nasrallah C, Cannone G, Briot J, Rottier K, Berizzi AE, Huang CY, Quast RB, Hoh F, Baneres JL, Malhaire F, Berto L, Dumazer A, Font-Ingles J, Gomez-Santacana X, Catena J, Kniazeff J, Goudet C, Llebaria A, Pin JP, Vinothkumar KR, Lebon G | 10.1016/J.CELREP.2021.109648 | 2021-09-08 | Yes | |
AA1R | A1 | Adenosine | A | Human | Cryo-EM | 7LD3 | - | 3.2 | R | Active | 100 | 88 | Gi/o | αi2 | - | 59 | - | - |
{2-Amino-4-[3,5-bis(trifluoromethyl)phenyl]thiophen-3-yl}(4-chlorophenyl)methanone
adenosine |
small-molecule small-molecule |
Ago-PAM Agonist |
adenosine | small-molecule | Yes | No | Draper-Joyce CJ, Bhola R, Wang J, Bhattarai A, Nguyen ATN, Cowie-Kent I, O'Sullivan K, Chia LY, Venugopal H, Valant C, Thal DM, Wootten D, Panel N, Carlsson J, Christie MJ, White PJ, Scammells P, May LT, Sexton PM, Danev R, Miao Y, Glukhova A, Imlach WL, Christopoulos A | 10.1038/S41586-021-03897-2 | 2021-09-08 | Yes | |
AA1R | A1 | Adenosine | A | Human | Cryo-EM | 7LD4 | 7LD4_refined | 3.3 | R | Active | 100 | 88 | Gi/o | αi2 | - | 59 | - | - |
adenosine
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Draper-Joyce CJ, Bhola R, Wang J, Bhattarai A, Nguyen ATN, Cowie-Kent I, O'Sullivan K, Chia LY, Venugopal H, Valant C, Thal DM, Wootten D, Panel N, Carlsson J, Christie MJ, White PJ, Scammells P, May LT, Sexton PM, Danev R, Miao Y, Glukhova A, Imlach WL, Christopoulos A | 10.1038/S41586-021-03897-2 | 2021-09-08 | Yes | |
GRM5 | mGlu5 | Metabotropic glutamate | C | Human | X-ray | 7P2L | 7P2L_refined | 2.5 | A | Inactive | - | 21 | - | - | - | - | T4-Lysozyme | - |
alloswitch-1
|
small-molecule | NAM | L-glutamic acid | small-molecule | No | No | Nasrallah C, Cannone G, Briot J, Rottier K, Berizzi AE, Huang CY, Quast RB, Hoh F, Baneres JL, Malhaire F, Berto L, Dumazer A, Font-Ingles J, Gomez-Santacana X, Catena J, Kniazeff J, Goudet C, Llebaria A, Pin JP, Vinothkumar KR, Lebon G | 10.1016/J.CELREP.2021.109648 | 2021-09-08 | Yes | |
AA2AR | A2A | Adenosine | A | Human | MicroED | 7RM5 | 7RM5_refined | 2.8 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Martynowycz MW, Shiriaeva A, Ge X, Hattne J, Nannenga BL, Cherezov V, Gonen T | 10.1073/PNAS.2106041118 | 2021-09-08 | Yes | |
GRM1 | mGlu1 | Metabotropic glutamate | C | Human | Cryo-EM | 7DGD | 7DGD_refined | 4.0 | A | Inactive | - | 66 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | L-glutamic acid | small-molecule | No | No | Zhang J, Qu L, Wu L, Tang X, Luo F, Xu W, Xu Y, Liu ZJ, Hua T | 10.1007/S13238-020-00808-5 | 2021-09-22 | Yes | |
LSHR | LH | Glycoprotein hormone | A | Human | Cryo-EM | 7FIJ | 7FIJ_refined | 3.8 | R | Inactive | 9 | 80 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | LH, hCG | peptide | Yes | No | Duan J, Xu P, Cheng X, Mao C, Croll T, He X, Shi J, Luan X, Yin W, You E, Liu Q, Zhang S, Jiang H, Zhang Y, Jiang Y, Xu HE | 10.1038/S41586-021-03924-2 | 2021-09-29 | Yes | |
ACM1 | M1 | Acetylcholine (muscarinic) | A | Human | X-ray | 6ZFZ | 6ZFZ_refined | 2.2 | A | Inactive | 2 | 62 | - | - | - | - | T4-Lysozyme | - |
CHEMBL3354065
|
small-molecule | Agonist | acetylcholine | small-molecule | No | No | Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB | 10.1016/J.CELL.2021.11.001 | 2021-10-06 | Yes | |
ACM1 | M1 | Acetylcholine (muscarinic) | A | Human | X-ray | 6ZG4 | 6ZG4_refined | 2.3 | A | Inactive | 2 | 62 | - | - | - | - | T4-Lysozyme | - |
Ethyl (4S)-4-[4-[(1-methylcyclobutyl)carbamoyl]piperidin-1-yl]azepane-1-carboxylate
|
small-molecule | Agonist | acetylcholine | small-molecule | No | No | Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB | 10.1016/J.CELL.2021.11.001 | 2021-10-06 | Yes | |
ACM1 | M1 | Acetylcholine (muscarinic) | A | Human | X-ray | 6ZG9 | 6ZG9_refined | 2.5 | A | Inactive | 2 | 62 | - | - | - | - | T4-Lysozyme | - |
7-fluoro-5-methyl-3-[1-(oxan-4-yl)piperidin-4-yl]-1H-benzimidazol-2-one
|
small-molecule | Agonist | acetylcholine | small-molecule | No | No | Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB | 10.1016/J.CELL.2021.11.001 | 2021-10-06 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7RTB | 7RTB_refined | 2.1 | R | Active | 100 | 83 | Gs | αs | - | 60 | - | Nanobody-35 |
Peptide-19
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Johnson RM, Zhang X, Piper SJ, Nettleton TJ, Vandekolk TH, Langmead CJ, Danev R, Sexton PM, Wootten D | 10.1016/J.BBRC.2021.09.016 | 2021-10-06 | Yes | |
BKRB1 | B1 | Bradykinin | A | Human | Cryo-EM | 7EIB | - | 3.0 | A | Active | 100 | 84 | Gq/11 | αq | Gq-Gi1 chimera | 61 | - | - |
[des-Arg10]kallidin
|
peptide | Agonist | bradykinin, [des-Arg9]bradykinin, [Hyp3]bradykinin, T-kinin, kallidin, Lys-[Hyp3]-bradykinin, [des-Arg10]kallidin | peptide | Yes | No | Yin YL, Ye C, Zhou F, Wang J, Yang D, Yin W, Wang MW, Xu HE, Jiang Y | 10.1038/S41594-021-00645-Y | 2021-10-13 | Yes | |
BKRB2 | B2 | Bradykinin | A | Human | Cryo-EM | 7F2O | - | 2.9 | R | Active | 100 | 73 | Gq/11 | αq | Gq-Gi1 chimera | 60 | - | scFv16 |
bradykinin
|
peptide | Agonist | bradykinin, [des-Arg9]bradykinin, [Hyp3]bradykinin, T-kinin, kallidin, Lys-[Hyp3]-bradykinin, [des-Arg10]kallidin | peptide | Yes | No | Yin YL, Ye C, Zhou F, Wang J, Yang D, Yin W, Wang MW, Xu HE, Jiang Y | 10.1038/S41594-021-00645-Y | 2021-10-13 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | X-ray | 7F8U | 7F8U_refined | 2.8 | A | Inactive | 1 | 65 | - | - | - | - | T4-Lysozyme | - |
lintitript
|
small-molecule | Antagonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | No | No | Zhang X, He C, Wang M, Zhou Q, Yang D, Zhu Y, Feng W, Zhang H, Dai A, Chu X, Wang J, Yang Z, Jiang Y, Sensfuss U, Tan Q, Han S, Reedtz-Runge S, Xu HE, Zhao S, Wang MW, Wu B, Zhao Q | 10.1038/S41589-021-00866-8 | 2021-10-13 | Yes | |
GASR | CCK2 | Cholecystokinin | A | Human | Cryo-EM | 7F8V | 7F8V_refined | 3.3 | R | Active | 100 | 62 | Gi/o | αi2 | - | 61 | - | - |
desulfated gastrin-17
|
peptide | Agonist | desulfated gastrin-17, desulfated gastrin-34, gastrin-14, CCK-58, CCK-8, CCK-39, gastrin-71, gastrin-34, desulfated gastrin-71, desulfated cholecystokinin-8, CCK-4, desulfated gastrin-14, gastrin-17, CCK-33 | peptide | Yes | No | Zhang X, He C, Wang M, Zhou Q, Yang D, Zhu Y, Feng W, Zhang H, Dai A, Chu X, Wang J, Yang Z, Jiang Y, Sensfuss U, Tan Q, Han S, Reedtz-Runge S, Xu HE, Zhao S, Wang MW, Wu B, Zhao Q | 10.1038/S41589-021-00866-8 | 2021-10-13 | Yes | |
GASR | CCK2 | Cholecystokinin | A | Human | Cryo-EM | 7F8W | 7F8W_refined | 3.1 | R | Active | 100 | 62 | Gq/11 | αq | Gq-Gi1 chimera | 62 | - | scFv16 |
desulfated gastrin-17
|
peptide | Agonist | desulfated gastrin-17, desulfated gastrin-34, gastrin-14, CCK-58, CCK-8, CCK-39, gastrin-71, gastrin-34, desulfated gastrin-71, desulfated cholecystokinin-8, CCK-4, desulfated gastrin-14, gastrin-17, CCK-33 | peptide | Yes | No | Zhang X, He C, Wang M, Zhou Q, Yang D, Zhu Y, Feng W, Zhang H, Dai A, Chu X, Wang J, Yang Z, Jiang Y, Sensfuss U, Tan Q, Han S, Reedtz-Runge S, Xu HE, Zhao S, Wang MW, Wu B, Zhao Q | 10.1038/S41589-021-00866-8 | 2021-10-13 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | X-ray | 7F8Y | 7F8Y_refined | 2.5 | A | Inactive | 1 | 65 | - | - | - | - | T4-Lysozyme | - |
DEVAZEPIDE
|
small-molecule | Antagonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | No | No | Zhang X, He C, Wang M, Zhou Q, Yang D, Zhu Y, Feng W, Zhang H, Dai A, Chu X, Wang J, Yang Z, Jiang Y, Sensfuss U, Tan Q, Han S, Reedtz-Runge S, Xu HE, Zhao S, Wang MW, Wu B, Zhao Q | 10.1038/S41589-021-00866-8 | 2021-10-13 | Yes | |
MC4R | MC4 | Melanocortin | A | Human | Cryo-EM | 7F53 | - | 3.0 | R | Active | 100 | 82 | Gs | αs | - | 58 | - | Nanobody-35 |
α-MSH
|
peptide | Agonist | ACTH, β-MSH, γ-MSH, α-MSH, agouti-related protein | peptide | Yes | No | Zhang H, Chen LN, Yang D, Mao C, Shen Q, Feng W, Shen DD, Dai A, Xie S, Zhou Y, Qin J, Sun JP, Scharf DH, Hou T, Zhou T, Wang MW, Zhang Y | 10.1038/S41422-021-00552-3 | 2021-11-03 | Yes | |
MC4R | MC4 | Melanocortin | A | Human | Cryo-EM | 7F54 | - | 3.0 | R | Active | 100 | 82 | Gs | αs | - | 58 | - | Nanobody-35 |
afamelanotide
|
peptide | Agonist | ACTH, β-MSH, γ-MSH, α-MSH, agouti-related protein | peptide | Yes | No | Zhang H, Chen LN, Yang D, Mao C, Shen Q, Feng W, Shen DD, Dai A, Xie S, Zhou Y, Qin J, Sun JP, Scharf DH, Hou T, Zhou T, Wang MW, Zhang Y | 10.1038/S41422-021-00552-3 | 2021-11-03 | Yes | |
MC4R | MC4 | Melanocortin | A | Human | Cryo-EM | 7F55 | - | 3.1 | R | Active | 100 | 82 | Gs | αs | - | 58 | - | Nanobody-35 |
bremelanotide
|
peptide | Agonist | ACTH, β-MSH, γ-MSH, α-MSH, agouti-related protein | peptide | Yes | No | Zhang H, Chen LN, Yang D, Mao C, Shen Q, Feng W, Shen DD, Dai A, Xie S, Zhou Y, Qin J, Sun JP, Scharf DH, Hou T, Zhou T, Wang MW, Zhang Y | 10.1038/S41422-021-00552-3 | 2021-11-03 | Yes | |
MC4R | MC4 | Melanocortin | A | Human | Cryo-EM | 7F58 | 7F58_refined | 3.1 | R | Active | 100 | 82 | Gs | αs | - | 58 | - | Nanobody-35 |
THIQ
|
small-molecule | Agonist | ACTH, β-MSH, γ-MSH, α-MSH, agouti-related protein | peptide | Yes | No | Zhang H, Chen LN, Yang D, Mao C, Shen Q, Feng W, Shen DD, Dai A, Xie S, Zhou Y, Qin J, Sun JP, Scharf DH, Hou T, Zhou T, Wang MW, Zhang Y | 10.1038/S41422-021-00552-3 | 2021-11-03 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | Cryo-EM | 7RMG | - | 3.0 | R | Active | 100 | 71 | Gs | αs | Gs-Gq chimera | 49 | - | Nanobody-35 |
substance P
|
peptide | Agonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Harris JA, Faust B, Gondin AB, Damgen MA, Suomivuori CM, Veldhuis NA, Cheng Y, Dror RO, Thal DM, Manglik A | 10.1038/S41589-021-00890-8 | 2021-11-03 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | Cryo-EM | 7RMH | 7RMH_refined | 3.1 | R | Active | 100 | 70 | Gs | αs | - | 55 | - | Nanobody-35 |
substance P
|
peptide | Agonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Harris JA, Faust B, Gondin AB, Damgen MA, Suomivuori CM, Veldhuis NA, Cheng Y, Dror RO, Thal DM, Manglik A | 10.1038/S41589-021-00890-8 | 2021-11-03 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | Cryo-EM | 7RMI | - | 3.2 | R | Active | 100 | 70 | Gs | αs | Gs-Gq chimera | 49 | - | Nanobody-35 |
substance P
|
peptide | Agonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Harris JA, Faust B, Gondin AB, Damgen MA, Suomivuori CM, Veldhuis NA, Cheng Y, Dror RO, Thal DM, Manglik A | 10.1038/S41589-021-00890-8 | 2021-11-03 | Yes | |
MC4R | MC4 | Melanocortin | A | Human | Cryo-EM | 7PIU | - | 2.6 | R | Active | 100 | 78 | Gs | αs | - | 48 | - | Nanobody-35 |
setmelanotide
|
peptide | Agonist | ACTH, β-MSH, γ-MSH, α-MSH, agouti-related protein | peptide | Yes | No | Heyder NA, Kleinau G, Speck D, Schmidt A, Paisdzior S, Szczepek M, Bauer B, Koch A, Gallandi M, Kwiatkowski D, Burger J, Mielke T, Beck-Sickinger AG, Hildebrand PW, Spahn CMT, Hilger D, Schacherl M, Biebermann H, Hilal T, Kuhnen P, Kobilka BK, Scheerer P | 10.1038/S41422-021-00569-8 | 2021-11-17 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7S8M | - | 2.5 | R | Active | 100 | 77 | Gi/o | αi1 | - | 62 | BRIL | scFv16 |
Cortistatin 14
|
peptide | Agonist | PAMP-20 | peptide | No | No | Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, Hayes BW, Liu J, Gumpper RH, Bender BJ, Slocum ST, Krumm BE, Lansu K, McCorvy JD, Kroeze WK, English JG, DiBerto JF, Olsen RHJ, Huang XP, Zhang S, Liu Y, Kim K, Karpiak J, Jan LY, Abraham SN, Jin J, Shoichet BK, Fay JF, Roth BL | 10.1038/S41586-021-04126-6 | 2021-11-17 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7S8N | 7S8N_refined | 2.9 | R | Active | 100 | 76 | Gq/11 | αq | Gq-Gs chimera | 57 | - | scFv16 |
(R)-ZINC-3573
|
small-molecule | Agonist | PAMP-20 | peptide | No | No | Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, Hayes BW, Liu J, Gumpper RH, Bender BJ, Slocum ST, Krumm BE, Lansu K, McCorvy JD, Kroeze WK, English JG, DiBerto JF, Olsen RHJ, Huang XP, Zhang S, Liu Y, Kim K, Karpiak J, Jan LY, Abraham SN, Jin J, Shoichet BK, Fay JF, Roth BL | 10.1038/S41586-021-04126-6 | 2021-11-17 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7S8O | 7S8O_refined | 2.6 | R | Active | 100 | 78 | Gi/o | αi1 | - | 62 | BRIL | scFv16 |
(R)-ZINC-3573
|
small-molecule | Agonist | PAMP-20 | peptide | No | No | Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, Hayes BW, Liu J, Gumpper RH, Bender BJ, Slocum ST, Krumm BE, Lansu K, McCorvy JD, Kroeze WK, English JG, DiBerto JF, Olsen RHJ, Huang XP, Zhang S, Liu Y, Kim K, Karpiak J, Jan LY, Abraham SN, Jin J, Shoichet BK, Fay JF, Roth BL | 10.1038/S41586-021-04126-6 | 2021-11-17 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | X-ray | 7V3Z | 7V3Z_refined | 3.3 | A | Active | 94 | 60 | - | - | - | - | Flavodoxin | - |
CP55940
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Wang X, Liu D, Shen L, Li F, Li Y, Yang L, Xu T, Tao H, Yao D, Wu L, Hirata K, Bohn LM, Makriyannis A, Liu X, Hua T, Liu ZJ, Wang J | 10.1021/JACS.1C06847 | 2021-11-24 | Yes | |
GP158 | GPR158 | C Orphans | C | Human | Cryo-EM | 7EWL | 7EWL_refined | 3.5 | A | Inactive | - | 41 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Jeong E, Kim Y, Jeong J, Cho Y | 10.1038/S41467-021-27147-1 | 2021-12-01 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | Cryo-EM | 7MTQ | - | 3.7 | B | Inactive | - | 85 | - | - | - | - | - | - |
LY341495
|
small-molecule | Antagonist | L-glutamic acid | small-molecule | No | No | Seven AB, Barros-Alvarez X, de Lapeyriere M, Papasergi-Scott MM, Robertson MJ, Zhang C, Nwokonko RM, Gao Y, Meyerowitz JG, Rocher JP, Schelshorn D, Kobilka BK, Mathiesen JM, Skiniotis G | 10.1038/S41586-021-03680-3 | 2021-07-07 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | Cryo-EM | 7MTR | 7MTR_refined | 3.3 | A | Active | - | 88 | - | - | - | - | - | - |
2-methoxy-6-propyl-N-(2-{4-[(1H-tetrazol-5-yl)methoxy]phenyl}ethyl)thieno[2,3-d]pyrimidin-4-amine
L-glutamic acid |
small-molecule small-molecule |
Ago-PAM Agonist |
L-glutamic acid | small-molecule | No | No | Seven AB, Barros-Alvarez X, de Lapeyriere M, Papasergi-Scott MM, Robertson MJ, Zhang C, Nwokonko RM, Gao Y, Meyerowitz JG, Rocher JP, Schelshorn D, Kobilka BK, Mathiesen JM, Skiniotis G | 10.1038/S41586-021-03680-3 | 2021-07-07 | Yes | |
GRM2 | mGlu2 | Metabotropic glutamate | C | Human | Cryo-EM | 7MTS | - | 3.2 | A | Active | - | 90 | Gi/o | αi1 | - | 58 | - | - |
2-methoxy-6-propyl-N-(2-{4-[(1H-tetrazol-5-yl)methoxy]phenyl}ethyl)thieno[2,3-d]pyrimidin-4-amine
L-glutamic acid |
small-molecule small-molecule |
Ago-PAM Agonist |
L-glutamic acid | small-molecule | No | No | Seven AB, Barros-Alvarez X, de Lapeyriere M, Papasergi-Scott MM, Robertson MJ, Zhang C, Nwokonko RM, Gao Y, Meyerowitz JG, Rocher JP, Schelshorn D, Kobilka BK, Mathiesen JM, Skiniotis G | 10.1038/S41586-021-03680-3 | 2021-07-07 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7DUQ | - | 2.5 | R | Active | 100 | 83 | Gs | αs | - | 61 | - | Nanobody-35 |
N-Tert-butyl-6,7-dichloroquinoxalin-2-amine
CHEMBL410972 |
small-molecule protein |
Ago-PAM Agonist |
glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Cong Z, Chen LN, Ma H, Zhou Q, Zou X, Ye C, Dai A, Liu Q, Huang W, Sun X, Wang X, Xu P, Zhao L, Xia T, Zhong W, Yang D, Eric Xu H, Zhang Y, Wang MW | 10.1038/S41467-021-24058-Z | 2021-07-14 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | Cryo-EM | 7F1Q | - | 2.9 | R | Active | 100 | 85 | Gi/o | αi1 | - | 61 | - | - |
CCL3
|
peptide | Agonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | - | - | 2021-07-14 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | Cryo-EM | 7F1R | - | 3.0 | R | Active | 100 | 79 | Gi/o | αi1 | - | 61 | - | - |
CCL5
|
peptide | Agonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | - | - | 2021-07-14 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | Cryo-EM | 7F1S | 7F1S_refined | 2.8 | R | Active | 100 | 78 | Gi/o | αi1 | - | 61 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | Zhang H, Chen K, Tan Q, Shao Q, Han S, Zhang C, Yi C, Chu X, Zhu Y, Xu Y, Zhao Q, Wu B | 10.1038/S41467-021-24438-5 | 2021-07-14 | Yes | |
CCR5 | CCR5 | Chemokine | A | Human | X-ray | 7F1T | - | 2.6 | A | Inactive | 15 | 86 | - | - | - | - | Rubredoxin | - |
CCL3
|
peptide | Agonist | CCL16, CCL5, CCL4, CCL7, CCL14, CCL3, CCL13, CCL2, CCL11, CCL8 | peptide | No | No | - | - | 2021-07-14 | Yes | |
V2R | V2 | Vasopressin and oxytocin | A | Human | Cryo-EM | 7DW9 | - | 2.6 | R | Active | 100 | 75 | Gs | αs | - | 60 | - | Nanobody-35 scFv16 |
vasopressin
|
peptide | Agonist | vasopressin, oxytocin | peptide | Yes | No | Zhou F, Ye C, Ma X, Yin W, Croll TI, Zhou Q, He X, Zhang X, Yang D, Wang P, Xu HE, Wang MW, Jiang Y | 10.1038/S41422-021-00480-2 | 2021-07-21 | Yes | |
ADRB3 | β3 | Adrenoceptors | A | Dog | Cryo-EM | 7DH5 | - | 3.2 | R | Active | 100 | 68 | Gs | αs | - | 59 | - | Nanobody-35 |
mirabegron
|
small-molecule | Agonist | - | - | Yes | No | Nagiri C, Kobayashi K, Tomita A, Kato M, Kobayashi K, Yamashita K, Nishizawa T, Inoue A, Shihoya W, Nureki O | 10.1016/J.MOLCEL.2021.06.024 | 2021-08-04 | Yes | |
GIPR | GIP | Glucagon | B1 | Human | Cryo-EM | 7DTY | - | 3.0 | R | Active | 100 | 79 | Gs | αs | - | 59 | - | Nanobody-35 |
GIP
|
small-molecule | Agonist | gastric inhibitory polypeptide | peptide | No | No | Zhao F, Zhang C, Zhou Q, Hang K, Zou X, Chen Y, Wu F, Rao Q, Dai A, Yin W, Shen DD, Zhang Y, Xia T, Stevens RC, Xu HE, Yang D, Zhao L, Wang MW | 10.7554/ELIFE.68719 | 2021-08-04 | Yes | |
FZD7 | FZD7 | Frizzled | F | Human | Cryo-EM | 7EVW | - | 3.2 | R | Active | 100 | 59 | Gs | αs | - | 59 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Xu L, Chen B, Schihada H, Wright SC, Turku A, Wu Y, Han GW, Kowalski-Jahn M, Kozielewicz P, Bowin CF, Zhang X, Li C, Bouvier M, Schulte G, Xu F | 10.1038/S41422-021-00525-6 | 2021-08-04 | Yes | |
5HT1F | 5-HT1F | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7EXD | 7EXD_refined | 3.4 | R | Active | 100 | 74 | Gi/o | αi1 | - | 62 | BRIL | scFv16 |
lasmiditan
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Huang S, Xu P, Tan Y, You C, Zhang Y, Jiang Y, Xu HE | 10.1038/S41422-021-00527-4 | 2021-08-04 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7KI0 | - | 2.5 | R | Active | 100 | 83 | Gs | αs | - | 53 | - | Nanobody-35 |
semaglutide
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhang X, Belousoff MJ, Liang YL, Danev R, Sexton PM, Wootten D | 10.1016/J.CELREP.2021.109374 | 2021-08-04 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7KI1 | - | 2.5 | R | Active | 100 | 83 | Gs | αs | - | 89 | - | Nanobody-35 |
Taspoglutide
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhang X, Belousoff MJ, Liang YL, Danev R, Sexton PM, Wootten D | 10.1016/J.CELREP.2021.109374 | 2021-08-04 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7DUR | - | 3.3 | R | Active | 100 | 80 | Gs | αs | - | 60 | - | Nanobody-35 |
N-Tert-butyl-6,7-dichloroquinoxalin-2-amine
|
small-molecule | Ago-PAM | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Cong Z, Chen LN, Ma H, Zhou Q, Zou X, Ye C, Dai A, Liu Q, Huang W, Sun X, Wang X, Xu P, Zhao L, Xia T, Zhong W, Yang D, Eric Xu H, Zhang Y, Wang MW | 10.1038/S41467-021-24058-Z | 2021-08-11 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7EVM | - | 2.5 | R | Active | 100 | 61 | Gs | αs | - | 60 | - | Nanobody-35 |
N-Tert-butyl-6,7-dichloroquinoxalin-2-amine
|
small-molecule | Ago-PAM | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Cong Z, Chen LN, Ma H, Zhou Q, Zou X, Ye C, Dai A, Liu Q, Huang W, Sun X, Wang X, Xu P, Zhao L, Xia T, Zhong W, Yang D, Eric Xu H, Zhang Y, Wang MW | 10.1038/S41467-021-24058-Z | 2021-08-11 | Yes | |
MTR1A | MT1 | Melatonin | A | Human | Cryo-EM | 7DB6 | 7DB6_refined | 3.3 | D | Active | 100 | 79 | Gi/o | αi1 | - | 62 | - | scFv16 |
ramelteon
|
small-molecule | Agonist | melatonin | small-molecule | Yes | No | Okamoto HH, Miyauchi H, Inoue A, Raimondi F, Tsujimoto H, Kusakizako T, Shihoya W, Yamashita K, Suno R, Nomura N, Kobayashi T, Iwata S, Nishizawa T, Nureki O | 10.1038/S41594-021-00634-1 | 2021-08-18 | Yes | |
PTH2R | PTH2 | Parathyroid hormone | B1 | Human | Cryo-EM | 7F16 | - | 2.8 | R | Active | 100 | 68 | Gs | αs | - | 58 | - | Nanobody-35 |
TIP39
|
peptide | Agonist | PTHrP-(1-34) (human), PTHrP, PTHrP-(1-36), TIP39, PTH | peptide | No | No | Wang X, Cheng X, Zhao L, Wang Y, Ye C, Zou X, Dai A, Cong Z, Chen J, Zhou Q, Xia T, Jiang H, Xu HE, Yang D, Wang MW | 10.1073/PNAS.2101279118 | 2021-08-18 | Yes | |
GHSR | ghrelin | Ghrelin | A | Human | Cryo-EM | 7F9Y | - | 2.9 | R | Active | 100 | 78 | Gq/11 | αq | Engineered G alpha | 59 | - | Nanobody-35 |
ghrelin
|
peptide | Agonist | [des-Gln14]ghrelin, ghrelin | peptide | Yes | No | Wang Y, Guo S, Zhuang Y, Yun Y, Xu P, He X, Guo J, Yin W, Xu HE, Xie X, Jiang Y | 10.1038/S41467-021-25364-2 | 2021-08-18 | Yes | |
GHSR | ghrelin | Ghrelin | A | Human | Cryo-EM | 7F9Z | 7F9Z_refined | 3.2 | R | Active | 100 | 77 | Gq/11 | αq | Engineered G alpha | 59 | - | Nanobody-35 scFv16 |
GHRP-6
|
peptide | Agonist | [des-Gln14]ghrelin, ghrelin | peptide | Yes | No | Wang Y, Guo S, Zhuang Y, Yun Y, Xu P, He X, Guo J, Yin W, Xu HE, Xie X, Jiang Y | 10.1038/S41467-021-25364-2 | 2021-08-18 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | Cryo-EM | 7EZH | 7EZH_refined | 3.2 | D | Active | 100 | 69 | Gi/o | αi1 | - | 61 | - | scFv16 |
CCK-8
|
peptide | Agonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | Yes | No | Liu Q, Yang D, Zhuang Y, Croll TI, Cai X, Dai A, He X, Duan J, Yin W, Ye C, Zhou F, Wu B, Zhao Q, Xu HE, Wang MW, Jiang Y | 10.1038/S41589-021-00841-3 | 2021-08-25 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | Cryo-EM | 7EZK | 7EZK_refined | 3.1 | D | Active | 100 | 69 | Gs | αs | - | 58 | - | - |
CCK-8
|
peptide | Agonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | Yes | No | Liu Q, Yang D, Zhuang Y, Croll TI, Cai X, Dai A, He X, Duan J, Yin W, Ye C, Zhou F, Wu B, Zhao Q, Xu HE, Wang MW, Jiang Y | 10.1038/S41589-021-00841-3 | 2021-08-25 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | Cryo-EM | 7EZM | - | 2.9 | D | Active | 100 | 71 | Gq/11 | αq | - | 63 | - | scFv16 |
CCK-8
|
peptide | Agonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | Yes | No | Liu Q, Yang D, Zhuang Y, Croll TI, Cai X, Dai A, He X, Duan J, Yin W, Ye C, Zhou F, Wu B, Zhao Q, Xu HE, Wang MW, Jiang Y | 10.1038/S41589-021-00841-3 | 2021-08-25 | Yes | |
GRM1 | mGlu1 | Metabotropic glutamate | C | Human | Cryo-EM | 7DGE | 7DGE_refined | 3.7 | A | Intermediate | - | 66 | - | - | - | - | - | Nanobody-43 |
quisqualate
|
small-molecule | Agonist | L-glutamic acid | small-molecule | No | No | Zhang J, Qu L, Wu L, Tang X, Luo F, Xu W, Xu Y, Liu ZJ, Hua T | 10.1007/S13238-020-00808-5 | 2021-09-22 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7E6T | 7E6T_refined | 3.0 | A | Active | - | 74 | - | - | - | - | - | - |
Calcium
Cyclomethyltryptophan |
small-molecule small-molecule |
Agonist PAM |
Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Chen X, Wang L, Cui Q, Ding Z, Han L, Kou Y, Zhang W, Wang H, Jia X, Dai M, Shi Z, Li Y, Li X, Geng Y | 10.7554/ELIFE.68578 | 2021-09-22 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7E6U | 7E6U_refined | 6.0 | A | Inactive | - | 72 | - | - | - | - | - | Nanobody-2D11 |
Apo (no ligand)
|
none | Apo (no ligand) | Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Chen X, Wang L, Cui Q, Ding Z, Han L, Kou Y, Zhang W, Wang H, Jia X, Dai M, Shi Z, Li Y, Li X, Geng Y | 10.7554/ELIFE.68578 | 2021-09-22 | Yes | |
S1PR5 | S1P5 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EW1 | 7EW1_refined | 3.4 | A | Active | 100 | 68 | Gi/o | αi1 | - | 64 | - | scFv16 |
siponimod
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yuan Y, Jia G, Wu C, Wang W, Cheng L, Li Q, Li Z, Luo K, Yang S, Yan W, Su Z, Shao Z | 10.1038/S41422-021-00566-X | 2021-09-29 | Yes | |
S1PR3 | S1P3 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EW2 | 7EW2_refined | 3.1 | R | Active | 100 | 77 | Gi/o | αi1 | - | 64 | - | scFv16 |
(S)-FTY720-phosphate
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Zhao C, Cheng L, Wang W, Wang H, Luo Y, Feng Y, Wang X, Fu H, Cai Y, Yang S, Fu P, Yan W, Shao Z | 10.1038/S41422-021-00567-W | 2021-09-29 | Yes | |
S1PR3 | S1P3 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EW3 | 7EW3_refined | 3.1 | R | Active | 100 | 77 | Gi/o | αi1 | - | 64 | - | scFv16 |
Sphingosine 1-phosphate
|
lipid | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Zhao C, Cheng L, Wang W, Wang H, Luo Y, Feng Y, Wang X, Fu H, Cai Y, Yang S, Fu P, Yan W, Shao Z | 10.1038/S41422-021-00567-W | 2021-09-29 | Yes | |
S1PR3 | S1P3 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EW4 | 7EW4_refined | 3.2 | R | Active | 100 | 76 | Gi/o | αi1 | - | 64 | - | scFv16 |
CYM-5541
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Zhao C, Cheng L, Wang W, Wang H, Luo Y, Feng Y, Wang X, Fu H, Cai Y, Yang S, Fu P, Yan W, Shao Z | 10.1038/S41422-021-00567-W | 2021-09-29 | Yes | |
LSHR | LH | Glycoprotein hormone | A | Human | Cryo-EM | 7FIG | - | 3.9 | R | Active | 100 | 79 | Gs | αs | - | 91 | - | Nanobody-35 |
Glycoprotein alpha
Choriogonadotropin beta |
protein protein |
Agonist | LH, hCG | peptide | Yes | No | Duan J, Xu P, Cheng X, Mao C, Croll T, He X, Shi J, Luan X, Yin W, You E, Liu Q, Zhang S, Jiang H, Zhang Y, Jiang Y, Xu HE | 10.1038/S41586-021-03924-2 | 2021-09-29 | Yes | |
LSHR | LH | Glycoprotein hormone | A | Human | Cryo-EM | 7FIH | - | 3.2 | R | Active | 100 | 79 | Gs | αs | - | 60 | - | - |
Glycoprotein alpha
Choriogonadotropin beta 5-Amino-N-(1,1-dimethylethyl)-2-(methylthio)-4-[3-[[2-(4-morpholinyl)acetyl]amino]phenyl]thieno[2,3-d]pyrimidine-6-carboxamide |
protein protein small-molecule |
Agonist | LH, hCG | peptide | Yes | No | Duan J, Xu P, Cheng X, Mao C, Croll T, He X, Shi J, Luan X, Yin W, You E, Liu Q, Zhang S, Jiang H, Zhang Y, Jiang Y, Xu HE | 10.1038/S41586-021-03924-2 | 2021-09-29 | Yes | |
LSHR | LH | Glycoprotein hormone | A | Human | Cryo-EM | 7FII | - | 4.3 | R | Active | 100 | 82 | Gs | αs | - | 91 | - | - |
Glycoprotein alpha
Choriogonadotropin beta |
protein protein |
Agonist | LH, hCG | peptide | Yes | No | Duan J, Xu P, Cheng X, Mao C, Croll T, He X, Shi J, Luan X, Yin W, You E, Liu Q, Zhang S, Jiang H, Zhang Y, Jiang Y, Xu HE | 10.1038/S41586-021-03924-2 | 2021-09-29 | Yes | |
GP158 | GPR158 | C Orphans | C | Human | Cryo-EM | 7EWR | 7EWR_refined | 4.7 | A | Inactive | - | 47 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Jeong E, Kim Y, Jeong J, Cho Y | 10.1038/S41467-021-27147-1 | 2021-12-01 | Yes | |
GP158 | GPR158 | C Orphans | C | Human | Cryo-EM | 7SHE | 7SHE_refined | 3.4 | A | Inactive | - | 45 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Patil DN, Singh S, Laboute T, Strutzenberg TS, Qiu X, Wu D, Novick SJ, Robinson CV, Griffin PR, Hunt JF, Izard T, Singh AK, Martemyanov KA | 10.1126/SCIENCE.ABL4732 | 2021-12-01 | Yes | |
GP158 | GPR158 | C Orphans | C | Human | Cryo-EM | 7SHF | 7SHF_refined | 3.4 | B | Inactive | - | 23 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Patil DN, Singh S, Laboute T, Strutzenberg TS, Qiu X, Wu D, Novick SJ, Robinson CV, Griffin PR, Hunt JF, Izard T, Singh AK, Martemyanov KA | 10.1126/SCIENCE.ABL4732 | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VDH | - | 2.9 | R | Active | 100 | 81 | Gi/o | αi1 | - | 62 | - | scFv16 |
compound 48/80
|
small-molecule | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VDL | - | 3.2 | R | Active | 100 | 78 | Gi/o | αi1 | - | 61 | - | scFv16 |
Cortistatin 14
|
peptide | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VDM | 7VDM_refined | 3.0 | R | Active | 100 | 77 | Gi/o | αi1 | - | 61 | - | scFv16 |
substance P
|
peptide | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VUY | - | 2.8 | R | Active | 100 | 78 | Gi/o | αi1 | - | 64 | - | scFv16 |
PAMP-12
|
peptide | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VV0 | 7VV0_refined | 3.5 | R | Active | 98 | 80 | - | - | - | - | - | - |
PAMP-12
|
peptide | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VV3 | - | 3.0 | R | Active | 100 | 79 | Gi/o | αi1 | - | 62 | - | scFv16 |
Cortistatin 14
|
peptide | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VV4 | 7VV4_refined | 3.0 | R | Active | 98 | 80 | - | - | - | - | - | - |
Cortistatin 14
|
peptide | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VV5 | 7VV5_refined | 2.8 | R | Active | 100 | 81 | Gi/o | αi1 | - | 64 | - | scFv16 |
compound 48/80
|
small-molecule | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
MRGX2 | MRGPRX2 | A orphans | A | Human | Cryo-EM | 7VV6 | 7VV6_refined | 3.3 | R | Active | 98 | 82 | - | - | - | - | - | - |
compound 48/80
|
small-molecule | Agonist | PAMP-20 | peptide | No | No | Yang F, Guo L, Li Y, Wang G, Wang J, Zhang C, Fang GX, Chen X, Liu L, Yan X, Liu Q, Qu C, Xu Y, Xiao P, Zhu Z, Li Z, Zhou J, Yu X, Gao N, Sun JP | 10.1038/S41586-021-04077-Y | 2021-12-01 | Yes | |
GHSR | ghrelin | Ghrelin | A | Human | Cryo-EM | 7NA7 | 7NA7_refined | 2.7 | R | Active | 100 | 80 | Gi/o | αi1 | - | 61 | - | Antibody fragment |
Ghrelin-27
|
peptide | Agonist | [des-Gln14]ghrelin, ghrelin | peptide | No | No | Liu H, Sun D, Myasnikov A, Damian M, Baneres JL, Sun J, Zhang C | 10.1038/S41467-021-26735-5 | 2021-12-15 | Yes | |
GHSR | ghrelin | Ghrelin | A | Human | Cryo-EM | 7NA8 | - | 2.7 | R | Active | 100 | 78 | Gi/o | αi1 | - | 61 | - | Antibody fragment |
ibutamoren
|
small-molecule | Agonist | [des-Gln14]ghrelin, ghrelin | peptide | No | No | Liu H, Sun D, Myasnikov A, Damian M, Baneres JL, Sun J, Zhang C | 10.1038/S41467-021-26735-5 | 2021-12-15 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | Cryo-EM | 7P00 | - | 2.7 | R | Active | 100 | 71 | Gq/11 | αq | Gq-Gs-Gi1 chimera | 59 | - | scFv16 |
substance P
|
peptide | Agonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Thom C, Ehrenmann J, Vacca S, Waltenspuhl Y, Schoppe J, Medalia O, Pluckthun A | 10.1126/SCIADV.ABK2872 | 2021-12-15 | Yes | |
NK1R | NK1 | Tachykinin | A | Human | Cryo-EM | 7P02 | - | 2.9 | R | Active | 100 | 71 | Gs | αs | Gs-Gi1 chimera | 57 | - | scFv16 |
substance P
|
peptide | Agonist | neuropeptide K, neurokinin A, neuropeptide-γ, neurokinin B, hemokinin 1, substance P | peptide | Yes | No | Thom C, Ehrenmann J, Vacca S, Waltenspuhl Y, Schoppe J, Medalia O, Pluckthun A | 10.1126/SCIADV.ABK2872 | 2021-12-15 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 7VOD | 7VOD_refined | 3.3 | A | Inactive | 1 | 58 | - | - | - | - | BRIL | - |
cariprazine
|
small-molecule | Agonist (partial) | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Chen Z, Fan L, Wang H, Yu J, Lu D, Qi J, Nie F, Luo Z, Liu Z, Cheng J, Wang S | 10.1038/S41593-021-00971-W | 2021-12-22 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 7VOE | 7VOE_refined | 2.9 | A | Inactive | 1 | 58 | - | - | - | - | BRIL | - |
aripiprazole
|
small-molecule | Agonist (partial) | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | - | - | 2021-12-22 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | X-ray | 7F8X | 7F8X_refined | 3.0 | A | Inactive | 1 | 66 | - | - | - | - | T4-Lysozyme | - |
NN9056
|
peptide | Agonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | Yes | No | Zhang X, He C, Wang M, Zhou Q, Yang D, Zhu Y, Feng W, Zhang H, Dai A, Chu X, Wang J, Yang Z, Jiang Y, Sensfuss U, Tan Q, Han S, Reedtz-Runge S, Xu HE, Zhao S, Wang MW, Wu B, Zhao Q | 10.1038/S41589-021-00866-8 | 2021-12-29 | Yes | |
GP139 | GPR139 | A orphans | A | Human | Cryo-EM | 7VUG | 7VUG_refined | 3.2 | R | Active | 100 | 80 | Gi/o | αi1 | - | 62 | - | scFv16 |
JNJ-63533054
|
small-molecule | Agonist | L-phenylalanine, L-tryptophan | small-molecule | Yes | No | Zhou Y, Daver H, Trapkov B, Wu L, Wu M, Harpsoe K, Gentry PR, Liu K, Larionova M, Liu J, Chen N, Brauner-Osborne H, Gloriam DE, Hua T, Liu ZJ | 10.1038/S41422-021-00591-W | 2021-12-29 | Yes | |
GP139 | GPR139 | A orphans | A | Human | Cryo-EM | 7VUH | 7VUH_refined | 3.2 | R | Active | 100 | 80 | Gs | αs | - | 61 | - | Nanobody-35 |
JNJ-63533054
|
small-molecule | Agonist | L-phenylalanine, L-tryptophan | small-molecule | Yes | No | Zhou Y, Daver H, Trapkov B, Wu L, Wu M, Harpsoe K, Gentry PR, Liu K, Larionova M, Liu J, Chen N, Brauner-Osborne H, Gloriam DE, Hua T, Liu ZJ | 10.1038/S41422-021-00591-W | 2021-12-29 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7SIM | 7SIM_refined | 2.7 | A | Active | - | 72 | - | - | - | - | - | - |
Cyclomethyltryptophan
|
small-molecule | Agonist | Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Park J, Zuo H, Frangaj A, Fu Z, Yen LY, Zhang Z, Mosyak L, Slavkovich VN, Liu J, Ray KM, Cao B, Vallese F, Geng Y, Chen S, Grassucci R, Dandey VP, Tan YZ, Eng E, Lee Y, Kloss B, Liu Z, Hendrickson WA, Potter CS, Carragher B, Graziano J, Conigrave AD, Frank J, Clarke OB, Fan QR | 10.1073/PNAS.2115849118 | 2022-01-19 | Yes | |
GHRHR | GHRH | Glucagon | B1 | Human | Cryo-EM | 7V9M | 7V9M_refined | 3.3 | R | Active | 100 | 63 | Gs | αs | - | 57 | - | Nanobody-35 |
Somatoliberin
|
peptide | Agonist | GHRH | peptide | No | No | Cong Z, Zhou F, Zhang C, Zou X, Zhang H, Wang Y, Zhou Q, Cai X, Liu Q, Li J, Shao L, Mao C, Wang X, Wu J, Xia T, Zhao LH, Jiang H, Zhang Y, Xu HE, Cheng X, Yang D, Wang MW | 10.1073/PNAS.2106606118 | 2021-10-20 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EVY | - | 3.0 | D | Active | 100 | 71 | Gi/o | αi1 | - | 64 | - | scFv16 |
siponimod
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yuan Y, Jia G, Wu C, Wang W, Cheng L, Li Q, Li Z, Luo K, Yang S, Yan W, Su Z, Shao Z | 10.1038/S41422-021-00566-X | 2021-09-29 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EVZ | - | 3.1 | D | Active | 100 | 71 | Gi/o | αi1 | - | 64 | - | scFv16 |
cenerimod
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yuan Y, Jia G, Wu C, Wang W, Cheng L, Li Q, Li Z, Luo K, Yang S, Yan W, Su Z, Shao Z | 10.1038/S41422-021-00566-X | 2021-09-29 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EW0 | 7EW0_refined | 3.4 | D | Active | 100 | 71 | Gi/o | αi1 | - | 64 | - | scFv16 |
ozanimod
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yuan Y, Jia G, Wu C, Wang W, Cheng L, Li Q, Li Z, Luo K, Yang S, Yan W, Su Z, Shao Z | 10.1038/S41422-021-00566-X | 2021-09-29 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EW7 | 7EW7_refined | 3.3 | D | Active | 100 | 75 | Gi/o | αi1 | - | 64 | - | scFv16 |
SEW2871
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yuan Y, Jia G, Wu C, Wang W, Cheng L, Li Q, Li Z, Luo K, Yang S, Yan W, Su Z, Shao Z | 10.1038/S41422-021-00566-X | 2021-09-29 | Yes | |
MSHR | MC1 | Melanocortin | A | Human | Cryo-EM | 7F4D | - | 3.0 | R | Active | 100 | 83 | Gs | αs | - | 59 | - | Nanobody-35 |
INTERMEDINE
|
protein | Agonist | ACTH, β-MSH, γ-MSH, α-MSH | peptide | Yes | No | Ma S, Chen Y, Dai A, Yin W, Guo J, Yang D, Zhou F, Jiang Y, Wang MW, Xu HE | 10.1038/S41422-021-00557-Y | 2021-09-08 | Yes | |
MSHR | MC1 | Melanocortin | A | Human | Cryo-EM | 7F4F | - | 2.9 | R | Active | 100 | 85 | Gs | αs | - | 59 | - | scFv16 |
CHEMBL407070
|
protein | Agonist | ACTH, β-MSH, γ-MSH, α-MSH | peptide | Yes | No | Ma S, Chen Y, Dai A, Yin W, Guo J, Yang D, Zhou F, Jiang Y, Wang MW, Xu HE | 10.1038/S41422-021-00557-Y | 2021-09-08 | Yes | |
OXYR | OT | Vasopressin and oxytocin | A | Human | Cryo-EM | 7RYC | - | 2.9 | O | Active | 100 | 73 | Gq/11 | αq | Gamma subunit fused to alpha subunit | 55 | - | scFv16 |
oxytocin
|
peptide | Agonist | vasopressin, oxytocin | peptide | Yes | No | Meyerowitz JG, Robertson MJ, Barros-Alvarez X, Panova O, Nwokonko RM, Gao Y, Skiniotis G | 10.1038/S41594-022-00728-4 | 2022-03-09 | Yes | |
MSHR | MC1 | Melanocortin | A | Human | Cryo-EM | 7F4H | - | 2.7 | R | Active | 100 | 84 | Gs | αs | - | 59 | - | Nanobody-35 scFv16 |
CHEMBL407070
|
protein | Agonist | ACTH, β-MSH, γ-MSH, α-MSH | peptide | Yes | No | Ma S, Chen Y, Dai A, Yin W, Guo J, Yang D, Zhou F, Jiang Y, Wang MW, Xu HE | 10.1038/S41422-021-00557-Y | 2021-09-08 | Yes | |
MSHR | MC1 | Melanocortin | A | Human | Cryo-EM | 7F4I | 7F4I_refined | 3.1 | R | Active | 100 | 84 | Gs | αs | - | 59 | - | Nanobody-35 |
bremelanotide
|
peptide | Agonist | ACTH, β-MSH, γ-MSH, α-MSH | peptide | Yes | No | Ma S, Chen Y, Dai A, Yin W, Guo J, Yang D, Zhou F, Jiang Y, Wang MW, Xu HE | 10.1038/S41422-021-00557-Y | 2021-09-08 | Yes | |
AGTR2 | AT2 | Angiotensin | A | Human | X-ray | 7JNI | 7JNI_refined | 3.0 | A | Active | 99 | 82 | - | - | - | - | BRIL | - |
olodanrigan
|
small-molecule | Antagonist | angiotensin-(1-7), angiotensin III, angiotensin II | peptide | Yes | No | Perryman R, Renziehausen A, Shaye H, Kostagianni AD, Tsiailanis AD, Thorne T, Chatziathanasiadou MV, Sivolapenko GB, El Mubarak MA, Han GW, Zarzycka B, Katritch V, Lebon G, Lo Nigro C, Lattanzio L, Morse SV, Choi JJ, O'Neill K, Kanaki Z, Klinakis A, Crook T, Cherezov V, Tzakos AG, Syed N | 10.1073/PNAS.2116289119 | 2022-02-09 | Yes | |
FPR1 | FPR1 | Formylpeptide | A | Human | Cryo-EM | 7T6T | 7T6T_refined | 3.2 | R | Active | 100 | 85 | Gi/o | αi1 | - | 61 | - | - |
synthetic peptide
|
peptide | Agonist | fMet-Leu-Phe, spinorphin, cathepsin G, annexin I | peptide | Yes | No | Zhuang Y, Wang L, Guo J, Sun D, Wang Y, Liu W, Xu HE, Zhang C | 10.1038/S41467-022-28586-0 | 2022-03-30 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | Cryo-EM | 7T6S | 7T6S_refined | 3.0 | R | Active | 100 | 85 | Gi/o | αi1 | - | 61 | - | scFv16 |
N-(4-chlorophenyl)-N'-[1-methyl-3-oxo-2-phenyl-5-(propan-2-yl)-2,3-dihydro-1H-pyrazol-4-yl]urea
|
small-molecule | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Zhuang Y, Wang L, Guo J, Sun D, Wang Y, Liu W, Xu HE, Zhang C | 10.1038/S41467-022-28586-0 | 2022-03-30 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | Cryo-EM | 7T6U | 7T6U_refined | 2.9 | R | Active | 100 | 85 | Gi/o | αi1 | - | 62 | - | - |
synthetic peptide
|
peptide | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Zhuang Y, Wang L, Guo J, Sun D, Wang Y, Liu W, Xu HE, Zhang C | 10.1038/S41467-022-28586-0 | 2022-03-30 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | Cryo-EM | 7T6V | - | 3.1 | R | Active | 100 | 85 | Gi/o | αi1 | - | 61 | - | scFv16 |
synthetic peptide
|
peptide | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Zhuang Y, Wang L, Guo J, Sun D, Wang Y, Liu W, Xu HE, Zhang C | 10.1038/S41467-022-28586-0 | 2022-03-30 | Yes | |
NPY1R | Y1 | Neuropeptide Y | A | Human | Cryo-EM | 7VGX | 7VGX_refined | 3.2 | R | Active | 100 | 73 | Gi/o | αi1 | - | 63 | - | scFv16 |
neuropeptide Y
|
peptide | Agonist | neuropeptide Y, peptide YY, pancreatic polypeptide | peptide | Yes | No | Park C, Kim J, Ko SB, Choi YK, Jeong H, Woo H, Kang H, Bang I, Kim SA, Yoon TY, Seok C, Im W, Choi HJ | 10.1038/S41467-022-28510-6 | 2022-02-23 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7T10 | - | 2.5 | R | Active | 100 | 78 | Gi/o | αi3 | - | 62 | - | scFv16 |
SOMATOSTATIN
|
protein | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Robertson MJ, Meyerowitz JG, Panova O, Borrelli K, Skiniotis G | 10.1038/S41594-022-00727-5 | 2022-03-09 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7T11 | 7T11_refined | 2.7 | R | Active | 100 | 77 | Gi/o | αi3 | - | 62 | - | scFv16 |
Octreotide
|
peptide | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Robertson MJ, Meyerowitz JG, Panova O, Borrelli K, Skiniotis G | 10.1038/S41594-022-00727-5 | 2022-03-09 | Yes | |
CCR1 | CCR1 | Chemokine | A | Human | Cryo-EM | 7VL9 | - | 2.6 | R | Active | 100 | 85 | Gi/o | αi1 | - | 62 | - | scFv16 |
CCL15(26-92)
|
peptide | Agonist | CCL16, CCL8, CCL5, CCL4, CCL7, CCL15, CCL14, CCL3, CCL13, CCL23 | peptide | No | No | Shao Z, Shen Q, Yao B, Mao C, Chen LN, Zhang H, Shen DD, Zhang C, Li W, Du X, Li F, Ma H, Chen ZH, Xu HE, Ying S, Zhang Y, Shen H | 10.1038/S41589-021-00918-Z | 2022-03-23 | Yes | |
CCR1 | CCR1 | Chemokine | A | Human | Cryo-EM | 7VLA | 7VLA_refined | 2.7 | R | Active | 100 | 85 | Gi/o | αi1 | - | 64 | - | scFv16 |
CCL15(27-92)
|
peptide | Agonist | CCL16, CCL8, CCL5, CCL4, CCL7, CCL15, CCL14, CCL3, CCL13, CCL23 | peptide | No | No | Shao Z, Shen Q, Yao B, Mao C, Chen LN, Zhang H, Shen DD, Zhang C, Li W, Du X, Li F, Ma H, Chen ZH, Xu HE, Ying S, Zhang Y, Shen H | 10.1038/S41589-021-00918-Z | 2022-03-23 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7TD4 | - | 2.6 | R | Active | 100 | 76 | Gi/o | αi1 | - | 63 | - | - |
siponimod
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Liu S, Paknejad N, Zhu L, Kihara Y, Ray M, Chun J, Liu W, Hite RK, Huang XY | 10.1038/S41467-022-28417-2 | 2022-02-09 | Yes | |
LT4R1 | BLT1 | Leukotriene | A | Human | Cryo-EM | 7VKT | 7VKT_refined | 2.9 | A | Active | 100 | 82 | Gi/o | αi1 | - | 64 | - | scFv16 |
LTB4
|
small-molecule | Agonist | LTB4, 20-hydroxy-LTB4, 12R-HETE | small-molecule | Yes | No | Wang N, He X, Zhao J, Jiang H, Cheng X, Xia Y, Eric Xu H, He Y | 10.1038/S41467-022-28820-9 | 2022-03-09 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7TD0 | - | 2.8 | R | Active | 100 | 80 | Gi/o | αi1 | - | 62 | - | - |
lysophosphatidic acid
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Liu S, Paknejad N, Zhu L, Kihara Y, Ray M, Chun J, Liu W, Hite RK, Huang XY | 10.1038/S41467-022-28417-2 | 2022-02-09 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7TD1 | - | 3.1 | R | Active | 100 | 80 | Gi/o | αi1 | - | 62 | - | - |
lysophosphatidic acid
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Liu S, Paknejad N, Zhu L, Kihara Y, Ray M, Chun J, Liu W, Hite RK, Huang XY | 10.1038/S41467-022-28417-2 | 2022-02-09 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7TD2 | - | 3.1 | R | Active | 100 | 80 | Gi/o | αi1 | - | 62 | - | - |
lysophosphatidic acid
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Liu S, Paknejad N, Zhu L, Kihara Y, Ray M, Chun J, Liu W, Hite RK, Huang XY | 10.1038/S41467-022-28417-2 | 2022-02-09 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7TD3 | - | 3.0 | R | Active | 100 | 76 | Gi/o | αi1 | - | 63 | - | - |
sphingosine 1-phosphate
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Liu S, Paknejad N, Zhu L, Kihara Y, Ray M, Chun J, Liu W, Hite RK, Huang XY | 10.1038/S41467-022-28417-2 | 2022-02-09 | Yes | |
MTR1A | MT1 | Melatonin | A | Human | Cryo-EM | 7VGY | - | 3.1 | A | Active | 100 | 80 | Gi/o | αi1 | - | 62 | - | scFv16 |
2-iodo-melatonin
|
small-molecule | Agonist | melatonin | small-molecule | Yes | No | Wang Q, Lu Q, Guo Q, Teng M, Gong Q, Li X, Du Y, Liu Z, Tao Y | 10.1038/S41467-022-28111-3 | 2022-03-02 | Yes | |
MTR1A | MT1 | Melatonin | A | Human | Cryo-EM | 7VGZ | 7VGZ_refined | 3.3 | B | Active | 100 | 81 | Gi/o | αi1 | - | 62 | - | scFv16 |
ramelteon
|
small-molecule | Agonist | melatonin | small-molecule | Yes | No | Wang Q, Lu Q, Guo Q, Teng M, Gong Q, Li X, Du Y, Liu Z, Tao Y | 10.1038/S41467-022-28111-3 | 2022-03-02 | Yes | |
MTR1B | MT2 | Melatonin | A | Human | Cryo-EM | 7VH0 | 7VH0_refined | 3.5 | A | Active | 100 | 75 | Gi/o | αi1 | - | 61 | - | scFv16 |
ramelteon
|
small-molecule | Agonist | melatonin | small-molecule | Yes | No | Wang Q, Lu Q, Guo Q, Teng M, Gong Q, Li X, Du Y, Liu Z, Tao Y | 10.1038/S41467-022-28111-3 | 2022-03-02 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 7PX4 | 7PX4_refined | 2.3 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
Preladenant conjugate PSB-2113
|
small-molecule | Antagonist | adenosine | small-molecule | No | No | Claff T, Klapschinski TA, Tiruttani Subhramanyam UK, Vaassen VJ, Schlegel JG, Vielmuth C, Voss JH, Labahn J, Muller CE | 10.1002/ANIE.202115545 | 2022-03-02 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 7PYR | 7PYR_refined | 2.6 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
Preladenant conjugate PSB-2115
|
small-molecule | Antagonist | adenosine | small-molecule | No | No | - | - | 2022-03-02 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYF | - | 2.2 | R | Active | 100 | 77 | Gs | αs | - | 58 | - | Nanobody-35 RAMP1 |
amylin peptide
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-23 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYH | - | 3.3 | R | Active | 100 | 78 | Gs | αs | - | 58 | - | Nanobody-35 |
Calcitonin human
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | - | - | 2022-03-23 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYI | - | 3.3 | R | Active | 100 | 77 | Gs | αs | - | 58 | - | Nanobody-35 |
Amylin rat
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-30 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYL | - | 3.3 | R | Active | 100 | 78 | Gs | αs | - | 58 | - | Nanobody-35 |
Amylin rat
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-23 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYN | - | 2.6 | R | Active | 100 | 79 | Gs | αs | - | 58 | - | Nanobody-35 |
Calcitonin salmon
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-30 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYO | 7TYO_refined | 2.7 | R | Active | 100 | 76 | Gs | αs | - | 58 | - | Nanobody-35 |
Calcitonin human
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-23 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYW | - | 3.0 | R | Active | 100 | 78 | Gs | αs | - | 58 | - | Nanobody-35 |
Calcitonin salmon
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-23 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TZF | - | 2.4 | R | Active | 100 | 77 | Gs | αs | - | 59 | - | Nanobody-35 RAMP3 |
amylin peptide
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-23 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYX | - | 2.6 | R | Active | 100 | 77 | Gs | αs | - | 59 | - | Nanobody-35 |
Amylin rat
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-30 | Yes | |
CALCR | CT | Calcitonin | B1 | Human | Cryo-EM | 7TYY | - | 3.0 | R | Active | 100 | 78 | Gs | αs | - | 58 | - | Nanobody-35 |
Calcitonin salmon
|
peptide | Agonist | calcitonin (salmon), α-CGRP, adrenomedullin 2/intermedin, calcitonin, β-CGRP, adrenomedullin, amylin | peptide | No | No | Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM | 10.1126/SCIENCE.ABM9609 | 2022-03-23 | Yes | |
GIPR | GIP | Glucagon | B1 | Human | Cryo-EM | 7FIN | - | 3.1 | R | Active | 100 | 82 | Gs | αs | - | 59 | - | Nanobody-35 |
Peptide-20
|
peptide | Agonist | gastric inhibitory polypeptide | peptide | No | No | Zhao F, Zhou Q, Cong Z, Hang K, Zou X, Zhang C, Chen Y, Dai A, Liang A, Ming Q, Wang M, Chen LN, Xu P, Chang R, Feng W, Xia T, Zhang Y, Wu B, Yang D, Zhao L, Xu HE, Wang MW | 10.1038/S41467-022-28683-0 | 2022-02-23 | Yes | |
GIPR | GIP | Glucagon | B1 | Human | Cryo-EM | 7FIY | - | 3.4 | R | Active | 100 | 77 | Gs | αs | - | 60 | - | Nanobody-35 |
tirzepatide
|
peptide | Agonist | gastric inhibitory polypeptide | peptide | No | No | Zhao F, Zhou Q, Cong Z, Hang K, Zou X, Zhang C, Chen Y, Dai A, Liang A, Ming Q, Wang M, Chen LN, Xu P, Chang R, Feng W, Xia T, Zhang Y, Wu B, Yang D, Zhao L, Xu HE, Wang MW | 10.1038/S41467-022-28683-0 | 2022-03-02 | Yes | |
GIPR | GIP | Glucagon | B1 | Human | Cryo-EM | 7VAB | 7VAB_refined | 3.2 | R | Active | 100 | 58 | Gs | αs | Mini-Gs | 60 | - | Nanobody-35 |
tirzepatide
|
peptide | Agonist | gastric inhibitory polypeptide | peptide | No | No | Zhao F, Zhou Q, Cong Z, Hang K, Zou X, Zhang C, Chen Y, Dai A, Liang A, Ming Q, Wang M, Chen LN, Xu P, Chang R, Feng W, Xia T, Zhang Y, Wu B, Yang D, Zhao L, Xu HE, Wang MW | 10.1038/S41467-022-28683-0 | 2022-03-02 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7FIM | - | 3.4 | R | Active | 100 | 83 | Gs | αs | - | 57 | - | Nanobody-35 |
tirzepatide
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhao F, Zhou Q, Cong Z, Hang K, Zou X, Zhang C, Chen Y, Dai A, Liang A, Ming Q, Wang M, Chen LN, Xu P, Chang R, Feng W, Xia T, Zhang Y, Wu B, Yang D, Zhao L, Xu HE, Wang MW | 10.1038/S41467-022-28683-0 | 2022-03-02 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7VBI | 7VBI_refined | 3.0 | R | Active | 100 | 83 | Gs | αs | Mini-Gs | 58 | - | - |
tirzepatide
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhao F, Zhou Q, Cong Z, Hang K, Zou X, Zhang C, Chen Y, Dai A, Liang A, Ming Q, Wang M, Chen LN, Xu P, Chang R, Feng W, Xia T, Zhang Y, Wu B, Yang D, Zhao L, Xu HE, Wang MW | 10.1038/S41467-022-28683-0 | 2022-03-02 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | Cryo-EM | 7V35 | 7V35_refined | 3.4 | R | Active | 100 | 82 | Gs | αs | - | 53 | - | Nanobody-35 |
Peptide-20
|
peptide | Agonist | glucagon | peptide | No | No | Zhao F, Zhou Q, Cong Z, Hang K, Zou X, Zhang C, Chen Y, Dai A, Liang A, Ming Q, Wang M, Chen LN, Xu P, Chang R, Feng W, Xia T, Zhang Y, Wu B, Yang D, Zhao L, Xu HE, Wang MW | 10.1038/S41467-022-28683-0 | 2022-03-02 | Yes | |
GRM3 | mGlu3 | Metabotropic glutamate | C | Human | Cryo-EM | 7WI6 | 7WI6_refined | 3.7 | A | Inactive | - | 82 | - | - | - | - | - | - |
LY341495
|
small-molecule | Antagonist | L-glutamic acid, NAAG | small-molecule | No | No | Fang W, Yang F, Xu C, Ling S, Lin L, Zhou Y, Sun W, Wang X, Liu P, Rondard P, Shi P, Pin JP, Tian C, Liu J | 10.1038/S41422-022-00623-Z | 2022-03-16 | Yes | |
GRM3 | mGlu3 | Metabotropic glutamate | C | Human | Cryo-EM | 7WI8 | 7WI8_refined | 4.2 | A | Inactive | - | 82 | - | - | - | - | - | - |
LY341495
|
small-molecule | Antagonist | L-glutamic acid, NAAG | small-molecule | No | No | Fang W, Yang F, Xu C, Ling S, Lin L, Zhou Y, Sun W, Wang X, Liu P, Rondard P, Shi P, Pin JP, Tian C, Liu J | 10.1038/S41422-022-00623-Z | 2022-03-16 | Yes | |
GRM3 | mGlu3 | Metabotropic glutamate | C | Human | Cryo-EM | 7WIH | 7WIH_refined | 3.7 | A | Active | - | 84 | - | - | - | - | - | - |
CHEMBL4081453
|
small-molecule | Agonist | L-glutamic acid, NAAG | small-molecule | No | No | Fang W, Yang F, Xu C, Ling S, Lin L, Zhou Y, Sun W, Wang X, Liu P, Rondard P, Shi P, Pin JP, Tian C, Liu J | 10.1038/S41422-022-00623-Z | 2022-03-16 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 7WU4 | - | 3.4 | R | Active | - | 31 | Gi/o | αi1 | Mini-Gi1 | 58 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Qu X, Qiu N, Wang M, Zhang B, Du J, Zhong Z, Xu W, Chu X, Ma L, Yi C, Han S, Shui W, Zhao Q, Wu B | 10.1038/S41586-022-04580-W | 2022-04-27 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 7WU5 | - | 3.0 | R | Active | - | 31 | Gi/o | αi1 | Mini-Gi1 | 58 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Qu X, Qiu N, Wang M, Zhang B, Du J, Zhong Z, Xu W, Chu X, Ma L, Yi C, Han S, Shui W, Zhao Q, Wu B | 10.1038/S41586-022-04580-W | 2022-04-27 | Yes | |
AGRL3 | ADGRL3 | ADGRL | B2 | Human | Cryo-EM | 7SF7 | - | 2.9 | A | Active | - | 19 | G12/13 | α13 | Gi2-mini-G13 chimera | 56 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Barros-Alvarez X, Nwokonko RM, Vizurraga A, Matzov D, He F, Papasergi-Scott MM, Robertson MJ, Panova O, Yardeni EH, Seven AB, Kwarcinski FE, Su H, Peroto MC, Meyerowitz JG, Shalev-Benami M, Tall GG, Skiniotis G | 10.1038/S41586-022-04575-7 | 2022-04-27 | Yes | |
AGRG1 | ADGRG1 | ADGRG | B2 | Human | Cryo-EM | 7SF8 | - | 2.7 | A | Active | - | 37 | G12/13 | α13 | Gi2-mini-G13 chimera | 56 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Barros-Alvarez X, Nwokonko RM, Vizurraga A, Matzov D, He F, Papasergi-Scott MM, Robertson MJ, Panova O, Yardeni EH, Seven AB, Kwarcinski FE, Su H, Peroto MC, Meyerowitz JG, Shalev-Benami M, Tall GG, Skiniotis G | 10.1038/S41586-022-04575-7 | 2022-04-27 | Yes | |
AGRG2 | ADGRG2 | ADGRG | B2 | Mouse | Cryo-EM | 7WUI | - | 3.1 | R | Active | - | 24 | Gs | αs | Mini-Gs | 58 | - | - |
IP15
|
peptide | Agonist | - | - | No | No | Xiao P, Guo S, Wen X, He QT, Lin H, Huang SM, Gou L, Zhang C, Yang Z, Zhong YN, Yang CC, Li Y, Gong Z, Tao XN, Yang ZS, Lu Y, Li SL, He JY, Wang C, Zhang L, Kong L, Sun JP, Yu X | 10.1038/S41586-022-04590-8 | 2022-04-27 | Yes | |
AGRG4 | ADGRG4 | ADGRG | B2 | Human | Cryo-EM | 7WUJ | - | 3.3 | E | Active | - | 9 | Gs | αs | Mini-Gs | 59 | - | scFv16 Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Xiao P, Guo S, Wen X, He QT, Lin H, Huang SM, Gou L, Zhang C, Yang Z, Zhong YN, Yang CC, Li Y, Gong Z, Tao XN, Yang ZS, Lu Y, Li SL, He JY, Wang C, Zhang L, Kong L, Sun JP, Yu X | 10.1038/S41586-022-04590-8 | 2022-04-27 | Yes | |
GPR88 | GPR88 | A orphans | A | Human | Cryo-EM | 7EJX | - | 2.4 | R | Active | 100 | 60 | Gi/o | αi1 | - | 61 | - | scFv16 |
compound 2 [PMID: 24793972]
|
small-molecule | Allosteric agonist | - | - | Yes | No | Chen G, Xu J, Inoue A, Schmidt MF, Bai C, Lu Q, Gmeiner P, Liu Z, Du Y | 10.1038/S41467-022-30081-5 | 2022-04-13 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | Cryo-EM | 7S0G | - | 3.9 | R | Active | 100 | 57 | Gs | αs | Gi1-Gs chimera | 56 | - | - |
LEVISOPRENALINE
|
small-molecule | Agonist | - | - | Yes | No | Alegre KO, Paknejad N, Su M, Lou JS, Huang J, Jordan KD, Eng ET, Meyerson JR, Hite RK, Huang XY | 10.1038/S41594-021-00679-2 | 2021-11-17 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | Cryo-EM | 7S0F | - | 3.0 | R | Active | 100 | 56 | Gi/o | αi1 | - | 63 | - | - |
LEVISOPRENALINE
|
small-molecule | Agonist | - | - | Yes | No | Alegre KO, Paknejad N, Su M, Lou JS, Huang J, Jordan KD, Eng ET, Meyerson JR, Hite RK, Huang XY | 10.1038/S41594-021-00679-2 | 2021-11-17 | Yes | |
NMUR1 | NMU1 | Neuromedin U | A | Human | Cryo-EM | 7W53 | - | 3.2 | R | Active | 100 | 62 | Gq/11 | αq | - | 54 | - | scFv16 |
Neuromedin U-25 (human)
|
peptide | Agonist | neuromedin S-33, neuromedin U-25, neuromedin S-36, neuromedin U-23 | peptide | Yes | No | You C, Zhang Y, Xu P, Huang S, Yin W, Eric Xu H, Jiang Y | 10.1038/S41467-022-29683-W | 2022-04-20 | Yes | |
NMUR2 | NMU2 | Neuromedin U | A | Human | Cryo-EM | 7W55 | - | 2.8 | R | Active | 100 | 73 | Gq/11 | αq | - | 60 | - | scFv16 |
Neuromedin U-25 (human)
|
peptide | Agonist | neuromedin S-33, neuromedin U-25, neuromedin S-36, neuromedin U-23 | peptide | Yes | No | You C, Zhang Y, Xu P, Huang S, Yin W, Eric Xu H, Jiang Y | 10.1038/S41467-022-29683-W | 2022-04-20 | Yes | |
NMUR1 | NMU1 | Neuromedin U | A | Human | Cryo-EM | 7W56 | - | 2.9 | R | Active | 100 | 65 | Gq/11 | αq | - | 59 | - | scFv16 |
Neuromedin-S
|
peptide | Agonist | neuromedin S-33, neuromedin U-25, neuromedin S-36, neuromedin U-23 | peptide | Yes | No | You C, Zhang Y, Xu P, Huang S, Yin W, Eric Xu H, Jiang Y | 10.1038/S41467-022-29683-W | 2022-04-20 | Yes | |
NMUR2 | NMU2 | Neuromedin U | A | Human | Cryo-EM | 7W57 | - | 3.2 | R | Active | 100 | 72 | Gq/11 | αq | - | 59 | - | scFv16 |
Neuromedin-S
|
peptide | Agonist | neuromedin S-33, neuromedin U-25, neuromedin S-36, neuromedin U-23 | peptide | Yes | No | You C, Zhang Y, Xu P, Huang S, Yin W, Eric Xu H, Jiang Y | 10.1038/S41467-022-29683-W | 2022-04-20 | Yes | |
AGRG2 | ADGRG2 | ADGRG | B2 | Mouse | Cryo-EM | 7WUQ | - | 2.9 | R | Active | - | 28 | Gs | αs | - | 55 | - | Nanobody-35 | - | - | - | - | - | No | No | Xiao P, Guo S, Wen X, He QT, Lin H, Huang SM, Gou L, Zhang C, Yang Z, Zhong YN, Yang CC, Li Y, Gong Z, Tao XN, Yang ZS, Lu Y, Li SL, He JY, Wang C, Zhang L, Kong L, Sun JP, Yu X | 10.1038/S41586-022-04590-8 | 2022-04-27 | Yes | |
AGRD1 | ADGRD1 | ADGRD | B2 | Human | Cryo-EM | 7EPT | - | 3.0 | R | Active | - | 31 | Gs | αs | - | 54 | - | Nanobody-35 | - | - | - | - | - | No | No | Ping YQ, Xiao P, Yang F, Zhao RJ, Guo SC, Yan X, Wu X, Zhang C, Lu Y, Zhao F, Zhou F, Xi YT, Yin W, Liu FZ, He DF, Zhang DL, Zhu ZL, Jiang Y, Du L, Feng SQ, Schoneberg T, Liebscher I, Xu HE, Sun JP | 10.1038/S41586-022-04619-Y | 2022-05-11 | Yes | |
AGRG5 | ADGRG5 | ADGRG | B2 | Human | Cryo-EM | 7EQ1 | - | 3.3 | R | Active | - | 54 | Gs | αs | - | 60 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Ping YQ, Xiao P, Yang F, Zhao RJ, Guo SC, Yan X, Wu X, Zhang C, Lu Y, Zhao F, Zhou F, Xi YT, Yin W, Liu FZ, He DF, Zhang DL, Zhu ZL, Jiang Y, Du L, Feng SQ, Schoneberg T, Liebscher I, Xu HE, Sun JP | 10.1038/S41586-022-04619-Y | 2022-05-11 | Yes | |
FPR1 | FPR1 | Formylpeptide | A | Human | Cryo-EM | 7EUO | 7EUO_refined | 2.9 | R | Active | 100 | 84 | Gi/o | αi1 | - | 62 | - | scFv16 |
Peptide Agonist fMLF
|
peptide | Agonist | fMet-Leu-Phe, spinorphin, cathepsin G, annexin I | peptide | Yes | No | Chen G, Wang X, Liao Q, Ge Y, Jiao H, Chen Q, Liu Y, Lyu W, Zhu L, van Zundert GCP, Robertson MJ, Skiniotis G, Du Y, Hu H, Ye RD | 10.1038/S41467-022-32822-Y | 2022-05-25 | Yes | |
OX2R | OX2 | Orexin | A | Human | Cryo-EM | 7SQO | 7SQO_refined | 3.2 | R | Active | 100 | 61 | Gi/o | αi1 | - | 61 | - | scFv16 |
methyl (2R,3S)-3-[(methanesulfonyl)amino]-2-({[(1s,4S)-4-phenylcyclohexyl]oxy}methyl)piperidine-1-carboxylate
|
small-molecule | Agonist | orexin-A, orexin-B | peptide | Yes | No | Yin J, Kang Y, McGrath AP, Chapman K, Sjodt M, Kimura E, Okabe A, Koike T, Miyanohana Y, Shimizu Y, Rallabandi R, Lian P, Bai X, Flinspach M, De Brabander JK, Rosenbaum DM | 10.1038/S41467-022-30601-3 | 2022-05-25 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7V68 | 7V68_refined | 3.4 | R | Active | 100 | 58 | Gi/o | αi1 | - | 62 | - | scFv16 |
iperoxo
LY2119620 |
small-molecule small-molecule |
Agonist PAM |
acetylcholine | small-molecule | Yes | No | Wang J, Wu M, Chen Z, Wu L, Wang T, Cao D, Wang H, Liu S, Xu Y, Li F, Liu J, Chen N, Zhao S, Cheng J, Wang S, Hua T | 10.1038/S41467-022-30595-Y | 2022-05-11 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7V69 | 7V69_refined | 3.4 | R | Active | 100 | 58 | Gi/o | αi1 | - | 62 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | acetylcholine | small-molecule | Yes | No | Wang J, Wu M, Chen Z, Wu L, Wang T, Cao D, Wang H, Liu S, Xu Y, Li F, Liu J, Chen N, Zhao S, Cheng J, Wang S, Hua T | 10.1038/S41467-022-30595-Y | 2022-05-11 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7V6A | - | 3.6 | R | Active | 100 | 58 | Gi/o | αi1 | - | 62 | - | scFv16 |
methyl 4-[4-(3-methyl-2-oxidanylidene-benzimidazol-1-yl)piperidin-1-yl]piperidine-1-carboxylate
|
small-molecule | Allosteric agonist | acetylcholine | small-molecule | Yes | No | Wang J, Wu M, Chen Z, Wu L, Wang T, Cao D, Wang H, Liu S, Xu Y, Li F, Liu J, Chen N, Zhao S, Cheng J, Wang S, Hua T | 10.1038/S41467-022-30595-Y | 2022-05-11 | Yes | |
VIPR2 | VPAC2 | VIP and PACAP | B1 | Human | Cryo-EM | 7VQX | - | 2.7 | R | Active | 100 | 82 | Gs | αs | - | 60 | - | Nanobody-35 |
PACAP-27
|
peptide | Agonist | secretin, PACAP-38, PACAP-27, VIP, GHRH, PHI | peptide | No | No | Xu Y, Feng W, Zhou Q, Liang A, Li J, Dai A, Zhao F, Yan J, Chen CW, Li H, Zhao LH, Xia T, Jiang Y, Xu HE, Yang D, Wang MW | 10.1038/S41467-022-30041-Z | 2022-05-18 | Yes | |
VIPR2 | VPAC2 | VIP and PACAP | B1 | Human | Cryo-EM | 7WBJ | - | 3.4 | R | Active | 100 | 82 | Gs | αs | - | 60 | - | Nanobody-35 |
PACAP-27
|
peptide | Agonist | secretin, PACAP-38, PACAP-27, VIP, GHRH, PHI | peptide | No | No | Xu Y, Feng W, Zhou Q, Liang A, Li J, Dai A, Zhao F, Yan J, Chen CW, Li H, Zhao LH, Xia T, Jiang Y, Xu HE, Yang D, Wang MW | 10.1038/S41467-022-30041-Z | 2022-05-18 | Yes | |
NPY1R | Y1 | Neuropeptide Y | A | Human | Cryo-EM | 7X9A | 7X9A_refined | 3.2 | R | Active | 100 | 80 | Gi/o | αi1 | - | 61 | - | - |
neuropeptide Y
|
peptide | Agonist | neuropeptide Y, peptide YY, pancreatic polypeptide | peptide | Yes | No | Tang T, Tan Q, Han S, Diemar A, Lobner K, Wang H, Schuss C, Behr V, Morl K, Wang M, Chu X, Yi C, Keller M, Kofoed J, Reedtz-Runge S, Kaiser A, Beck-Sickinger AG, Zhao Q, Wu B | 10.1126/SCIADV.ABM1232 | 2022-05-18 | Yes | |
NPY2R | Y2 | Neuropeptide Y | A | Human | Cryo-EM | 7X9B | 7X9B_refined | 3.4 | R | Active | 100 | 79 | Gi/o | αi1 | - | 62 | - | - |
neuropeptide Y
|
peptide | Agonist | neuropeptide Y-(3-36), peptide YY, pancreatic polypeptide, PYY-(3-36), neuropeptide Y | peptide | Yes | No | Tang T, Tan Q, Han S, Diemar A, Lobner K, Wang H, Schuss C, Behr V, Morl K, Wang M, Chu X, Yi C, Keller M, Kofoed J, Reedtz-Runge S, Kaiser A, Beck-Sickinger AG, Zhao Q, Wu B | 10.1126/SCIADV.ABM1232 | 2022-05-18 | Yes | |
NPY4R | Y4 | Neuropeptide Y | A | Human | Cryo-EM | 7X9C | 7X9C_refined | 3.0 | R | Active | 100 | 81 | Gi/o | αi1 | - | 61 | - | - |
Pancreatic polypeptide
|
peptide | Agonist | neuropeptide Y, peptide YY, pancreatic polypeptide, PYY-(3-36) | peptide | Yes | No | Tang T, Tan Q, Han S, Diemar A, Lobner K, Wang H, Schuss C, Behr V, Morl K, Wang M, Chu X, Yi C, Keller M, Kofoed J, Reedtz-Runge S, Kaiser A, Beck-Sickinger AG, Zhao Q, Wu B | 10.1126/SCIADV.ABM1232 | 2022-05-18 | Yes | |
ADRB3 | β3 | Adrenoceptors | A | Dog | Cryo-EM | 7XJH | - | 3.3 | R | Active | 100 | 68 | Gs | αs | - | 59 | - | Nanobody-35 |
LEVISOPRENALINE
|
small-molecule | Agonist | - | - | Yes | No | Nagiri C, Kobayashi K, Tomita A, Kato M, Kobayashi K, Yamashita K, Nishizawa T, Inoue A, Shihoya W, Nureki O | 10.1016/J.MOLCEL.2021.06.024 | 2022-05-04 | Yes | |
ADRB3 | β3 | Adrenoceptors | A | Dog | Cryo-EM | 7XJI | - | 3.9 | R | Active | 100 | 68 | Gs | αs | - | 59 | - | Nanobody-35 |
3-[3-[2-[[(2~{S})-2-(3-chlorophenyl)-2-oxidanyl-ethyl]amino]ethylamino]phenyl]benzoic acid
|
small-molecule | Agonist | - | - | Yes | No | Nureki I, Kobayashi K, Tanaka T, Demura K, Inoue A, Shihoya W, Nureki O | 10.1016/J.BBRC.2022.04.065 | 2022-05-04 | Yes | |
BKRB2 | B2 | Bradykinin | A | Human | Cryo-EM | 7F6H | 7F6H_refined | 2.9 | A | Active | 100 | 78 | Gq/11 | αq | - | 63 | - | - |
bradykinin
|
peptide | Agonist | bradykinin, [des-Arg9]bradykinin, [Hyp3]bradykinin, T-kinin, kallidin, Lys-[Hyp3]-bradykinin, [des-Arg10]kallidin | peptide | Yes | No | Shen J, Zhang D, Fu Y, Chen A, Yang X, Zhang H | 10.1038/S41467-022-28399-1 | 2022-01-05 | Yes | |
BKRB2 | B2 | Bradykinin | A | Human | Cryo-EM | 7F6I | - | 2.8 | A | Active | 100 | 78 | Gq/11 | αq | - | 63 | - | - |
kallidin
|
peptide | Agonist | bradykinin, [des-Arg9]bradykinin, [Hyp3]bradykinin, T-kinin, kallidin, Lys-[Hyp3]-bradykinin, [des-Arg10]kallidin | peptide | Yes | No | Shen J, Zhang D, Fu Y, Chen A, Yang X, Zhang H | 10.1038/S41467-022-28399-1 | 2022-01-05 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7S15 | 7S15_refined | 3.8 | R | Active | 93 | 83 | - | - | - | - | - | - |
CHEMBL5191519
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Griffith DA, Edmonds DJ, Fortin JP, Kalgutkar AS, Kuzmiski JB, Loria PM, Saxena AR, Bagley SW, Buckeridge C, Curto JM, Derksen DR, Dias JM, Griffor MC, Han S, Jackson VM, Landis MS, Lettiere D, Limberakis C, Liu Y, Mathiowetz AM, Patel JC, Piotrowski DW, Price DA, Ruggeri RB, Tess DA. | 10.1021/acs.jmedchem.1c01856 | 2022-06-08 | Yes | |
OX2R | OX2 | Orexin | A | Human | Cryo-EM | 7SR8 | - | 3.3 | R | Active | 100 | 64 | Gq/11 | αq | - | 63 | - | scFv16 |
methyl (2R,3S)-3-[(methanesulfonyl)amino]-2-({[(1s,4S)-4-phenylcyclohexyl]oxy}methyl)piperidine-1-carboxylate
|
small-molecule | Agonist | orexin-A, orexin-B | peptide | Yes | No | Yin J, Kang Y, McGrath AP, Chapman K, Sjodt M, Kimura E, Okabe A, Koike T, Miyanohana Y, Shimizu Y, Rallabandi R, Lian P, Bai X, Flinspach M, De Brabander JK, Rosenbaum DM | 10.1038/S41467-022-30601-3 | 2022-06-08 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7WIC | 7WIC_refined | 2.8 | R | Active | 100 | 78 | Gi/o | αi1 | - | 64 | - | scFv16 |
SOMATOSTATIN
|
protein | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Chen LN, Wang WW, Dong YJ, Shen DD, Guo J, Yu X, Qin J, Ji SY, Zhang H, Shen Q, He Q, Yang B, Zhang Y, Li Q, Mao C | 10.1038/S41422-022-00669-Z | 2022-06-01 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7WIG | - | 2.7 | R | Active | 100 | 77 | Gi/o | αi1 | - | 64 | - | scFv16 |
~{N}-[(2~{R})-1-[[(1~{R},3~{S})-3-(aminomethyl)cyclohexyl]methylamino]-3-(1~{H}-indol-3-yl)-1-oxidanylidene-propan-2-yl]spiro[indene-1,4'-piperidine]-1'-carboxamide
|
small-molecule | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Chen LN, Wang WW, Dong YJ, Shen DD, Guo J, Yu X, Qin J, Ji SY, Zhang H, Shen Q, He Q, Yang B, Zhang Y, Li Q, Mao C | 10.1038/S41422-022-00669-Z | 2022-06-01 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7F1O | - | 3.1 | F | Active | 100 | 62 | Gs | αs | - | 60 | - | Nanobody-35 |
dopamine
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Teng X, Chen S, Wang Q, Chen Z, Wang X, Huang N, Zheng S | 10.1126/SCIADV.ABO4158 | 2022-06-15 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7F0T | - | 3.1 | F | Active | 100 | 63 | Gs | αs | - | 58 | - | Nanobody-35 |
dopamine
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Teng X, Chen S, Wang Q, Chen Z, Wang X, Huang N, Zheng S | 10.1126/SCIADV.ABO4158 | 2022-06-15 | Yes | |
GP158 | GPR158 | C Orphans | C | Human | Cryo-EM | 7EWP | 7EWP_refined | 4.3 | A | Inactive | - | 47 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Jeong E, Kim Y, Jeong J, Cho Y | 10.1038/S41467-021-27147-1 | 2021-12-01 | Yes | |
GP139 | GPR139 | A orphans | A | Human | Cryo-EM | 7VUI | 7VUI_refined | 3.3 | R | Active | 100 | 79 | Gs | αs | - | 59 | - | Nanobody-35 |
JNJ-63533054
|
small-molecule | Agonist | L-phenylalanine, L-tryptophan | small-molecule | Yes | No | Zhou Y, Daver H, Trapkov B, Wu L, Wu M, Harpsoe K, Gentry PR, Liu K, Larionova M, Liu J, Chen N, Brauner-Osborne H, Gloriam DE, Hua T, Liu ZJ | 10.1038/S41422-021-00591-W | 2021-12-29 | Yes | |
GP139 | GPR139 | A orphans | A | Human | Cryo-EM | 7VUJ | 7VUJ_refined | 3.8 | R | Active | 100 | 79 | Gs | αs | - | 59 | - | Nanobody-35 |
JNJ-63533054
|
small-molecule | Agonist | L-phenylalanine, L-tryptophan | small-molecule | Yes | No | Zhou Y, Daver H, Trapkov B, Wu L, Wu M, Harpsoe K, Gentry PR, Liu K, Larionova M, Liu J, Chen N, Brauner-Osborne H, Gloriam DE, Hua T, Liu ZJ | 10.1038/S41422-021-00591-W | 2021-12-29 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7S1M | 7S1M_refined | 2.4 | R | Active | 100 | 82 | Gs | αs | - | 59 | - | Nanobody-35 |
exendin-4
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Cary BP, Deganutti G, Zhao P, Truong TT, Piper SJ, Liu X, Belousoff MJ, Danev R, Sexton PM, Wootten D, Gellman SH | 10.1038/S41589-021-00945-W | 2022-01-05 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7S3I | - | 2.5 | R | Active | 100 | 57 | Gs | αs | - | 59 | - | Nanobody-35 |
exendin-4
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Cary BP, Deganutti G, Zhao P, Truong TT, Piper SJ, Liu X, Belousoff MJ, Danev R, Sexton PM, Wootten D, Gellman SH | 10.1038/S41589-021-00945-W | 2022-01-05 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EO2 | 7EO2_refined | 2.9 | A | Active | 100 | 73 | Gi/o | αi1 | - | 62 | - | scFv16 |
(S)-FTY720-phosphate
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Xu Z, Ikuta T, Kawakami K, Kise R, Qian Y, Xia R, Sun MX, Zhang A, Guo C, Cai XH, Huang Z, Inoue A, He Y | 10.1038/S41589-021-00930-3 | 2022-01-05 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7EO4 | 7EO4_refined | 2.9 | A | Active | 100 | 74 | Gi/o | αi1 | - | 43 | - | scFv16 |
siponimod
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Xu Z, Ikuta T, Kawakami K, Kise R, Qian Y, Xia R, Sun MX, Zhang A, Guo C, Cai XH, Huang Z, Inoue A, He Y | 10.1038/S41589-021-00930-3 | 2022-01-05 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7WF7 | 7WF7_refined | 3.4 | A | Active | 100 | 71 | Gi/o | αi1 | - | 40 | - | scFv16 |
sphingosine 1-phosphate
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Xu Z, Ikuta T, Kawakami K, Kise R, Qian Y, Xia R, Sun MX, Zhang A, Guo C, Cai XH, Huang Z, Inoue A, He Y | 10.1038/S41589-021-00930-3 | 2022-01-05 | Yes | |
ADA1B | α1B | Adrenoceptors | A | Human | X-ray | 7B6W | - | 2.9 | A | Inactive | 1 | 51 | - | - | - | - | DARPin D12 | - |
(+)-cyclazosin
|
small-molecule | Inverse agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Deluigi M, Morstein L, Schuster M, Klenk C, Merklinger L, Cridge RR, de Zhang LA, Klipp A, Vacca S, Vaid TM, Mittl PRE, Egloff P, Eberle SA, Zerbe O, Chalmers DK, Scott DJ, Pluckthun A | 10.1038/s41467-021-27911-3 | 2022-01-12 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 7WC4 | 7WC4_refined | 3.2 | A | Inactive | 1 | 61 | - | - | - | - | BRIL | - |
5-hydroxytryptamine
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S | 10.1126/SCIENCE.ABL8615 | 2022-01-26 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 7WC5 | 7WC5_refined | 3.2 | A | Inactive | 1 | 60 | - | - | - | - | BRIL | - |
psilocin
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S | 10.1126/SCIENCE.ABL8615 | 2022-01-26 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 7WC6 | 7WC6_refined | 2.6 | A | Inactive | 1 | 58 | - | - | - | - | BRIL | - |
Lysergide
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S | 10.1126/SCIENCE.ABL8615 | 2022-01-26 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 7WC7 | 7WC7_refined | 2.6 | A | Inactive | 1 | 59 | - | - | - | - | BRIL | - |
lisuride
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S | 10.1126/SCIENCE.ABL8615 | 2022-01-26 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 7WC8 | 7WC8_refined | 2.5 | A | Inactive | 1 | 59 | - | - | - | - | BRIL | - |
LUMATEPERONE
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S | 10.1126/SCIENCE.ABL8615 | 2022-01-26 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | X-ray | 7WC9 | 7WC9_refined | 2.5 | A | Inactive | 1 | 59 | - | - | - | - | BRIL | - |
IHCH-7086
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | No | No | Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S | 10.1126/SCIENCE.ABL8615 | 2022-01-26 | Yes | |
GHSR | ghrelin | Ghrelin | A | Human | X-ray | 7F83 | 7F83_refined | 2.9 | A | Inactive | 12 | 78 | - | - | - | - | BRIL | - |
PF-05190457
|
small-molecule | Inverse agonist | [des-Gln14]ghrelin, ghrelin | peptide | No | No | Qin J, Cai Y, Xu Z, Ming Q, Ji SY, Wu C, Zhang H, Mao C, Shen DD, Hirata K, Ma Y, Yan W, Zhang Y, Shao Z | 10.1038/S41467-022-27975-9 | 2022-01-19 | Yes | |
GHSR | ghrelin | Ghrelin | A | Human | Cryo-EM | 7W2Z | 7W2Z_refined | 2.8 | R | Active | 100 | 82 | Gi/o | αo | - | 60 | - | scFv16 |
Ghrelin
|
peptide | Agonist | [des-Gln14]ghrelin, ghrelin | peptide | Yes | No | Qin J, Cai Y, Xu Z, Ming Q, Ji SY, Wu C, Zhang H, Mao C, Shen DD, Hirata K, Ma Y, Yan W, Zhang Y, Shao Z | 10.1038/S41467-022-27975-9 | 2022-01-19 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7LLL | 7LLL_refined | 3.7 | R | Active | 100 | 79 | Gs | αs | - | 59 | - | Nanobody-35 |
exendin-4
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Deganutti G, Liang YL, Zhang X, Khoshouei M, Clydesdale L, Belousoff MJ, Venugopal H, Truong TT, Glukhova A, Keller AN, Gregory KJ, Leach K, Christopoulos A, Danev R, Reynolds CA, Zhao P, Sexton PM, Wootten D | 10.1038/S41467-021-27760-0 | 2022-01-12 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7LLY | 7LLY_refined | 3.3 | R | Active | 100 | 77 | Gs | αs | - | 50 | - | Nanobody-35 |
Pro-glucagon
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Deganutti G, Liang YL, Zhang X, Khoshouei M, Clydesdale L, Belousoff MJ, Venugopal H, Truong TT, Glukhova A, Keller AN, Gregory KJ, Leach K, Christopoulos A, Danev R, Reynolds CA, Zhao P, Sexton PM, Wootten D | 10.1038/S41467-021-27760-0 | 2022-01-12 | Yes | |
US28 | US28 | Unclassified | A | strain AD169 | Cryo-EM | 7RKF | - | 4.0 | R | Active | 100 | 84 | Gq/11 | α11 | - | 97 | - | scFv16 |
Fractalkine
|
peptide | Agonist | - | - | Yes | No | Tsutsumi N, Maeda S, Qu Q, Vogele M, Jude KM, Suomivuori CM, Panova O, Waghray D, Kato HE, Velasco A, Dror RO, Skiniotis G, Kobilka BK, Garcia KC | 10.1126/SCIADV.ABL5442 | 2022-01-26 | Yes | |
US28 | US28 | Unclassified | A | strain AD169 | Cryo-EM | 7RKM | - | 3.5 | R | Active | 100 | 83 | Gi/o | αi1 | - | 61 | - | scFv16 |
Fractalkine
|
peptide | Agonist | - | - | Yes | No | Tsutsumi N, Maeda S, Qu Q, Vogele M, Jude KM, Suomivuori CM, Panova O, Waghray D, Kato HE, Velasco A, Dror RO, Skiniotis G, Kobilka BK, Garcia KC | 10.1126/SCIADV.ABL5442 | 2022-01-26 | Yes | |
US28 | US28 | Unclassified | A | strain AD169 | Cryo-EM | 7RKN | - | 3.6 | R | Active | 100 | 83 | Gi/o | αi1 | - | 61 | - | scFv16 |
Fractalkine
|
peptide | Agonist | - | - | Yes | No | Tsutsumi N, Maeda S, Qu Q, Vogele M, Jude KM, Suomivuori CM, Panova O, Waghray D, Kato HE, Velasco A, Dror RO, Skiniotis G, Kobilka BK, Garcia KC | 10.1126/SCIADV.ABL5442 | 2022-01-26 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7SIL | 7SIL_refined | 2.7 | A | Active | - | 72 | - | - | - | - | - | - |
Cyclomethyltryptophan
tecalcet |
small-molecule small-molecule |
Agonist | Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Park J, Zuo H, Frangaj A, Fu Z, Yen LY, Zhang Z, Mosyak L, Slavkovich VN, Liu J, Ray KM, Cao B, Vallese F, Geng Y, Chen S, Grassucci R, Dandey VP, Tan YZ, Eng E, Lee Y, Kloss B, Liu Z, Hendrickson WA, Potter CS, Carragher B, Graziano J, Conigrave AD, Frank J, Clarke OB, Fan QR | 10.1073/PNAS.2115849118 | 2022-01-19 | Yes | |
CASR | CaS | Calcium-sensing | C | Human | Cryo-EM | 7SIN | 7SIN_refined | 5.9 | A | Inactive | - | 74 | - | - | - | - | - | - |
NPS 2143
|
small-molecule | Antagonist | Ca2+, spermine, Mg2+, L-tryptophan | small-molecule | No | No | Park J, Zuo H, Frangaj A, Fu Z, Yen LY, Zhang Z, Mosyak L, Slavkovich VN, Liu J, Ray KM, Cao B, Vallese F, Geng Y, Chen S, Grassucci R, Dandey VP, Tan YZ, Eng E, Lee Y, Kloss B, Liu Z, Hendrickson WA, Potter CS, Carragher B, Graziano J, Conigrave AD, Frank J, Clarke OB, Fan QR | 10.1073/PNAS.2115849118 | 2022-01-19 | Yes | |
CCR1 | CCR1 | Chemokine | A | Human | Cryo-EM | 7VL8 | 7VL8_refined | 2.9 | R | Active | 100 | 80 | Gi/o | αi1 | - | 62 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | CCL16, CCL8, CCL5, CCL4, CCL7, CCL15, CCL14, CCL3, CCL13, CCL23 | peptide | No | No | Shao Z, Shen Q, Yao B, Mao C, Chen LN, Zhang H, Shen DD, Zhang C, Li W, Du X, Li F, Ma H, Chen ZH, Xu HE, Ying S, Zhang Y, Shen H | 10.1038/S41589-021-00918-Z | 2022-03-23 | Yes | |
ADA2A | α2A | Adrenoceptors | A | Human | Cryo-EM | 7EJ0 | - | 3.2 | R | Active | 100 | 56 | Gi/o | αo | - | 61 | - | scFv16 |
(-)-noradrenaline
|
small-molecule | Agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Xu J, Cao S, Hubner H, Weikert D, Chen G, Lu Q, Yuan D, Gmeiner P, Liu Z, Du Y | 10.1126/SCIADV.ABJ5347 | 2022-04-13 | Yes | |
ADA2A | α2A | Adrenoceptors | A | Human | Cryo-EM | 7EJ8 | - | 3.0 | R | Active | 100 | 57 | Gi/o | αo | - | 61 | - | scFv16 |
brimonidine
|
small-molecule | Agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Xu J, Cao S, Hubner H, Weikert D, Chen G, Lu Q, Yuan D, Gmeiner P, Liu Z, Du Y | 10.1126/SCIADV.ABJ5347 | 2022-04-13 | Yes | |
ADA2A | α2A | Adrenoceptors | A | Human | Cryo-EM | 7EJA | 7EJA_refined | 3.6 | R | Active | 100 | 58 | Gi/o | αo | - | 59 | - | scFv16 |
dexmedetomidine
|
small-molecule | Agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Xu J, Cao S, Hubner H, Weikert D, Chen G, Lu Q, Yuan D, Gmeiner P, Liu Z, Du Y | 10.1126/SCIADV.ABJ5347 | 2022-04-13 | Yes | |
ADA2A | α2A | Adrenoceptors | A | Human | Cryo-EM | 7EJK | - | 3.4 | R | Active | 100 | 55 | Gi/o | αo | - | 61 | - | scFv16 |
oxymetazoline
|
small-molecule | Agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Xu J, Cao S, Hubner H, Weikert D, Chen G, Lu Q, Yuan D, Gmeiner P, Liu Z, Du Y | 10.1126/SCIADV.ABJ5347 | 2022-04-13 | Yes | |
FPR1 | FPR1 | Formylpeptide | A | Human | Cryo-EM | 7WVU | 7WVU_refined | 3.3 | R | Active | 100 | 85 | Gi/o | αi1 | - | 62 | - | - |
FME-LEU-PHE
|
peptide | Agonist | fMet-Leu-Phe, spinorphin, cathepsin G, annexin I | peptide | Yes | No | Zhu Y, Lin X, Zong X, Han S, Wang M, Su Y, Ma L, Chu X, Yi C, Zhao Q, Wu B | 10.1038/S41467-022-29361-X | 2022-04-13 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | Cryo-EM | 7WVV | 7WVV_refined | 2.9 | R | Active | 100 | 85 | Gi/o | αi2 | - | 63 | BRIL | - |
synthetic peptide
|
peptide | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Zhu Y, Lin X, Zong X, Han S, Wang M, Su Y, Ma L, Chu X, Yi C, Zhao Q, Wu B | 10.1038/S41467-022-29361-X | 2022-04-13 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | Cryo-EM | 7WVW | 7WVW_refined | 3.1 | R | Active | 100 | 85 | Gi/o | αi2 | - | 63 | BRIL | - |
FME-TYR-PHE-ILE-ASN-ILE-LEU-THE-LEU
|
peptide | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Zhu Y, Lin X, Zong X, Han S, Wang M, Su Y, Ma L, Chu X, Yi C, Zhao Q, Wu B | 10.1038/S41467-022-29361-X | 2022-04-13 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | Cryo-EM | 7WVX | 7WVX_refined | 2.8 | R | Active | 100 | 85 | Gi/o | αi2 | - | 61 | BRIL | - |
humanin
|
peptide | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Zhu Y, Lin X, Zong X, Han S, Wang M, Su Y, Ma L, Chu X, Yi C, Zhao Q, Wu B | 10.1038/S41467-022-29361-X | 2022-04-13 | Yes | |
FPR2 | FPR2/ALX | Formylpeptide | A | Human | Cryo-EM | 7WVY | - | 3.0 | R | Active | 100 | 85 | Gi/o | αi2 | - | 63 | BRIL | - |
Amyloid beta-Peptide (1-42)
|
peptide | Agonist | 15-deoxy-LXA4, aspirin triggered lipoxin A4, LTC4, resolvin D1, aspirin-triggered resolvin D1, PrP106-126, fMet-Leu-Phe, annexin I, LXA4, LL-37, humanin, LTD4, serum amyloid A | peptide | Yes | No | Zhu Y, Lin X, Zong X, Han S, Wang M, Su Y, Ma L, Chu X, Yi C, Zhao Q, Wu B | 10.1038/S41467-022-29361-X | 2022-04-13 | Yes | |
GALR1 | GAL1 | Galanin | A | Human | Cryo-EM | 7WQ3 | 7WQ3_refined | 2.7 | R | Active | 100 | 83 | Gi/o | αi1 | - | 64 | - | scFv16 |
galanin
|
peptide | Agonist | galanin, galanin-like peptide | peptide | Yes | No | Duan J, Shen DD, Zhao T, Guo S, He X, Yin W, Xu P, Ji Y, Chen LN, Liu J, Zhang H, Liu Q, Shi Y, Cheng X, Jiang H, Eric Xu H, Zhang Y, Xie X, Jiang Y | 10.1038/S41467-022-29072-3 | 2022-04-20 | Yes | |
GALR2 | GAL2 | Galanin | A | Human | Cryo-EM | 7WQ4 | 7WQ4_refined | 2.6 | R | Active | 100 | 73 | Gq/11 | αq | - | 60 | - | Nanobody-35 |
galanin
|
peptide | Agonist | spexin-1, galanin, galanin-like peptide | peptide | Yes | No | Duan J, Shen DD, Zhao T, Guo S, He X, Yin W, Xu P, Ji Y, Chen LN, Liu J, Zhang H, Liu Q, Shi Y, Cheng X, Jiang H, Eric Xu H, Zhang Y, Xie X, Jiang Y | 10.1038/S41467-022-29072-3 | 2022-04-20 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 7SBF | - | 2.9 | R | Active | 100 | 71 | Gi/o | αi1 | - | 61 | BRIL | scFv16 |
N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-N'-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea
|
small-molecule | Agonist | - | - | Yes | No | Wang H, Hetzer F, Huang W, Qu Q, Meyerowitz J, Kaindl J, Hubner H, Skiniotis G, Kobilka BK, Gmeiner P | 10.1002/ANIE.202200269 | 2022-04-20 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 7SCG | - | 3.0 | D | Active | 100 | 71 | Gi/o | αi1 | - | 61 | - | scFv16 |
(2E)-N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-(naphthalen-1-yl)prop-2-enamide
|
small-molecule | Agonist | - | - | Yes | No | Wang H, Hetzer F, Huang W, Qu Q, Meyerowitz J, Kaindl J, Hubner H, Skiniotis G, Kobilka BK, Gmeiner P | 10.1002/ANIE.202200269 | 2022-04-20 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 7U2L | - | 3.2 | D | Active | 100 | 71 | Gi/o | αi1 | - | 61 | - | scFv16 |
N-(5-carbamimidamidopentyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
|
small-molecule | Agonist | - | - | Yes | No | Faouzi A, Wang H, Zaidi SA, DiBerto JF, Che T, Qu Q, Robertson MJ, Madasu MK, El Daibani A, Varga BR, Zhang T, Ruiz C, Liu S, Xu J, Appourchaux K, Slocum ST, Eans SO, Cameron MD, Al-Hasani R, Pan YX, Roth BL, McLaughlin JP, Skiniotis G, Katritch V, Kobilka BK, Majumdar S | 10.1038/S41586-022-05588-Y | 2022-05-04 | Yes | |
S1PR2 | S1P2 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7T6B | 7T6B_refined | 3.2 | R | Active | 100 | 75 | G12/13 | α13 | - | 60 | - | scFv16 |
sphingosine 1-phosphate
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Chen H, Chen K, Huang W, Staudt LM, Cyster JG, Li X | 10.1126/SCIADV.ABN0067 | 2022-04-06 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 7EZC | 7EZC_refined | 3.8 | B | Active | 67 | 70 | - | - | - | - | BRIL | - |
UK-432,097
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Cui M, Zhou Q, Xu Y, Weng Y, Yao D, Zhao S, Song G | 10.1107/S2052252522001907 | 2022-04-13 | Yes | |
GP183 | GPR183 | A orphans | A | Human | Cryo-EM | 7TUY | 7TUY_refined | 3.0 | R | Active | 67 | 73 | - | - | - | - | BRIL | anti-BRIL Fab heavy chain anti-BRIL Fab light chain anti-Fab Nanobody |
8-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-3-[(3,4-dichlorophenyl)methyl]-1-oxa-3,8-diazaspiro[4.5]decan-2-one
|
small-molecule | Inverse agonist | 7α,27-dihydroxycholesterol, 25-hydroxycholesterol, 7β, 27-dihydroxycholesterol, 7β, 25-dihydroxycholesterol, 7α-hydroxycholesterol, 27-hydroxycholesterol, 7α,25-dihydroxycholesterol, 7β-hydroxycholesterol | small-molecule | No | No | Chen H, Huang W, Li X | 10.1016/J.STR.2022.04.006 | 2022-04-13 | Yes | |
GP183 | GPR183 | A orphans | A | Human | Cryo-EM | 7TUZ | 7TUZ_refined | 3.1 | R | Active | 100 | 79 | Gi/o | αi1 | - | 64 | - | scFv16 |
(2S,4aS,4bS,7R,8S,8aS,9R,10aR)-7-[(2R,3R)-7-hydroxy-3,7-dimethyloctan-2-yl]-4a,7,8-trimethyltetradecahydrophenanthrene-2,9-diol
|
small-molecule | Agonist | 7α,27-dihydroxycholesterol, 25-hydroxycholesterol, 7β, 27-dihydroxycholesterol, 7β, 25-dihydroxycholesterol, 7α-hydroxycholesterol, 27-hydroxycholesterol, 7α,25-dihydroxycholesterol, 7β-hydroxycholesterol | small-molecule | No | No | Chen H, Huang W, Li X | 10.1016/J.STR.2022.04.006 | 2022-04-13 | Yes | |
GIPR | GIP | Glucagon | B1 | Human | Cryo-EM | 7RA3 | - | 3.2 | R | Active | 100 | 80 | Gs | αs | Engineered G alpha | 56 | - | scFv16 Nanobody-35 |
gastric inhibitory polypeptide (human) - Incretin
|
peptide | Agonist | gastric inhibitory polypeptide | peptide | No | No | Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, Suter TM, Dunbar JD, Carpenter JW, Mohammed FA, Aihara E, Brown RA, Bueno AB, Emmerson PJ, Moyers JS, Kobilka TS, Coghlan MP, Kobilka BK, Sloop KW | 10.1073/PNAS.2116506119 | 2022-04-13 | Yes | |
GIPR | GIP | Glucagon | B1 | Human | Cryo-EM | 7RBT | 7RBT_refined | 3.1 | R | Active | 100 | 81 | Gs | αs | - | 56 | - | scFv16 Nanobody-35 |
tirzepatide
2-fluoro-4-[(1R)-6-methoxy-1-methyl-2-{(1S)-1-[4-(propan-2-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinolin-5-yl]-6-[(2-methylpropyl)amino]phenol |
peptide small-molecule |
Agonist PAM |
gastric inhibitory polypeptide | peptide | No | No | Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, Suter TM, Dunbar JD, Carpenter JW, Mohammed FA, Aihara E, Brown RA, Bueno AB, Emmerson PJ, Moyers JS, Kobilka TS, Coghlan MP, Kobilka BK, Sloop KW | 10.1073/PNAS.2116506119 | 2022-04-13 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7RG9 | 7RG9_refined | 3.2 | R | Active | 100 | 58 | Gs | αs | - | 56 | - | scFv16 Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, Suter TM, Dunbar JD, Carpenter JW, Mohammed FA, Aihara E, Brown RA, Bueno AB, Emmerson PJ, Moyers JS, Kobilka TS, Coghlan MP, Kobilka BK, Sloop KW | 10.1073/PNAS.2116506119 | 2022-04-13 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7RGP | - | 2.9 | R | Active | 100 | 82 | Gs | αs | Engineered G alpha | 55 | - | scFv16 Nanobody-35 |
tirzepatide
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, Suter TM, Dunbar JD, Carpenter JW, Mohammed FA, Aihara E, Brown RA, Bueno AB, Emmerson PJ, Moyers JS, Kobilka TS, Coghlan MP, Kobilka BK, Sloop KW | 10.1073/PNAS.2116506119 | 2022-04-13 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7VBH | - | 3.0 | R | Active | 100 | 83 | Gs | αs | - | 53 | - | Nanobody-35 |
Peptide 20
|
peptide | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Zhao F, Zhou Q, Cong Z, Hang K, Zou X, Zhang C, Chen Y, Dai A, Liang A, Ming Q, Wang M, Chen LN, Xu P, Chang R, Feng W, Xia T, Zhang Y, Wu B, Yang D, Zhao L, Xu HE, Wang MW | 10.1038/S41467-022-28683-0 | 2022-04-06 | Yes | |
AGRD1 | ADGRD1 | ADGRD | B2 | Human | Cryo-EM | 7WU2 | - | 2.8 | R | Active | - | 32 | Gs | αs | Mini-Gs | 53 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Qu X, Qiu N, Wang M, Zhang B, Du J, Zhong Z, Xu W, Chu X, Ma L, Yi C, Han S, Shui W, Zhao Q, Wu B | 10.1038/S41586-022-04580-W | 2022-04-27 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 7WU3 | - | 3.1 | R | Active | - | 31 | Gs | αs | Mini-Gs | 54 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Qu X, Qiu N, Wang M, Zhang B, Du J, Zhong Z, Xu W, Chu X, Ma L, Yi C, Han S, Shui W, Zhao Q, Wu B | 10.1038/S41586-022-04580-W | 2022-04-27 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | Cryo-EM | 8DCR | - | 2.6 | R | Active | 100 | 57 | Gs | αs | - | 51 | T4-Lysozyme | Nanobody-35 |
Dobutamine
|
small-molecule | Agonist | - | - | Yes | No | Su M, Paknejad N, Zhu L, Wang J, Do HN, Miao Y, Liu W, Hite RK, Huang XY | 10.1038/S41467-022-31823-1 | 2022-07-27 | Yes | |
ADRB1 | β1 | Adrenoceptors | A | Wild turkey | Cryo-EM | 8DCS | - | 2.5 | R | Active | 100 | 57 | Gs | αs | - | 51 | T4-Lysozyme | Nanobody-35 |
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile
|
small-molecule | Agonist | - | - | Yes | No | Su M, Paknejad N, Zhu L, Wang J, Do HN, Miao Y, Liu W, Hite RK, Huang XY | 10.1038/S41467-022-31823-1 | 2022-07-27 | Yes | |
5HT2C | 5-HT2C | 5-Hydroxytryptamine | A | Human | Cryo-EM | 8DPG | - | 3.6 | A | Active | 100 | 58 | Gq/11 | αq | Gi2-mini-Gq chimera | 62 | - | scFv16 |
psilocin
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Gumpper RH, Fay JF, Roth BL | 10.1016/J.CELREP.2022.111211 | 2022-08-24 | Yes | |
5HT2C | 5-HT2C | 5-Hydroxytryptamine | A | Human | Cryo-EM | 8DPH | - | 3.2 | A | Active | 100 | 58 | Gq/11 | αq | Gi2-mini-Gq chimera | 62 | - | scFv16 |
lorcaserin
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Gumpper RH, Fay JF, Roth BL | 10.1016/J.CELREP.2022.111211 | 2022-08-24 | Yes | |
5HT2C | 5-HT2C | 5-Hydroxytryptamine | A | Human | Cryo-EM | 8DPI | - | 3.4 | A | Active | 100 | 58 | Gq/11 | αq | Gi2-mini-Gq chimera | 62 | - | scFv16 |
lorcaserin
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Gumpper RH, Fay JF, Roth BL | 10.1016/J.CELREP.2022.111211 | 2022-08-24 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7XAT | 7XAT_refined | 2.9 | A | Active | 100 | 78 | Gi/o | αi1 | - | 63 | - | scFv16 |
SOMATOSTATIN
|
protein | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Bo Q, Yang F, Li Y, Meng X, Zhang H, Zhou Y, Ling S, Sun D, Lv P, Liu L, Shi P, Tian C | 10.1038/S41421-022-00405-2 | 2022-08-31 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7XAU | - | 3.0 | A | Active | 100 | 76 | Gi/o | αi1 | - | 63 | - | scFv16 |
Octreotide
|
peptide | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Bo Q, Yang F, Li Y, Meng X, Zhang H, Zhou Y, Ling S, Sun D, Lv P, Liu L, Shi P, Tian C | 10.1038/S41421-022-00405-2 | 2022-08-31 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7XAV | 7XAV_refined | 2.9 | A | Active | 100 | 76 | Gi/o | αi1 | - | 63 | - | scFv16 |
lanreotide
|
peptide | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Bo Q, Yang F, Li Y, Meng X, Zhang H, Zhou Y, Ling S, Sun D, Lv P, Liu L, Shi P, Tian C | 10.1038/S41421-022-00405-2 | 2022-08-31 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | X-ray | 7XN9 | 7XN9_refined | 2.6 | A | Inactive | 4 | 79 | - | - | - | - | - | - |
L-054,522
|
small-molecule | Antagonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Zhao W, Han S, Qiu N, Feng W, Lu M, Zhang W, Wang M, Zhou Q, Chen S, Xu W, Du J, Chu X, Yi C, Dai A, Hu L, Shen MY, Sun Y, Zhang Q, Ma Y, Zhong W, Yang D, Wang MW, Wu B, Zhao Q | 10.1038/S41422-022-00679-X | 2022-08-03 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | X-ray | 7XNA | - | 2.7 | A | Inactive | 4 | 78 | - | - | - | - | - | - |
CYN 154806
|
peptide | Antagonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | No | No | Zhao W, Han S, Qiu N, Feng W, Lu M, Zhang W, Wang M, Zhou Q, Chen S, Xu W, Du J, Chu X, Yi C, Dai A, Hu L, Shen MY, Sun Y, Zhang Q, Ma Y, Zhong W, Yang D, Wang MW, Wu B, Zhao Q | 10.1038/S41422-022-00679-X | 2022-08-03 | Yes | |
SSR4 | SST4 | Somatostatin | A | Human | Cryo-EM | 7XMS | - | 2.9 | R | Active | 100 | 71 | Gi/o | αi1 | - | 63 | - | scFv16 |
SOMATOSTATIN
|
protein | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Zhao W, Han S, Qiu N, Feng W, Lu M, Zhang W, Wang M, Zhou Q, Chen S, Xu W, Du J, Chu X, Yi C, Dai A, Hu L, Shen MY, Sun Y, Zhang Q, Ma Y, Zhong W, Yang D, Wang MW, Wu B, Zhao Q | 10.1038/S41422-022-00679-X | 2022-08-03 | Yes | |
SSR4 | SST4 | Somatostatin | A | Human | Cryo-EM | 7XMT | 7XMT_refined | 2.8 | R | Active | 100 | 68 | Gi/o | αi1 | - | 63 | - | scFv16 |
J-2156
|
small-molecule | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Zhao W, Han S, Qiu N, Feng W, Lu M, Zhang W, Wang M, Zhou Q, Chen S, Xu W, Du J, Chu X, Yi C, Dai A, Hu L, Shen MY, Sun Y, Zhang Q, Ma Y, Zhong W, Yang D, Wang MW, Wu B, Zhao Q | 10.1038/S41422-022-00679-X | 2022-08-03 | Yes | |
TRFR | TRH1 | Thyrotropin-releasing hormone | A | Human | Cryo-EM | 7X1T | - | 3.3 | A | Active | 100 | 68 | Gq/11 | αq | - | 61 | - | scFv16 |
taltirelin
|
small-molecule | Agonist | TRH | peptide | Yes | No | Yang F, Zhang H, Meng X, Li Y, Zhou Y, Ling S, Sun D, Lv P, Liu L, Shi P, Tian C | 10.1038/S41422-022-00646-6 | 2022-08-31 | Yes | |
TRFR | TRH1 | Thyrotropin-releasing hormone | A | Human | Cryo-EM | 7X1U | - | 3.2 | A | Active | 100 | 68 | Gq/11 | αq | - | 62 | - | scFv16 |
TRH
|
peptide | Agonist | TRH | peptide | Yes | No | Yang F, Zhang H, Meng X, Li Y, Zhou Y, Ling S, Sun D, Lv P, Liu L, Shi P, Tian C | 10.1038/S41422-022-00646-6 | 2022-08-31 | Yes | |
OXYR | OT | Vasopressin and oxytocin | A | Human | Cryo-EM | 7QVM | 7QVM_refined | 3.3 | R | Active | 100 | 64 | Gi/o | αo | - | 59 | - | scFv16 |
oxytocin
|
peptide | Agonist | vasopressin, oxytocin | peptide | Yes | No | Waltenspuhl Y, Ehrenmann J, Vacca S, Thom C, Medalia O, Pluckthun A | 10.1038/S41467-022-31325-0 | 2022-08-10 | Yes | |
CCR2 | CCR2 | Chemokine | A | Human | Cryo-EM | 7XA3 | 7XA3_refined | 2.9 | R | Active | 100 | 79 | Gi/o | αi1 | - | 65 | - | scFv16 |
C-C motif chemokine 2
|
peptide | Agonist | CCL16, CCL24, CCL7, CCL2, CCL13, CCL26, CCL11, CCL8 | peptide | No | No | Shao Z, Tan Y, Shen Q, Hou L, Yao B, Qin J, Xu P, Mao C, Chen LN, Zhang H, Shen DD, Zhang C, Li W, Du X, Li F, Chen ZH, Jiang Y, Xu HE, Ying S, Ma H, Zhang Y, Shen H | 10.1038/S41421-022-00403-4 | 2022-08-24 | Yes | |
CCR3 | CCR3 | Chemokine | A | Human | Cryo-EM | 7X9Y | 7X9Y_refined | 3.1 | R | Active | 100 | 83 | Gi/o | αi1 | - | 62 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | CCL24, CCL5, CXCL9, CCL7, CCL15, CXCL11, CCL2, CCL13, CCL26, CXCL10, CCL28, CCL11, CCL8 | peptide | No | No | Shao Z, Tan Y, Shen Q, Hou L, Yao B, Qin J, Xu P, Mao C, Chen LN, Zhang H, Shen DD, Zhang C, Li W, Du X, Li F, Chen ZH, Jiang Y, Xu HE, Ying S, Ma H, Zhang Y, Shen H | 10.1038/S41421-022-00403-4 | 2022-08-24 | Yes | |
TSHR | TSH | Glycoprotein hormone | A | Human | Cryo-EM | 7XW5 | - | 3.0 | R | Active | 100 | 75 | Gs | αs | - | 60 | - | Nanobody-35 |
Thyrotropin subunit beta
Glycoprotein hormones alpha chain N-[4-[[5-[(2S)-3-benzyl-5-hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl]-2-methoxyphenyl]methoxy]phenyl]acetamide |
protein protein small-molecule |
Agonist | TSH | peptide | Yes | No | Duan J, Xu P, Luan X, Ji Y, He X, Song N, Yuan Q, Jin Y, Cheng X, Jiang H, Zheng J, Zhang S, Jiang Y, Xu HE | 10.1038/S41586-022-05173-3 | 2022-08-24 | Yes | |
TSHR | TSH | Glycoprotein hormone | A | Human | Cryo-EM | 7XW6 | - | 2.8 | R | Active | 100 | 74 | Gs | αs | - | 59 | - | Nanobody-35 |
M22 antibody heavy chain
M22 antibody light chain N-[4-[[5-[(2S)-3-benzyl-5-hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl]-2-methoxyphenyl]methoxy]phenyl]acetamide |
protein protein small-molecule |
Agonist | TSH | peptide | Yes | No | Duan J, Xu P, Luan X, Ji Y, He X, Song N, Yuan Q, Jin Y, Cheng X, Jiang H, Zheng J, Zhang S, Jiang Y, Xu HE | 10.1038/S41586-022-05173-3 | 2022-08-17 | Yes | |
TSHR | TSH | Glycoprotein hormone | A | Human | Cryo-EM | 7XW7 | 7XW7_refined | 5.5 | R | Inactive | 14 | 74 | - | - | - | - | - | - |
K1-70 scFv light chain
K1-70 scFv heavy chain |
protein protein |
Antagonist | TSH | peptide | Yes | No | Duan J, Xu P, Luan X, Ji Y, He X, Song N, Yuan Q, Jin Y, Cheng X, Jiang H, Zheng J, Zhang S, Jiang Y, Xu HE | 10.1038/S41586-022-05173-3 | 2022-08-17 | Yes | |
S1PR5 | S1P5 | Lysophospholipid (S1P) | A | Human | X-ray | 7YXA | 7YXA_refined | 2.2 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
4-[6-(2-naphthalen-1-ylethoxy)-2,3,4,5-tetrahydro-1H-3-benzazepin-3-ium-3-yl]butanoic acid
|
small-molecule | Antagonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Lyapina E, Marin E, Gusach A, Orekhov P, Gerasimov A, Luginina A, Vakhrameev D, Ergasheva M, Kovaleva M, Khusainov G, Khorn P, Shevtsov M, Kovalev K, Bukhdruker S, Okhrimenko I, Popov P, Hu H, Weierstall U, Liu W, Cho Y, Gushchin I, Rogachev A, Bourenkov G, Park S, Park G, Hyun HJ, Park J, Gordeliy V, Borshchevskiy V, Mishin A, Cherezov V | 10.1038/S41467-022-32447-1 | 2022-08-10 | Yes | |
PE2R3 | EP3 | Prostanoid | A | Human | Cryo-EM | 7WU9 | 7WU9_refined | 3.4 | R | Active | 100 | 70 | Gi/o | αi1 | - | 38 | - | scFv16 | - | - | - | PGD2, PGE1, thromboxane A2, PGF2α, PGE2, PGI2 | small-molecule | Yes | No | Suno R, Sugita Y, Morimoto K, Takazaki H, Tsujimoto H, Hirose M, Suno-Ikeda C, Nomura N, Hino T, Inoue A, Iwasaki K, Kato T, Iwata S, Kobayashi T | 10.1016/J.CELREP.2022.111323 | 2022-08-17 | Yes | |
AA2AR | A2A | Adenosine | A | Human | Cryo-EM | 7T32 | 7T32_refined | 3.4 | A | Inactive | 1 | 69 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Zhang K, Wu H, Hoppe N, Manglik A, Cheng Y | 10.1038/S41467-022-32125-2 | 2022-08-10 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 8CU6 | 8CU6_refined | 2.8 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
LJ-4517
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Shiriaeva A, Park D, Kim G, Lee Y, Hou X, Jarhad DB, Kim G, Yu J, Hyun YE, Kim W, Gao ZG, Jacobson KA, Han GW, Stevens RC, Jeong LS, Choi S, Cherezov V. | 10.1021/acs.jmedchem.2c00462 | 2022-08-31 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 8CU7 | 8CU7_refined | 2.1 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
LJ-4517
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Shiriaeva A, Park D, Kim G, Lee Y, Hou X, Jarhad DB, Kim G, Yu J, Hyun YE, Kim W, Gao ZG, Jacobson KA, Han GW, Stevens RC, Jeong LS, Choi S, Cherezov V. | 10.1021/acs.jmedchem.2c00462 | 2022-08-31 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 8DU3 | 8DU3_refined | 2.5 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
CHEMBL5206530
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Bolteau R, Duroux R, Laversin A, Vreulz B, Shiriaeva A, Stauch B, Han GW, Cherezov V, Renault N, Barczyk A, Ravez S, Coevoet M, Melnyk P, Liberelle M, Yous S. | 10.1016/j.ejmech.2022.114620 | 2022-08-10 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 7VVJ | - | 3.2 | R | Active | 100 | 62 | Gs | αs | - | 59 | - | Nanobody-35 |
PTHrP[1-36]
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Kobayashi K, Kawakami K, Kusakizako T, Miyauchi H, Tomita A, Kobayashi K, Shihoya W, Yamashita K, Nishizawa T, Kato HE, Inoue A, Nureki O | 10.1016/J.MOLCEL.2022.07.003 | 2022-08-03 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 7VVK | - | 3.3 | R | Active | 100 | 56 | Gs | αs | - | 58 | - | Nanobody-35 |
teriparatide
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Kobayashi K, Kawakami K, Kusakizako T, Miyauchi H, Tomita A, Kobayashi K, Shihoya W, Yamashita K, Nishizawa T, Kato HE, Inoue A, Nureki O | 10.1016/J.MOLCEL.2022.07.003 | 2022-08-03 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 7VVL | - | 2.8 | R | Active | 100 | 58 | Gs | αs | - | 58 | - | Nanobody-35 |
teriparatide
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Kobayashi K, Kawakami K, Kusakizako T, Miyauchi H, Tomita A, Kobayashi K, Shihoya W, Yamashita K, Nishizawa T, Kato HE, Inoue A, Nureki O | 10.1016/J.MOLCEL.2022.07.003 | 2022-08-03 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 7VVM | - | 3.2 | R | Active | 100 | 60 | Gs | αs | - | 58 | - | Nanobody-35 |
Parathyroid hormone
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Kobayashi K, Kawakami K, Kusakizako T, Miyauchi H, Tomita A, Kobayashi K, Shihoya W, Yamashita K, Nishizawa T, Kato HE, Inoue A, Nureki O | 10.1016/J.MOLCEL.2022.07.003 | 2022-08-03 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 7VVN | - | 3.8 | R | Active | 100 | 51 | Gs | αs | - | 58 | - | Nanobody-35 |
teriparatide
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Kobayashi K, Kawakami K, Kusakizako T, Miyauchi H, Tomita A, Kobayashi K, Shihoya W, Yamashita K, Nishizawa T, Kato HE, Inoue A, Nureki O | 10.1016/J.MOLCEL.2022.07.003 | 2022-08-03 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 7VVO | 7VVO_refined | 4.1 | R | Active | 100 | 51 | Gs | αs | - | 58 | - | Nanobody-35 |
Parathyroid hormone
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Kobayashi K, Kawakami K, Kusakizako T, Miyauchi H, Tomita A, Kobayashi K, Shihoya W, Yamashita K, Nishizawa T, Kato HE, Inoue A, Nureki O | 10.1016/J.MOLCEL.2022.07.003 | 2022-08-03 | Yes | |
AGRG2 | ADGRG2 | ADGRG | B2 | Mouse | Cryo-EM | 7XKD | - | 2.4 | R | Active | - | 26 | Gs | αs | - | 57 | - | Nanobody-35 |
PRASTERONE
|
small-molecule | Agonist | - | - | No | No | Lin H, Xiao P, Bu RQ, Guo S, Yang Z, Yuan D, Zhu ZL, Zhang CX, He QT, Zhang C, Ping YQ, Zhao RJ, Ma CS, Liu CH, Zhang XN, Jiang D, Huang S, Xi YT, Zhang DL, Xue CY, Yang BS, Li JY, Lin HC, Zeng XH, Zhao H, Xu WM, Yi F, Liu Z, Sun JP, Yu X | 10.1038/S41589-022-01084-6 | 2022-08-10 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7F1Z | - | 3.5 | F | Active | 100 | 62 | Gs | αs | - | 60 | - | - |
dopamine
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Teng X, Chen S, Wang Q, Chen Z, Wang X, Huang N, Zheng S | 10.1126/SCIADV.ABO4158 | 2022-06-15 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7F23 | - | 3.6 | F | Active | 100 | 62 | Gs | αs | - | 60 | - | Nanobody-35 |
dopamine
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Teng X, Chen S, Wang Q, Chen Z, Wang X, Huang N, Zheng S | 10.1126/SCIADV.ABO4158 | 2022-06-15 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7F24 | - | 4.2 | F | Active | 100 | 62 | Gs | αs | - | 57 | - | - |
dopamine
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Teng X, Chen S, Wang Q, Chen Z, Wang X, Huang N, Zheng S | 10.1126/SCIADV.ABO4158 | 2022-06-15 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7X2C | 7X2C_refined | 3.2 | F | Active | 100 | 63 | Gs | αs | - | 58 | - | Nanobody-35 |
fenoldopam
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Teng X, Chen S, Nie Y, Xiao P, Yu X, Shao Z, Zheng S | 10.1038/S41467-022-30929-W | 2022-06-29 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7X2D | 7X2D_refined | 3.3 | F | Active | 100 | 63 | Gs | αs | - | 58 | - | Nanobody-35 |
TAVAPADON
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Teng X, Chen S, Nie Y, Xiao P, Yu X, Shao Z, Zheng S | 10.1038/S41467-022-30929-W | 2022-06-15 | Yes | |
DRD1 | D1 | Dopamine | A | Human | Cryo-EM | 7X2F | 7X2F_refined | 3.0 | F | Active | 100 | 63 | Gs | αs | - | 58 | - | Nanobody-35 |
dopamine
mevidalen |
small-molecule small-molecule |
Agonist PAM |
L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Teng X, Chen S, Nie Y, Xiao P, Yu X, Shao Z, Zheng S | 10.1038/S41467-022-30929-W | 2022-06-15 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Human | Cryo-EM | 7UL2 | 7UL2_refined | 2.4 | R | Inactive | 4 | 69 | - | - | - | - | - | Nanobody-6 |
meclinertant
|
small-molecule | Inverse agonist | neuromedin N, large neurotensin, neurotensin, large neuromedin N | peptide | Yes | No | Robertson MJ, Papasergi-Scott MM, He F, Seven AB, Meyerowitz JG, Panova O, Peroto MC, Che T, Skiniotis G | 10.1038/S41594-022-00859-8 | 2022-06-29 | Yes | |
HRH2 | H2 | Histamine | A | Human | Cryo-EM | 7UL3 | 7UL3_refined | 3.0 | A | Inactive | 4 | 75 | - | - | - | - | - | Nanobody-6M NabFab HC NabFab LC |
famotidine
|
small-molecule | Antagonist | histamine | small-molecule | Yes | No | Robertson MJ, Papasergi-Scott MM, He F, Seven AB, Meyerowitz JG, Panova O, Peroto MC, Che T, Skiniotis G | 10.1038/S41594-022-00859-8 | 2022-06-29 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7XMR | - | 3.1 | R | Active | 100 | 77 | Gi/o | αi1 | - | 63 | - | - |
SOMATOSTATIN
|
protein | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Zhao W, Han S, Qiu N, Feng W, Lu M, Zhang W, Wang M, Zhou Q, Chen S, Xu W, Du J, Chu X, Yi C, Dai A, Hu L, Shen MY, Sun Y, Zhang Q, Ma Y, Zhong W, Yang D, Wang MW, Wu B, Zhao Q | 10.1038/S41422-022-00679-X | 2022-08-03 | Yes | |
GALR2 | GAL2 | Galanin | A | Human | Cryo-EM | 7XJK | - | 3.3 | F | Active | 100 | 72 | Gq/11 | αq | - | 63 | - | scFv16 |
Galanin, Human
|
peptide | Agonist | spexin-1, galanin, galanin-like peptide | peptide | Yes | No | Jiang W, Zheng S | 10.1073/PNAS.2121465119 | 2022-06-29 | Yes | |
GALR2 | GAL2 | Galanin | A | Human | Cryo-EM | 7XJL | - | 3.5 | F | Active | 100 | 72 | Gq/11 | αq | - | 63 | - | scFv16 |
Spexin
|
small-molecule | Agonist | spexin-1, galanin, galanin-like peptide | peptide | Yes | No | Jiang W, Zheng S | 10.1073/PNAS.2121465119 | 2022-06-29 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 7UL4 | 7UL4_refined | 2.8 | A | Inactive | 4 | 72 | - | - | - | - | - | Megabody-6 |
alvimopan
|
small-molecule | Antagonist | - | - | Yes | No | Robertson MJ, Papasergi-Scott MM, He F, Seven AB, Meyerowitz JG, Panova O, Peroto MC, Che T, Skiniotis G | 10.1038/S41594-022-00859-8 | 2022-06-29 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7UL5 | 7UL5_refined | 3.1 | A | Inactive | 4 | 77 | - | - | - | - | - | Nanobody-6 |
Apo (no ligand)
|
none | Apo (no ligand) | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Robertson MJ, Papasergi-Scott MM, He F, Seven AB, Meyerowitz JG, Panova O, Peroto MC, Che T, Skiniotis G | 10.1038/S41594-022-00859-8 | 2022-06-29 | Yes | |
TRFR | TRH1 | Thyrotropin-releasing hormone | A | Human | Cryo-EM | 7WKD | - | 3.0 | R | Active | 100 | 66 | Gq/11 | αq | - | 60 | - | scFv16 |
TRH
|
peptide | Agonist | TRH | peptide | Yes | No | Xu Y, Cai H, You C, He X, Yuan Q, Jiang H, Cheng X, Jiang Y, Xu HE | 10.1038/S41422-022-00641-X | 2022-06-15 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | X-ray | 7FEE | 7FEE_refined | 2.7 | A | Inactive | 10 | 61 | - | - | - | - | GlgA glycogen synthase | - |
CP55940
6-methyl-3-[(1S)-2-nitro-1-thiophen-2-yl-ethyl]-2-phenyl-1H-indole |
small-molecule small-molecule |
Agonist PAM |
anandamide, 2-arachidonoylglycerol | small-molecule | No | No | Yang X, Wang X, Xu Z, Wu C, Zhou Y, Wang Y, Lin G, Li K, Wu M, Xia A, Liu J, Cheng L, Zou J, Yan W, Shao Z, Yang S | 10.1038/S41589-022-01038-Y | 2022-06-15 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | Cryo-EM | 7WV9 | 7WV9_refined | 3.4 | R | Active | 100 | 61 | Gi/o | αi2 | - | 63 | - | scFv16 |
CP55940
6-methyl-3-[(1S)-2-nitro-1-thiophen-2-yl-ethyl]-2-phenyl-1H-indole |
small-molecule small-molecule |
Agonist PAM |
anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Yang X, Wang X, Xu Z, Wu C, Zhou Y, Wang Y, Lin G, Li K, Wu M, Xia A, Liu J, Cheng L, Zou J, Yan W, Shao Z, Yang S | 10.1038/S41589-022-01038-Y | 2022-06-15 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7X8R | - | 2.6 | R | Active | 100 | 64 | Gs | αs | - | 59 | - | Nanobody-35 |
CHEMBL2158411
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Cong Z, Zhou Q, Li Y, Chen LN, Zhang ZC, Liang A, Liu Q, Wu X, Dai A, Xia T, Wu W, Zhang Y, Yang D, Wang MW | 10.1073/PNAS.2200155119 | 2022-06-29 | Yes | |
GLP1R | GLP-1 | Glucagon | B1 | Human | Cryo-EM | 7X8S | 7X8S_refined | 3.1 | R | Active | 100 | 65 | Gs | αs | - | 60 | - | Nanobody-35 |
CHEMBL2158488
|
small-molecule | Agonist | glucagon-like peptide 1-(7-36) amide, glucagon-like peptide 1-(7-37), glucagon | peptide | No | No | Cong Z, Zhou Q, Li Y, Chen LN, Zhang ZC, Liang A, Liu Q, Wu X, Dai A, Xia T, Wu W, Zhang Y, Yang D, Wang MW | 10.1073/PNAS.2200155119 | 2022-06-29 | Yes | |
SMO | SMO | Frizzled | F | Human | X-ray | 7ZI0 | 7ZI0_refined | 3.0 | A | Inactive | 4 | 61 | - | - | - | - | BRIL | - |
3-chloro-N-[trans-4-(methylamino)cyclohexyl]-N-{[3-(pyridin-4-yl)phenyl]methyl}-1-benzothiophene-2-carboxamide
|
small-molecule | Antagonist | - | - | No | No | Kinnebrew M, Woolley RE, Ansell TB, Byrne EFX, Frigui S, Luchetti G, Sircar R, Nachtergaele S, Mydock-McGrane L, Krishnan K, Newstead S, Sansom MSP, Covey DF, Siebold C, Rohatgi R | 10.1126/SCIADV.ABM5563 | 2022-06-15 | Yes | |
5HT2A | 5-HT2A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7RAN | - | 3.5 | A | Active | 100 | 57 | Gq/11 | αq | Gi2-mini-Gq chimera | 65 | - | scFv16 |
3-[(3R)-3-methyl-1,2,3,6-tetrahydropyridin-1-ium-5-yl]-1H-pyrrolo[2,3-b]pyridine
|
small-molecule | Agonist | tryptamine, 5-hydroxytryptamine | small-molecule | Yes | No | Kaplan AL, Confair DN, Kim K, Barros-Alvarez X, Rodriguiz RM, Yang Y, Kweon OS, Che T, McCorvy JD, Kamber DN, Phelan JP, Martins LC, Pogorelov VM, DiBerto JF, Slocum ST, Huang XP, Kumar JM, Robertson MJ, Panova O, Seven AB, Wetsel AQ, Wetsel WC, Irwin JJ, Skiniotis G, Shoichet BK, Roth BL, Ellman JA | 10.1038/S41586-022-05258-Z | 2022-07-06 | Yes | |
5HT4R | 5-HT4 | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7XT8 | - | 3.1 | R | Active | 100 | 76 | Gs | αs | - | 60 | BRIL | Nanobody-35 |
5-hydroxytryptamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Huang S, Xu P, Shen DD, Simon IA, Mao C, Tan Y, Zhang H, Harpsoe K, Li H, Zhang Y, You C, Yu X, Jiang Y, Zhang Y, Gloriam DE, Xu HE | 10.1016/J.MOLCEL.2022.05.031 | 2022-07-27 | Yes | |
5HT4R | 5-HT4 | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7XT9 | - | 3.2 | R | Active | 100 | 76 | Gs | αs | - | 60 | BRIL | - |
5-hydroxytryptamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Huang S, Xu P, Shen DD, Simon IA, Mao C, Tan Y, Zhang H, Harpsoe K, Li H, Zhang Y, You C, Yu X, Jiang Y, Zhang Y, Gloriam DE, Xu HE | 10.1016/J.MOLCEL.2022.05.031 | 2022-07-27 | Yes | |
5HT4R | 5-HT4 | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7XTA | 7XTA_refined | 3.2 | R | Active | 100 | 73 | Gi/o | αi1 | - | 62 | BRIL | scFv16 |
5-hydroxytryptamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Huang S, Xu P, Shen DD, Simon IA, Mao C, Tan Y, Zhang H, Harpsoe K, Li H, Zhang Y, You C, Yu X, Jiang Y, Zhang Y, Gloriam DE, Xu HE | 10.1016/J.MOLCEL.2022.05.031 | 2022-07-27 | Yes | |
5HT5A | 5-HT5A | 5-Hydroxytryptamine | A | Human | X-ray | 7UM4 | 7UM4_refined | 2.8 | A | Inactive | 34 | 71 | - | - | - | - | PGS | - |
CHEMBL3654198
|
small-molecule | Antagonist | 5-hydroxytryptamine | small-molecule | No | No | Zhang S, Chen H, Zhang C, Yang Y, Popov P, Liu J, Krumm BE, Cao C, Kim K, Xiong Y, Katritch V, Shoichet BK, Jin J, Fay JF, Roth BL | 10.1038/S41594-022-00796-6 | 2022-07-20 | Yes | |
5HT5A | 5-HT5A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7UM5 | - | 2.7 | A | Active | 100 | 75 | Gi/o | αo | Mini-Go | 60 | - | scFv16 |
5-CT
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Zhang S, Chen H, Zhang C, Yang Y, Popov P, Liu J, Krumm BE, Cao C, Kim K, Xiong Y, Katritch V, Shoichet BK, Jin J, Fay JF, Roth BL | 10.1038/S41594-022-00796-6 | 2022-07-20 | Yes | |
5HT5A | 5-HT5A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7UM6 | - | 2.8 | A | Active | 100 | 72 | Gi/o | αo | Mini-Go | 60 | - | scFv16 |
lisuride
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Zhang S, Chen H, Zhang C, Yang Y, Popov P, Liu J, Krumm BE, Cao C, Kim K, Xiong Y, Katritch V, Shoichet BK, Jin J, Fay JF, Roth BL | 10.1038/S41594-022-00796-6 | 2022-07-20 | Yes | |
5HT5A | 5-HT5A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7UM7 | 7UM7_refined | 2.8 | A | Active | 100 | 72 | Gi/o | αo | Mini-Go | 60 | - | scFv16 |
methylergonovine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Zhang S, Chen H, Zhang C, Yang Y, Popov P, Liu J, Krumm BE, Cao C, Kim K, Xiong Y, Katritch V, Shoichet BK, Jin J, Fay JF, Roth BL | 10.1038/S41594-022-00796-6 | 2022-07-20 | Yes | |
5HT6R | 5-HT6 | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7XTB | 7XTB_refined | 3.3 | R | Active | 100 | 63 | Gs | αs | - | 60 | BRIL | Nanobody-35 |
5-hydroxytryptamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Huang S, Xu P, Shen DD, Simon IA, Mao C, Tan Y, Zhang H, Harpsoe K, Li H, Zhang Y, You C, Yu X, Jiang Y, Zhang Y, Gloriam DE, Xu HE | 10.1016/J.MOLCEL.2022.05.031 | 2022-07-27 | Yes | |
5HT7R | 5-HT7 | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7XTC | 7XTC_refined | 3.2 | R | Active | 100 | 57 | Gs | αs | - | 61 | BRIL | Nanobody-35 |
5-CT
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Huang S, Xu P, Shen DD, Simon IA, Mao C, Tan Y, Zhang H, Harpsoe K, Li H, Zhang Y, You C, Yu X, Jiang Y, Zhang Y, Gloriam DE, Xu HE | 10.1016/J.MOLCEL.2022.05.031 | 2022-07-27 | Yes | |
APJ | apelin | Apelin | A | Human | X-ray | 7SUS | 7SUS_refined | 2.7 | A | Inactive | 4 | 76 | - | - | - | - | Rubredoxin | - |
(1R,2S)-N-[4-(2,6-dimethoxyphenyl)-5-(6-methylpyridin-2-yl)-1,2,4-triazol-3-yl]-1-(5-methylpyrimidin-2-yl)-1-oxidanyl-propane-2-sulfonamide
|
small-molecule | Agonist | apelin-36, apelin-13, apelin receptor early endogenous ligand, Elabela/Toddler-32, Elabela/Toddler-11, [Pyr1]apelin-13, apelin-17, Elabela/Toddler-21 | peptide | Yes | No | Yue Y, Liu L, Wu LJ, Wu Y, Wang L, Li F, Liu J, Han GW, Chen B, Lin X, Brouillette RL, Breault E, Longpre JM, Shi S, Lei H, Sarret P, Stevens RC, Hanson MA, Xu F | 10.1038/S41594-022-00797-5 | 2022-07-27 | Yes | |
APJ | apelin | Apelin | A | Human | Cryo-EM | 7W0L | 7W0L_refined | 3.6 | R | Active | 100 | 78 | Gi/o | αi1 | - | 64 | BRIL | scFv16 |
(1R,2S)-N-[4-(2,6-dimethoxyphenyl)-5-(6-methylpyridin-2-yl)-1,2,4-triazol-3-yl]-1-(5-methylpyrimidin-2-yl)-1-oxidanyl-propane-2-sulfonamide
|
small-molecule | Agonist | apelin-36, apelin-13, apelin receptor early endogenous ligand, Elabela/Toddler-32, Elabela/Toddler-11, [Pyr1]apelin-13, apelin-17, Elabela/Toddler-21 | peptide | Yes | No | Yue Y, Liu L, Wu LJ, Wu Y, Wang L, Li F, Liu J, Han GW, Chen B, Lin X, Brouillette RL, Breault E, Longpre JM, Shi S, Lei H, Sarret P, Stevens RC, Hanson MA, Xu F | 10.1038/S41594-022-00797-5 | 2022-07-27 | Yes | |
APJ | apelin | Apelin | A | Human | Cryo-EM | 7W0M | 7W0M_refined | 3.7 | R | Active | 100 | 76 | Gi/o | αi1 | - | 62 | BRIL | scFv16 |
(1R,2S)-N-[4-(2,6-dimethoxyphenyl)-5-(6-methylpyridin-2-yl)-1,2,4-triazol-3-yl]-1-(5-methylpyrimidin-2-yl)-1-oxidanyl-propane-2-sulfonamide
|
small-molecule | Agonist | apelin-36, apelin-13, apelin receptor early endogenous ligand, Elabela/Toddler-32, Elabela/Toddler-11, [Pyr1]apelin-13, apelin-17, Elabela/Toddler-21 | peptide | Yes | No | Yue Y, Liu L, Wu LJ, Wu Y, Wang L, Li F, Liu J, Han GW, Chen B, Lin X, Brouillette RL, Breault E, Longpre JM, Shi S, Lei H, Sarret P, Stevens RC, Hanson MA, Xu F | 10.1038/S41594-022-00797-5 | 2022-07-27 | Yes | |
APJ | apelin | Apelin | A | Human | Cryo-EM | 7W0N | - | 4.2 | R | Active | 100 | 78 | Gi/o | αi1 | - | 64 | BRIL | scFv16 |
apelin receptor early endogenous ligand
|
peptide | Agonist | apelin-36, apelin-13, apelin receptor early endogenous ligand, Elabela/Toddler-32, Elabela/Toddler-11, [Pyr1]apelin-13, apelin-17, Elabela/Toddler-21 | peptide | Yes | No | Yue Y, Liu L, Wu LJ, Wu Y, Wang L, Li F, Liu J, Han GW, Chen B, Lin X, Brouillette RL, Breault E, Longpre JM, Shi S, Lei H, Sarret P, Stevens RC, Hanson MA, Xu F | 10.1038/S41594-022-00797-5 | 2022-07-27 | Yes | |
APJ | apelin | Apelin | A | Human | Cryo-EM | 7W0O | 7W0O_refined | 3.8 | R | Active | 100 | 77 | Gi/o | αi1 | - | 64 | BRIL | scFv16 |
apelin receptor early endogenous ligand
|
peptide | Agonist | apelin-36, apelin-13, apelin receptor early endogenous ligand, Elabela/Toddler-32, Elabela/Toddler-11, [Pyr1]apelin-13, apelin-17, Elabela/Toddler-21 | peptide | Yes | No | Yue Y, Liu L, Wu LJ, Wu Y, Wang L, Li F, Liu J, Han GW, Chen B, Lin X, Brouillette RL, Breault E, Longpre JM, Shi S, Lei H, Sarret P, Stevens RC, Hanson MA, Xu F | 10.1038/S41594-022-00797-5 | 2022-07-27 | Yes | |
APJ | apelin | Apelin | A | Human | Cryo-EM | 7W0P | 7W0P_refined | 3.2 | R | Active | 100 | 77 | Gi/o | αi1 | - | 64 | BRIL | scFv16 |
apelin receptor early endogenous ligand
|
peptide | Agonist | apelin-36, apelin-13, apelin receptor early endogenous ligand, Elabela/Toddler-32, Elabela/Toddler-11, [Pyr1]apelin-13, apelin-17, Elabela/Toddler-21 | peptide | Yes | No | Yue Y, Liu L, Wu LJ, Wu Y, Wang L, Li F, Liu J, Han GW, Chen B, Lin X, Brouillette RL, Breault E, Longpre JM, Shi S, Lei H, Sarret P, Stevens RC, Hanson MA, Xu F | 10.1038/S41594-022-00797-5 | 2022-07-27 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | Cryo-EM | 7XOU | - | 3.2 | R | Active | 100 | 67 | Gs | αs | - | 58 | - | Nanobody-35 |
CCK-8
|
peptide | Agonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | Yes | No | Ding Y, Zhang H, Liao YY, Chen LN, Ji SY, Qin J, Mao C, Shen DD, Lin L, Wang H, Zhang Y, Li XM | 10.1038/S41421-022-00420-3 | 2022-07-20 | Yes | |
CCKAR | CCK1 | Cholecystokinin | A | Human | Cryo-EM | 7XOV | 7XOV_refined | 3.0 | R | Active | 100 | 67 | Gs | αs | - | 58 | - | Nanobody-35 |
SR146131
|
small-molecule | Agonist | CCK-58, CCK-8, CCK-39, desulfated cholecystokinin-8, CCK-4, gastrin-17, CCK-33 | peptide | Yes | No | Ding Y, Zhang H, Liao YY, Chen LN, Ji SY, Qin J, Mao C, Shen DD, Lin L, Wang H, Zhang Y, Li XM | 10.1038/S41421-022-00420-3 | 2022-07-20 | Yes | |
GASR | CCK2 | Cholecystokinin | A | Human | Cryo-EM | 7XOW | 7XOW_refined | 3.1 | R | Active | 100 | 62 | Gq/11 | αq | - | 61 | - | scFv16 |
desulfated gastrin-17
|
peptide | Agonist | desulfated gastrin-17, desulfated gastrin-34, gastrin-14, CCK-58, CCK-8, CCK-39, gastrin-71, gastrin-34, desulfated gastrin-71, desulfated cholecystokinin-8, CCK-4, desulfated gastrin-14, gastrin-17, CCK-33 | peptide | Yes | No | Ding Y, Zhang H, Liao YY, Chen LN, Ji SY, Qin J, Mao C, Shen DD, Lin L, Wang H, Zhang Y, Li XM | 10.1038/S41421-022-00420-3 | 2022-07-20 | Yes | |
GASR | CCK2 | Cholecystokinin | A | Human | Cryo-EM | 7XOX | 7XOX_refined | 3.1 | R | Active | 100 | 62 | Gq/11 | αq | - | 61 | - | scFv16 |
CCK-8
|
peptide | Agonist | desulfated gastrin-17, desulfated gastrin-34, gastrin-14, CCK-58, CCK-8, CCK-39, gastrin-71, gastrin-34, desulfated gastrin-71, desulfated cholecystokinin-8, CCK-4, desulfated gastrin-14, gastrin-17, CCK-33 | peptide | Yes | No | Ding Y, Zhang H, Liao YY, Chen LN, Ji SY, Qin J, Mao C, Shen DD, Lin L, Wang H, Zhang Y, Li XM | 10.1038/S41421-022-00420-3 | 2022-07-20 | Yes | |
GALR2 | GAL2 | Galanin | A | Human | Cryo-EM | 7XBD | - | 3.1 | A | Active | 100 | 72 | Gq/11 | αq | - | 64 | - | scFv16 |
Galanin, Human
|
peptide | Agonist | spexin-1, galanin, galanin-like peptide | peptide | Yes | No | Heo Y, Ishimoto N, Jeon YE, Yun JH, Ohki M, Anraku Y, Sasaki M, Kita S, Fukuhara H, Ikuta T, Kawakami K, Inoue A, Maenaka K, Tame JRH, Lee W, Park SY | 10.1371/JOURNAL.PBIO.3001714 | 2022-07-13 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7WJ5 | - | 3.7 | R | Active | 100 | 76 | Gi/o | αi1 | - | 60 | BRIL | scFv16 |
SOMATOSTATIN
|
protein | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Heo Y, Yoon E, Jeon YE, Yun JH, Ishimoto N, Woo H, Park SY, Song JJ, Lee W | 10.7554/ELIFE.76823 | 2022-07-13 | Yes | |
CX3C1 | CX3CR1 | Chemokine | A | Human | Cryo-EM | 7XBW | 7XBW_refined | 2.8 | R | Active | 16 | 81 | Gi/o | αi1 | - | 61 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | CX3CL1 | peptide | Yes | No | Lu M, Zhao W, Han S, Lin X, Xu T, Tan Q, Wang M, Yi C, Chu X, Yang W, Zhu Y, Wu B, Zhao Q | 10.1126/SCIADV.ABN8048 | 2022-07-13 | Yes | |
CX3C1 | CX3CR1 | Chemokine | A | Human | Cryo-EM | 7XBX | - | 3.4 | R | Active | 16 | 81 | Gi/o | αi1 | - | 61 | - | - |
CX3CL1
|
peptide | Agonist | CX3CL1 | peptide | Yes | No | - | - | 2022-07-13 | Yes | |
ACKR3 | ACKR3 | Chemokine | A | Human | Cryo-EM | 7SK3 | 7SK3_refined | 3.8 | A | Active | 96 | 84 | - | - | - | - | - | CID25 Fab light chain CID25 Fab heavy chain CID24 Fab light chain CID24 Fab heavy chain |
CXCL12α
|
peptide | Agonist | CXCL12α, CXCL11 | peptide | Yes | No | Yen YC, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM | 10.1126/SCIADV.ABN8063 | 2022-07-27 | Yes | |
ACKR3 | ACKR3 | Chemokine | A | Human | Cryo-EM | 7SK4 | 7SK4_refined | 3.3 | A | Active | 96 | 84 | - | - | - | - | - | CID25 Fab light chain CID25 Fab heavy chain CID24 Fab light chain CID24 Fab heavy chain |
Stromal cell-derived factor 1
|
peptide | Agonist | CXCL12α, CXCL11 | peptide | Yes | No | Yen YC, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM | 10.1126/SCIADV.ABN8063 | 2022-07-27 | Yes | |
ACKR3 | ACKR3 | Chemokine | A | Human | Cryo-EM | 7SK5 | 7SK5_refined | 4.0 | A | Active | 96 | 83 | - | - | - | - | - | CID24 Fab heavy chain CID24 Fab light chain anti-Fab Nanobody |
Stromal cell-derived factor 1
|
peptide | Agonist | CXCL12α, CXCL11 | peptide | Yes | No | Yen YC, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM | 10.1126/SCIADV.ABN8063 | 2022-07-27 | Yes | |
ACKR3 | ACKR3 | Chemokine | A | Human | Cryo-EM | 7SK6 | 7SK6_refined | 4.0 | A | Active | 96 | 83 | - | - | - | - | - | CID24 Fab light chain CID24 Fab heavy chain |
Stromal cell-derived factor 1
|
peptide | Agonist | CXCL12α, CXCL11 | peptide | Yes | No | Yen YC, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM | 10.1126/SCIADV.ABN8063 | 2022-07-27 | Yes | |
ACKR3 | ACKR3 | Chemokine | A | Human | Cryo-EM | 7SK7 | - | 3.3 | A | Active | 96 | 74 | - | - | - | - | - | CID25 Fab light chain CID25 Fab heavy chain anti-Fab Nanobody |
Stromal cell-derived factor 1
(1R)-4-[7-(3-carboxypropoxy)-6-methylquinolin-8-yl]-1-{[2-(4-hydroxypiperidin-1-yl)-1,3-thiazol-4-yl]methyl}-1,4-diazepan-1-ium |
peptide small-molecule |
Agonist Partial agonist |
CXCL12α, CXCL11 | peptide | Yes | No | Yen YC, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM | 10.1126/SCIADV.ABN8063 | 2022-07-27 | Yes | |
ACKR3 | ACKR3 | Chemokine | A | Human | Cryo-EM | 7SK8 | 7SK8_refined | 3.3 | A | Active | 96 | 85 | - | - | - | - | - | CID25 Fab light chain CID25 Fab heavy chain CID24 Fab light chain CID24 Fab heavy chain |
Stromal cell-derived factor 1
(1R)-4-[7-(3-carboxypropoxy)-6-methylquinolin-8-yl]-1-{[2-(4-hydroxypiperidin-1-yl)-1,3-thiazol-4-yl]methyl}-1,4-diazepan-1-ium |
peptide small-molecule |
Agonist Partial agonist |
CXCL12α, CXCL11 | peptide | Yes | No | Yen YC, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM | 10.1126/SCIADV.ABN8063 | 2022-07-27 | Yes | |
ACKR3 | ACKR3 | Chemokine | A | Human | Cryo-EM | 7SK9 | 7SK9_refined | 3.7 | A | Active | 96 | 78 | - | - | - | - | - | CID24 Fab heavy chain CID24 Fab light chain |
(1R)-4-[7-(3-carboxypropoxy)-6-methylquinolin-8-yl]-1-{[2-(4-hydroxypiperidin-1-yl)-1,3-thiazol-4-yl]methyl}-1,4-diazepan-1-ium
|
small-molecule | Partial agonist | CXCL12α, CXCL11 | peptide | Yes | No | Yen YC, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM | 10.1126/SCIADV.ABN8063 | 2022-07-27 | Yes | |
GPBAR | GPBA | Bile acid | A | Human | Cryo-EM | 7XTQ | 7XTQ_refined | 3.2 | R | Active | 100 | 83 | Gs | αs | - | 58 | - | Nanobody-35 |
CHEMBL2181246
|
small-molecule | Agonist | lithocholic acid, cholic acid, chenodeoxycholic acid, deoxycholic acid | small-molecule | No | No | Ma L, Yang F, Wu X, Mao C, Guo L, Miao T, Zang SK, Jiang X, Shen DD, Wei T, Zhou H, Wei Q, Li S, Shu Q, Feng S, Jiang C, Chu B, Du L, Sun JP, Yu X, Zhang Y, Zhang P | 10.1073/PNAS.2117054119 | 2022-07-06 | Yes | |
MRGRD | MRGPRD | A orphans | A | Human | Cryo-EM | 7Y12 | - | 3.1 | R | Active | 100 | 82 | Gi/o | αi1 | - | 62 | BRIL | scFv16 |
β-alanine
|
small-molecule | Agonist | β-alanine | small-molecule | No | No | Suzuki S, Iida M, Hiroaki Y, Tanaka K, Kawamoto A, Kato T, Oshima A | 10.1038/S42003-022-03668-3 | 2022-07-20 | Yes | |
MRGRD | MRGPRD | A orphans | A | Human | Cryo-EM | 7Y13 | 7Y13_refined | 3.1 | R | Active | 58 | 82 | - | - | - | - | BRIL | - |
Apo (no ligand)
|
none | Apo (no ligand) | β-alanine | small-molecule | No | No | Suzuki S, Iida M, Hiroaki Y, Tanaka K, Kawamoto A, Kato T, Oshima A | 10.1038/S42003-022-03668-3 | 2022-07-20 | Yes | |
MRGRD | MRGPRD | A orphans | A | Human | Cryo-EM | 7Y14 | 7Y14_refined | 3.2 | R | Active | 58 | 82 | - | - | - | - | BRIL | - |
β-alanine
|
small-molecule | Agonist | β-alanine | small-molecule | No | No | Suzuki S, Iida M, Hiroaki Y, Tanaka K, Kawamoto A, Kato T, Oshima A | 10.1038/S42003-022-03668-3 | 2022-07-20 | Yes | |
MRGRD | MRGPRD | A orphans | A | Human | Cryo-EM | 7Y15 | 7Y15_refined | 2.9 | R | Active | 100 | 82 | Gi/o | αi1 | - | 62 | BRIL | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | β-alanine | small-molecule | No | No | Suzuki S, Iida M, Hiroaki Y, Tanaka K, Kawamoto A, Kato T, Oshima A | 10.1038/S42003-022-03668-3 | 2022-07-20 | Yes | |
5HT2C | 5-HT2C | 5-Hydroxytryptamine | A | Human | Cryo-EM | 8DPF | - | 2.8 | A | Active | 100 | 58 | Gq/11 | αq | Gi2-mini-Gq chimera | 62 | - | scFv16 |
lorcaserin
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Gumpper RH, Fay JF, Roth BL | 10.1016/J.CELREP.2022.111211 | 2022-08-24 | Yes | |
AGRL3 | ADGRL3 | ADGRL | B2 | Mouse | Cryo-EM | 7WY8 | - | 2.8 | R | Active | - | 17 | Gs | αs | Mini-Gs | 59 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Qian Y, Ma Z, Liu C, Li X, Zhu X, Wang N, Xu Z, Xia R, Liang J, Duan Y, Yin H, Xiong Y, Zhang A, Guo C, Chen Z, Huang Z, He Y | 10.1016/J.MOLCEL.2022.10.009 | 2022-10-26 | Yes | |
AGRL3 | ADGRL3 | ADGRL | B2 | Mouse | Cryo-EM | 7X10 | - | 2.9 | R | Active | - | 17 | G12/13 | α12 | - | 55 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Qian Y, Ma Z, Liu C, Li X, Zhu X, Wang N, Xu Z, Xia R, Liang J, Duan Y, Yin H, Xiong Y, Zhang A, Guo C, Chen Z, Huang Z, He Y | 10.1016/J.MOLCEL.2022.10.009 | 2022-11-09 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 7X2V | - | 3.1 | R | Active | - | 30 | Gi/o | αi1 | - | 62 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Zhu X, Qian Y, Li X, Xu Z, Xia R, Wang N, Liang J, Yin H, Zhang A, Guo C, Wang G, He Y | 10.1038/S41467-022-33173-4 | 2022-09-28 | Yes | |
5HT5A | 5-HT5A | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7X5H | 7X5H_refined | 3.1 | R | Active | 100 | 77 | Gi/o | αi1 | - | 63 | BRIL | scFv16 |
5-CT
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Tan Y, Xu P, Huang S, Yang G, Zhou F, He X, Ma H, Xu HE, Jiang Y | 10.1038/S41421-022-00412-3 | 2022-09-14 | Yes | |
T2R46 | TAS2R46 | Taste 2 | T | Human | Cryo-EM | 7XP4 | - | 3.0 | R | Active | - | 97 | Gi/o | αt3 | - | 63 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Xu W, Wu L, Liu S, Liu X, Cao X, Zhou C, Zhang J, Fu Y, Guo Y, Wu Y, Tan Q, Wang L, Liu J, Jiang L, Fan Z, Pei Y, Yu J, Cheng J, Zhao S, Hao X, Liu ZJ, Hua T | 10.1126/SCIENCE.ABO1633 | 2022-10-12 | Yes | |
T2R46 | TAS2R46 | Taste 2 | T | Human | Cryo-EM | 7XP5 | - | 3.1 | R | Active | - | 97 | Gi/o | αt3 | - | 63 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Xu W, Wu L, Liu S, Liu X, Cao X, Zhou C, Zhang J, Fu Y, Guo Y, Wu Y, Tan Q, Wang L, Liu J, Jiang L, Fan Z, Pei Y, Yu J, Cheng J, Zhao S, Hao X, Liu ZJ, Hua T | 10.1126/SCIENCE.ABO1633 | 2022-10-12 | Yes | |
T2R46 | TAS2R46 | Taste 2 | T | Human | Cryo-EM | 7XP6 | - | 3.0 | R | Active | - | 92 | Gi/o | αt3 | - | 63 | - | Nanobody-35 |
strychnine
|
small-molecule | Agonist | - | - | No | No | Xu W, Wu L, Liu S, Liu X, Cao X, Zhou C, Zhang J, Fu Y, Guo Y, Wu Y, Tan Q, Wang L, Liu J, Jiang L, Fan Z, Pei Y, Yu J, Cheng J, Zhao S, Hao X, Liu ZJ, Hua T | 10.1126/SCIENCE.ABO1633 | 2022-10-12 | Yes | |
OX2R | OX2 | Orexin | A | Human | X-ray | 7XRR | 7XRR_refined | 2.9 | A | Inactive | 1 | 70 | - | - | - | - | - | - |
lemborexant
|
small-molecule | Antagonist | orexin-A, orexin-B | peptide | No | No | Asada H, Im D, Hotta Y, Yasuda S, Murata T, Suno R, Iwata S | 10.1016/J.STR.2022.11.001 | 2022-11-23 | Yes | |
TRFR | TRH1 | Thyrotropin-releasing hormone | A | Human | Cryo-EM | 7XW9 | - | 2.7 | R | Active | 100 | 72 | Gq/11 | αq | - | 58 | - | scFv16 |
TRH
|
peptide | Agonist | TRH | peptide | Yes | No | - | - | 2022-12-28 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7Y24 | 7Y24_refined | 3.3 | E | Active | 100 | 77 | Gi/o | αo | - | 60 | - | scFv16 |
Octreotide
|
peptide | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Chen S, Teng X, Zheng S | 10.1038/S41589-022-01130-3 | 2022-10-19 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7Y26 | - | 3.3 | E | Active | 100 | 73 | Gq/11 | αq | Mini-Gq | 62 | - | scFv16 |
Octreotide
|
peptide | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Chen S, Teng X, Zheng S | 10.1038/S41589-022-01130-3 | 2022-10-19 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7Y27 | - | 3.5 | E | Active | 100 | 74 | Gq/11 | αq | Mini-Gq | 64 | - | scFv16 |
SOMATOSTATIN
|
protein | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Chen S, Teng X, Zheng S | 10.1038/S41589-022-01130-3 | 2022-10-19 | Yes | |
GPR17 | GPR17 | A orphans | A | Human | Cryo-EM | 7Y89 | - | 3.0 | A | Active | 100 | 78 | Gi/o | αi1 | - | 58 | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | ATP, LTE4, LTC4, UDP, UDP-glucose, UDP-galactose, LTD4 | small-molecule | Yes | No | Ye F, Wong TS, Chen G, Zhang Z, Zhang B, Gan S, Gao W, Li J, Wu Z, Pan X, Du Y | 10.1002/MCO2.159 | 2022-10-12 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7YU3 | 7YU3_refined | 3.4 | R | Active | 100 | 80 | Gi/o | αi1 | - | 63 | - | scFv16 |
[(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Akasaka H, Tanaka T, Sano FK, Matsuzaki Y, Shihoya W, Nureki O | 10.1038/S41467-022-33121-2 | 2022-10-05 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7YU4 | 7YU4_refined | 3.3 | A | Active | 99 | 73 | - | - | - | - | - | - |
[(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Akasaka H, Tanaka T, Sano FK, Matsuzaki Y, Shihoya W, Nureki O | 10.1038/S41467-022-33121-2 | 2022-10-05 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7YU5 | 7YU5_refined | 3.3 | R | Active | 100 | 80 | Gi/o | αi1 | - | 63 | - | scFv16 |
[(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Akasaka H, Tanaka T, Sano FK, Matsuzaki Y, Shihoya W, Nureki O | 10.1038/S41467-022-33121-2 | 2022-10-05 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7YU6 | 7YU6_refined | 3.5 | R | Active | 100 | 80 | Gi/o | αi1 | - | 63 | - | scFv16 |
[(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Akasaka H, Tanaka T, Sano FK, Matsuzaki Y, Shihoya W, Nureki O | 10.1038/S41467-022-33121-2 | 2022-10-05 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7YU7 | 7YU7_refined | 3.8 | R | Active | 100 | 80 | Gi/o | αi1 | - | 63 | - | scFv16 |
[(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Akasaka H, Tanaka T, Sano FK, Matsuzaki Y, Shihoya W, Nureki O | 10.1038/S41467-022-33121-2 | 2022-10-05 | Yes | |
OPRM | μ | Opioid | A | Human | Cryo-EM | 8EF5 | 8EF5_refined | 3.3 | R | Active | 100 | 72 | Gi/o | αi1 | - | 64 | - | scFv16 |
fentanyl
|
small-molecule | Agonist | dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin, endomorphin-2 | peptide | Yes | No | Zhuang Y, Wang Y, He B, He X, Zhou XE, Guo S, Rao Q, Yang J, Liu J, Zhou Q, Wang X, Liu M, Liu W, Jiang X, Yang D, Jiang H, Shen J, Melcher K, Chen H, Jiang Y, Cheng X, Wang MW, Xie X, Xu HE | 10.1016/J.CELL.2022.09.041 | 2022-11-09 | Yes | |
LPAR1 | LPA1 | Lysophospholipid (LPA) | A | Human | Cryo-EM | 7YU8 | - | 4.5 | R | Active | 100 | 80 | Gi/o | αi1 | - | 63 | - | scFv16 |
[(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate
|
small-molecule | Agonist | 1-O-Oleoyl-D-glycerol 3-phosphoric acid | small-molecule | Yes | No | Akasaka H, Tanaka T, Sano FK, Matsuzaki Y, Shihoya W, Nureki O | 10.1038/S41467-022-33121-2 | 2022-10-05 | Yes | |
MRGX1 | MRGPRX1 | A orphans | A | Human | Cryo-EM | 8DWC | - | 2.9 | R | Active | 100 | 78 | Gs | αs | Gs-mini-Gq chimera | 56 | - | scFv16 |
Proenkephalin-A
|
peptide | Agonist | bovine adrenal medulla peptide 8-22 | peptide | No | No | Liu Y, Cao C, Huang XP, Gumpper RH, Rachman MM, Shih SL, Krumm BE, Zhang S, Shoichet BK, Fay JF, Roth BL | 10.1038/S41589-022-01173-6 | 2022-11-02 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 8E9X | - | 2.7 | A | Active | 100 | 57 | Gi/o | αo | mini-Go | 61 | - | scFv16 |
CHEMBL73538
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | Zhang S, Gumpper RH, Huang XP, Liu Y, Krumm BE, Cao C, Fay JF, Roth BL | 10.1038/S41586-022-05489-0 | 2022-11-30 | Yes | |
MRGX1 | MRGPRX1 | A orphans | A | Human | Cryo-EM | 8DWG | - | 2.7 | R | Active | 100 | 77 | Gs | αs | Gs-mini-Gq chimera | 56 | - | scFv16 |
Proenkephalin-A
CHEMBL5177388 |
peptide small-molecule |
Agonist PAM |
bovine adrenal medulla peptide 8-22 | peptide | No | No | Liu Y, Cao C, Huang XP, Gumpper RH, Rachman MM, Shih SL, Krumm BE, Zhang S, Shoichet BK, Fay JF, Roth BL | 10.1038/S41589-022-01173-6 | 2022-11-02 | Yes | |
MRGX1 | MRGPRX1 | A orphans | A | Human | Cryo-EM | 8DWH | - | 3.3 | R | Active | 100 | 77 | Gs | αs | Gs-mini-Gq chimera | 56 | - | - |
compound 16 [PMID: 31498617]
|
small-molecule | Agonist | bovine adrenal medulla peptide 8-22 | peptide | No | No | Liu Y, Cao C, Huang XP, Gumpper RH, Rachman MM, Shih SL, Krumm BE, Zhang S, Shoichet BK, Fay JF, Roth BL | 10.1038/S41589-022-01173-6 | 2022-11-02 | Yes | |
PACR | PAC1 | VIP and PACAP | B1 | Human | Cryo-EM | 8E3X | 8E3X_refined | 2.3 | R | Active | 100 | 77 | Gs | αs | - | 59 | - | Nanobody-35 |
[Ac-His1]PACAP-27
|
peptide | Agonist | PHV, PACAP-38, PACAP-27, PHM, VIP, PHI | peptide | No | No | Piper SJ, Deganutti G, Lu J, Zhao P, Liang YL, Lu Y, Fletcher MM, Hossain MA, Christopoulos A, Reynolds CA, Danev R, Sexton PM, Wootten D | 10.1038/S41467-022-34629-3 | 2022-11-23 | Yes | |
VIPR1 | VPAC1 | VIP and PACAP | B1 | Human | Cryo-EM | 8E3Y | - | 2.3 | R | Active | 100 | 81 | Gs | αs | - | 56 | - | Nanobody-35 |
[Ac-His1]PACAP-27
|
peptide | Agonist | PACAP-38, secretin, PACAP-27, PHM, VIP, GHRH, PHI | peptide | No | No | Piper SJ, Deganutti G, Lu J, Zhao P, Liang YL, Lu Y, Fletcher MM, Hossain MA, Christopoulos A, Reynolds CA, Danev R, Sexton PM, Wootten D | 10.1038/S41467-022-34629-3 | 2022-11-23 | Yes | |
VIPR1 | VPAC1 | VIP and PACAP | B1 | Human | Cryo-EM | 8E3Z | 8E3Z_refined | 2.7 | R | Active | 100 | 81 | Gs | αs | - | 55 | - | Nanobody-35 |
Vasoactive intestinal polypeptide
|
small-molecule | Agonist | PACAP-38, secretin, PACAP-27, PHM, VIP, GHRH, PHI | peptide | No | No | Piper SJ, Deganutti G, Lu J, Zhao P, Liang YL, Lu Y, Fletcher MM, Hossain MA, Christopoulos A, Reynolds CA, Danev R, Sexton PM, Wootten D | 10.1038/S41467-022-34629-3 | 2022-11-23 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 8E9W | - | 2.7 | A | Active | 100 | 47 | Gq/11 | αq | mini-Gq | 59 | - | scFv16 |
CHEMBL73538
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | Zhang S, Gumpper RH, Huang XP, Liu Y, Krumm BE, Cao C, Fay JF, Roth BL | 10.1038/S41586-022-05489-0 | 2022-11-30 | Yes | |
AGTR1 | AT1 | Angiotensin | A | Human | Cryo-EM | 7F6G | 7F6G_refined | 2.9 | A | Active | 100 | 86 | Gq/11 | αq | - | 97 | - | - |
SAR1-AngII
|
peptide | Agonist | angiotensin II, angiotensin III, angiotensin IV, angiotensin A | peptide | Yes | No | - | - | 2023-03-29 | Yes | |
OPRX | NOP | Opioid | A | Human | Cryo-EM | 8F7X | 8F7X_refined | 3.3 | R | Active | 100 | 77 | Gi/o | αi1 | - | 62 | - | scFv16 |
nociceptin/orphanin FQ
|
peptide | Agonist | nociceptin/orphanin FQ | peptide | Yes | No | Wang Y, Zhuang Y, DiBerto JF, Zhou XE, Schmitz GP, Yuan Q, Jain MK, Liu W, Melcher K, Jiang Y, Roth BL, Xu HE | 10.1016/J.CELL.2022.12.026 | 2022-12-14 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 8HA0 | - | 2.6 | R | Active | 100 | 61 | Gs | αs | - | 60 | - | Nanobody-35 |
teriparatide
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Zhao LH, Yuan QN, Dai AT, He XH, Chen CW, Zhang C, Xu YW, Zhou Y, Wang MW, Yang DH, Xu HE | 10.1038/S41401-022-01032-Z | 2022-12-21 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 8HAF | - | 3.3 | R | Active | 100 | 62 | Gs | αs | - | 60 | - | Nanobody-35 |
PTHrP-(1-36)
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Zhao LH, Yuan QN, Dai AT, He XH, Chen CW, Zhang C, Xu YW, Zhou Y, Wang MW, Yang DH, Xu HE | 10.1038/S41401-022-01032-Z | 2022-12-21 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 8HAO | - | 3.8 | R | Active | 100 | 61 | Gs | αs | - | 60 | - | Nanobody-35 |
teriparatide
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Zhao LH, Yuan QN, Dai AT, He XH, Chen CW, Zhang C, Xu YW, Zhou Y, Wang MW, Yang DH, Xu HE | 10.1038/S41401-022-01032-Z | 2022-12-21 | Yes | |
C5AR1 | C5a1 | Complement peptide | A | Human | Cryo-EM | 7Y65 | - | 3.2 | D | Active | 100 | 81 | Gi/o | αi1 | - | 64 | - | scFv16 |
C5a
|
peptide | Agonist | C5a des-Arg, C5a, ribosomal protein S19, C3a | peptide | Yes | No | Feng Y, Zhao C, Deng Y, Wang H, Ma L, Liu S, Tian X, Wang B, Bin Y, Chen P, Yan W, Fu P, Shao Z | 10.1038/S41422-023-00779-2 | 2023-03-01 | Yes | |
RL3R2 | RXFP4 | Relaxin family peptide | A | Human | Cryo-EM | 7YJ4 | - | 3.2 | R | Active | 100 | 76 | Gi/o | αi2 | - | 58 | - | scFv16 |
Insulin-like peptide INSL5 B chain
Insulin-like peptide INSL5 A chain |
peptide peptide |
Agonist | relaxin-3, relaxin-3 (B chain), INSL5 | peptide | Yes | No | Chen Y, Zhou Q, Wang J, Xu Y, Wang Y, Yan J, Wang Y, Zhu Q, Zhao F, Li C, Chen CW, Cai X, Bathgate RAD, Shen C, Eric Xu H, Yang D, Liu H, Wang MW | 10.1038/S41467-023-36182-Z | 2023-03-01 | Yes | |
RL3R2 | RXFP4 | Relaxin family peptide | A | Human | Cryo-EM | 7YK6 | 7YK6_refined | 3.0 | R | Active | 100 | 76 | Gi/o | αi2 | - | 59 | - | scFv16 |
CHEMBL4522365
|
small-molecule | Agonist | relaxin-3, relaxin-3 (B chain), INSL5 | peptide | Yes | No | Chen Y, Zhou Q, Wang J, Xu Y, Wang Y, Yan J, Wang Y, Zhu Q, Zhao F, Li C, Chen CW, Cai X, Bathgate RAD, Shen C, Eric Xu H, Yang D, Liu H, Wang MW | 10.1038/S41467-023-36182-Z | 2023-03-01 | Yes | |
RL3R2 | RXFP4 | Relaxin family peptide | A | Human | Cryo-EM | 7YK7 | 7YK7_refined | 2.8 | R | Active | 100 | 75 | Gi/o | αi2 | - | 61 | - | scFv16 |
DC591053
|
small-molecule | Agonist | relaxin-3, relaxin-3 (B chain), INSL5 | peptide | Yes | No | Chen Y, Zhou Q, Wang J, Xu Y, Wang Y, Yan J, Wang Y, Zhu Q, Zhao F, Li C, Chen CW, Cai X, Bathgate RAD, Shen C, Eric Xu H, Yang D, Liu H, Wang MW | 10.1038/S41467-023-36182-Z | 2023-03-01 | Yes | |
NPY2R | Y2 | Neuropeptide Y | A | Human | Cryo-EM | 7YON | 7YON_refined | 3.0 | R | Active | 100 | 79 | Gi/o | αi1 | - | 62 | - | scFv16 |
Peptide YY
|
peptide | Agonist | neuropeptide Y-(3-36), peptide YY, pancreatic polypeptide, PYY-(3-36), neuropeptide Y | peptide | Yes | No | Kang H, Park C, Choi YK, Bae J, Kwon S, Kim J, Choi C, Seok C, Im W, Choi HJ | 10.1016/J.STR.2022.11.010 | 2023-03-22 | Yes | |
NPY2R | Y2 | Neuropeptide Y | A | Human | Cryo-EM | 7YOO | 7YOO_refined | 3.1 | R | Active | 99 | 79 | - | - | - | - | - | - |
neuropeptide Y
|
peptide | Agonist | neuropeptide Y-(3-36), peptide YY, pancreatic polypeptide, PYY-(3-36), neuropeptide Y | peptide | Yes | No | Kang H, Park C, Choi YK, Bae J, Kwon S, Kim J, Choi C, Seok C, Im W, Choi HJ | 10.1016/J.STR.2022.11.010 | 2023-03-22 | Yes | |
5HT6R | 5-HT6 | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7YS6 | 7YS6_refined | 3.0 | A | Active | 100 | 61 | Gs | αs | - | 59 | - | scFv16 |
5-hydroxytryptamine
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | - | - | 2023-03-29 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 7ZBC | - | 1.8 | A | Inactive | 21 | 87 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Gruhl T, Weinert T, Rodrigues MJ, Milne CJ, Ortolani G, Nass K, Nango E, Sen S, Johnson PJM, Cirelli C, Furrer A, Mous S, Skopintsev P, James D, Dworkowski F, Bath P, Kekilli D, Ozerov D, Tanaka R, Glover H, Bacellar C, Brunle S, Casadei CM, Diethelm AD, Gashi D, Gotthard G, Guixa-Gonzalez R, Joti Y, Kabanova V, Knopp G, Lesca E, Ma P, Martiel I, Muhle J, Owada S, Pamula F, Sarabi D, Tejero O, Tsai CJ, Varma N, Wach A, Boutet S, Tono K, Nogly P, Deupi X, Iwata S, Neutze R, Standfuss J, Schertler G, Panneels V | 10.1038/S41586-023-05863-6 | 2023-03-29 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 7ZBE | 7ZBE_refined | 1.8 | A | Inactive | 21 | 87 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Inverse agonist | - | - | No | No | Gruhl T, Weinert T, Rodrigues MJ, Milne CJ, Ortolani G, Nass K, Nango E, Sen S, Johnson PJM, Cirelli C, Furrer A, Mous S, Skopintsev P, James D, Dworkowski F, Bath P, Kekilli D, Ozerov D, Tanaka R, Glover H, Bacellar C, Brunle S, Casadei CM, Diethelm AD, Gashi D, Gotthard G, Guixa-Gonzalez R, Joti Y, Kabanova V, Knopp G, Lesca E, Ma P, Martiel I, Muhle J, Owada S, Pamula F, Sarabi D, Tejero O, Tsai CJ, Varma N, Wach A, Boutet S, Tono K, Nogly P, Deupi X, Iwata S, Neutze R, Standfuss J, Schertler G, Panneels V | 10.1038/S41586-023-05863-6 | 2023-03-29 | Yes | |
C5AR1 | C5a1 | Complement peptide | A | Human | Cryo-EM | 7Y66 | - | 2.9 | D | Active | 100 | 80 | Gi/o | αi1 | - | 63 | - | scFv16 |
BM213
|
peptide | Agonist | C5a des-Arg, C5a, ribosomal protein S19, C3a | peptide | Yes | No | Feng Y, Zhao C, Deng Y, Wang H, Ma L, Liu S, Tian X, Wang B, Bin Y, Chen P, Yan W, Fu P, Shao Z | 10.1038/S41422-023-00779-2 | 2023-03-01 | Yes | |
C5AR1 | C5a1 | Complement peptide | A | Human | Cryo-EM | 7Y67 | 7Y67_refined | 2.8 | D | Active | 100 | 79 | Gi/o | αi1 | - | 63 | - | scFv16 |
C089
|
peptide | Agonist | C5a des-Arg, C5a, ribosomal protein S19, C3a | peptide | Yes | No | Feng Y, Zhao C, Deng Y, Wang H, Ma L, Liu S, Tian X, Wang B, Bin Y, Chen P, Yan W, Fu P, Shao Z | 10.1038/S41422-023-00779-2 | 2023-03-01 | Yes | |
O51E2 | Olfactory 51E2 | Olfactory | A | Human | Cryo-EM | 8F76 | 8F76_refined | 3.1 | A | Active | 100 | 94 | Gs | αs | mini-Gs | 55 | - | Nanobody-35 |
propanoic acid
|
small-molecule | Agonist | - | - | No | No | Billesbolle CB, de March CA, van der Velden WJC, Ma N, Tewari J, Del Torrent CL, Li L, Faust B, Vaidehi N, Matsunami H, Manglik A | 10.1038/S41586-023-05798-Y | 2023-03-22 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 8A6C | 8A6C_refined | 1.8 | A | Inactive | 21 | 87 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Agonist | - | - | No | No | Gruhl T, Weinert T, Rodrigues MJ, Milne CJ, Ortolani G, Nass K, Nango E, Sen S, Johnson PJM, Cirelli C, Furrer A, Mous S, Skopintsev P, James D, Dworkowski F, Bath P, Kekilli D, Ozerov D, Tanaka R, Glover H, Bacellar C, Brunle S, Casadei CM, Diethelm AD, Gashi D, Gotthard G, Guixa-Gonzalez R, Joti Y, Kabanova V, Knopp G, Lesca E, Ma P, Martiel I, Muhle J, Owada S, Pamula F, Sarabi D, Tejero O, Tsai CJ, Varma N, Wach A, Boutet S, Tono K, Nogly P, Deupi X, Iwata S, Neutze R, Standfuss J, Schertler G, Panneels V | 10.1038/S41586-023-05863-6 | 2023-03-29 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 8A6D | 8A6D_refined | 1.8 | A | Inactive | 21 | 87 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Agonist | - | - | No | No | Gruhl T, Weinert T, Rodrigues MJ, Milne CJ, Ortolani G, Nass K, Nango E, Sen S, Johnson PJM, Cirelli C, Furrer A, Mous S, Skopintsev P, James D, Dworkowski F, Bath P, Kekilli D, Ozerov D, Tanaka R, Glover H, Bacellar C, Brunle S, Casadei CM, Diethelm AD, Gashi D, Gotthard G, Guixa-Gonzalez R, Joti Y, Kabanova V, Knopp G, Lesca E, Ma P, Martiel I, Muhle J, Owada S, Pamula F, Sarabi D, Tejero O, Tsai CJ, Varma N, Wach A, Boutet S, Tono K, Nogly P, Deupi X, Iwata S, Neutze R, Standfuss J, Schertler G, Panneels V | 10.1038/S41586-023-05863-6 | 2023-03-29 | Yes | |
OPSD | Rhodopsin | Opsins | A | Bovine | X-ray | 8A6E | 8A6E_refined | 1.8 | A | Inactive | 21 | 87 | - | - | - | - | - | - |
Retinal (11-cis)
|
small-molecule | Agonist | - | - | No | No | Gruhl T, Weinert T, Rodrigues MJ, Milne CJ, Ortolani G, Nass K, Nango E, Sen S, Johnson PJM, Cirelli C, Furrer A, Mous S, Skopintsev P, James D, Dworkowski F, Bath P, Kekilli D, Ozerov D, Tanaka R, Glover H, Bacellar C, Brunle S, Casadei CM, Diethelm AD, Gashi D, Gotthard G, Guixa-Gonzalez R, Joti Y, Kabanova V, Knopp G, Lesca E, Ma P, Martiel I, Muhle J, Owada S, Pamula F, Sarabi D, Tejero O, Tsai CJ, Varma N, Wach A, Boutet S, Tono K, Nogly P, Deupi X, Iwata S, Neutze R, Standfuss J, Schertler G, Panneels V | 10.1038/S41586-023-05863-6 | 2023-03-29 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | Cryo-EM | 8FMZ | - | 2.6 | A | Active | 100 | 66 | Gq/11 | αq | mini-Gq | 62 | - | scFv16 |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Krumm BE, DiBerto JF, Olsen RHJ, Kang HJ, Slocum ST, Zhang S, Strachan RT, Huang XP, Slosky LM, Pinkerton AB, Barak LS, Caron MG, Kenakin T, Fay JF, Roth BL | 10.1021/ACS.BIOCHEM.3C00029 | 2023-03-29 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | Cryo-EM | 8FN0 | - | 2.9 | A | Active | 100 | 67 | Gi/o | αo | mini-Go | 60 | - | scFv16 |
neurotensin
CHEMBL4576388 |
peptide small-molecule |
Agonist PAM |
neuromedin N, neurotensin | peptide | Yes | No | Krumm BE, DiBerto JF, Olsen RHJ, Kang HJ, Slocum ST, Zhang S, Strachan RT, Huang XP, Slosky LM, Pinkerton AB, Barak LS, Caron MG, Kenakin T, Fay JF, Roth BL | 10.1021/ACS.BIOCHEM.3C00029 | 2023-03-29 | Yes | |
NTR1 | NTS1 | Neurotensin | A | Rat | Cryo-EM | 8FN1 | - | 2.9 | A | Active | 100 | 66 | Gi/o | αo | - | 60 | - | scFv16 |
neurotensin
|
peptide | Agonist | neuromedin N, neurotensin | peptide | Yes | No | Krumm BE, DiBerto JF, Olsen RHJ, Kang HJ, Slocum ST, Zhang S, Strachan RT, Huang XP, Slosky LM, Pinkerton AB, Barak LS, Caron MG, Kenakin T, Fay JF, Roth BL | 10.1021/ACS.BIOCHEM.3C00029 | 2023-03-29 | Yes | |
AA2AR | A2A | Adenosine | A | Human | MicroED | 8FYN | 8FYN_refined | 2.0 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
ZM-241385
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Martynowycz MW, Shiriaeva A, Clabbers MTB, Nicolas WJ, Weaver SJ, Hattne J, Gonen T | 10.1038/S41467-023-36733-4 | 2023-03-08 | Yes | |
FFAR4 | FFA4 | Free fatty acid | A | Human | Cryo-EM | 8G59 | 8G59_refined | 2.6 | R | Active | 100 | 78 | Gq/11 | αq | - | 61 | - | - |
TUG-891
|
small-molecule | Agonist | linoleic acid, α-linolenic acid, oleic acid, myristic acid | small-molecule | Yes | No | Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, Guo SC, Du YQ, Chen LN, Shen DD, Yang ZS, Zhang HQ, Huang SM, He YH, Cheng J, Zhong YN, Shang P, Chen J, Zhang DL, Wang QL, Liu MX, Li GY, Guo Y, Xu HE, Wang C, Zhang C, Feng S, Yu X, Zhang Y, Sun JP | 10.1126/SCIENCE.ADD6220 | 2023-03-08 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 8GNE | - | 2.3 | A | Inactive | 1 | 72 | - | - | - | - | BRIL | - |
Sipagladenant
|
small-molecule | Inverse agonist | adenosine | small-molecule | Yes | Yes | Ohno Y, Suzuki M, Asada H, Kanda T, Saki M, Miyagi H, Yasunaga M, Suno C, Iwata S, Saito JI, Uchida S | 10.1124/MOLPHARM.122.000633 | 2023-03-22 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 8GNG | 8GNG_refined | 3.2 | X | Inactive | 1 | 69 | - | - | - | - | - | Antibody fab fragment light chain Antibody fab fragment heavy chain |
istradefylline
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | No | Ohno Y, Suzuki M, Asada H, Kanda T, Saki M, Miyagi H, Yasunaga M, Suno C, Iwata S, Saito JI, Uchida S | 10.1124/MOLPHARM.122.000633 | 2023-03-22 | Yes | |
ACTHR | MC2 | Melanocortin | A | Human | Cryo-EM | 8GY7 | - | 3.3 | R | Active | 100 | 92 | Gs | αs | - | 59 | BRIL | - |
ACTH
|
peptide | Agonist | ACTH | peptide | Yes | No | Luo P, Feng W, Ma S, Dai A, Wu K, Chen X, Yuan Q, Cai X, Yang D, Wang MW, Eric Xu H, Jiang Y | 10.1038/S41422-022-00751-6 | 2023-01-11 | Yes | |
GPR35 | GPR35 | A orphans | A | Human | Cryo-EM | 8H8J | 8H8J_refined | 3.2 | C | Active | 100 | 92 | G12/13 | α13 | - | 60 | - | scFv16 |
lodoxamide
|
small-molecule | Agonist | 2-oleoyl-LPA, kynurenic acid, 1-Lyso-2-oleoyl-phosphatidic acid, 2-Oleoyllysophosphatydic acid | small-molecule | Yes | No | Duan J, Liu Q, Yuan Q, Ji Y, Zhu S, Tan Y, He X, Xu Y, Shi J, Cheng X, Jiang H, Eric Xu H, Jiang Y | 10.1038/S41421-022-00499-8 | 2023-02-08 | Yes | |
EDNRB | ETB | Endothelin | A | Human | Cryo-EM | 8HBD | 8HBD_refined | 3.0 | R | Active | 100 | 68 | Gi/o | αi1 | - | 61 | - | scFv16 |
sovateltide
|
peptide | Agonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | - | - | 2023-03-22 | Yes | |
EDNRA | ETA | Endothelin | A | Human | Cryo-EM | 8HCQ | 8HCQ_refined | 3.0 | R | Active | 100 | 71 | Gq/11 | αq | - | 57 | - | scFv16 |
ENDOTHELIN
|
protein | Agonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | - | - | 2023-03-22 | Yes | |
EDNRB | ETB | Endothelin | A | Human | Cryo-EM | 8HCX | 8HCX_refined | 3.5 | C | Active | 100 | 66 | Gq/11 | αq | - | 61 | - | scFv16 |
ENDOTHELIN
|
protein | Agonist | endothelin-3, endothelin-1, endothelin-2 | peptide | Yes | No | - | - | 2023-03-22 | Yes | |
AA2BR | A2B | Adenosine | A | Human | Cryo-EM | 8HDO | - | 2.9 | R | Active | 100 | 83 | Gs | αs | mini-Gs | 59 | - | Nanobody-35 |
BAY 60-6583
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Cai H, Xu Y, Guo S, He X, Sun J, Li X, Li C, Yin W, Cheng X, Jiang H, Xu HE, Xie X, Jiang Y | 10.1038/S41421-022-00503-1 | 2023-01-18 | Yes | |
AA2BR | A2B | Adenosine | A | Human | Cryo-EM | 8HDP | - | 3.2 | R | Active | 100 | 84 | Gs | αs | mini-Gs | 60 | - | Nanobody-35 |
adenosine
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Cai H, Xu Y, Guo S, He X, Sun J, Li X, Li C, Yin W, Cheng X, Jiang H, Xu HE, Xie X, Jiang Y | 10.1038/S41421-022-00503-1 | 2023-01-18 | Yes | |
GPR21 | GPR21 | A orphans | A | Human | Cryo-EM | 8HIX | - | 3.1 | R | Active | 100 | 81 | Gs | αs | mini-Gs | 61 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Chen B, Wu Y, Han Y, Qi A, Wang J, Yang Z, Wei X, Zhao T, Wu L, Xie X, Sun J, Zheng J, Zhao S, Xu F | 10.1038/S41467-023-35882-W | 2023-03-15 | Yes | |
GPR21 | GPR21 | A orphans | A | Human | Cryo-EM | 8HJ0 | - | 3.1 | R | Active | 100 | 81 | Gs | αs | mini-Gs | 61 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Chen B, Wu Y, Han Y, Qi A, Wang J, Yang Z, Wei X, Zhao T, Wu L, Xie X, Sun J, Zheng J, Zhao S, Xu F | 10.1038/S41467-023-35882-W | 2023-03-15 | Yes | |
GPR21 | GPR21 | A orphans | A | Human | Cryo-EM | 8HJ2 | 8HJ2_refined | 3.8 | R | Active | 100 | 81 | Gs | αs | mini-Gs | 61 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Chen B, Wu Y, Han Y, Qi A, Wang J, Yang Z, Wei X, Zhao T, Wu L, Xie X, Sun J, Zheng J, Zhao S, Xu F | 10.1038/S41467-023-35882-W | 2023-03-15 | Yes | |
GPR21 | GPR21 | A orphans | A | Human | Cryo-EM | 8HMV | 8HMV_refined | 2.9 | A | Active | 100 | 79 | Gs | αs | - | 58 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Wong TS, Gao W, Chen G, Qiu C, He G, Ye F, Wu Z, Zeng Z, Du Y | 10.1002/MCO2.205 | 2023-03-01 | Yes | |
FSHR | FSH | Glycoprotein hormone | A | Human | Cryo-EM | 8I2H | 8I2H_refined | 6.0 | A | Inactive | 14 | 82 | - | - | - | - | - | - |
Apo (no ligand)
|
none | Apo (no ligand) | FSH | peptide | Yes | No | Duan J, Xu P, Zhang H, Luan X, Yang J, He X, Mao C, Shen DD, Ji Y, Cheng X, Jiang H, Jiang Y, Zhang S, Zhang Y, Xu HE | 10.1038/S41467-023-36170-3 | 2023-03-22 | Yes | |
GPR20 | GPR20 | A orphans | A | Human | Cryo-EM | 8HS2 | 8HS2_refined | 3.1 | R | Active | 67 | 80 | - | - | - | - | BRIL | Antibody fab fragment heavy chain Antibody fab fragment light chain |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Jiang S, Wu Y, Wei X, Han GW, Wu L, Liu J, Chen B, Zhang Z, Zhao S, Cherezov V, Xu F | 10.1038/S41421-023-00520-8 | 2023-03-08 | Yes | |
GPR20 | GPR20 | A orphans | A | Human | Cryo-EM | 8HS3 | - | 3.1 | R | Active | 100 | 78 | Gi/o | αi1 | - | 62 | BRIL | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Jiang S, Wu Y, Wei X, Han GW, Wu L, Liu J, Chen B, Zhang Z, Zhao S, Cherezov V, Xu F | 10.1038/S41421-023-00520-8 | 2023-03-08 | Yes | |
GPR20 | GPR20 | A orphans | A | Human | Cryo-EM | 8HSC | - | 3.2 | R | Active | 100 | 76 | Gi/o | αi1 | - | 62 | BRIL | Antibody fab fragment light chain Antibody fab fragment heavy chain scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Lin X, Jiang S, Wu Y, Wei X, Han GW, Wu L, Liu J, Chen B, Zhang Z, Zhao S, Cherezov V, Xu F | 10.1038/S41421-023-00520-8 | 2023-03-08 | Yes | |
FSHR | FSH | Glycoprotein hormone | A | Human | Cryo-EM | 8I2G | - | 2.8 | R | Active | 100 | 86 | Gs | αs | fused Gs | 58 | - | Nanobody-35 |
Follitropin subunit beta
Glycoprotein alpha FSHR agonist 1 |
peptide peptide small-molecule |
Agonist | FSH | peptide | Yes | No | Duan J, Xu P, Zhang H, Luan X, Yang J, He X, Mao C, Shen DD, Ji Y, Cheng X, Jiang H, Jiang Y, Zhang S, Zhang Y, Xu HE | 10.1038/S41467-023-36170-3 | 2023-03-29 | Yes | |
FFAR4 | FFA4 | Free fatty acid | A | Human | Cryo-EM | 8ID3 | 8ID3_refined | 3.1 | R | Active | 100 | 81 | Gi/o | αi1 | - | 64 | - | scFv16 |
9-Hydroxyoctadecanoic acid
|
small-molecule | Agonist | linoleic acid, α-linolenic acid, oleic acid, myristic acid | small-molecule | Yes | No | Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, Guo SC, Du YQ, Chen LN, Shen DD, Yang ZS, Zhang HQ, Huang SM, He YH, Cheng J, Zhong YN, Shang P, Chen J, Zhang DL, Wang QL, Liu MX, Li GY, Guo Y, Xu HE, Wang C, Zhang C, Feng S, Yu X, Zhang Y, Sun JP | 10.1126/SCIENCE.ADD6220 | 2023-03-15 | Yes | |
FFAR4 | FFA4 | Free fatty acid | A | Human | Cryo-EM | 8ID4 | 8ID4_refined | 3.1 | R | Active | 100 | 79 | Gi/o | αi1 | - | 64 | - | scFv16 |
linoleic acid
|
small-molecule | Agonist | linoleic acid, α-linolenic acid, oleic acid, myristic acid | small-molecule | Yes | No | Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, Guo SC, Du YQ, Chen LN, Shen DD, Yang ZS, Zhang HQ, Huang SM, He YH, Cheng J, Zhong YN, Shang P, Chen J, Zhang DL, Wang QL, Liu MX, Li GY, Guo Y, Xu HE, Wang C, Zhang C, Feng S, Yu X, Zhang Y, Sun JP | 10.1126/SCIENCE.ADD6220 | 2023-03-15 | Yes | |
FFAR4 | FFA4 | Free fatty acid | A | Human | Cryo-EM | 8ID6 | 8ID6_refined | 2.8 | R | Active | 100 | 80 | Gi/o | αi1 | - | 64 | - | scFv16 |
oleic acid
|
small-molecule | Agonist | linoleic acid, α-linolenic acid, oleic acid, myristic acid | small-molecule | Yes | No | Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, Guo SC, Du YQ, Chen LN, Shen DD, Yang ZS, Zhang HQ, Huang SM, He YH, Cheng J, Zhong YN, Shang P, Chen J, Zhang DL, Wang QL, Liu MX, Li GY, Guo Y, Xu HE, Wang C, Zhang C, Feng S, Yu X, Zhang Y, Sun JP | 10.1126/SCIENCE.ADD6220 | 2023-03-15 | Yes | |
FFAR4 | FFA4 | Free fatty acid | A | Human | Cryo-EM | 8ID8 | - | 3.0 | R | Active | 100 | 81 | Gi/o | αi1 | - | 64 | - | scFv16 |
TUG-891
|
small-molecule | Agonist | linoleic acid, α-linolenic acid, oleic acid, myristic acid | small-molecule | Yes | No | Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, Guo SC, Du YQ, Chen LN, Shen DD, Yang ZS, Zhang HQ, Huang SM, He YH, Cheng J, Zhong YN, Shang P, Chen J, Zhang DL, Wang QL, Liu MX, Li GY, Guo Y, Xu HE, Wang C, Zhang C, Feng S, Yu X, Zhang Y, Sun JP | 10.1126/SCIENCE.ADD6220 | 2023-03-15 | Yes | |
FFAR4 | FFA4 | Free fatty acid | A | Human | Cryo-EM | 8ID9 | 8ID9_refined | 3.0 | R | Active | 100 | 78 | Gi/o | αi1 | - | 56 | - | scFv16 |
EPA
|
small-molecule | Agonist | linoleic acid, α-linolenic acid, oleic acid, myristic acid | small-molecule | Yes | No | Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, Guo SC, Du YQ, Chen LN, Shen DD, Yang ZS, Zhang HQ, Huang SM, He YH, Cheng J, Zhong YN, Shang P, Chen J, Zhang DL, Wang QL, Liu MX, Li GY, Guo Y, Xu HE, Wang C, Zhang C, Feng S, Yu X, Zhang Y, Sun JP | 10.1126/SCIENCE.ADD6220 | 2023-03-15 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7T8X | 7T8X_refined | 3.2 | A | Active | 100 | 59 | Gi/o | αo | - | 62 | - | Antibody fragment |
acetylcholine
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | - | - | 2023-01-25 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7T90 | 7T90_refined | 3.3 | A | Active | 100 | 59 | Gi/o | αo | - | 62 | - | scFv16 |
acetylcholine
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | - | - | 2023-01-25 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7T94 | - | 3.2 | A | Active | 100 | 57 | Gi/o | αo | - | 62 | - | Antibody fragment |
acetylcholine
LY2119620 |
small-molecule small-molecule |
Agonist PAM |
acetylcholine | small-molecule | Yes | No | - | - | 2023-01-25 | Yes | |
ACM2 | M2 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7T96 | - | 3.2 | A | Active | 100 | 59 | Gi/o | αo | - | 62 | - | scFv16 |
acetylcholine
LY2119620 |
small-molecule small-molecule |
Agonist PAM |
acetylcholine | small-molecule | Yes | No | - | - | 2023-01-25 | Yes | |
RXFP1 | RXFP1 | Relaxin family peptide | A | Human | Cryo-EM | 7TMW | - | 3.2 | R | Active | 100 | 36 | Gs | αs | Gs fused to receptor | 57 | - | Nanobody-35 |
H2 relaxin
|
small-molecule | Agonist | relaxin-1, relaxin-3, relaxin | peptide | Yes | No | - | - | 2023-02-15 | Yes | |
GRPR | BB2 | Bombesin | A | Human | Cryo-EM | 7W3Z | - | 3.0 | A | Active | 100 | 78 | Gq/11 | αq | - | 98 | - | scFv16 |
Gastrin-releasing peptide
|
peptide | Agonist | neuromedin C, neuromedin B, gastrin releasing peptide(14-27) (human), GRP-(18-27), gastrin-releasing peptide | peptide | Yes | No | Peng S, Zhan Y, Zhang D, Ren L, Chen A, Chen ZF, Zhang H | 10.1073/PNAS.2216230120 | 2023-02-22 | Yes | |
GRPR | BB2 | Bombesin | A | Human | Cryo-EM | 7W40 | - | 3.0 | A | Active | 100 | 78 | Gq/11 | αq | - | 79 | - | scFv16 |
Bombesin
|
peptide | Agonist | neuromedin C, neuromedin B, gastrin releasing peptide(14-27) (human), GRP-(18-27), gastrin-releasing peptide | peptide | Yes | No | Peng S, Zhan Y, Zhang D, Ren L, Chen A, Chen ZF, Zhang H | 10.1073/PNAS.2216230120 | 2023-02-22 | Yes | |
GRPR | BB2 | Bombesin | A | Human | X-ray | 7W41 | 7W41_refined | 3.0 | A | Inactive | 4 | 75 | - | - | - | - | GlgA glycogen synthase | - |
PD 176252
|
small-molecule | Antagonist | neuromedin C, neuromedin B, gastrin releasing peptide(14-27) (human), GRP-(18-27), gastrin-releasing peptide | peptide | No | No | Peng S, Zhan Y, Zhang D, Ren L, Chen A, Chen ZF, Zhang H | 10.1073/PNAS.2216230120 | 2023-02-22 | Yes | |
HCAR2 | HCA2 | Hydroxycarboxylic acid | A | Human | Cryo-EM | 7XK2 | 7XK2_refined | 3.1 | R | Active | 100 | 78 | Gi/o | αi1 | - | 63 | - | scFv16 |
MK 6892
|
small-molecule | Agonist | β-D-hydroxybutyric acid, butyric acid | small-molecule | Yes | No | Yang Y, Kang HJ, Gao R, Wang J, Han GW, DiBerto JF, Wu L, Tong J, Qu L, Wu Y, Pileski R, Li X, Zhang XC, Zhao S, Kenakin T, Wang Q, Stevens RC, Peng W, Roth BL, Rao Z, Liu ZJ | 10.1038/S41467-023-37177-6 | 2023-02-22 | Yes | |
NMUR2 | NMU2 | Neuromedin U | A | Human | Cryo-EM | 7XK8 | 7XK8_refined | 3.3 | R | Active | 100 | 68 | Gi/o | αi1 | - | 64 | - | - |
Neuromedin U-25 (human)
|
peptide | Agonist | neuromedin S-33, neuromedin U-25, neuromedin S-36, neuromedin U-23 | peptide | Yes | No | Zhao W, Zhang W, Wang M, Lu M, Chen S, Tang T, Schnapp G, Wagner H, Brennauer A, Yi C, Chu X, Han S, Wu B, Zhao Q | 10.1038/S41467-022-34814-4 | 2023-02-22 | Yes | |
OPRK | κ | Opioid | A | Human | X-ray | 7YIT | - | 3.3 | A | Active | 100 | 74 | - | - | - | - | BRIL | Nanobody-39 |
nalfurafine
|
small-molecule | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | El Daibani A, Paggi JM, Kim K, Laloudakis YD, Popov P, Bernhard SM, Krumm BE, Olsen RHJ, Diberto J, Carroll FI, Katritch V, Wunsch B, Dror RO, Che T | 10.1038/S41467-023-37041-7 | 2023-04-12 | Yes | |
FFAR1 | FFA1 | Free fatty acid | A | Human | Cryo-EM | 8EIT | - | 2.8 | R | Active | 100 | 89 | Gq/11 | αq | - | 63 | - | scFv16 |
docosahexaenoic acid
|
small-molecule | Agonist | α-linolenic acid, oleic acid, myristic acid, docosahexaenoic acid | small-molecule | No | No | Kumari P, Inoue A, Chapman K, Lian P, Rosenbaum DM | 10.1073/PNAS.2219569120 | 2023-05-24 | Yes | |
GLR | glucagon | Glucagon | B1 | Human | Cryo-EM | 8FU6 | 8FU6_refined | 2.9 | R | Active | 100 | 72 | Gs | αs | - | 54 | - | Nanobody-35 |
Glucagon derivative ZP3780
|
peptide | Agonist | glucagon | peptide | No | No | Krishna Kumar K, O'Brien ES, Habrian CH, Latorraca NR, Wang H, Tuneew I, Montabana E, Marqusee S, Hilger D, Isacoff EY, Mathiesen JM, Kobilka BK | 10.1016/J.CELL.2023.02.028 | 2023-04-12 | Yes | |
DRD2 | D2 | Dopamine | A | Human | Cryo-EM | 8IRS | 8IRS_refined | 3.0 | R | Active | 100 | 60 | Gi/o | αi1 | - | 63 | BRIL | scFv16 |
rotigotine
|
small-molecule | Agonist | dopamine | small-molecule | Yes | No | Xu P, Huang S, Krumm BE, Zhuang Y, Mao C, Zhang Y, Wang Y, Huang XP, Liu YF, He X, Li H, Yin W, Jiang Y, Zhang Y, Roth BL, Xu HE | 10.1038/S41422-023-00808-0 | 2023-06-07 | Yes | |
TAAR9 | TAAR9 | A orphans | A | Mouse | Cryo-EM | 8IWM | - | 3.2 | R | Active | 97 | 78 | - | - | - | - | - | - |
2-Phenylethanaminium
|
small-molecule | Agonist | - | - | Yes | No | Guo L, Cheng J, Lian S, Liu Q, Lu Y, Zheng Y, Zhu K, Zhang M, Kong Y, Zhang C, Rong N, Zhuang Y, Fang G, Jiang J, Zhang T, Han X, Liu Z, Xia M, Liu S, Zhang L, Liberles SD, Yu X, Xu Y, Yang F, Li Q, Sun JP | 10.1038/S41586-023-06106-4 | 2023-05-31 | Yes | |
TAAR9 | TAAR9 | A orphans | A | Mouse | Cryo-EM | 8IW1 | - | 3.4 | R | Active | 100 | 78 | Gs | αolf | Golf-Gi chimera | 59 | - | scFv16 |
2-Phenylethanaminium
|
small-molecule | Agonist | - | - | Yes | No | Guo L, Cheng J, Lian S, Liu Q, Lu Y, Zheng Y, Zhu K, Zhang M, Kong Y, Zhang C, Rong N, Zhuang Y, Fang G, Jiang J, Zhang T, Han X, Liu Z, Xia M, Liu S, Zhang L, Liberles SD, Yu X, Xu Y, Yang F, Li Q, Sun JP | 10.1038/S41586-023-06106-4 | 2023-05-31 | Yes | |
TAAR9 | TAAR9 | A orphans | A | Mouse | Cryo-EM | 8IW4 | - | 3.5 | R | Active | 100 | 85 | Gs | αs | - | 45 | - | scFv16 |
SPERMIDINE
|
small-molecule | Agonist | - | - | Yes | No | Guo L, Cheng J, Lian S, Liu Q, Lu Y, Zheng Y, Zhu K, Zhang M, Kong Y, Zhang C, Rong N, Zhuang Y, Fang G, Jiang J, Zhang T, Han X, Liu Z, Xia M, Liu S, Zhang L, Liberles SD, Yu X, Xu Y, Yang F, Li Q, Sun JP | 10.1038/S41586-023-06106-4 | 2023-05-31 | Yes | |
TAAR9 | TAAR9 | A orphans | A | Mouse | Cryo-EM | 8IW7 | - | 3.0 | R | Active | 100 | 78 | Gs | αs | - | 59 | - | scFv16 |
2-Phenylethanaminium
|
small-molecule | Agonist | - | - | Yes | No | Guo L, Cheng J, Lian S, Liu Q, Lu Y, Zheng Y, Zhu K, Zhang M, Kong Y, Zhang C, Rong N, Zhuang Y, Fang G, Jiang J, Zhang T, Han X, Liu Z, Xia M, Liu S, Zhang L, Liberles SD, Yu X, Xu Y, Yang F, Li Q, Sun JP | 10.1038/S41586-023-06106-4 | 2023-05-31 | Yes | |
TAAR9 | TAAR9 | A orphans | A | Mouse | Cryo-EM | 8IW9 | - | 3.1 | R | Active | 100 | 89 | Gs | αs | mini-Gs | 59 | - | scFv16 Nanobody-35 |
Cadaverine
|
small-molecule | Agonist | - | - | Yes | No | Guo L, Cheng J, Lian S, Liu Q, Lu Y, Zheng Y, Zhu K, Zhang M, Kong Y, Zhang C, Rong N, Zhuang Y, Fang G, Jiang J, Zhang T, Han X, Liu Z, Xia M, Liu S, Zhang L, Liberles SD, Yu X, Xu Y, Yang F, Li Q, Sun JP | 10.1038/S41586-023-06106-4 | 2023-05-31 | Yes | |
TAAR9 | TAAR9 | A orphans | A | Mouse | Cryo-EM | 8IWE | - | 3.4 | R | Active | 97 | 85 | - | - | - | - | - | - |
SPERMIDINE
|
small-molecule | Agonist | - | - | Yes | No | Guo L, Cheng J, Lian S, Liu Q, Lu Y, Zheng Y, Zhu K, Zhang M, Kong Y, Zhang C, Rong N, Zhuang Y, Fang G, Jiang J, Zhang T, Han X, Liu Z, Xia M, Liu S, Zhang L, Liberles SD, Yu X, Xu Y, Yang F, Li Q, Sun JP | 10.1038/S41586-023-06106-4 | 2023-05-31 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 7XKA | - | 3.1 | A | Active | 99 | 69 | - | - | - | - | T4-Lysozyme | Antibody fragment |
(5R,6R)-6-(methylamino)-5,6,7,8-tetrahydronaphthalene-1,2,5-triol
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | - | - | 2023-04-26 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 8G2Y | - | 3.4 | R | Active | - | 28 | Gs | αs | mini Gs-Gq chimera | 49 | - | Nanobody-35 |
[1-Myristoyl-glycerol-3-YL]phosphonylcholine
|
small-molecule | Agonist | - | - | No | No | Jones DTD, Dates AN, Rawson SD, Burruss MM, Lipper CH, Blacklow SC | 10.1038/S41467-023-38083-7 | 2023-05-10 | Yes | |
MTLR | motilin | Motilin | A | Human | Cryo-EM | 8IBV | 8IBV_refined | 3.2 | R | Active | 100 | 68 | Gq/11 | αq | - | 60 | BRIL | scFv16 |
motilin
|
peptide | Agonist | motilin | peptide | Yes | No | You C, Zhang Y, Xu Y, Xu P, Li Z, Li H, Huang S, Chen Z, Li J, Xu HE, Jiang Y | 10.1126/SCIADV.ADE9020 | 2023-04-12 | Yes | |
CNR2 | CB2 | Cannabinoid | A | Human | Cryo-EM | 8GUS | 8GUS_refined | 3.0 | R | Active | 100 | 81 | Gi/o | αi1 | - | 62 | - | scFv16 |
CHEMBL2179724
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Li X, Chang H, Bouma J, de Paus LV, Mukhopadhyay P, Paloczi J, Mustafa M, van der Horst C, Kumar SS, Wu L, Yu Y, van den Berg RJBHN, Janssen APA, Lichtman A, Liu ZJ, Pacher P, van der Stelt M, Heitman LH, Hua T | 10.1038/S41467-023-37112-9 | 2023-05-10 | Yes | |
GP174 | GPR174 | A orphans | A | Human | Cryo-EM | 7XV3 | 7XV3_refined | 2.8 | R | Active | 100 | 87 | Gs | αs | - | 59 | - | - |
(2~{S})-2-$l^{4}-azanyl-3-[[(2~{R})-3-octadecanoyloxy-2-oxidanyl-propoxy]-oxidanyl-oxidanylidene-$l^{6}-phosphanyl]oxy-propanoic acid
|
small-molecule | Agonist | lysophosphatidylserine | small-molecule | Yes | No | Liang J, Inoue A, Ikuta T, Xia R, Wang N, Kawakami K, Xu Z, Qian Y, Zhu X, Zhang A, Guo C, Huang Z, He Y | 10.1038/S41467-023-36575-0 | 2023-02-15 | Yes | |
P2Y12 | P2Y12 | P2Y | A | Human | Cryo-EM | 7XXI | 7XXI_refined | 3.0 | A | Active | 100 | 86 | Gi/o | αi2 | - | 61 | - | - |
2MeSADP
|
small-molecule | Agonist | ATP, ADP | small-molecule | Yes | No | - | - | 2023-06-07 | Yes | |
OPRK | κ | Opioid | A | Human | Cryo-EM | 8DZP | - | 2.7 | A | Active | 100 | 74 | Gi/o | αi1 | - | 60 | - | scFv16 |
SALVINORIN B METHOXYMETHYL ETHER
|
small-molecule | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Han J, Zhang J, Nazarova AL, Bernhard SM, Krumm BE, Zhao L, Lam JH, Rangari VA, Majumdar S, Nichols DE, Katritch V, Yuan P, Fay JF, Che T | 10.1038/S41586-023-06030-7 | 2023-05-03 | Yes | |
OPRK | κ | Opioid | A | Human | Cryo-EM | 8DZR | - | 2.6 | A | Active | 100 | 68 | Gi/o | αt3 | - | 58 | - | scFv16 |
CHEMBL277863
|
small-molecule | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Han J, Zhang J, Nazarova AL, Bernhard SM, Krumm BE, Zhao L, Lam JH, Rangari VA, Majumdar S, Nichols DE, Katritch V, Yuan P, Fay JF, Che T | 10.1038/S41586-023-06030-7 | 2023-05-03 | Yes | |
MRGX1 | MRGPRX1 | A orphans | A | Human | Cryo-EM | 8HJ5 | 8HJ5_refined | 3.0 | F | Active | 100 | 78 | Gq/11 | αq | - | 60 | BRIL | scFv16 Nanobody-35 |
compound 16 [PMID: 31498617]
|
small-molecule | Agonist | bovine adrenal medulla peptide 8-22 | peptide | No | No | - | - | 2023-05-31 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7TRS | 7TRS_refined | 2.8 | R | Active | 100 | 56 | Gi/o | αi1 | - | 63 | - | scFv16 |
acetylcholine
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | - | - | 2023-05-17 | Yes | |
ADRB2 | β2 | Adrenoceptors | A | Human | X-ray | 7XK9 | - | 3.4 | A | Active | 99 | 69 | - | - | - | - | T4-Lysozyme | Camelid Antibody Fragment |
CHEMBL6913
|
small-molecule | Agonist | L-NOREPINEPHRINE, Zn2+, (-)-noradrenaline, noradrenaline, (-)-adrenaline | small-molecule | Yes | No | - | - | 2023-04-26 | Yes | |
HCAR2 | HCA2 | Hydroxycarboxylic acid | A | Human | X-ray | 7ZLY | - | 2.7 | A | Active | 67 | 83 | - | - | - | - | BRIL | - |
Apo (no ligand)
|
none | Apo (no ligand) | β-D-hydroxybutyric acid, butyric acid | small-molecule | Yes | No | Yang Y, Kang HJ, Gao R, Wang J, Han GW, DiBerto JF, Wu L, Tong J, Qu L, Wu Y, Pileski R, Li X, Zhang XC, Zhao S, Kenakin T, Wang Q, Stevens RC, Peng W, Roth BL, Rao Z, Liu ZJ | 10.1038/S41467-023-37177-6 | 2023-04-12 | Yes | |
HCAR2 | HCA2 | Hydroxycarboxylic acid | A | Human | X-ray | 7ZL9 | - | 2.7 | A | Active | 67 | 83 | - | - | - | - | BRIL | - |
Apo (no ligand)
|
none | Apo (no ligand) | β-D-hydroxybutyric acid, butyric acid | small-molecule | Yes | No | Yang Y, Kang HJ, Gao R, Wang J, Han GW, DiBerto JF, Wu L, Tong J, Qu L, Wu Y, Pileski R, Li X, Zhang XC, Zhao S, Kenakin T, Wang Q, Stevens RC, Peng W, Roth BL, Rao Z, Liu ZJ | 10.1038/S41467-023-37177-6 | 2023-04-12 | Yes | |
GALR1 | GAL1 | Galanin | A | Human | Cryo-EM | 7XJJ | 7XJJ_refined | 3.3 | E | Active | 100 | 77 | Gi/o | αo | - | 61 | - | scFv16 |
galanin
|
peptide | Agonist | galanin, galanin-like peptide | peptide | Yes | No | - | - | 2023-05-03 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 8FLS | 8FLS_refined | 3.1 | R | Active | 100 | 61 | Gs | αs | - | 59 | - | Nanobody-35 |
abaloparatide
|
small-molecule | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Cary BP, Gerrard EJ, Belousoff MJ, Fletcher MM, Jiang Y, Russell IC, Piper SJ, Wootten D, Sexton PM | 10.1016/J.STR.2023.04.002 | 2023-04-26 | Yes | |
AA2AR | A2A | Adenosine | A | Human | X-ray | 8CIC | - | 2.1 | A | Inactive | 1 | 71 | - | - | - | - | BRIL | - |
AB928
|
small-molecule | Antagonist | adenosine | small-molecule | Yes | Yes | Claff T, Schlegel JG, Voss JH, Vaassen VJ, Weisse RH, Cheng RKY, Markovic-Mueller S, Bucher D, Strater N, Muller CE | 10.1038/S42004-023-00894-6 | 2023-05-31 | Yes | |
NK2R | NK2 | Tachykinin | A | Human | Cryo-EM | 7XWO | 7XWO_refined | 2.7 | B | Active | 100 | 68 | Gq/11 | αq | - | 59 | BRIL | scFv16 |
HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2
|
peptide | Agonist | neuropeptide K, neurokinin A, neurokinin B, hemokinin 1, substance P, neuropeptide γ | peptide | Yes | No | - | - | 2023-05-31 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 8G94 | 8G94_refined | 3.2 | A | Active | 100 | 75 | Gi/o | αi1 | - | 62 | - | scFv16 |
Early activation antigen CD69
|
peptide | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Chen H, Qin Y, Chou M, Cyster JG, Li X | 10.7554/ELIFE.88204 | 2023-04-19 | Yes | |
OPRK | κ | Opioid | A | Human | Cryo-EM | 7Y1F | 7Y1F_refined | 3.3 | R | Active | 100 | 75 | Gi/o | αi1 | - | 61 | - | scFv16 |
dynorphin A-(1-8)
|
peptide | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Chen Y, Chen B, Wu T, Zhou F, Xu F | 10.1093/PROCEL/PWAC033 | 2023-05-24 | Yes | |
GPR12 | GPR12 | A orphans | A | Human | Cryo-EM | 7Y3G | 7Y3G_refined | 2.8 | R | Active | 100 | 78 | Gs | αs | - | 56 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | sphingosine 1-phosphate | small-molecule | Yes | No | Li H, Zhang J, Yu Y, Luo F, Wu L, Liu J, Chen N, Liu Z, Hua T | 10.1016/J.SCIB.2022.12.023 | 2023-06-07 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7TRQ | - | 2.5 | R | Active | 100 | 57 | Gi/o | αi1 | - | 64 | - | scFv16 |
iperoxo
VU0467154 |
small-molecule small-molecule |
Agonist PAM |
acetylcholine | small-molecule | Yes | No | - | - | 2023-05-17 | Yes | |
AA2BR | A2B | Adenosine | A | Human | Cryo-EM | 7XY7 | - | 3.3 | R | Active | 100 | 85 | Gs | αs | mini Gs | 57 | BRIL | - |
NECA
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Chen Y, Zhang J, Weng Y, Xu Y, Lu W, Liu W, Liu M, Hua T, Song G | 10.1126/SCIADV.ADD3709 | 2023-05-03 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7YAE | 7YAE_refined | 3.4 | E | Active | 100 | 76 | Gi/o | αi1 | - | 64 | - | scFv16 |
Octreotide
|
peptide | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Zhao J, Fu H, Yu J, Hong W, Tian X, Qi J, Sun S, Zhao C, Wu C, Xu Z, Cheng L, Chai R, Yan W, Wei X, Shao Z | 10.1038/S41467-023-36673-Z | 2023-04-19 | Yes | |
OPRK | κ | Opioid | A | Human | Cryo-EM | 8DZQ | - | 2.8 | A | Active | 100 | 72 | Gi/o | αo | - | 61 | - | scFv16 |
SALVINORIN B METHOXYMETHYL ETHER
|
small-molecule | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Han J, Zhang J, Nazarova AL, Bernhard SM, Krumm BE, Zhao L, Lam JH, Rangari VA, Majumdar S, Nichols DE, Katritch V, Yuan P, Fay JF, Che T | 10.1038/S41586-023-06030-7 | 2023-05-03 | Yes | |
FFAR1 | FFA1 | Free fatty acid | A | Human | Cryo-EM | 8EJC | - | 3.0 | R | Active | 100 | 90 | Gq/11 | αq | - | 65 | - | scFv16 |
fasiglifam
|
small-molecule | Agonist | α-linolenic acid, oleic acid, myristic acid, docosahexaenoic acid | small-molecule | No | No | Kumari P, Inoue A, Chapman K, Lian P, Rosenbaum DM | 10.1073/PNAS.2219569120 | 2023-05-24 | Yes | |
C5AR1 | C5a1 | Complement peptide | A | Human | Cryo-EM | 7Y64 | - | 2.9 | D | Active | 100 | 84 | Gi/o | αi1 | - | 63 | - | scFv16 |
C5a anaphylatoxin
|
peptide | Agonist | C5a des-Arg, C5a, ribosomal protein S19, C3a | peptide | Yes | No | Feng Y, Zhao C, Deng Y, Wang H, Ma L, Liu S, Tian X, Wang B, Bin Y, Chen P, Yan W, Fu P, Shao Z | 10.1038/S41422-023-00779-2 | 2023-03-01 | Yes | |
OPRK | κ | Opioid | A | Human | Cryo-EM | 8DZS | - | 2.7 | A | Active | 100 | 71 | Gi/o | αz | - | 59 | - | scFv16 |
CHEMBL277863
|
small-molecule | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Han J, Zhang J, Nazarova AL, Bernhard SM, Krumm BE, Zhao L, Lam JH, Rangari VA, Majumdar S, Nichols DE, Katritch V, Yuan P, Fay JF, Che T | 10.1038/S41586-023-06030-7 | 2023-05-03 | Yes | |
C3AR | C3a | Complement peptide | A | Human | Cryo-EM | 8HK3 | 8HK3_refined | 3.2 | C | Active | 100 | 59 | Gi/o | αi1 | - | 63 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | C5a, C3a | peptide | Yes | No | Wang Y, Liu W, Xu Y, He X, Yuan Q, Luo P, Fan W, Zhu J, Zhang X, Cheng X, Jiang Y, Xu HE, Zhuang Y | 10.1038/S41589-023-01339-W | 2023-05-10 | Yes | |
MTLR | motilin | Motilin | A | Human | Cryo-EM | 8IBU | 8IBU_refined | 3.5 | R | Active | 100 | 66 | Gq/11 | αq | - | 60 | BRIL | scFv16 |
erythromycin
|
small-molecule | Agonist | motilin | peptide | Yes | No | You C, Zhang Y, Xu Y, Xu P, Li Z, Li H, Huang S, Chen Z, Li J, Xu HE, Jiang Y | 10.1126/SCIADV.ADE9020 | 2023-04-12 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 8FLQ | - | 2.6 | R | Active | 100 | 61 | Gs | αs | - | 59 | - | Nanobody-35 |
Parathyroid hormone
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Cary BP, Gerrard EJ, Belousoff MJ, Fletcher MM, Jiang Y, Russell IC, Piper SJ, Wootten D, Sexton PM | 10.1016/J.STR.2023.04.002 | 2023-04-26 | Yes | |
CNR2 | CB2 | Cannabinoid | A | Human | Cryo-EM | 8GUT | - | 3.0 | R | Active | 100 | 81 | Gi/o | αi1 | - | 62 | - | scFv16 |
1-[[4-[5-Fluoro-6-[(oxan-4-ylamino)methyl]pyridin-2-yl]phenyl]methyl]-3-(2-methylpropyl)imidazolidine-2,4-dione
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Li X, Chang H, Bouma J, de Paus LV, Mukhopadhyay P, Paloczi J, Mustafa M, van der Horst C, Kumar SS, Wu L, Yu Y, van den Berg RJBHN, Janssen APA, Lichtman A, Liu ZJ, Pacher P, van der Stelt M, Heitman LH, Hua T | 10.1038/S41467-023-37112-9 | 2023-05-10 | Yes | |
DRD5 | D5 | Dopamine | A | Human | Cryo-EM | 8IRV | 8IRV_refined | 3.1 | R | Active | 100 | 58 | Gs | αs | - | 60 | BRIL | - |
rotigotine
|
small-molecule | Agonist | L-NOREPINEPHRINE, 5-hydroxytryptamine, dopamine, (-)-noradrenaline, noradrenaline | small-molecule | Yes | No | Xu P, Huang S, Krumm BE, Zhuang Y, Mao C, Zhang Y, Wang Y, Huang XP, Liu YF, He X, Li H, Yin W, Jiang Y, Zhang Y, Roth BL, Xu HE | 10.1038/S41422-023-00808-0 | 2023-06-07 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7TRK | - | 2.8 | R | Active | 100 | 57 | Gi/o | αi1 | - | 64 | - | scFv16 |
iperoxo
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | - | - | 2023-05-17 | Yes | |
SSR2 | SST2 | Somatostatin | A | Human | Cryo-EM | 7YAC | 7YAC_refined | 3.2 | E | Active | 100 | 76 | Gi/o | αi1 | - | 64 | - | scFv16 |
Paltusotine
|
small-molecule | Agonist | CST-17, SRIF-28, SRIF-14, cortistatin-14 | peptide | Yes | No | Zhao J, Fu H, Yu J, Hong W, Tian X, Qi J, Sun S, Zhao C, Wu C, Xu Z, Cheng L, Chai R, Yan W, Wei X, Shao Z | 10.1038/S41467-023-36673-Z | 2023-04-19 | Yes | |
FFAR1 | FFA1 | Free fatty acid | A | Human | Cryo-EM | 8EJK | - | 3.4 | R | Active | 100 | 89 | Gq/11 | αq | - | 65 | - | scFv16 |
fasiglifam
|
small-molecule | Agonist | α-linolenic acid, oleic acid, myristic acid, docosahexaenoic acid | small-molecule | No | No | Kumari P, Inoue A, Chapman K, Lian P, Rosenbaum DM | 10.1073/PNAS.2219569120 | 2023-05-24 | Yes | |
CNR2 | CB2 | Cannabinoid | A | Human | Cryo-EM | 8GUQ | 8GUQ_refined | 3.1 | R | Active | 100 | 81 | Gi/o | αi1 | - | 62 | - | scFv16 |
olorinab
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Li X, Chang H, Bouma J, de Paus LV, Mukhopadhyay P, Paloczi J, Mustafa M, van der Horst C, Kumar SS, Wu L, Yu Y, van den Berg RJBHN, Janssen APA, Lichtman A, Liu ZJ, Pacher P, van der Stelt M, Heitman LH, Hua T | 10.1038/S41467-023-37112-9 | 2023-05-10 | Yes | |
C3AR | C3a | Complement peptide | A | Human | Cryo-EM | 8HK2 | 8HK2_refined | 2.9 | A | Active | 100 | 59 | Gi/o | αi1 | - | 64 | - | scFv16 |
C3a anaphylatoxin
|
peptide | Agonist | C5a, C3a | peptide | Yes | No | Wang Y, Liu W, Xu Y, He X, Yuan Q, Luo P, Fan W, Zhu J, Zhang X, Cheng X, Jiang Y, Xu HE, Zhuang Y | 10.1038/S41589-023-01339-W | 2023-05-10 | Yes | |
C3AR | C3a | Complement peptide | A | Human | Cryo-EM | 8IA8 | - | 2.9 | A | Active | 100 | 59 | Gi/o | αi1 | - | 61 | - | scFv16 |
ALA-SER-LYS-LEU-GLY-LEU-ALA-ARG
|
peptide | Agonist | C5a, C3a | peptide | Yes | No | - | - | 2023-05-24 | Yes | |
TAAR9 | TAAR9 | A orphans | A | Mouse | Cryo-EM | 8ITF | - | 3.5 | R | Active | 100 | 86 | Gs | αs | - | 59 | - | scFv16 Nanobody-35 |
N,N-Dimethylcyclohexylamine
|
small-molecule | Agonist | - | - | Yes | No | Guo L, Cheng J, Lian S, Liu Q, Lu Y, Zheng Y, Zhu K, Zhang M, Kong Y, Zhang C, Rong N, Zhuang Y, Fang G, Jiang J, Zhang T, Han X, Liu Z, Xia M, Liu S, Zhang L, Liberles SD, Yu X, Xu Y, Yang F, Li Q, Sun JP | 10.1038/S41586-023-06106-4 | 2023-05-31 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 8FLT | - | 3.0 | R | Active | 100 | 45 | Gs | αs | - | 59 | - | Nanobody-35 |
M-PTH(1-14)
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Cary BP, Gerrard EJ, Belousoff MJ, Fletcher MM, Jiang Y, Russell IC, Piper SJ, Wootten D, Sexton PM | 10.1016/J.STR.2023.04.002 | 2023-04-26 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 8FLU | - | 2.8 | R | Active | 100 | 61 | Gs | αs | - | 58 | - | Nanobody-35 |
PTH
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Cary BP, Gerrard EJ, Belousoff MJ, Fletcher MM, Jiang Y, Russell IC, Piper SJ, Wootten D, Sexton PM | 10.1016/J.STR.2023.04.002 | 2023-04-26 | Yes | |
CNR1 | CB1 | Cannabinoid | A | Human | Cryo-EM | 8GHV | 8GHV_refined | 2.8 | D | Active | 100 | 59 | Gi/o | αi1 | - | 62 | - | scFv16 |
CHEMBL4208628
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Krishna Kumar K, Robertson MJ, Thadhani E, Wang H, Suomivuori CM, Powers AS, Ji L, Nikas SP, Dror RO, Inoue A, Makriyannis A, Skiniotis G, Kobilka B | 10.1038/S41467-023-37864-4 | 2023-05-24 | Yes | |
CNR2 | CB2 | Cannabinoid | A | Human | Cryo-EM | 8GUR | - | 2.8 | R | Active | 100 | 78 | Gi/o | αi1 | - | 64 | - | scFv16 |
CP55940
|
small-molecule | Agonist | anandamide, 2-arachidonoylglycerol | small-molecule | Yes | No | Li X, Chang H, Bouma J, de Paus LV, Mukhopadhyay P, Paloczi J, Mustafa M, van der Horst C, Kumar SS, Wu L, Yu Y, van den Berg RJBHN, Janssen APA, Lichtman A, Liu ZJ, Pacher P, van der Stelt M, Heitman LH, Hua T | 10.1038/S41467-023-37112-9 | 2023-05-10 | Yes | |
C5AR1 | C5a1 | Complement peptide | A | Human | Cryo-EM | 8HK5 | 8HK5_refined | 3.0 | A | Active | 100 | 84 | Gi/o | αi1 | - | 63 | - | - |
C5a
|
peptide | Agonist | C5a des-Arg, C5a, ribosomal protein S19, C3a | peptide | Yes | No | Wang Y, Liu W, Xu Y, He X, Yuan Q, Luo P, Fan W, Zhu J, Zhang X, Cheng X, Jiang Y, Xu HE, Zhuang Y | 10.1038/S41589-023-01339-W | 2023-05-10 | Yes | |
DRD3 | D3 | Dopamine | A | Human | Cryo-EM | 8IRT | - | 2.7 | R | Active | 100 | 68 | Gi/o | αi1 | - | 63 | BRIL | scFv16 |
rotigotine
|
small-molecule | Agonist | dopamine | small-molecule | Yes | No | Xu P, Huang S, Krumm BE, Zhuang Y, Mao C, Zhang Y, Wang Y, Huang XP, Liu YF, He X, Li H, Yin W, Jiang Y, Zhang Y, Roth BL, Xu HE | 10.1038/S41422-023-00808-0 | 2023-06-07 | Yes | |
ACM4 | M4 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 7TRP | - | 2.4 | R | Active | 100 | 56 | Gi/o | αi1 | - | 64 | - | scFv16 |
iperoxo
LY2033298 |
small-molecule small-molecule |
Agonist PAM |
acetylcholine | small-molecule | Yes | No | - | - | 2023-05-17 | Yes | |
P2RY1 | P2Y1 | P2Y | A | Human | Cryo-EM | 7XXH | 7XXH_refined | 2.9 | R | Active | 100 | 81 | Gq/11 | α11 | - | 63 | - | scFv16 |
2MeSADP
|
small-molecule | Agonist | ATP, ADP | small-molecule | Yes | No | - | - | 2023-06-07 | Yes | |
PTH1R | PTH1 | Parathyroid hormone | B1 | Human | Cryo-EM | 8FLR | - | 2.9 | R | Active | 100 | 61 | Gs | αs | - | 59 | - | Nanobody-35 |
PTHrP[1-36]
|
peptide | Agonist | PTHrP, TIP39, PTHrP-(1-36), PTH | peptide | No | No | Cary BP, Gerrard EJ, Belousoff MJ, Fletcher MM, Jiang Y, Russell IC, Piper SJ, Wootten D, Sexton PM | 10.1016/J.STR.2023.04.002 | 2023-04-26 | Yes | |
AA2BR | A2B | Adenosine | A | Human | Cryo-EM | 7XY6 | - | 3.0 | R | Active | 100 | 86 | Gs | αs | - | 57 | BRIL | - |
BAY 60-6583
|
small-molecule | Agonist | adenosine | small-molecule | Yes | No | Chen Y, Zhang J, Weng Y, Xu Y, Lu W, Liu W, Liu M, Hua T, Song G | 10.1126/SCIADV.ADD3709 | 2023-05-03 | Yes | |
CML1 | chemerin | Chemerin receptor | A | Human | Cryo-EM | 7YKD | - | 2.8 | A | Active | 100 | 76 | Gi/o | αi1 | - | 61 | - | scFv16 |
chemerin C-terminal peptide
|
peptide | Agonist | resolvin E1, chemerin, EPA, 18R-HEPE, chemerin C-terminal peptide | peptide | Yes | No | Wang J, Chen G, Liao Q, Lyu W, Liu A, Zhu L, Du Y, Ye RD | 10.1073/PNAS.2214324120 | 2023-04-19 | Yes | |
AGRG2 | ADGRG2 | ADGRG | B2 | Mouse | Cryo-EM | 7XKE | - | 2.9 | R | Active | - | 25 | Gs | αs | Mini-Gs | 60 | - | Nanobody-35 |
PRASTERONE
|
small-molecule | Agonist | - | - | No | No | Lin H, Xiao P, Bu RQ, Guo S, Yang Z, Yuan D, Zhu ZL, Zhang CX, He QT, Zhang C, Ping YQ, Zhao RJ, Ma CS, Liu CH, Zhang XN, Jiang D, Huang S, Xi YT, Zhang DL, Xue CY, Yang BS, Li JY, Lin HC, Zeng XH, Zhao H, Xu WM, Yi F, Liu Z, Sun JP, Yu X | 10.1038/S41589-022-01084-6 | 2022-08-10 | Yes | |
AGRG2 | ADGRG2 | ADGRG | B2 | Mouse | Cryo-EM | 7XKF | - | 2.4 | R | Active | - | 26 | Gs | αs | - | 57 | - | Nanobody-35 |
PRASTERONE
|
small-molecule | Agonist | - | - | No | No | Lin H, Xiao P, Bu RQ, Guo S, Yang Z, Yuan D, Zhu ZL, Zhang CX, He QT, Zhang C, Ping YQ, Zhao RJ, Ma CS, Liu CH, Zhang XN, Jiang D, Huang S, Xi YT, Zhang DL, Xue CY, Yang BS, Li JY, Lin HC, Zeng XH, Zhao H, Xu WM, Yi F, Liu Z, Sun JP, Yu X | 10.1038/S41589-022-01084-6 | 2022-08-10 | Yes | |
AGRG2 | ADGRG2 | ADGRG | B2 | Mouse | Cryo-EM | 7YP7 | - | 3.1 | R | Active | - | 24 | Gs | αs | - | 59 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | - | - | 2022-08-24 | Yes | |
SMO | SMO | Frizzled | F | Mouse | Cryo-EM | 8CXO | 8CXO_refined | 3.7 | A | Inactive | 15 | 43 | - | - | - | - | GlgA glycogen synthase | - |
Cholesterol
|
small-molecule | Agonist | - | - | No | No | Zhang K, Wu H, Hoppe N, Manglik A, Cheng Y | 10.1038/S41467-022-32125-2 | 2022-08-03 | Yes | |
GP119 | GPR119 | GPR18, GPR55 and GPR119 | A | Human | Cryo-EM | 7XZ6 | - | 2.8 | R | Active | 100 | 87 | Gs | αs | - | 60 | BRIL | Nanobody-35 |
APD668
|
small-molecule | Agonist | N-palmitoylethanolamine, SEA, N-oleoylethanolamide, anandamide | small-molecule | Yes | No | Xu P, Huang S, Guo S, Yun Y, Cheng X, He X, Cai P, Lan Y, Zhou H, Jiang H, Jiang Y, Xie X, Xu HE | 10.1038/S41594-022-00816-5 | 2022-08-24 | Yes | |
TSHR | TSH | Glycoprotein hormone | A | Human | Cryo-EM | 7T9I | - | 2.9 | R | Active | 100 | 78 | Gs | αs | Mini-Gs | 56 | - | Nanobody-35 |
Thyrotropin subunit beta
Glycoprotein hormones alpha chain |
protein protein |
Agonist | TSH | peptide | Yes | No | Faust B, Billesbolle CB, Suomivuori CM, Singh I, Zhang K, Hoppe N, Pinto AFM, Diedrich JK, Muftuoglu Y, Szkudlinski MW, Saghatelian A, Dror RO, Cheng Y, Manglik A | 10.1038/S41586-022-05159-1 | 2022-08-03 | Yes | |
TSHR | TSH | Glycoprotein hormone | A | Human | Cryo-EM | 7T9M | - | 3.1 | R | Inactive | 27 | 74 | - | - | - | - | - | - |
CS-17 light chain
CS-17 heavy chain |
protein protein |
Inverse agonist | TSH | peptide | Yes | No | Faust B, Billesbolle CB, Suomivuori CM, Singh I, Zhang K, Hoppe N, Pinto AFM, Diedrich JK, Muftuoglu Y, Szkudlinski MW, Saghatelian A, Dror RO, Cheng Y, Manglik A | 10.1038/S41586-022-05159-1 | 2022-08-10 | Yes | |
TSHR | TSH | Glycoprotein hormone | A | Human | Cryo-EM | 7T9N | - | 2.9 | R | Active | 100 | 73 | Gs | αs | Mini-Gs | 56 | - | M22 Fab light chain M22 Fab heavy chain Nanobody-35 |
M22 antibody heavy chain
M22 antibody light chain |
protein protein |
Agonist | TSH | peptide | Yes | No | Faust B, Billesbolle CB, Suomivuori CM, Singh I, Zhang K, Hoppe N, Pinto AFM, Diedrich JK, Muftuoglu Y, Szkudlinski MW, Saghatelian A, Dror RO, Cheng Y, Manglik A | 10.1038/S41586-022-05159-1 | 2022-08-03 | Yes | |
TSHR | TSH | Glycoprotein hormone | A | Human | Cryo-EM | 7UTZ | - | 2.4 | R | Active | 100 | 79 | Gs | αs | Mini-Gs | 56 | - | Nanobody-35 |
Thyrotropin subunit beta
Glycoprotein hormones alpha chain analog TR1402 |
protein protein |
Agonist | TSH | peptide | Yes | No | Faust B, Billesbolle CB, Suomivuori CM, Singh I, Zhang K, Hoppe N, Pinto AFM, Diedrich JK, Muftuoglu Y, Szkudlinski MW, Saghatelian A, Dror RO, Cheng Y, Manglik A | 10.1038/S41586-022-05159-1 | 2022-08-03 | Yes | |
HRH3 | H3 | Histamine | A | Human | X-ray | 7F61 | 7F61_refined | 2.6 | A | Inactive | 7 | 68 | - | - | - | - | BRIL | - |
N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide
|
small-molecule | Antagonist | histamine | small-molecule | No | No | Peng X, Yang L, Liu Z, Lou S, Mei S, Li M, Chen Z, Zhang H | 10.1038/S41467-022-33880-Y | 2022-10-26 | Yes | |
P2Y12 | P2Y12 | P2Y | A | Human | X-ray | 7PP1 | - | 2.8 | A | Intermediate | 41 | 78 | - | - | - | - | BRIL | - |
selatogrel
|
small-molecule | Antagonist | ATP, ADP | small-molecule | Yes | No | Pons V, Garcia C, Tidten-Luksch N, Mac Sweeney A, Caroff E, Gales C, Riederer MA | 10.1016/j.bcp.2022.115291 | 2022-11-02 | Yes | |
V2R | V2 | Vasopressin and oxytocin | A | Human | Cryo-EM | 7R0C | - | 4.7 | A | Active | 100 | 76 | Beta | Beta-arrestin-1 | - | 84 | - | scFv30 |
vasopressin
|
peptide | Agonist | vasopressin, oxytocin | peptide | Yes | No | Bous J, Fouillen A, Orcel H, Trapani S, Cong X, Fontanel S, Saint-Paul J, Lai-Kee-Him J, Urbach S, Sibille N, Sounier R, Granier S, Mouillac B, Bron P | 10.1126/SCIADV.ABO7761 | 2022-09-14 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7SRQ | 7SRQ_refined | 2.7 | R | Intermediate | 41 | 53 | - | - | - | - | - | - |
Lysergide
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Cao C, Barros-Alvarez X, Zhang S, Kim K, Damgen MA, Panova O, Suomivuori CM, Fay JF, Zhong X, Krumm BE, Gumpper RH, Seven AB, Robertson MJ, Krogan NJ, Huttenhain R, Nichols DE, Dror RO, Skiniotis G, Roth BL | 10.1016/J.NEURON.2022.08.006 | 2022-09-21 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7SRR | - | 2.9 | R | Active | 100 | 57 | Gq/11 | αq | Gi2-mini-Gq chimera | 63 | - | scFv16 |
Lysergide
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Cao C, Barros-Alvarez X, Zhang S, Kim K, Damgen MA, Panova O, Suomivuori CM, Fay JF, Zhong X, Krumm BE, Gumpper RH, Seven AB, Robertson MJ, Krogan NJ, Huttenhain R, Nichols DE, Dror RO, Skiniotis G, Roth BL | 10.1016/J.NEURON.2022.08.006 | 2022-09-21 | Yes | |
5HT2B | 5-HT2B | 5-Hydroxytryptamine | A | Human | Cryo-EM | 7SRS | - | 3.3 | R | Active | 100 | 60 | Beta | Beta-arrestin-1 | - | 85 | - | Fab light chain Fab heavy chain Fab30 heavy chain Fab30 light chain |
Lysergide
|
small-molecule | Agonist | 5-hydroxytryptamine | small-molecule | Yes | No | Cao C, Barros-Alvarez X, Zhang S, Kim K, Damgen MA, Panova O, Suomivuori CM, Fay JF, Zhong X, Krumm BE, Gumpper RH, Seven AB, Robertson MJ, Krogan NJ, Huttenhain R, Nichols DE, Dror RO, Skiniotis G, Roth BL | 10.1016/J.NEURON.2022.08.006 | 2022-09-21 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 7T2G | - | 2.5 | R | Active | 100 | 70 | Gi/o | αi1 | - | 62 | BRIL | - |
CHEMBL58362
|
small-molecule | Agonist | - | - | Yes | No | Qu Q, Huang W, Aydin D, Paggi JM, Seven AB, Wang H, Chakraborty S, Che T, DiBerto JF, Robertson MJ, Inoue A, Suomivuori CM, Roth BL, Majumdar S, Dror RO, Kobilka BK, Skiniotis G | 10.1038/S41589-022-01208-Y | 2022-12-07 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 7T2H | - | 3.2 | D | Active | 100 | 71 | Gi/o | αi1 | - | 61 | - | scFv16 |
LOFENTANIL
|
small-molecule | Agonist | - | - | Yes | No | Qu Q, Huang W, Aydin D, Paggi JM, Seven AB, Wang H, Chakraborty S, Che T, DiBerto JF, Robertson MJ, Inoue A, Suomivuori CM, Roth BL, Majumdar S, Dror RO, Kobilka BK, Skiniotis G | 10.1038/S41589-022-01208-Y | 2022-12-07 | Yes | |
CRFR2 | CRF2 | Corticotropin-releasing factor | B1 | Human | Cryo-EM | 7TRY | - | 3.7 | P | Active | 100 | 79 | Gq/11 | α11 | - | 62 | - | - |
Urocortin
|
peptide | Agonist | urocortin 1, urocortin 3, corticotrophin-releasing hormone, urocortin 2 | peptide | No | No | Zhao LH, Lin J, Ji SY, Zhou XE, Mao C, Shen DD, He X, Xiao P, Sun J, Melcher K, Zhang Y, Yu X, Xu HE | 10.1038/S41467-022-33851-3 | 2022-11-09 | Yes | |
CRFR2 | CRF2 | Corticotropin-releasing factor | B1 | Human | Cryo-EM | 7TS0 | 7TS0_refined | 2.8 | P | Active | 100 | 72 | Gi/o | αo | - | 63 | - | scFv16 |
Urocortin
|
peptide | Agonist | urocortin 1, urocortin 3, corticotrophin-releasing hormone, urocortin 2 | peptide | No | No | Zhao LH, Lin J, Ji SY, Zhou XE, Mao C, Shen DD, He X, Xiao P, Sun J, Melcher K, Zhang Y, Yu X, Xu HE | 10.1038/S41467-022-33851-3 | 2022-11-09 | Yes | |
OPRM | μ | Opioid | A | Mouse | Cryo-EM | 7U2K | - | 3.3 | D | Active | 100 | 71 | Gi/o | αi1 | - | 61 | - | - |
CHEMBL147044
|
small-molecule | Agonist | - | - | Yes | No | Faouzi A, Wang H, Zaidi SA, DiBerto JF, Che T, Qu Q, Robertson MJ, Madasu MK, El Daibani A, Varga BR, Zhang T, Ruiz C, Liu S, Xu J, Appourchaux K, Slocum ST, Eans SO, Cameron MD, Al-Hasani R, Pan YX, Roth BL, McLaughlin JP, Skiniotis G, Katritch V, Kobilka BK, Majumdar S | 10.1038/S41586-022-05588-Y | 2022-12-07 | Yes | |
FPR1 | FPR1 | Formylpeptide | A | Human | Cryo-EM | 7VFX | 7VFX_refined | 2.8 | R | Active | 100 | 84 | Gi/o | αi1 | - | 62 | - | scFv16 |
Peptide agonist fMet-Ile-Phe-Leu
|
peptide | Agonist | fMet-Leu-Phe, spinorphin, cathepsin G, annexin I | peptide | Yes | No | Chen G, Wang X, Liao Q, Ge Y, Jiao H, Chen Q, Liu Y, Lyu W, Zhu L, van Zundert GCP, Robertson MJ, Skiniotis G, Du Y, Hu H, Ye RD | 10.1038/S41467-022-32822-Y | 2022-09-21 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7VIE | 7VIE_refined | 2.9 | F | Active | 100 | 73 | Gi/o | αi1 | - | 64 | - | scFv16 |
sphingosine 1-phosphate
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yu L, He L, Gan B, Ti R, Xiao Q, Hu H, Zhu L, Wang S, Ren R | 10.1073/PNAS.2117716119 | 2022-09-28 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7VIF | 7VIF_refined | 2.8 | F | Active | 100 | 73 | Gi/o | αi1 | - | 64 | - | scFv16 |
(S)-FTY720-phosphate
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yu L, He L, Gan B, Ti R, Xiao Q, Hu H, Zhu L, Wang S, Ren R | 10.1073/PNAS.2117716119 | 2022-09-28 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7VIG | - | 2.9 | F | Active | 100 | 73 | Gi/o | αi1 | - | 63 | - | scFv16 |
icanbelimod
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yu L, He L, Gan B, Ti R, Xiao Q, Hu H, Zhu L, Wang S, Ren R | 10.1073/PNAS.2117716119 | 2022-09-28 | Yes | |
S1PR1 | S1P1 | Lysophospholipid (S1P) | A | Human | Cryo-EM | 7VIH | - | 3.0 | F | Active | 100 | 73 | Gi/o | αi1 | - | 64 | - | scFv16 |
icanbelimod
|
small-molecule | Agonist | dihydrosphingosine 1-phosphate, sphingosine 1-phosphate, sphingosylphosphorylcholine | small-molecule | Yes | No | Yu L, He L, Gan B, Ti R, Xiao Q, Hu H, Zhu L, Wang S, Ren R | 10.1073/PNAS.2117716119 | 2022-09-28 | Yes | |
ADA2A | α2A | Adrenoceptors | A | Human | Cryo-EM | 7W6P | - | 3.5 | R | Active | 100 | 55 | Gi/o | αo | - | 58 | - | scFv16 |
N-pyridin-4-ylisoquinolin-4-amine
|
small-molecule | Agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Fink EA, Xu J, Hubner H, Braz JM, Seemann P, Avet C, Craik V, Weikert D, Schmidt MF, Webb CM, Tolmachova NA, Moroz YS, Huang XP, Kalyanaraman C, Gahbauer S, Chen G, Liu Z, Jacobson MP, Irwin JJ, Bouvier M, Du Y, Shoichet BK, Basbaum AI, Gmeiner P | 10.1126/SCIENCE.ABN7065 | 2022-09-28 | Yes | |
ADA2A | α2A | Adrenoceptors | A | Human | Cryo-EM | 7W7E | 7W7E_refined | 3.4 | R | Active | 100 | 56 | Gi/o | αo | - | 59 | - | scFv16 |
5-(3-Bicyclo[4.2.0]octa-1,3,5-trienyl)-1,2,3,6-tetrahydropyridine
|
small-molecule | Agonist | (-)-noradrenaline, (-)-adrenaline | small-molecule | Yes | No | Fink EA, Xu J, Hubner H, Braz JM, Seemann P, Avet C, Craik V, Weikert D, Schmidt MF, Webb CM, Tolmachova NA, Moroz YS, Huang XP, Kalyanaraman C, Gahbauer S, Chen G, Liu Z, Jacobson MP, Irwin JJ, Bouvier M, Du Y, Shoichet BK, Basbaum AI, Gmeiner P | 10.1126/SCIENCE.ABN7065 | 2022-09-28 | Yes | |
GP119 | GPR119 | GPR18, GPR55 and GPR119 | A | Human | Cryo-EM | 7WCM | 7WCM_refined | 2.3 | R | Active | 100 | 86 | Gs | αs | - | 60 | - | Nanobody-35 |
MBX-2982
|
small-molecule | Agonist | N-palmitoylethanolamine, SEA, N-oleoylethanolamide, anandamide | small-molecule | Yes | No | Qian Y, Wang J, Yang L, Liu Y, Wang L, Liu W, Lin Y, Yang H, Ma L, Ye S, Wu S, Qiao A | 10.1038/S41467-022-34696-6 | 2022-12-21 | Yes | |
GP119 | GPR119 | GPR18, GPR55 and GPR119 | A | Human | Cryo-EM | 7WCN | - | 2.9 | R | Active | 100 | 86 | Gs | αs | - | 60 | - | Nanobody-35 |
AR231453
|
small-molecule | Agonist | N-palmitoylethanolamine, SEA, N-oleoylethanolamide, anandamide | small-molecule | Yes | No | Qian Y, Wang J, Yang L, Liu Y, Wang L, Liu W, Lin Y, Yang H, Ma L, Ye S, Wu S, Qiao A | 10.1038/S41467-022-34696-6 | 2022-12-21 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 7WXU | - | 2.9 | R | Active | - | 30 | Gq/11 | αq | - | 60 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Zhu X, Qian Y, Li X, Xu Z, Xia R, Wang N, Liang J, Yin H, Zhang A, Guo C, Wang G, He Y | 10.1038/S41467-022-33173-4 | 2022-09-28 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 7WXW | - | 2.8 | R | Active | - | 30 | Gs | αs | Mini-Gs | 59 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Zhu X, Qian Y, Li X, Xu Z, Xia R, Wang N, Liang J, Yin H, Zhang A, Guo C, Wang G, He Y | 10.1038/S41467-022-33173-4 | 2022-09-28 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 7WY0 | - | 2.8 | R | Active | - | 30 | G12/13 | α13 | - | 55 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Zhu X, Qian Y, Li X, Xu Z, Xia R, Wang N, Liang J, Yin H, Zhang A, Guo C, Wang G, He Y | 10.1038/S41467-022-33173-4 | 2022-09-28 | Yes | |
AGRL3 | ADGRL3 | ADGRL | B2 | Mouse | Cryo-EM | 7WY5 | - | 2.8 | R | Active | - | 17 | Gq/11 | αq | Mini-Gq | 59 | - | Nanobody-35 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Qian Y, Ma Z, Liu C, Li X, Zhu X, Wang N, Xu Z, Xia R, Liang J, Duan Y, Yin H, Xiong Y, Zhang A, Guo C, Chen Z, Huang Z, He Y | 10.1016/J.MOLCEL.2022.10.009 | 2022-10-26 | Yes | |
AGRL3 | ADGRL3 | ADGRL | B2 | Mouse | Cryo-EM | 7WYB | - | 3.0 | R | Active | - | 17 | Gi/o | αi1 | - | 64 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Qian Y, Ma Z, Liu C, Li X, Zhu X, Wang N, Xu Z, Xia R, Liang J, Duan Y, Yin H, Xiong Y, Zhang A, Guo C, Chen Z, Huang Z, He Y | 10.1016/J.MOLCEL.2022.10.009 | 2022-10-26 | Yes | |
GPR88 | GPR88 | A orphans | A | Human | Cryo-EM | 7WZ4 | - | 3.0 | R | Active | 100 | 61 | Gi/o | αi1 | - | 61 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | Yes | No | Chen G, Xu J, Inoue A, Schmidt MF, Bai C, Lu Q, Gmeiner P, Liu Z, Du Y | 10.1038/S41467-022-30081-5 | 2022-10-26 | Yes | |
AGRF1 | ADGRF1 | ADGRF | B2 | Human | Cryo-EM | 7WZ7 | - | 2.8 | R | Active | - | 30 | G12/13 | α12 | Mini-G12 | 55 | - | scFv16 |
Apo (no ligand)
|
none | Apo (no ligand) | - | - | No | No | Zhu X, Qian Y, Li X, Xu Z, Xia R, Wang N, Liang J, Yin H, Zhang A, Guo C, Wang G, He Y | 10.1038/S41467-022-33173-4 | 2022-09-28 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 8EA0 | 8EA0_refined | 2.6 | A | Active | 99 | 48 | - | - | - | - | - | - |
iperoxo
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | Zhang S, Gumpper RH, Huang XP, Liu Y, Krumm BE, Cao C, Fay JF, Roth BL | 10.1038/S41586-022-05489-0 | 2022-11-30 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 8E9Y | - | 2.8 | A | Active | 100 | 47 | Gq/11 | αq | mini-Gq | 61 | - | scFv16 |
Clozapine N-oxide
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | Zhang S, Gumpper RH, Huang XP, Liu Y, Krumm BE, Cao C, Fay JF, Roth BL | 10.1038/S41586-022-05489-0 | 2022-11-30 | Yes | |
ACM3 | M3 | Acetylcholine (muscarinic) | A | Human | Cryo-EM | 8E9Z | - | 2.7 | A | Active | 100 | 47 | Gq/11 | αq | mini-Gq | 62 | - | scFv16 |
iperoxo
|
small-molecule | Agonist | acetylcholine | small-molecule | Yes | No | Zhang S, Gumpper RH, Huang XP, Liu Y, Krumm BE, Cao C, Fay JF, Roth BL | 10.1038/S41586-022-05489-0 | 2022-11-30 | Yes | |
OPRM | μ | Opioid | A | Human | Cryo-EM | 8EF6 | 8EF6_refined | 3.2 | R | Active | 100 | 72 | Gi/o | αi1 | - | 64 | - | scFv16 |
morphine
|
small-molecule | Agonist | dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin, endomorphin-2 | peptide | Yes | No | Zhuang Y, Wang Y, He B, He X, Zhou XE, Guo S, Rao Q, Yang J, Liu J, Zhou Q, Wang X, Liu M, Liu W, Jiang X, Yang D, Jiang H, Shen J, Melcher K, Chen H, Jiang Y, Cheng X, Wang MW, Xie X, Xu HE | 10.1016/J.CELL.2022.09.041 | 2022-11-09 | Yes | |
OPRM | μ | Opioid | A | Human | Cryo-EM | 8EFB | 8EFB_refined | 3.2 | R | Active | 100 | 71 | Gi/o | αi1 | - | 64 | - | scFv16 |
OLICERIDINE
|
small-molecule | Agonist | dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin, endomorphin-2 | peptide | Yes | No | Zhuang Y, Wang Y, He B, He X, Zhou XE, Guo S, Rao Q, Yang J, Liu J, Zhou Q, Wang X, Liu M, Liu W, Jiang X, Yang D, Jiang H, Shen J, Melcher K, Chen H, Jiang Y, Cheng X, Wang MW, Xie X, Xu HE | 10.1016/J.CELL.2022.09.041 | 2022-11-09 | Yes | |
OPRM | μ | Opioid | A | Human | Cryo-EM | 8EFL | 8EFL_refined | 3.2 | R | Active | 100 | 72 | Gi/o | αi1 | - | 64 | - | scFv16 |
CHEMBL4452384
|
small-molecule | Agonist | dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin, endomorphin-2 | peptide | Yes | No | Zhuang Y, Wang Y, He B, He X, Zhou XE, Guo S, Rao Q, Yang J, Liu J, Zhou Q, Wang X, Liu M, Liu W, Jiang X, Yang D, Jiang H, Shen J, Melcher K, Chen H, Jiang Y, Cheng X, Wang MW, Xie X, Xu HE | 10.1016/J.CELL.2022.09.041 | 2022-11-09 | Yes | |
OPRK | κ | Opioid | A | Human | Cryo-EM | 8F7W | 8F7W_refined | 3.2 | R | Active | 100 | 75 | Gi/o | αi1 | - | 64 | - | scFv16 |
dynorphin A-(1-8)
|
peptide | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, big dynorphin, β-neoendorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, [Met]enkephalin, [Leu]enkephalin | peptide | Yes | No | Wang Y, Zhuang Y, DiBerto JF, Zhou XE, Schmitz GP, Yuan Q, Jain MK, Liu W, Melcher K, Jiang Y, Roth BL, Xu HE | 10.1016/J.CELL.2022.12.026 | 2022-12-14 | Yes | |
OPRM | μ | Opioid | A | Human | Cryo-EM | 8EFO | 8EFO_refined | 2.8 | R | Active | 100 | 72 | Gi/o | αi1 | - | 64 | - | scFv16 |
PZM21
|
small-molecule | Agonist | dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin, endomorphin-2 | peptide | Yes | No | Zhuang Y, Wang Y, He B, He X, Zhou XE, Guo S, Rao Q, Yang J, Liu J, Zhou Q, Wang X, Liu M, Liu W, Jiang X, Yang D, Jiang H, Shen J, Melcher K, Chen H, Jiang Y, Cheng X, Wang MW, Xie X, Xu HE | 10.1016/J.CELL.2022.09.041 | 2022-11-09 | Yes | |
OPRM | μ | Opioid | A | Human | Cryo-EM | 8EFQ | - | 3.3 | R | Active | 100 | 71 | Gi/o | αi1 | - | 61 | - | - |
DAMGO
|
peptide | Agonist | dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin, endomorphin-2 | peptide | Yes | No | Zhuang Y, Wang Y, He B, He X, Zhou XE, Guo S, Rao Q, Yang J, Liu J, Zhou Q, Wang X, Liu M, Liu W, Jiang X, Yang D, Jiang H, Shen J, Melcher K, Chen H, Jiang Y, Cheng X, Wang MW, Xie X, Xu HE | 10.1016/J.CELL.2022.09.041 | 2022-11-09 | Yes | |
OPRM | μ | Opioid | A | Human | Cryo-EM | 8F7Q | - | 3.2 | R | Active | 100 | 72 | Gi/o | αi1 | - | 64 | - | scFv16 |
β-endorphin
|
peptide | Agonist | dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin, endomorphin-2 | peptide | Yes | No | Wang Y, Zhuang Y, DiBerto JF, Zhou XE, Schmitz GP, Yuan Q, Jain MK, Liu W, Melcher K, Jiang Y, Roth BL, Xu HE | 10.1016/J.CELL.2022.12.026 | 2022-12-14 | Yes | |
OPRM | μ | Opioid | A | Human | Cryo-EM | 8F7R | 8F7R_refined | 3.3 | R | Active | 100 | 72 | Gi/o | αi1 | - | 63 | - | scFv16 |
endomorphin-1
|
peptide | Agonist | dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin, endomorphin-2 | peptide | Yes | No | Wang Y, Zhuang Y, DiBerto JF, Zhou XE, Schmitz GP, Yuan Q, Jain MK, Liu W, Melcher K, Jiang Y, Roth BL, Xu HE | 10.1016/J.CELL.2022.12.026 | 2022-12-14 | Yes | |
OPRD | δ | Opioid | A | Human | Cryo-EM | 8F7S | 8F7S_refined | 3.0 | R | Active | 100 | 78 | Gi/o | αi1 | - | 62 | - | - |
DELTORPHIN II
|
protein | Agonist | α-neoendorphin, dynorphin A-(1-13), β-endorphin, dynorphin A-(1-8), dynorphin A, dynorphin B, endomorphin-1, [Met]enkephalin, [Leu]enkephalin | peptide | No | No | Wang Y, Zhuang Y, DiBerto JF, Zhou XE, Schmitz GP, Yuan Q, Jain MK, Liu W, Melcher K, Jiang Y, Roth BL, Xu HE | 10.1016/J.CELL.2022.12.026 | 2022-12-14 | Yes |
Pick reference from selection
Superpositions structures selected in the browser to the reference checked in this table
PDB | UniProt | IUPHAR | Rec. family | Class | Species | State | PDB Date |
---|